ࡱ>  km`abcdefghijc %fjbjb&&  DD `lllllll88l"!!!^``````,RZl!^!!!ll! ll^d4llll!^:,llJ htXx J0RKKJls{o{ Nutrition Implications of Pancreatic Cancer  Sodexo Dietetic Internship Andrea Young Abstract Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. The detection of pancreatic cancer typically occurs during advanced stages, causing the prognosis to be poor. Cancer and cancer treatments have many nutritional implications; with the advice of a Registered Dietitian nutritional complications can be minimized and help improve a patients quality of life. Upon meeting several patients with pancreatic cancer and knowing little about the condition, I decided to research the topic and find what a Registered Dietitian can do to help these individuals. Patient centered care with goals and advice that are realistic and achievable can help a patient improve their nutrition status and possibly minimize adverse effective from cancer and cancer treatments. Introduction After meeting patients in the acute care setting at St. Marys Medical Center with pancreatic cancer I became interested in the disease and the complications that may arise from the cancer and the treatments. Having not previously known about pancreatic cancer and its poor prognosis gave me further interest in researching the topic in detail. Being up to date on different treatment options available can help guide the Registered Dietitian to different nutrition implications that can occur. By taking a more detailed look into pancreatic cancer I hoped to learn about current treatments and nutritional advice that can be provided to patients. Normal Anatomy and Physiology of the Pancreas The pancreas is a slender complex organ ranging in length from six to nine inches. Located below the liver and posterior of the stomach the pancreas consists of a head, located within the curvature of the duodenum, a body, and a tail, which extends to the spleen. There are two types of active cells within the pancreas consisting of endocrine and exocrine tissues. (1, 2) Refer to figure 1 in the appendix. The endocrine portion of the pancreas consists of the islets of Langerhan, which primarily secretes the hormones insulin and glucagon into the blood. Alpha cells of the pancreatic islet secrete glucagon and the beta cells secrete insulin. (1) Endocrine glands do not have ducts but rather have extensive blood vessels in the connective tissue of the glands; the hormones secreted by endocrine glands are secreted into the bloodstream. Acinar glands compose the exocrine portion of the pancreas and produces digestive enzymes, which are packaged into granules and released into the pancreatic juice. Clusters of acini cells form lobules, which secrete digestive enzymes into a network of ducts, these ducts join the main pancreatic duct known as the Wirsung Duct, which runs the length of the pancreas. (2) Ducts are structures that carry fluids within the body and resemble tubes. The pancreas and gallbladder share a duct for entry into the duodenum. Bile ducts carry bile, made in the liver, to the gallbladder. When a food is consumed the gallbladder releases bile into a common bile duct. The pancreatic duct joins the common bile duct at the hepatopancreatic ampulla, which empties into the duodenum at the major duodenal papilla. The hepatopancreatic ampullar sphincter also known as the sphincter of Oddi regulates the opening of the ampulla into the duodenum. (1, 3) The parasympathetic nervous system and hormones stimulate the pancreas to release pancreatic juice. The hormone secretin is secreted by the proximal small intestine in response to the release of acidic chyme into the duodenum. The pancreas is stimulated by the secretin to secrete water, bicarbonate, and pancreatic enzymes into the duodenum. Cholecystokinin stimulates the release of bile from the gallbladder and stimulates the pancreas to secrete pancreatic juice and enzymes into the duodenum. (2) The presence of fatty acids and other lipids in the duodenum is the major stimulus for the release of cholecystokinin.(1) Vasoactive intestinal polypeptide is located within the neurons of the small intestine and stimulates the pancreas to release bicarbonate into the small intestine. Somatostatin is a hormone that inhibits pancreatic exocrine secretions. Insulin release is inhibited by Amylin, galanin, as well as somatostatin, where as glucose-dependent insulinotropic polypeptide and glucagon-like peptide stimulate insulin secretions. (2) Functions of the Pancreas Endocrine and exocrine cells are the main component of the pancreas giving the pancreas hormonal and digestive functions. Insulin, amylin, glucagon, pancreatic polypeptide and somatostatin are the hormones secreted by the pancreas. (1) The role of insulin and glucagon will be reviewed in this section. The pancreas secretes insulin when increased levels of glucose are within the blood; insulin is an anabolic hormone involved in glucose, lipid, and amino acid synthesis and storage. Insulin inhibits the expression of catabolic hormones, which would catabolize glucose, lipids, and proteins. When serum glucose levels drop the pancreas releases glucagon into the blood. Glucagon stimulates the catabolism of stored glucose, lipids, and proteins within the body for energy. (2, 3) Pancreatic juice, which is the exocrine secretion of the pancreas, has two major components, an aqueous component and an enzymatic component. Pancreatic juice is delivered to the small intestine where its function is digestion. The aqueous component of pancreatic juice contains sodium and potassium as well as bicarbonate. The bicarbonate ions are a major part of the aqueous component and neutralize the acidic chyme coming from the stomach. Pancreatic secretions increase the pH of the duodenum providing the proper environment for the function of pancreatic enzymes. (1, 2) Acinar cells of the pancreas produce the enzymes of the pancreatic juice. (1) The enzymes produced allow for adequate digestion of protein, carbohydrates, and lipids; these enzymes released by the pancreas digest about 50% of ingested protein, 50% of indigested carbohydrates, and 80-90% of ingested fats. (2) Proteolytic enzymes include trypsin, chymotrypsin, and carboxypeptidase; these enzymes are secreted in their inactive form to prevent digestion of the tissues, which produce them. Pancreatic amylase digests polysaccharides and lastly pancreatic lipases break down lipids into monoglycerides, free fatty acids, and cholesterol. (1) Process of Cancer Cancer begins with cell growth that is abnormal and out of control. Cells are what build tissues and tissues form organs. When cells become cancerous they can affect the tissues that them make up. Normal cells grow, divide, and die. DNA is in every cell and is what directs the cells actions. When normal cells have damaged DNA the cell repairs the damage or the cell dies. Cancer cells have damaged DNA, these cells are not repaired and do not die but rather multiply with the same damaged DNA. (3) Refer to figure 2 in the appendix. (4) Cancer is able to invade other tissues, shed cancer cells, or spread to other organs. Invasion occurs when a malignant tumor grows and invades near by organs. When cancer cells break off from the main tumor the cancer cells are shedding, this may lead to new tumor formation on the surface of nearby organs and tissues. Cancer is considered to have spread when cancer cells break off from the original tumor and spread through the circulatory or lymphatic system, once the cancer has spread the cancer cells can attached to and grow on different tissues. When cancer has invaded, shed, or spread to other tissues it is considered to have metastasized.(4) Cancer Staging Staging of cancer is done to determine the severity of an individuals cancer and generally covers the extent of the tumor, whether the tumor has spread to the lymph nodes, and whether metastasis has occurred. This method of staging is used by the National Cancer Institute and is termed the TNM system, the letters representing tumor, lymph nodes, and metastasis. Using the TNM system a number is added to each letter indicating size or extent of the primary tumor and the extent of the cancer spread. For TNM staging see table 1 in the appendix. (4) TNM staging combinations correspond to one of five stages for many caners. In general Stage 0 indicates carcinoma in situ; Stage I, Stage II, and Stage III indicate more extensive cancer including a larger tumor size and possible spreading of the cancer, beyond the organ in which it first developed, to nearby lymph nodes or organs adjacent to the location of the primary tumor. Stage IV cancer typically has spread to another organ. (4) Pancreatic Cancer About 60% of pancreatic tumors originate in the head of the pancreas, 15% in the body, and 5% in the tail, 20% are diffuse within the pancreas. There are two main types of pancreatic cancer; the most common type is exocrine pancreatic cancer, which starts in the ducts that carry pancreatic juices. Endocrine pancreatic cancer, also known as islet cell cancer, is less common and begins within the cells that make hormones. Cancer of the pancreas is a broad definition because as many as twenty different types of tumors are categorized under the term pancreatic cancer. Different tumors of the pancreas have different treatments because of each tumors unique prognosis. See table 2 in the appendix for types of pancreatic tumors. Primary and metastatic are two broad ways to classify pancreatic caner. Primary pancreatic cancer refers to cancer arising from the pancreas where as metastatic pancreatic cancer refers to cancer originating in other organs and later spreading to the pancreas. Primary pancreatic cancer is typical in the majority of cases and can be sub-grouped into cancers showing endocrine differentiation and those that do not. (4, 5, 6) Epidemiology of Pancreatic Cancer Pancreatic cancer is the fourth leading cause of cancer related deaths within the United States. Incidence rates seem to be increasing due to pancreatic cancer becoming more common as well as the difficulty in diagnosing until in advanced stages. It was estimated that within the year 2012 43,920 individuals would be diagnosed with pancreatic cancer, and 37,390 deaths would occur due to pancreatic cancer. Survival from pancreatic cancer is poor compared to other cancers; only 6% of pancreatic cancer patients live more than 5 years after diagnosis. Survival rates are generally low with pancreatic cancer due to delayed diagnosis and metastasis of cancer.(7) The cause of pancreatic cancer is unknown, however it is believed genetics plays a major role. Lifestyle factors may also play a major role in the development of pancreatic cancer; some of these factors include, smoking, exposure to chemicals such as gasoline and fuel oils, as well as being obese and consuming a diet high in red meat or low in fruits and vegetables; doses of alcohol greater than 30 grams per day contributes to only a modest increase. Other risk factors for pancreatic cancer include older age, males, African American, family history, cirrhosis, and chronic pancreatitis. Type II diabetes is not a true risk factor. Although risk factors can increase an individuals risk of developing cancer, risk factors do not cause the disease. People with none of these risk factors could still develop pancreatic cancer. (8, 9) Signs and Symptoms Symptoms of pancreatic cancer typically occur once the cancer has progressed to advanced stages. Each individual can experience the common symptoms that occur differently. Severe abdominal pain, which radiates into the back, is a common symptom of most patients. Weight loss due to malignant cancer cells depriving healthy cells of nutrients, as well as digestive problems, which may occur due to the pancreas integral part of digestion are common in pancreatic cancer patients. (9, 10) Nausea and vomiting can occur during advanced stages of pancreatic caner, this can occur when the tumor grows large enough to block part of the digestive tract, typically the duodenum. (7) Diabetes occurs in 25-50% of patients and may lead to symptoms of glucose intolerance such as polyuria and polydipsia. Jaundice, a yellowing of the skin and whites of the eyes, occurs in about 80-90% of patients with adenocarcinomas of the head of the pancreas. Jaundice occurs when a tumor blocks the flow of bile, when blood cells break down into bilirubin once worn out, bilirubin is eliminated into the bile, if the flow of bile is obstructed jaundice occurs. Severe itching may also occur due to the build up of bile acids. When cancer is in the body and tail of the pancreas splenic vein obstruction can occur leading to splenomegaly, gastric and esophageal varices, and GI hemorrhage. Because many of these symptoms occur late in diagnosis 90% of patients have locally advanced tumors, cancer has spread to regional lymph nodes or metastasized to the liver or lungs. (10) Diagnosis of Pancreatic Cancer Pancreatic cancer can be difficult to diagnose. As stated before symptoms do not typically arise until advanced stages and many symptoms may be mistaken as signs of other conditions. The pancreas is also located deep behind other organs and can be difficult to see and assess without proper equipment. The first step of diagnosing is to determine the size and extent of the pancreatic tumor; this will ensure the most appropriate and effective treatment. There are many ways to diagnose a patient with pancreatic cancer including physical exam, imaging, blood test, biopsy, as well as several other methods. The doctor may first start with a physical exam of the patient, feeling the abdomen for abnormal changes around the pancreas, liver, gallbladder, and spleen; checking for abdominal fluid buildup is also common as well as checking the skin and eyes for signs of jaundice. Although a physical exam will not confirm diagnosis of pancreatic cancer it can be a starting point to initiate further testing to be completed. (4, 11, 12, 13) Blood tests can be completed to help support a diagnosis of pancreatic caner as well as monitor the progression of the disease and the effects of treatment. Hepatic function tests can be completed to assess levels of bilirubin and liver enzymes. Higher bilirubin levels can indicate a blockage of the bile duct, however pancreatic cancer is not the only cause of increased bilirubin levels. Another blood test is the CA 19-9, which is a tumor marker. CA 19-9 is an antigen existing on the surface of cancer cells. Elevated levels of CA 19-9 can indicate a presence of a pancreatic mass or biliary obstruction, and may support pancreatic cancer as a diagnosis. However CA-19-9 can be elevated for multiple reasons and cannot be used alone to make a diagnosis. (12, 14) Diagnostic imaging is important and needed to determine the extent of the tumor and whether cancer cells have spread to other tissues. Several imaging tests can be done including the CT scan, MRI, MRCP, EUS, and ERCP. Computer tomography scan, which is abbreviated CT scan, is done to identify the location of a tumor and the extent of the pancreatic tumor. The scan allows for a detailed picture of the pancreas and nearby organs, and blood vessels. (4, 12) Magnetic resonance imaging, or MRI, is another type of imaging used; this procedure uses large magnetic radiofrequency to create a detailed image of the pancreas. Magnetic resonance cholangiopancreatography, abbreviated MRCP, is a type of MRI, this is used to create an image of the pancreatic ducts and channels in the pancreas. An endoscopic ultrasound, also known as EUS, can be done to provide a detailed picture of the pancreas and remove pancreatic cells and fluid for a biopsy. The EUS procedure is completed by inserting an endoscope through the mouth down to the stomach, at the end of the endoscope is an ultrasound probe. The endoscopic retrograde cholangiopancreatography, also known as ERCP, is another type of imaging that can be done. This procedure allows for images of the pancreatic duct, which allow the physician to determine if the ducts have narrowed or have become blocked. The ERCP also allows for removal of pancreatic cells for biopsy and to guide for placement of a bile duct stent to relieve jaundice. (4, 6, 11, 12) The findings of the imaging techniques can determine the diagnostic technique to be used next. Percutaneous needle aspiration of an accessible lesion may be considered for tissue diagnosis if the CT or MRCP shows unresectable or metastatic disease. MRCP or endoscopic ultrasound may be used to stage pancreatic cancer or detect small tumors unseen by a CT scan; this is done when the CT scan shows a possible resectable tumor or no tumor. ERCP may be used as a first diagnostic procedure if a patient has obstructive jaundice. (10, 11) After having a physical examination, laboratory work, and imaging test, a biopsy is the next tool needed. Biopsy remains the gold standard for diagnosing pancreatic cancer. The biopsy is important to determine the type of tumor that is present, there are about 20 different types of tumors and each responds differently to different types of treatment. The endoscopic ultrasound and the endoscopic retrograde cholangiopancreatography are the most common techniques for biopsy. A laparoscopic procedure can also be performed to obtain a biopsy; this procedure is completed by inserting a laparoscope through the abdomen, allowing for a visual of the pancreas as well as the ability to remove a small amount of tissue and fluid. (11, 12) The best treatment option is chosen after learning the extent or stage of the cancer. Often times a laparotomy is performed to view the extent of the pancreatic tumor and determine whether successful removal of the tumor would be possible without causing undue harm to the patient. Once all the procedures have been completed the stage is typically able to be determined. When staging cancer tumor size, whether the tumor has invaded nearby tissue, and whether the cancer has spread are considered. (4, 12) Pancreatic Cancer Staging Stage 0 is pancreatic carcinoma in situ. The tumor at this stage remains of the surface of the pancreatic duct cells; the cancer has not invaded deeper tissue or spread outside of the pancreas. Stage IA pancreatic cancer indicates the tumor is less than 2cm and is contained within the pancreas. Stage IB indicates the tumor is greater than 2cm and is contained within the pancreas. Stage IIA pancreatic cancer indicates the tumor has begun to grow outside the pancreas. At this stage the cancer has not spread to lymph nodes, major blood vessels, or distant sites. Stage IIB indicates the tumor is confined to the pancreas or growing outside the pancreas. At this stage the cancer has not spread into nearby large blood vessels, major nerves, or distant sites but has spread to nearby lymph nodes. Stage III pancreatic cancer indicates the tumor is growing outside of the pancreas and within nearby large blood vessels or major nerves, it may or may not have spread to nearby lymph nodes but has not spread to distant sites. Stage IV pancreatic cancer indicates the cancer has spread to near by organs such as the liver, lungs or peritoneum. (3, 6, 12) Treatment options for pancreatic cancer depend on the stage of the cancer. Stages IA and IB are local and resectable, meaning because the cancer is only in the pancreas or has spread just beyond the pancreas a surgeon can remove the entire tumor. Stages IIA and IIB are locally advanced and potentially resectable. Stage III is locally advanced and unresectable. When using the term locally advanced it indicates the cancer has not yet spread to distant organs but still cannot be completely removed, many times the cancer cannot be removed due to the cancer being present in nearby blood vessels. If surgery is done it is typically to relieve symptoms or problems such as blocked bile ducts. Lastly Stage IV is metastatic and unresectable. When the cancer is metastatic, surgery is typically done to relieve symptoms and not for a cure. (3,15) Treatment Treatment options for pancreatic cancer include surgery, chemotherapy, targeted therapy, radiation therapy and symptomatic therapies. As stated previously, pancreatic cancer diagnosis tends to occur in advanced stages and treatment strategies tend to exclude surgery. Only a small percentage of pancreatic cancer patients have surgery. The surgeries that are available include the Whipple procedure, distal pancreatectomy, and total pancreatectomy. Although treatments are available, the prognosis of pancreatic cancer remains poor. (9) Surgery The Whipple procedure, also called a pancreaticoduodenectomy, is the most common surgery for pancreatic cancer. This procedure is done to remove cancer that is in the head of the pancreas; the surgery also removes part of the small intestine, the lower half of the bile duct, the surrounding lymph nodes, the gallbladder, and the pylorus. Part of the portal vein may also be removed if it has been invaded by the pancreatic tumor. The surgeon then reconnects the remaining pancreas, stomach, and bile duct to the small intestine allowing for the pancreatic digestive enzymes, bile, and stomach contents to flow into the small intestine during digestion. If the pylorus is preserved and not removed the surgery is called a pylorus preserving Whipple. The most common complication following the Whipple procedure is gastroparesis, which occurs on average for 7-10 days but can occur up to a few weeks following the procedure. In 10% of patients serious abdominal infection occurs due to a fistula, which causes leakage, where the pancreas has been connected to the intestine, this typically requires draining tubes, antibiotics, and supplemental feedings. Long-term effects including digestive difficulties may occur following the Whipple procedure. (12, 15) The distal pancreatectomy is performed in patients with exocrine tumors located in the tail of the pancreas. In this procedure the tail of the pancreas is removed, sometimes part of the body of the pancreas is also removed as well as the spleen. Pancreatic juice leaking is the most common complication of this surgery. Serious complications include leakage and infection. (12,15) Total pancreatectomy is rarely performed but is done when the entire pancreas, head, body, and tail have been invaded by the tumor. In addition to the entire pancreas being removed the gallbladder, pylorus, duodenum, lower half of the bile duct, nearby lymph nodes, and occasionally the spleen are removed. Due to the removal of the entire pancreas the patient will be diabetic following the procedure and must use insulin to control blood glucose. The patient will also require pancreatic enzymes to be taken with food for appropriate digestion. (12,15) Chemotherapy Surgery as previously states is not for all patients, however many times chemotherapy is used in conjunction with radiation and surgery to provide the most optimal outcomes. Chemotherapy can be used alone but often is used in conjunction with other treatments such as radiation therapy. Chemotherapy is a systemic treatment attacking all rapidly dividing cells in the body by preventing them from growing and dividing, including cancer cells and healthy cells. Chemotherapy can prevent pancreatic tumors from growing and sometimes shrinks them. Extended survival with the use chemotherapy has been shown in many pancreatic cancer patients including patients who have chemotherapy in addition to surgery or radiation for tumors confined to the pancreas, patients using chemotherapy for primary treatment of inoperable tumors which are confined to the pancreas, and for patients using chemotherapy for treatment of metastatic pancreatic tumors. The most common type of chemotherapy to be used for pancreatic cancer is Gemzar; the generic name is gemcitabine, this drug was approved to be the standard of care for pancreatic caner in 1996. Fluorouracil was the standard chemotherapy used prior to gemcitabine. Gemzar is typically used after a patient has had surgery for tumors, which were confined to the pancreas. Used in combination with other chemotherapy drugs Gemzar can be used to control the metastasis of cancerous cells and improve survival. (12, 15) Although chemotherapy has many positive effects on treating cancer it also has many adverse effects due to the attack of rapidly dividing cells, including healthy cells. Healthy rapidly dividing cells within the body include bone marrow, bloods cells, cells of hair follicles, and cells of the reproductive and digestive tract. Side effects generally depend on the type of chemotherapy, the dose, and length of treatment. Common side effects include fatigue, hair loss, low blood cell count, gastrointestinal discomfort, diarrhea, abdominal cramping, nausea, vomiting, neuropathy, as well as loss of appetite and change of taste. (12, 15) Targeted Therapy In addition to surgery and chemotherapy, targeted therapy is an additional option. Tarceva, generic name erlotinib, was FDA approved in 2005. Tarceva used in combination with chemotherapy drug Gemzar is used in locally advanced and metastatic pancreatic cancer, which cannot be removed surgically. Targeted therapy works in two ways, both of which cause little to no harm to healthy cells. The first way targeted therapy works is by stopping abnormal growth behavior of a tumor by blocking the process that changes normal cells into cancer. The second way targeted therapy works is by preventing the formation of blood vessels that bring nutrients to the tumor. Specifically Tarceva targets Human Epidermal Growth Factor Receptor 1, which is found in abnormally high levels on the surface of some pancreatic cancer cells. By targeting this growth factor, Tarceva blocks the growth of the cancerous cells. The side effects of this target therapy include fatigue, rash, nausea, loss of appetitive, and diarrhea. (15) Radiation Radiation treatment is the last treatment option for pancreatic cancer aside from symptomatic treatment. Radiation can be used in combination with surgery and chemotherapy, however when radiation is given along with chemotherapy the chemotherapy is at a lower dose than when it is administered alone. Chemotherapy acts as a radiosensitizer, which enhances the effects of the radiation on the tumor. Unlike chemotherapy radiation cannot kill cancer cells, which have spread, radiation is considered a local treatment. Radiation therapy uses high-energy waves to kill cancer cells or prevent them from dividing, prevent tumors from growing, and sometimes shrinks the tumor. There are two main types of radiation therapy including external beam radiation and internal radiation also known as brachytherapy. External beam radiation, as its name indicates, is delivered by a linear accelerator located outside of the body, which focuses x-rays directly on the tumor. Internal radiation, rarely used in pancreatic caner, involves the implantation of small amounts of radioactive materials in or near the caner. Radiation does have some adverse side effects associated with it. Patients may experience some abdominal discomfort towards the end of treatments, however the treatments are not painful. Overtime however, the effects of radiation can build up. Common side effects include loss of appetite, nausea, diarrhea, and fatigue. Side effects typically peak from four to five weeks after the first radiation treatment and resolve one to two weeks after completed treatment. (4, 12, 15) Symptomatic Treatment Surgery, chemotherapy, targeted therapy, and radiation therapy all can help by varying degrees the treatment of pancreatic cancer. However, as pancreatic cancer does progress it can affect multiple organs causing multiple side effects such as pain, nausea, and jaundice. Side effects from surgery, chemotherapy, targeted therapy and radiation can cause decreased ability of digestion, nausea, vomiting, and fatigue. Pain management is important throughout the process of treating pancreatic cancer. Pain, which radiates from the abdomen to the back, occurs when the pancreatic cancer cells invade the celiac plexus, a cluster of nerves in the lower abdomen from which sensory nerves in the pancreas, gallbladder, biliary tract, and other nearby organs grow. Pain management using opioid analgesics, such as morphine can effectively relieve pain in most patients. (12) As mentioned previously pancreatic tumors can block the bile duct causing a buildup of bilirubin in the liver leading to jaundice and itching. For relief from jaundice a stent can be placed into the bile duct relieving the blockage. This treatment can relieve the patient from discomfort and improve the patients quality of life. (12) Rehabilitation services may be necessary for patients following treatments and surgery in order to help build strength, flexibility, balance, and endurance. Treatments for depression may also be necessary as well as supportive measures throughout the treatment. (12) Treatments that help decrease the progression or eliminate pancreatic cancer can interfere with the production of digestive enzymes and insulin. Patients typically require medications and enzymes to aid in digestion and maintain blood sugar levels. Nutrition is essential in these patients. (10, 12) Many of the medications patients take are for the nutrition implications that occur. Pancreatic enzymes including pancrelipase and pancreatin are commonly taken. Enteric coating of the enzyme aids in maintaining the integrity of the enzyme until it reaches the small intestine. As much as 20,000-30,000 units of lipase may be needed per meal and 10,000 units may be needed with snacks. In addition insulin may be needed if the patient is hyperglycemic, however with islet cell tumors hypoglycemia may occur, it is important to monitor glucose at meals. Acid reducing medications such as proton pump inhibitors or H2 blockers are typically needed. Water-miscible fat-soluble vitamins A, D, E, and K, such as Vitamax, Source CF, and ADEKs, will be needed until intake of pancreatic enzymes is sufficient. Appetite stimulants such as Megace may be appropriate if the patients intake is declining. Antiemetics and diuretics may be needed. If the patient has loose stool Calcium Carbonate twice daily may be useful. Imodium and Lomotil are antidiarrheal medications, which may be useful if loose stools are persistent. Pain medications are often needed to treat pain associated with pancreatic cancer. Often opioids such as codeine, hydrocodone, hydromorphone, oxycodone, and morphine are needed for the treatment of pain, however acetaminophen and NSAIDs, such as aspirin and ibuprofen are also commonly used as well. (9) For nutrition implications of these medications refer to the Medication Bibliography on page 42. Labs to Review for Pancreatic Cancer It is necessary to monitor lab values especially glucose, amylase, lipase, bilirubin, aspartate aminotransferase and alanine aminotransferase, prealbumin, C-reactive protein, fat soluble vitamins, as well as sodium, potassium, chloride, phosphorus, magnesium, and calcium. If a patient is receiving chemotherapy monitoring WBC and platelet count is also important. (9, 14) Monitoring blood glucose levels is necessary to determine if the patient is having problems producing insulin or glucagon causing either hyper or hypoglycemia. In these cases a patient may require insulin or Diazoxide, a drug which blocks insulin release from the pancreas to prevent hypoglycemia. (9, 14) Amylase and lipase levels may increase if there is an obstruction of the pancreatic duct causing an outpouring of amylase into the intrapancreatic lymph system and free peritoneum. Blood vessels drain the free peritoneum and absorb the lymph picking up excess amylase. Lipase levels are less useful in chronic pancreatic diseases such as pancreatic carcinoma. (9,14) Bilirubin is another lab value that is important to monitor. Bilirubin metabolism begins with the breakdown of red blood cells; hemoglobin is released from red blood cells and broken down to heme and globin molecules. Heme is then catabolized to form biliverdin, which is transformed into bilirubin, also known as indirect bilirubin. In the liver, indirect bilirubin is conjugated forming conjugated or direct bilirubin. The conjugated bilirubin is then excreted from the liver and eventually into the common bile duct. High levels of conjugated bilirubin may indicate extrahepatic duct obstruction or among other possibilities extensive liver metastasis. (9,14) An increase in alanine aminotransferase, also known as ALT, levels may indicate injury or disease affecting the liver parenchyma causing a release of this hepatocellular enzyme into the blood stream. In general most ALT elevations are caused by liver disease. When disease or injury affects the cells of the liver tissue, the cells lyse. The aspartate aminotransferase, also known as AST, is released and picked up by the blood causing the serum levels to rise. The amount of AST elevation is directly related to the number of cells affected by the disease or injury. Increased levels may indicate hepatic metastasis. (9,14) Prealbumin is one of the major plasma proteins and can be used to determine protein status, however prealbumin is significantly reduced in hepatobiliary disease because of impaired synthesis. Serum levels of prealbumin can decrease with inflammation, infection, malignancy, malnutrition, and with zinc deficiency. To help determine the degree of inflammation occurring in the body C-reactive protein, CRP, is a nonspecific, acute-phase reactant used to diagnosis infectious disease, and inflammatory disorders. The liver primarily produces CRP during an acute inflammatory process and other diseases. (9, 14) Monitoring fat-soluble vitamins is necessary to indicate if the patient is able to absorb fats. Lastly monitoring electrolytes, such as sodium, potassium, chloride, phosphorus, magnesium, and calcium is also important for monitoring hydration status and acid base balance. (9,14) When a patient is undergoing chemotherapy the patients white blood cell count can become very low due to the failure of the bone marrow to produce more cells. During times that white blood cells are low the patient is considered to be under neutropenic precautions meaning the patient is very vulnerable to infection and cannot effectively fight infections. The platelet count may also be low during this time. Platelets are essential for blood clotting; platelet count can be used to monitor the course of a disease such as thrombocytopenia or bone marrow failure. (9, 14) Palliative Care and Hospice When the patient is looking for symptomatic relief rather than a cure palliative care is an option. The focus of palliative care is to prevent, treat, reduce, or remove discomfort. Length of life and quality of life are equally important when talking about palliative care. Palliative care respects the cycle of life and recognizes death as a natural end of life cycle. Hospice is appropriate for patients wanting high quality end of life during the last months, day, and hours of life. Life expectancy for these patients is generally no longer than six months. Hospice focuses on relieving symptoms and increasing comfort. (15) Medical Nutrition Therapy An interdisciplinary approach to the treatment of pancreatic cancer is necessary for optimal outcomes; once pancreatic cancer is diagnosed there are many nutritional implications that can compromise the patients outcome. The advice of a registered dietitian can help prevent nutritional deficiencies, preserve lean body mass, reduce and control nausea and vomiting, control side effects of therapies, manage pancreatic cancer related diabetes, manage nutrition support and weaning of nutrition support, and maximize the patients quality of life. (9) When pancreatic cancer is present, many conditions that affect nutritional status occur including malabsorption, anorexia, early satiety, abdominal pain, and constipation from medications, and pancreatic fistula, to name a few. Physical observations of a patient may reveal the presence of dehydration and cachexia, which typically occurs with advanced stages. All of the factors previously mentioned are necessary to consider when assessing the patient and choosing the most appropriate nutrition. (9, 15, 16) Nutrition Implications of Cancer Cancer is a catabolic disease and process. Cancer cachexia is very common among cancer patients; this wasting syndrome is characterized by weight loss, anorexia, early satiety, progressive debilitation, and malnutrition. Tumor factors such as proteolysis-inducing factor, tumor necrosis factor, and lipid mobilizing factor all promote catabolism. High protein turnover and loss of nitrogen, significant loss of muscle mass, and impaired physical capacity are common in malnourished cancer patients. A loss of lean body mass due to mobilization of protein stores is common, as well as altered nutrient utilization causing glucose intolerance, insulin resistance, increased glucose turnover, lipolysis, hyperlipidemia, and increased protein turnover. Cachexia is typically characterized by a disproportionate loss of muscle mass, involuntary weight loss greater than 5% within 6 months, typically low serum albumin, and increase serum C-reactive protein. (9) Nutrition status of patients with cancer can vary. When beginning cancer therapy patients with anorexia, weight loss, and other symptoms of nutritional problems may complicate the treatments and expected recovery. In addition some patients may have preexisting comorbid diseases that may further complicate treatment. Cancer patients that best tolerate treatments and have better recovery are those who typically have had early interventions to side effects, maintained their weight, and maintained nutritional stores. (4) Many cancer patients experience a decrease in food and beverage intake, which many times are due to a decrease in appetite, change in small and taste, nausea, vomiting, diarrhea, and lethargy. It is important for cancer patients to maintain a well balanced diet, providing them with adequate calories, proteins, fluids, vitamins and minerals. (4, 9) Nutrition Assessment The nutrition assessment of a patient includes an evaluation of calorie, protein, and fluid needs, as well as an evaluation for the need of pancreatic enzymes, acknowledging anorexia, and among other nutritional assessments evaluating for malnutrition. When calculating patients nutritional needs it is important to consider an individuals diagnosis, comorbidities, anticancer therapies, and the presence of fever, infection. Nutrition requirements for cancer patients are determined based on the individual patient as well as cancer-specific requirements. Many patients have typical needs of 25-30kcal/kg to maintain their body weight. However, some patients have an increase resting energy expenditure, which increases their nutritional needs. Energy needs can typically be calculated at 30kcal/kg of body weight for maintaining weight or at 35-45kcal/kg of body weight if a patient has lost weight, is febrile, septic, or very active. Other equations are available to calculate energy needs; using indirect calorimetry is ideal to determine energy needs. (3, 9) Protein needs may be higher for cancer patients, to maintain body weight 1.0 1.5gm/kg is needed where as for repletion of lean body mass 1.5 2.0gm/kg would be appropriate to protect against muscle wasting, malnutrition, cachexia, and losses from treatments. When assessing protein needs it is important to take into consideration if the patients body is under stress, experiencing malnutrition, and the extent of the cancer. Protein needs are generally increased when the body is under stress due to its many important functions, including maintaining a healthy immune system and repairing tissues. (3, 9) Appropriate fluid intake to avoid dehydration is also important; consuming 1ml/kcal is typically appropriate. When calculating fluid requirements, it is important to ensure the patient is maintaining hydration and electrolyte balance. It is also necessary to take into consideration fever, ascites, edema, vomiting, diarrhea, IV fluids, impaired renal function, and medications when determining fluid needs. (6, 9) It is important to monitor for weight loss; weight loss can contribute to fatigue, delay in the length of recovery, and adversely affect quality of life. Reevaluation of patients nutritional needs is necessary to ensure the appropriate amounts of calories, proteins, and fluids are being provided. (6, 9) Pancreatic insufficiency is common when diagnosed with pancreatic cancer, when this occurs the pancreas is unable to secrete enzymes needed for digestion. Typically the Whipple procedure, total pancreatectomy, blockage or narrowing of the pancreatic or biliary duct, or pancreatic or duodenal tumors can specifically cause the need for pancreatic enzymes. Patients should consider initiation of pancreatic enzymes when they have feelings of indigestion, cramping after meals, large amounts of gas, foul smelling gas or stools, floating or fatty stools, frequent stools, loose stools, and weight loss. In addition to taking the pancreatic enzymes for pancreatic insufficiency medium chain triglycerides, fat-soluble vitamins, and essential fatty acids should also be included to prevent deficiencies due to possible malabsorption of fats. According to the Academy of Nutrition and Dietetics supplementation of Omega-3 fatty acids has not been shown to have anticachetic effects leading to changes in body composition and is not recommended for patients with pancreatic caner. Eicosapentaenoic acid also was not associated with an increase in lean body mass. In addition the use of eicosapentaenoic acid after 12 weeks of supplementation did not show a decrease in C-reactive protein. (9, 15, 16, 17) Malnutrition and Cancer Anorexia can become a serious problem and progress to cause malnutrition for patients with pancreatic cancer. Although a lack of appetite can be increased through medications it may first be appropriate to try adding nutritional supplements in between meals, increase the calorie contents of foods, and eat small frequent meals throughout the day. The etiology of the anorexia is important when providing recommendations. Abdominal and back pains caused by pancreatic cancer may also cause the patient to have anorexia, the use of pain medications in this scenario may help decrease the patients anorexia. In addition to anorexia, delayed gastric emptying may become a concern for the patient, which would cause early satiety. It is important to avoid simple sugars when having delayed gastric emptying and consuming about six to eight small meals per day. (9, 15) Malnutrition is a common problem that may arise for many reasons with pancreatic cancer patients. One indicator for malnutrition is BMI, a BMI of 18.5kg/m2 or less indicates a patient is underweight. However, BMI is not the only indicator for malnutrition and individuals with a healthy BMI or are considered overweight and obese may be malnourished. Many laboratory tests also can help indicate malnutrition, such as low levels of albumin, prealbumin, total protein, C-reactive protein, transferrin saturation, lymphocytes, and electrolytes. In addition the Subjective Global Assessment, SGA, is a tool that is found to be predictive of nutrition associated complications. The SGA identifies malnutrition, distinguishes malnutrition from a disease state, predicts outcomes, and identifies patients in whom nutritional therapy can alter outcomes. Malnutrition may also be identified when a patient is losing weight or has an alteration in gastrointestinal symptoms, such as vomiting and diarrhea. Malnutrition requires an increase in a patients calories and protein needs. (9) Surgery and Nutrition As discussed previously there are several surgical options for pancreatic cancer patients. Including the Whipple procedure, pylorus preserving Whipple procedure, distal pancreatectomy, and a total pancreatectomy. All of these surgeries cause an alteration of the gastrointestinal tract and initially require additional nutrition recommendations. Following surgery, one complication that can occur is the formation of a pancreatic fistula, when this occurs there may be leakage of pancreatic secretions from disrupted pancreatic ducts from the site of the resection. Pancreatic fistulas can lead to morbidity due to malnutrition and infection. The majority of patients with pancreatic fistulas can be managed with either maintenance of an oral diet or parenteral nutrition until closure of the fistula depending on the patients condition. (18,19,20) Following the Whipple procedure the most common complication is delayed gastric emptying, which typically resolves in 7-10days but could last a few weeks. If the patient is not receiving adequate nutrition, enteral nutrition support may be considered. The patient may also experience digestive difficulties, requiring the use of pancreatic enzymes. Initially the patient will only eat small amounts of easily digestible foods. Parenteral nutrition is not necessarily required following this procedure and many patients show better outcomes from standard nutrition. Diarrhea is also a common problem for the fist few months after the procedure. Most patients will experience weight loss, however to avoid malnutrition it may be necessary to consume supplements between meals. Diabetes may also develop depending on how much of the pancreas was removed and how many insulin producing cells were removed. The same complications occur following the pylorus preserving Whipple procedure, however some studies have shown increased delayed gastric empty following the pylorus preserving procedure. (15,18, 21,22) The distal pancreatectomy has minimal nutrition complications compared to the other procedures. However the total pancreatectomy has the most nutritional implication following the procedure. The patient will have diabetes and require insulin injections following the procedure due to the entire pancreas being removed, in addition the patient will lack pancreatic digestive juices and with everything consumed will need to take pancreatic enzymes for proper digestion of food. With total pancreatectomy vitamin B12 supplementation may be required, particularly with steatorrhea. (15) Postoperative feeding can be done through enteral feeds supplemented with fiber and a combination of prebiotics and probiotics administered through a jejunostomy. This may reduce infections and antibiotic use. If enteral nutrition is not possible, parenteral nutrition should be initiated in critically ill patients who are malnourished with a weight loss of more than 10% prior to admission or if the patient is less than 90% of their ideal body weight. If enteral nutrition is not possible, parental nutrition is to be used, the parenteral nutrition should be provided for five to seven days preoperatively and continued into the postoperative period. Only initiate parenteral nutrition if support is to be provided for seven or more days. (16) Chemotherapy, Targeted Therapy, and Radiation: Nutrition Implications Chemotherapy, as previously discussed, kills rapidly dividing cells, which can cause many nutritional complications. Some nutrition related side effect include anemia, neutropenia, electrolyte imbalance, constipation, diarrhea, malabsorption, dysphagia, stomatitis, mucositis, dehydration, nausea, vomiting, anorexia, dysgeusia, fatigue, weight loss, and pain. Management of these side effects can help improve outcomes and improve the patients quality of life. When these side effects of chemotherapy are present, the patient may become malnourished and decline in overall health if not appropriately handled. There are many techniques to help resolve these side effects. As with chemotherapy, targeted therapy has similar but less, nutritional side effects. The side effects include fatigue, loss of appetite, nausea, and diarrhea. As with many drugs the severity of the side effects depends on the dose of the drug and the duration of its use. (9, 15, 16, 23) Radiation therapys effects can build up over time with additional treatments. The side effects include loss of appetite, nausea, diarrhea, and fatigue. The side effects typically peak at four to five weeks after the initial treatment and resolve within one to two weeks after the treatment is complete. Skin redness may occur as well as burning of the skin and within the abdomen, this may occurs after multiple treatments, however it is less likely in pancreatic cancer patients. If burning occurs, the patient may have discomfort during meals and therefore have a decreased intake. (9, 15, 16, 23) When a patient is being treated with chemotherapy, targeted therapy, and radiation, it is important to control side effects. If the side effects are not addressed, the patient may decline due to their interrelationship. For example if a patient is experiencing vomiting and diarrhea the patient may subsequently become dehydrated, malnourished, and experience weight loss. Oral Intake and Aggressive Feeding Oral feeding is the optimal feeding technique unless contraindicated. The patient should feed orally if possible. If the patients intake decreases it is necessary to determine the cause of the decreased intake. Individuals experiencing early satiety, anorexia, and alteration in taste, xerostomia, mucositis, nausea, diarrhea, fatigue, or depression may require eating foods high in energy, protein, and micronutrients to help maintain nutritional status. (4,9,21) Poor appetite or loss of appetite is a common problem with cancer patients, the cause being multifactorial. Cancer itself, cancer treatment, and psychosocial factors may all effect appetite. Consuming frequent high calorie meals and snacks that are easy to prepare may be helpful in addition to eating in a clam and comfortable environment. Planning a daily menu in advance, arranging for help in preparing meals, and adding extra protein and calories to foods is also helpful. (4,13,23) Alternations in smell and taste are related to unknown effects of cancer, treatments, mucositis, thrush, or medications. Change in taste, or dysgeusia, can result in food avoidance, including weight loss and anorexia. Changing the types of foods eaten as well as adding additional spices may help improve the taste of food. Rinsing the mouth prior to eating may help improve the taste of foods. If the taste of metal is bothersome using plastic utensils may be helpful. It may also be helpful to have someone else prepare meals to avoid strong scents. In addition if food aroma is a problem consuming cold foods may be helpful. (4, 9, 23) Xerostomia is a condition of dry mouth and commonly is caused by radiation especially to the head and neck area. Dry mouth may affect taste sensation and ability to swallow. Drinking plenty of liquids and eating moist foods with extra sauces, gravies, butter, or margarine is helpful. Hard candies, frozen desserts, and ice chips can also help. Consuming very sweet or tart foods and beverages may help stimulate saliva. (4, 9, 23) Sore mouth is caused when rapidly dividing cells inside the mouth are damaged by treatments such as chemotherapy and radiation therapy. Patients may be more susceptible to infection and bleeding in their mouth. It may be easier to eat when carefully choosing foods and taking good care of their mouths. The best foods to choose are foods that are soft, easy to chew and swallow, and nonirritating. Acidic, spicy, salty, and coarse-textured foods are considered irritants. (4,9,23) Nausea is a very common problem of all cancer patients. Eating before treatments is important, as well as identifying foods that trigger nausea. Nausea is typically caused by spicy, greasy, and strong odor foods. Frequent eating and slowly sipping fluids is helpful. In addition eating bland, soft, and easily digestible foods may help in addition to sitting up or recline with a raised head for one hour after eating. If nausea is persistent, nausea medication may help. (4,9,23) Diarrhea is caused by radiation, chemotherapy, gastrointestinal surgery, or emotional distress. It is necessary to maintain hydration status and electrolyte balance when having diarrhea to avoid hyponatremia, hypokalemia, and dehydration. Greasy foods, hot or cold liquids, and caffeine may worsen diarrhea. Drinking one cup of liquid following each loose bowel movement will help prevent dehydration. In addition consuming broth, soups, sports drinks, bananas, and canned fruits may help replenish electrolytes. (4,9,23) At times patients may find eating to be exhausting but should be encouraged to try eating; resting before and after meals may help eating be less exhausting. Due to the poor prognosis of pancreatic cancer, many patients may feel depressed and have little desire to eat. Talking about feelings and fears may make emotions more manageable. (4,9,23) Nutritional Supplements and Appetite Stimulants When the patient is not hungry for solid foods, high calorie beverages and supplements can always be consumed. Nutritional supplements such as Ensure, Boost, Carnation Instant Breakfast, and Magic Cup can help increase calories and protein intake. These are especially helpful for patients who do not have an appetite or who cannot consume enough calories in a day. (3, 9) Appetite stimulants are appropriate for patients with no appetite and who have nausea and vomiting under control. Appetite stimulants include medications such as Dronabinol, Megestrol Acetate, and Anabolic Steroids such as, Oxandrolone, Nandrolone, and Decanoate. Dronabinol is a marijuana derivative, which takes on average four to six weeks to show effects; patients may experience extreme tiredness and impaired memory when taking this drug. Megestrol Acetate, also known as Megace, is useful for stimulating appetite. The dose of Megace needed to stimulate appetite is typically 800mg/day. Anabolic steroids use for appetite stimulation, known as Oxandrin, is a synthetic testosterone that promotes weight gain and increased muscle mass. However, hepatic changes or tumors have been reported. Elevation of low-density lipoprotein can occur with prolonged used causing possible cardiovascular effects. (9, 24, 25) Enteral and Parenteral Nutrition Support When adequate oral intake is not possible, supplemental feeds may be initiated through enteral nutrition. If the patient cannot feed orally and their gastrointestinal tract is functional enteral feeds would be initiated at that time as well. When malnutrition is of concern, the patient may require supplemental enteral nutrition feeding. Patients may require either short-term enteral feedings or may require long-term enteral nutrition. Short-tern enteral nutrition would require a nasogastric or a nasojejunal tube. Long-term enteral nutrition is indicated when enteral nutrition is required for three to four weeks, a gastrostomy or jejunostomy feeding tube should place. Contraindications for enteral nutrition include malfunctioning gastrointestinal tract, malabsorptive conditions, mechanical obstructions, severe bleeding, severe diarrhea, intractable vomiting, gastrointestinal fistula in locations difficult to bypass with an enteral tube, inflammatory bowel process, or overall prognosis not consistent with aggressive nutrition support. Enteral nutrition generally has fewer complications than parenteral nutrition and helps maintain the function of the gut. If enteral nutrition is indicated a formula is chosen based on the patients nutritional needs, comorbid conditions, and energy and protein content needs among other factors. (4,9) However, if the patient does not have a functioning gastrointestinal tract, parenteral nutrition can be initiated. Parenteral nutrition may also be required if the patient requires short-term supplemental nutrition but is experiencing thrush, mucositis, or esophagitis and a temporary tube cannot be replaced. Complications from parenteral nutrition can occur including fluid overload, hyperglycemia, electrolyte imbalance, and infections. If parenteral nutrition is indicated, either a central or peripheral intravenous line must be placed. Central lines can tolerate a higher osmolality solution, allowing for more calories and protein to be administered at one time. (4,9) Nutrition support is generally indicated when treatment options are aggressive. When patients are considering less aggressive treatments or are looking for comfort measure nutrition support may not be initiated. However, for patients who start with aggressive treatments and nutrition support, nutrition support may be maintained while receiving comfort care. (4) Palliative Care and Hospice: Nutrition When a patient and their family decide for palliative care or hospice the focus of nutrition becomes comfort care. Palliative care will provide nutrition for the patient, however the focus is on pleasure and not on providing enough nutrients for the patient. The goal of palliative care is to treat and prevent symptoms, side effects, and psychological, social, and spiritual concerns caused by the cancer or the treatment. However hospice care focuses on providing a high quality of life during the last months of life. The nutrition and hydration of the patient is based on the patient and caregivers wishes. (4,15) Presentation of the Patient October 5, 2012 DR was admitted to St. Marys Medical Center for nausea, vomiting, abdominal pain and diarrhea. She is a 72 year old Caucasian female, who lives at home with her husband and prepares the meals for her husband. DRs past medical history includes transient ischemic attack, angina, coronary stent, hypercholesterolemia, hypertension, deep venous thrombosis in her right leg, gastroesophageal reflux disease, renal disease, urinary tract infection, spinal stenosis, spinal fusion, and type 2 diabetes. DR was having nausea, vomiting, abdominal pain, and diarrhea for several months prior to admission and had a thirty-pound weight loss. The CAT scan done on admission revealed multiple liver metastases as well as a mass in the head of the pancreas. Prior to admission the patient underwent an ERCP and biliary stent at Jefferson University Hospital. The ERCP revealed Stage IV pancreatic cancer involving the liver and pancreatic head with obstructive jaundice. Hospital Course October 4, 2012: The patient arrived at St. Marys Medical Centers ER complaining of nausea, vomiting, abdominal pain, and diarrhea. She also reports having a thirty-pound weight loss in the past six months. A CAT scan was done and revealed diffuse lobular pancreatic enlargement with diffuse infiltrative masses compatible with neoplasm, presumably adenocarcinoma, which biopsy previously confirmed. Liver metastases and ascites were also noted. October 6, 2012: The patient is jaundiced but currently has no further nausea and vomiting. The patient underwent an abdominal ultrasound revealing multiple intrahepatic masses, the 8mm common bile duct stent is in position, and there is no persistent or recurrent bilary ductal dilatation, additional small amounts of ascites are noted. The patient currently taking Omeprazole, Lovenox, Zofran, Morphine, Loperamide, and Sliding Scale Insulin. October 8, 2012: A CT scan was done showing stable pancreatic mass with local porta hepatis nodes. New pleural effusions, ascites, and anasarca are also noted. October 10, 2012: At this time DR had an access port placed. During the day the patient had significant abdominal pain, discomfort and nausea. At this time the patients medications include Bacitracin, Lantus, Omeprazole, Lovenox, Zofran, Morphine, Loperamide, Pancrelipase, and Novolog. October 15, 2012: The patient received 250ml packed red blood cell transfusion. October 16, 2012: DR continues to have nausea. The physician states the prognosis of the patient is poor. Medications include Promethazine, Procrit, Zofran, Dilaudid, Norvasc, Ativan, Lantus, Omeprazole, Pancrelipase, and Novolog. October 17, 2012: The patient received 250ml packed red blood cell transfusion. October 18, 2012: The patient received 125ml packed red blood cells and 256ml of platelet cell transfusion. October 21, 2012: The physician initiated total parenteral nutrition. DR had tenting of the skin, decreased breathing, abdomen soft and distended with tenderness, as well as +1 pitting edema. The patient looks cachectic and has moderate discomfort. The patients blood counts are improving after receiving chemotherapy, cycle 1, with Gemcitabine. The physician plans to wait for the patients platelet count to increase over 75,000mcL and may consider 5-FU- oxaliplatin. The physician plans to add insulin to the TPN as well as taper down the TPN. October 22, 2012: The physician states the patient has improving appetite and remains on TPN, however plan to discontinue by half. The patient has extremity swelling causing her difficulties to ambulate. The patient also has significant anasarca. The patient is stating she wants to go home, however her husband feels he cannot take care of her. DR does not want to go to a skilled nursing facility and wants to remain a full code. Today patients husband toured Chandler Hall, an inpatient hospice center. October 23, 2012: TPN is running at half strength. October 24, 2012: The patient has a poor prognosis, and is status post one cycle of chemotherapy, has hypoalbuminemia, and anasarca. The patient is discharged to hospice with metastatic pancreatic cancer, +3 pitting edema, diffuse anasarca, malnutrition requiring TPN, thrombocytopenia, anemia, neutropenia, hyperglycemia, hypoglycemia, pancreatic insufficiency, liver failure with elevated bilirubin levels. Patients Lab Values Throughout the patients hospital course her lab work was monitored. For lab values refer to table 3 in the appendix. Upon admission, the patients bilirubin, liver enzymes, and glucose levels were elevated, in addition the patients albumin level was low. A few days following DRs admission, her CA 19-9 Antigen was at 52704units/mL, normal values are less than 34units/mL, this antigen is a marker for pancreatic cancer. The patients glucose levels ranged from 378mg/dL to 42mg/dL throughout her hospital course; as DRs hospital stay progressed her glucose levels remained high until her last glucose level, which was very low. The patients bilirubin levels decreased but were still elevated, the decrease may have been due to the stent the patient had placed prior to admission. The patients liver enzymes remained elevated and increased throughout her stay, which may have been due to the metastasis of the cancer to her liver. DRs albumin levels remained low throughout her stay and the only prealbumin value was also very low at 4.0mg/dL. Lastly DRs platelet count and white blood cells decreased throughout her stay, this was possibly due to her chemotherapy treatments. Nutrition Course of the Patient Assessment: On October 5th, DR was experiencing nausea and vomiting and had lost 30 pounds in six months. DRs weight loss of 23% in six months is considered significant. When speaking with the patient she states she has had nausea, vomiting, diarrhea, and a decrease in appetite for several months and has been experiencing some pain. DRs weight at the time of visit was 47kg, height of 157cm, and BMI of 19kg/m2. Due to DRs low BMI, recent weight loss, and recent nausea, vomiting, and diarrhea, her energy and protein needs were estimated at 30-35kcal/kg and 1.2-1.3gm of protein/kg; DRs needs were calculated to be 1410-1645kcal and 56-61gm of protein. Diagnosis: Inadequate oral intake related to metastatic pancreatic cancer as evidenced by a significant weight loss of 23% in 6 months. Intervention: Recommend a regular diet with Ensure Plus twice a day and consuming at least 75% of meals. Recommend weighing patient two times per week. Monitor and Evaluate: Monitor meal intake percentages and patients intake of Ensure Plus twice daily. Additionally monitor DRs weight. Assessment: On October 8th, DRs appetite had not improved since October 5th. Her meal intakes were fair, consuming about 25-50% of meals. DR is expected to start chemotherapy soon. Her needs were kept the same as her initial assessment. Diagnosis: Inadequate oral intake related to patient with no appetite as evidence by patient consuming 25-50% of meals. Intervention: Encouraged patient to try consuming small frequent meals, recommended to continue drinking Ensure Plus twice daily, and continue with the anti-nausea medication. Recommend weighing patient 2x per week. Megace was recommended if DRs intake did not improve. Monitor and Evaluate: Monitor tolerance to diet, monitor blood glucose levels. Monitor weights two times per week. The patient was followed up with again on October 11th with no significant changes noted. Assessment: On October 15th, DR stated she was ordering small amounts of food, and having intermittent nausea and vomiting. The patient received chemotherapy on October 10th. DR is now taking pancreatic enzymes. High calorie supplements were discussed with the patient, who expressed her concern about not consuming enough solid foods and was also concerned about controlling her nausea. Diagnosis: Inadequate oral intake related to chemotherapy and pancreatic cancer as evidence by poor meal intakes, weight loss, and intermittent nausea. Intervention: Encourage small frequent meals and consumption of Ensure Plus twice a day, weigh twice a week, control nausea with medications. Monitor and Evaluate: Monitor patients intake and the need for an appetite stimulant, as well as recommend small frequent meals, and control of nausea. Assessment: At DRs next follow up on October 18th, it was noted the physician initiated TPN. Through a central line, the patient was receiving a TPN solution containing 70% carbohydrates, 30% lipids, and 1.2gm of protein/kg. DRs oral intake decreased to poor intake, consuming less than 25% of meals. At this time DRs albumin was 1.1gm/dL and glucose of 169mg/dL. DR at the time of the visit had inadequate meal intakes, had initiated TPN, and decreased serum protein. DR was experiencing excessive fluid overload, edema, and elevated blood glucose levels. Recommended to consider a nasojejunal tube for nutrition support rather than TPN. Diagnosis: Inadequate oral intake related to patient has nausea, vomiting, and no appetite as evidence by patient consuming less than 25% of meals and initiated on TPN. Intervention: Continue to encourage small frequent meals, continue consume Ensure Plus twice daily, and weigh patient 2x per week. Monitor and Evaluate: Monitor patients weight and continue to monitor meal intakes. Monitor tolerance to TPN, may want to consider discontinuing TPN and initiating nasojejunal feeds. October 22nd was DRs final follow up assessment. Assessment: DR was still consuming only fair intake, albumin of 1.2mg/dL and prealbumin of 4mg/dL. The patient was still receiving TPN at this time. She expressed concern that she was not receiving enough oral nutrition. The physician at this time is noting the patient to have a poor prognosis and plans to wean DR from TPN. The TPN is contributing to fluid retention and weight gain. The patient is currently receiving Lasix and Aldactone. The patient and patients family are thinking of hospice. Diagnosis: Inadequate oral intake, related to poor appetite, nausea, and vomiting, as evidence by patient consuming less than 25% of meals. Interventions: Recommend discontinuing TPN and providing a regular house diet. Monitor and Evaluation: Will monitor meal intakes, watch for weaning of TPN, and will monitor for the plan of care. Critical Comments After researching the topic of pancreatic cancer and learning all of the nutritional implications, there are several things I would change about her nutritional care. It would have been beneficial to speak with the nurses and physicians at further lengths to discuss the patients nutrition and plan of care. Making sure the patient was receiving Zofran as needed, as well as explain different techniques to the patient regarding reducing nausea. Additionally ensuring the patient was receiving the pancreatic enzymes at the appropriate time may have helped the patient with digestion of food. Talking with the attending physician may have prevented the initiation of TPN, which was not appropriate for this patient. Speaking with the physician at further lengths may have encouraged the use of a tube feeding for supplemental feedings, which may have improved outcome or quality of life. A multidisciplinary care approach as well as acting as a patient advocate could have contributed to an optimal outcome. Monitoring DRs labs more closely may have been beneficial, the patients albumin and prealbumin remained very low, and liver enzymes increased over her time of stay. Additionally checking the C-reactive protein and transferrin saturation may have provided additional information on the patients nutritional status. Although DR was not consuming sufficient nutrition, regardless it may have been more appropriate when calculating the patients needs to adjust the patients body weight for ascites, which the patient presented with on admission. Additionally I would have reassessed the patients needs and would have recommended additional nutritional supplements and oral intake before initiating TPN. After the initiation of TPN the patients triglycerides were elevated, glucose was high, as well as increased liver enzymes. The patient also had fluid overload while on TPN. When TPN was initiated and throughout the time she was receiving TPN, DRs white blood cells were low, which increased her risk of infection with TPN. Expressing these concerns with the physician would have been appropriate. After researching pancreatic cancer, it is necessary to consider that the patient had Stage IV pancreatic cancer. This cancer was unresectable, and chemotherapy was her only option. Comfort measures were possibly all that could have been done in this case. Helping the patient overcome pain, nausea, vomiting and diarrhea through comfort measures may have improved DRs meal intake as well as improve her quality of life. Summary Many nutrition implications of pancreatic cancer can arise depending on the type of pancreatic cancer, stage of cancer, and the treatments that may be provided. An individualized plan of care is needed for patients because no two patients are the same. The nutritional status of an individual throughout their course of treatment is important for recovery and quality of life. It is necessary to also inquire as to why a patient is having nutritional problems and find ways to help the patient achieve a solution. Always remembering to have a multidisciplinary approach and patient centered care is key for optimal outcomes. Glossary of Pertinent Medical Terms Antigen: Antigens cause the immune system to make antibodies against the antigen. Carcinoma in situ: A group of abnormal cells that remain in the place where they first formed. They have not spread. These abnormal cells may become cancerous and spread into nearby normal tissue. Also called stage 0 disease. Computed Tomography Scan: Also known as a CT scan. This is a technique that combines a series of x-rays to create cross-sectional images of the bones and soft tissues within the body. C-Reactive Protein: Abbreviated CRP is a protein produced by the liver and found in the blood. CRP increases after an injury, infection, or inflammation and decreases when the injury heals or infection or inflammation clears. DNA: Deoxyribonucleic acid is the heredity material within cells; DNA provides the instructions for development and function of cells. Eicosapentaenoic Acid: Abbreviated EPA, a type of Omega-3 fatty acid with 20 carbon atoms, commonly found in fish. Endoscopic Retrograde Cholangiopancreatography: Also known as an ERCP, this test combines the use of an endoscope with an x-ray to examine the tubes that drain the liver, gallbladder, and pancreas. Endoscopic Ultrasound: Also known as EUS, this procedure combines an endoscopy and an ultrasound to obtain images of the digestive tract and surrounding organs. Eosinophils: Type of white blood cell produced in the bone marrow and migrates to tissues. Different types of white blood cells release substances when foreign substances enter the body; the substances released from the other white blood cells attract eosinophils, which release toxic substances to kill invading substances. Esophageal Varices: These are abnormally enlarged and extremely dilated veins in the lower esophagus. Fistula: An abnormal or surgically made passage between a hollow organ and the body surface, or between two hollow organs. Fluorouracil: Also known as 5-FU, is an antimetabolite used as an Antineoplastic agent. Gastric Varices: These are abnormally enlarged and extremely dilated veins in the stomach, typically in the fundus and cardia, which are located at the top portion of the stomach below the esophagus. Laparotomy: A laparotomy is a procedure to explore the organs within the abdomen. A surgical incision is made into the abdomen wall. Magnetic Resonance Cholangiopancreatography: Also known as a MRCP, this is an imaging technique using magnetic resonance imaging to visualize the biliary and pancreatic ducts. Magnetic Resonance Imaging: Also known as an MRI, this test using a magnetic field and pulses of radio wave energy to produce pictures of organs and structures inside the body. Mucin: This is a glycoprotein component of mucus. Non-Steroidal Anti-Inflammatory Drugs: Abbreviated NSAIDs, these are medicines that relieve pain, swelling, stiffness, and inflammation. Oxaliplatin: An Antineoplastic agent used to treat metastatic carcinoma with 5-FU. Portal Vein: This is a large vein that brings blood from the digestive organs, spleen, pancreas, and gallbladder to the liver. Pylorus: This is the lower part of the stomach that connects the stomach to the duodenum. Splenomegaly: Is an enlargement of the spleen, an organ, which is involved in the production and removal of blood cells, also forming part of the immune system. Tumor Necrosis Factor: Abbreviated TNF, is a proinflammatory cytokine that is produced by white blood cells; has an antineoplastic effect; one of multiple proteins capable of inducing necrosis of tumor cells that possess a wide range of proinflammatory actions. Xerostomia: Abnormal dryness of the mouth resulting from decreased secretion of saliva. Medication Bibliography MedicationsIndicationContraindication Food-Drug InteractionAldactone (Spironolactone)Ascites from cirrhosis Anuria. Caution with renal impairment, hyponatremia, diabetes mellitus, and elderly patients.Take with meals or milk to decrease GI irritation and increase absorption. Avoid natural licorice. May cause dry mouth, nausea, vomiting, gastritis, cramps, and diarrhea.Ativan (Lorazepam)Anxiety with depressionCaution with respiratory impairment, central nervous system depression, seizure history, renal impairment, hepatic impairment, and elderly patients.May take with food if GI distress occurs. Limit caffeine to <400-500mg/day. Anorexia, decrease in weight, increased appetite increased thirst, dry mouth, nausea, vomiting, constipation, and diarrhea may occur.Creon (Pancrelipase)Exocrine pancreatic secretion deficiency (Pancreatic Cancer)Caution if hyperuricemia, renal impairment, recurrent GI obstruction history, short bowel syndrome history, and Crohns disease.Must take with food. Take with meal or snack and fluid. Follow by glass of water or juice. Insure adequate hydration/fluid intake. Nausea, vomiting, stomach cramps, bloating, constipation, diarrhea, and flatulence may occur.Dilaudid (Hydromorphone)Moderate to Severe PainRespiratory depression, asthma, and GI obstruction. Caution with elderly, renal impairment, hepatic impairment, and pulmonary impairment.Take with food. Increase fluid and fiber to prevent constipation. Anorexia, decrease in weight, dehydration, dry mouth, taste change, dysphagia, dyspepsia, decrease gastric mobility, nausea, vomiting, constipation, and diarrhea may occur. Avoid Alcohol. Gemzar (Gemcitabine)Pancreatic CancerCaution with renal impairment, hepatic impairment, and myelosuppression.Decreases bowel movement, may cause nausea, vomiting, and diarrhea, may cause fever. May cause stomatitis.Lantus (Insulin Glargine)Type 2 DiabetesHypoglycemia, Caution with infection, illness, or stress, hypokalemia, renal impairment, and hepatic impairment.Long Acting, Onset 1-2hrs, Duration 12-18hrs. No peak time, should never be mixed with another insulin in the same syringe.Lovenox (Enoxaparin)Prevention and treatment of deep venous thrombosisHypersensitive to pork products. Caution if bleeding risk, recent surgery or trauma, diabetic retinopathy, and coagulation disorder.Do not take with pork allergy: derived from porcine intestinal mucosa.Norvasc (Amlodipine)Hypertension and AnginaCaution with severe coronary artery disease, aortic stenosis, congestive heart failure, hepatic impairment and in elderly patients.Grapefruit Juice and Alcohol increase effects of hypotension. Avoid natural licorice. Take without regard to meals. May take with food to decrease GI stress.Novolog (Insulin Aspart)Type 2 DiabetesHypoglycemia, caution with infection, illness, or stress, hypokalemia, renal impairment, or hepatic impairment.Rapid Acting, Onset: 0-15 minutes, Peaks: 1-2hours, Duration <5hours. Do not skip meals and administer insulin.Phenergan (Promethazine)Nausea and VomitingRespiratory distress. Caution if GI obstruction, hepatic impairment, and seizure disorder.Take with meals or milk to decrease GI irritation. Dry mouth, constipation, nausea, and vomiting may occur.Priolsec (Omeprazole) Gastroesophageal RefluxCaution with long-term use, high dose treatment hepatic impairment, hypomagnesemia, and patients over 50 years old.Take 30-60 minutes before a meal. Follow by cool water. May decrease absorption of iron and vitamin B12. May decrease calcium absorption. Calcium citrate is better absorbed with PPIs. Avoid gingko and St. Johns Wort, may decrease drug level.Procrit (Epoetin Alfa)Cancer ChemotherapyHypersensitive to drug, albumin, or mammal-derived products. Uncontrolled hypertension.May need iron, vitamin B12, or Folate supplement. Nausea, vomiting, and diarrhea may occur.Reglan (Metoclopramide)Nausea, and Gastroesophageal RefluxSeizure disorder, GI bleeding or perforation, or GI obstruction. Caution with depression, hypertension, congestive heart failure, cirrhosis, diabetes mellitus, renal impairment, and elderly patients.Take half hour before meals and bedtime. Dry mouth, increased gastric emptying, nausea, diarrhea, and constipation may occur. May increase appetite.Zofran (Ondansetron)Prevent chemotherapy associated nausea and vomitingCaution with hepatic impairment, abdominal surgery, and PKU.Take half-hour before chemotherapy, dry mouth, abdominal pain, constipation, and diarrhea, may occur. Appendix Figure 1  Appendix Figure 2  Appendix Table 1 TNM Staging SystemPrimary Tumor (T)Tx Primary tumor cannot be evaluatedT0No evidence of primary tumor TisCarcinoma in situ T1, T2, T3, T4Size and/or extent of the primary tumor Regional Lymph Nodes (N)NxRegional lymph nodes cannot be evaluatedN0No regional lymph node involvement N1, N2, N3Involvement of regional lymph nodes. Number of lymph nodes and/or extent of spreadDistant Metastasis (M)MXDistant metastasis cannot be evaluatedM0No distant metastasisM1Distant metastasis is present* Example T3 N2 M0 refers to a large tumor that has spread outside of the tissue to the nearby lymph nodes but not to other parts of the body.  Appendix Table 2 Types of Pancreatic Tumors Common Non-Endocrine Adenocarcinomas: Most common type of pancreatic caner, accounting for greater than 75% of all pancreas cancers. Adenocarcinomas form glands. These glands are collections of cells surrounding an empty space. This type of tumor can grow large and invade nerves causing back pains. This type of cancer also frequently metastasizes to the liver and lymph nodes. When this tumor metastasizes it may be considered unresectable. Rare Non-Endocrine Tumors Acinar Cell Carcinomas: This rare cancer may produce excess amounts of digestive enzymes normally produced by the pancreas. Increased enzymes cause distinct symptoms in 20% of acninar cell carcinoma cases; symptoms include unusual skin rashes, joint pain, and an increased level of eosinophils. Adenosquamous Carcinomas: This type of pancreatic cancer is similar to adenocarcinoma because it too forms glands. The cancer cells tend to flatten as they grow. Colloid Carcinomas: Colloid Carcinoma is a distinctive tumor of the pancreas associated with better prognosis that adenocarcinoma. Giant Cell Tumors: Giant cell tumors have unusually large cells. The tumor is not necessarily larger just the cells are larger. These tumors are no called Undifferentiated Carcinomas with Osteoclast-like Giant Cells. Hepatoid Carcinomas: These types of pancreatic tumors are extremely rare. The cells that form this type of cancer resemble cells of a liver cancer. Intraductal Papillary-Mucinous Neoplasms: The tumors characteristically grow along the ducts of the pancreas that drain the pancreatic fluid into the small intestine. It is believed this type of cancer starts as a curable lesion, however if untreated may progress to invasive pancreatic caner. Mucinous Cystic Neoplasms: Rare, cystic, fluid containing tumor of the pancreas. These tumors can develop into cancer over time. Pancreatoblastomas: Rare malignant tumors, which primarily occur in children. Often referred to as pancreatic caner of infancy. Serous Cystadenomas: These tumors are rare and usually benign growth. These tumors are cystic, fluid containing tumors with a sponge like appearance. Serous Cystadenomas can grown to be large and may need to be removed if symptoms such as pain and weight loss occur. Most patients are cured with the removal of this tumor. Signet Ring Cell Carcinoma: This is a rare form of pancreatic cancer, composed of infiltrating individual cells with a large mucin vacuole. A large mucin vacuole pushes the nucleus to the side, causing the cell to appear in a ring-like shape. Solid and Pseudopapillary Tumors: These are rare tumors that occur primarily in women in their thirties. Some parts of the tumors are solid while other parts of the tumor are papillary. Although these tumors are considered cancers, they have a good prognosis. These tumors can spread and should be completely removed. Undifferentiated Carcinomas: This is an extremely aggressive form of pancreatic cancer. The cells do not resemble any normal cell type in the body. Endocrine: Endocrine Islet Cell Tumors: These tumors are very uncommon, accounting for about 1% of pancreatic cancers. Endocrine tumors may produce highly active hormones and therefore have very dramatic symptoms. Insulinomas producing large amounts of insulin resulting in hypoglycemia Glucagonomas producing glucagon resulting in a very distinctive rash. Appendix Table 3 Patients Lab Values LabsReference Range10/610/710/910/1010/1410/1710/1810/1910/2210/23Na136-145mg/dL137135L138136136136137136132L135LK3.5-5.1mg/dL3.3L4.53.4L3.63.73.73.3L4.1L4.53.8Cl98-107mg/dL1041001051021001041031039897LCa8.5-10.1mg/dL7.0L7.7L7.4L7.2L7.9L7.6L7.6L8.4L8.2L8.0LPhos2.5-4.9mg/dL1.6LMg1.8-2.4mg/dL1.81.3L*1.4L*1.7L1.81.8Glucose74-106mg/dL336H378H188H188H249H168H127H293H152H42LTotal Bilirubin0.20-1.00mg/dL13.37H14.69H7.37H5.97H8.93H8.227.54H6.62H7.55HDirect Bilirubin0.0-0.2mg/dL11.85H6.08H4.41H6.34H5.34HIndirect Bilirubin0.10-1.00mg/dL2.84H1.29H1.56H1.20H1.28HAmmonia<32mcg/dL44H42HAlk Phos50-136units/L312H382H382H297H490H420H434H659H631HAST15-37units/L123H113H76H497H490H420H434H659H631HALT12-78units/L112H121H88H73214H191H185H166H135HAlbumin 3.4-5.0mg/dL1.3L1.6L1.2L1.7L1.4L1.1L1.2L1.3L1.3LPrealbumin20-40mg/dL4LTriglyceride<150mg/dL172hB Natriuretic Peptide0-100pg/mL221HCA 19-9 Antigen<34units/mL52704HWBC4.5-10.0gM/dL9.811.5H8.27.212.0H3.5L5.46.07.68.1RBC4.00-5.20gm/dL3.66L3.69L3.57L3.10L2.81L2.63L3.71L3.67L3.70L3.52LHgb11.6-15.0gm/dL11.011.810.7L9.3L8.4L7.9L11.5L11.1L11.5L11.1LHct35-45gm/dL32.4L35.731.9L27.3L25.1L23.6L33.2L33.2L34.2L32.7LPlt Count30-400gm/dL103L130L98L91L61L16L*27L*11L*20L*67L References 1. Seeley R, Stephens T, Tate P. Anatomy and Physiology. Eighth Edition. New York: McGraw Hill; 2008. 2. Gropper S, Smith J, Groff J. Advanced Nutrition and Human Metabolism. Fifth Edition. California: Wadsworth; 2009 3. American Cancer Society. American Cancer Society Pancreatic Cancer Website. Available at: http://www.cancer.org/cancer/pancreaticcancer/detailedguide/index. Accessed December 22, 2012 4. National Cancer Institute at the National Institutes of Health. NIH Pancreatic Cancer Website. Available at: http://cancer.gov/cancertopics/types/pancreatic. Accessed December 22, 2012 5. Morana G, Cancian L, Pozzi Mucelli R, Cugini C. Staging cancer of the pancreas. Cancer Imaging: The Official Publication Of The International Cancer Imaging Society. October 4, 2010; 10 Available from: MEDLINE, Ma. Accessed December 22, 2012. 6. John Hopkins Medicine. The Sol Goldman Pancreatic Cancer Research Center Website. Available at: http://pathology.jhu.edu/pc/BasicOverview1.php?area=ba. Accessed December 22, 2012 7. The National Pancreas Foundation. The National Pancreas Foundation About Pancreatic Cancer Website. Available at: http://pancreasfoundation.org/about-pancreatic-cancer/. Accessed December 22, 2012 8. Ohio State Wexner Medical Center. Wexner Medical Center Pancreatic Cancer Website. Available at: http://medicalcenter.osu.edu/patientcare/healthcare_services/liver_biliary_pancreatic_disease/disorders_of_pancreas/pancreatic_cancer/Pages/index.aspx. Accessed December 22, 2012 9. Escott-Stump S. Nutrition and Diagnosis Related Care Seventh Edition. Maryland: Lippincott Willims & Wilkins; 2012. 10. The Merck Manual. Nineteenth Edition. New Jersey: Merk Sharp & Dohme Crop; 2011 11. The University of Texas MD Anderson Cancer Center. MD Anderson Cancer Center Pancreatic Cancer Website. Available at: http://www.mdanderson.org/patient-and-cancer-information/cancer-information/cancer-types/pancreatic-cancer/diagnosis/index.html. Accessed: January 3, 2013 12. Memorial Sloan-Kettering Cancer Center. Pancreatic Cancer Website. Available at: http://www.mskcc.org/cancer-care/adult/pancreatic. Accessed January 4, 2013 13. Porner M, Seufferlein T. Novel approaches to target pancreatic cancer. Current Cancer Drug Targets. July 2011; 11(6): 698-713. Available from MEDLINE, MA. Accessed January 4, 2013. 14. Pagana K, Pagana T. Mosbys Diagnostic and laboratory Test Reference. Tenth Edition. Missouri: Elsevier; 2011. 15. Pancreatic Cancer Action Network. Learning About Pancreatic Cancer. Available at: http://www.pancan.org/section_facing_pancreatic_cancer/learn_about_pan_cancer/treatment/Treatment_by_stage.php. Accessed January 4, 2013 16. Academy of Nutrition and Dietetics. Nutrition Interventions: Pancreatic Cancer. Available at: http://www.nutritioncaremanual.org/content.cfm?ncm_content_id=91817. Accessed January 21, 2013. 17. Academy of Nutrition and Dietetics. Executive Summary of Recommendations: Pancreatic Cancer and Oncology Nutrition. Available at: http://andevidencelibrary.com/topic.cfm?cat=3250. Accessed January 21, 2013 18. WebMD. Pancreatic Cancer Health Care: Whipple Procedure. Available at: http://www.webmd.com/cancer/pancreatic-cancer/whipple-procedure?page=2. Accessed January 22, 2013. 19. Fendrich V, Merz M, Bartsch D, et al. Neuroendocrine pancreatic tumors are risk factors for pancreatic fistula after pancreatic surgery. Digestive Surgery 2011;28(4):263-269. Available from MEDLINE. Accessed January 22, 2013. 20. Aranha GV, Aaron JM, Shoup M, Pickleman J. Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 2006;1440(4):561-568. Available from MEDLINE. Accessed January 22, 2013. 21. Liu C, Du Z, Wang Y, et al. Enteral nutrition is superior to total parenteral nutrition for pancreatic cancer patients who underwent pancreaticoduodenectomy. Asia Pacific Journal Of Clinical Nutrition. 2011;20(2):154-160. Available from: MEDLINE. Accessed January 22, 2012. 22. Tran K, Smeenk H, Eijck C, et al. Pylorus preserving pancreaticoduodenectomy verus standard whipple procedure. Ann Surg. 2004;240(5):738-745. Available from: NCBI. Accessed January 22, 2012. 23. Eating Hints For Cancer Patients Before, During & After Treatment. NIH Publication; 2006. 24. Barberio J. Nurses Pocket Drug Guide 2012. New York: McGraw-Hill; 2012 25. Pronsky Z, Crowe J. Food Medication Interactions. Birchrunville Pa: Food-Medication Interactions; 2010. PAGE  PAGE 53 012<e| = k +-efo!!0$A$d&e&"(6(,,w/x/h22288 9JJJLMMTTT W W WW___geheieqeregggkk-rGrrrквкغغhKfah!5hnh!5 h h! hlh!hlh!5 hnh!#jh!UaJmHnHsHtHhnh!5CJ$OJQJF023456789:;<Xefghijklmno $da$gd! $dha$gd! f$fopqz| = k ,fopq$d`a$gd! $da$gd! $da$gd!q!0$@$"(5(,,w/228 9= @FHJLLMQTT WW$d`a$gd! $da$gd!W[{]__heggkkOp-r.r/rGruv x$Jbk̊ $da$gd!$d`a$gd!"J"#@ӐԐDEZЪKMvSTyxyST{Ž͵ͮ͵ͦ͟͵ͽŵ h&h!h&h!5 hIAh!hBu;h!5 h dh!h_h!5hrh!5hKfah!5 h_h! hrh! h)h!h)h!5 hKfah!hlh!5 hlh!8#@ӐژEZѪL@v d`gd!dgd! $da$gd!$d`a$gd!TxK5fH*58CT{$ & Fda$gd!$d`a$gd! $da$gd!g(yc!FBv&)l $d`a$gd! $da$gd!$ Sda$gd!$ & Fda$gd!gw(:yct!2FWBSTUw%&'~)4ACE!EGmx,4 >   ` u $ & L W @hI*h!H*hh!H*hh!>* hI*h!hrh!5hlh!5 hlh!P@J223<k$;       ! ! !;!!!!r"s""##"$#$,$$$$$%%%%L&M&üõíüüüўÖÏ h&h!hLh!5hSh!5 h3*h!h3*h!5 hSh! h&^h! huh! h#\th!huh!5hrh!5 hlh!hlh!5 hI*h!hh!>*5     23kl&'     ! !!! $dha$gd! $dha$gd! $da$gd!$d`a$gd!!s"t"###$$$$$$$%%M&N&&&''''q(r(((G)H))) $dha$gd!M&N&{&&&'''''' (r(((((F)G)P)))G*]*P+[++++,,*,C,,,K-`-w-x- . ...2/3///0000P1Q1购hBu;h!mHnHsHh!hBu;h!5hVh!5 hlh! h+h!h+h!5 h&h! hLh! hSh!hSh!5h#\th!5 h&^h! h k$h!h k$h!5h&h!54)F*G*O+P++++++++++++++++++++$$Ifa$gd!l $da$gd! $da$gd! $dha$gd!+,,+,C,,L-Ikd$$Ifl\,a'5 5 5 5 t0(64 l4a$$Ifa$gd!lL-M-T-`-x- .._IIIII$$Ifa$gd!lkde$$Ifl\,a'5 5 5 5 t0(64 l4a....3//0_IIIII$$Ifa$gd!lkd$$Ifl\,a'5 5 5 5 t0(64 l4a0000Q1O2_II3I$$Ifa$gd!l$$Ifa$gd!lkd/$$Ifl\,a'5 5 5 5 t0(64 l4aO2P2Q2R2Z2h2z22.3Ikd$$Ifl\,a'5 5 5 5 t0(64 l4a$$Ifa$gd!lQ1P2z222-3J3Y3Z333F4Q4]4^44455\5f5r5s5556666667777888888Q9R9E:O:]:^:q:r:::%;.;>;?;b;c;*<+<<<<< = =G=H=u==========#jh!UaJmHnHsHtHhm%h!5hh!5hlh!5 hBu;h! hlh!h!L.3/373J3Z33G4_IIIII$$Ifa$gd!lkd$$Ifl\,a'5 5 5 5 t0(64 l4aG4H4Q4^445]5_IIIII$$Ifa$gd!lkd^$$Ifl\,a'5 5 5 5 t0(64 l4a]5^5f5s5566_IIIII$$Ifa$gd!lkd$$Ifl\,a'5 5 5 5 t0(64 l4a66666G77_IIIII$$Ifa$gd!lkd($$Ifl\,a'5 5 5 5 t0(64 l4a77777@88_IIIII$$Ifa$gd!lkd$$Ifl\,a'5 5 5 5 t0(64 l4a888888R9 :F:_IIIIIII$$Ifa$gd!lkd$$Ifl\,a'5 5 5 5 t0(64 l4aF:G:O:^:r:_I*I$$j&#$/Ifa$gd!l$$Ifa$gd!lkdW$$Ifl\,a'5 5 5 5 t0(64 l4ar::&;';.;?;c;+<<Ikd$$Ifl\,a'5 5 5 5 t0(64 l4a$$Ifa$gd!l<<<< =H==_IIIII$$Ifa$gd!lkd!$$Ifl \,a'5 5 5 5 t0(64 l4a==========_TTTTTTTT $da$gd!kd$$Ifly\,a'5 5 5 5 t0(64 l4a ===========================  gd!gd! $da$gd!=== > >>>#>4>5>=>>>Q>R>c>>?????@@@AA A!AIABBC%D&DBDDDDOEPEeE,F-FDFFFFGGHuHvHHHI?J@J^J6Kº›””””””””›” hOh! h!5hOh!5>*hh!5hOh!5h7`h!5h!h@mh!5#jh!UaJmHnHsHtHhh!5hm%h!5 hm%h!hP&h!5:======================= > >>>>>  gd!>>>>>>>>>>>>>> >!>">#>5>6>7>8>9>:>;><>=>>>  gd!>>Q>R>d>mN$$}&P#$/Ifa$gd!lskd$$Ifl"** t 6P}0*64 l4a$$}&P#$/Ifa$gd!ld>e>i>>mm$$}&P#$/Ifa$gd!lVskdK$$Ifl** t 6P}0*64 l4a>>>>{\\$$}&P#$/Ifa$gd!lVkd$$Ifl0*}~ t 6P}0*64 l4a>>>>{\\$$}&P#$/Ifa$gd!lVkd$$Ifl0*}~ t 6P}0*64 l4a>>>>{\\$$}&P#$/Ifa$gd!lVkd$$Ifl"0*}~ t 6P}0*64 l4a>>?{\$$}&P#$/Ifa$gd!lVkd$$Ifl0*}~ t 6P}0*64 l4a???m$$}&P#$/Ifa$gd!lVskdo$$Ifl** t 6P}0*64 l4a???G?mm$$}&P#$/Ifa$gd!lVskd$$Ifl** t 6P}0*64 l4aG?H?K?o?{\\$$}&P#$/Ifa$gd!lVkd/ $$Ifl"0*}~ t 6P}0*64 l4ao?p?{??{\\$$}&P#$/Ifa$gd!lVkd $$Ifl0*}~ t 6P}0*64 l4a???{\$$}&P#$/Ifa$gd!lVkd $$IflL0*}~ t 6P}0*64 l4a???m$$}&P#$/Ifa$gd!lVskd $$Ifl** t 6P}0*64 l4a???@mm$$}&P#$/Ifa$gd!lVskd $$Ifl"** t 6P}0*64 l4a@@@-@{\\$$}&P#$/Ifa$gd!lVkdB $$Ifl0*}~ t 6P}0*64 l4a-@.@1@O@{\\$$}&P#$/Ifa$gd!lVkd $$Ifl0*}~ t 6P}0*64 l4aO@P@Q@{\$$}&P#$/Ifa$gd!lVkd$ $$Ifl"0*}~ t 6P}0*64 l4aQ@R@@o$$}&P#$/Ifa$gd!lVpkd $$Ifl"** t 6P}0*64 l4a@@@@@@@@@@@@@@vvvvvvvvvv  gd!$ a$gd!pkd $$Ifl"** t 6P}0*64 l4a @@@AA A!A7A8AIAABBBBCzC&DBDDDD $ & Fa$gd! $^a$gd! $`a$gd!$a$gd!$a$gd!gd!  gd!DPEeEE-FDFzFFFoGGGGGHEHvHHHHIAII@J^JJ7K $`a$gd!$a$gd! $ & Fa$gd!6K7K[KzL{LLMM>M}N~NNNNNNNNNNNNNNNNNNNNNNNNNNNOOOOOOOOOOO O#O$O'O(O+O,O/O0O4O5O9O:O;O7K[KKK@L{LLLMM>MMM8N~NNNNNNNNNNNN  gd! $ & Fa$gd! $ & Fa$gd!$a$gd!NNNNNNNNNNNNNNNNOOOOO O$O(O,OFfB$$Ifa$gd!l $  a$gd!  gd!,O0O5O:O;O=OJOOOSOXO\O`OdOiOnOrOvOwOzOOOOOOOOOFfFf$$Ifa$gd!lP?P@PDPEPMPYP^PcPhPmPrPwP|PFf"Ff@$$Ifa$gd!l|PPPPPPPPPPPPPPPPPPPQQ QQQQQQFfr)Ff &$$Ifa$gd!lQQ$Q%Q&Q9QHQIQOQUQ[Q\Q]Q^QdQjQkQlQtQ~QQQQQQQQFf>0Ff,$$Ifa$gd!lkQlQsQtQ~QQQQQQQQQQQRRRRRR%R3R6R@RARPRQRYRZRgRRRRRRRRRRRRRRRRRRRRRSSSSSSS+S-S4S;S*hPAh!H* h!6 hnh!hnh!>*h! h!>*hlh!>*hlh!6 hlh!hBu;h!CJhBu;h!CJhBu;h!5CJhBu;h!5CJOJQJ4ITOTUT[TaTbTlTxT}TTTTTTTTTTTTTUUdgd! $da$gd! $da$gd!Ff_Ffl\$$Ifa$gd!lULVWWX}YZ [a[w\]]D^#__`gaNbc.ddQee ffffh]hgd! &`#$gd!dgd!aIaKaabbbccdddaeeee f f fffffffff f!f$f%fh!0JmHnHu h!0Jjh!0JU hh!hIAh!6hrh!6 hIAh! h!6h! h!>*hIAh!>*f!f"f#f$f%fdgd!h]hgd! &`#$gd!( 00:p!/ =!"#$% T/  b6#I|O&$@(8xYPyp{w6ei6ac'bbacv'w۶nAlQTA@A( (/T<ϑ?c ^XI ZFՈ"d'D" d,-@҂}H>k3ɒآ܊A 9E kؑ{{ؽؽ*vQpAxb(aä>?&%ԔTe;urzXv0,Hwr%ʤ)w(BGr4#"@y`4!5%|E{o~ﶹq\mI8_\Xh e^^^ok*yxx+qfgOT$ikzz bSLCgN+PeZYCżDit7@3qA=Mtˌ8? ҆^*qp Ʉ!xWl#H/v/v/-g,%ٶBvM*:K-Lp; aE,;e;YuN(iV1b唌2k4SW?yO`߅дh_x`gxθ^^^oXY=A&K_f|wm..l74TgƅFU~l0fVyw%=`86 0x#w"+ۦn^W-M#Zl߰ 3ef@:4^^^?rxEZ [aΦwtOZ-1~ocL.Y#$ '\0e%#ي򬜢ާ]1]Ԯ}>>v%iY"x9i ZuN`k<;`xΓ>^HsȳCyE] Y]"Hm Os WwiϦ[7n6͘)'"w_=W/+! +C$wP`DH!X@ I;\yxsnSYCd>5_o t-2 5=V^UDk*?8Oe~x9o{(v˗^6X z/v"8`',pq,a1UJ)b%5֊=?mxl@[=$ w';`Ao.PS0uXN%_93pyF? =,׶]!eFt0׊gKh#8`$"(BBN"%*x%8J&c`ӖjLҘщC +Bݰshf 78Iڛ;pYa4⑼# zb7RtFX=ބ_b58WpZSr_ņԸbi$8L݌OyfU딱_WlNM>;>!*V^#n'YcцXʻ ;"ƨV1Y\8w΋;OAY˴Dt=ڱ_¾*]6V/UÈNv,KN Ь'I.,9 +/:aTΠ=auCs]Eނ.MX#S Sy$σwzyE<-J1A]SЭfu zOȎ1,x^b9PPzF2iJN3.\!2eU^G,c)Ņh*H]54UՍ׫}y-W59٧됰9+RCR<"%y[jam7[v^y8{ogn/bڱ2;͓ ]@zv-hCX^մ%Qc$I t"d37[n3wd4_ʴ$WkϤ$foѲ(RNbA^]"rֻN0Xr:*OhuiEB \^þN_vrM +􍵖.G9XPW\46f}8hShA=0MV(1,* 9bbؿ/z~jϑ -xyd4diCկ#")"'HM%jc&*9hW(s WNgzğ'DFnmϭOd,Ul$1=XВ`*>_SzvȘE[dls &1؜r^]jOhcήp˴uuh=ڽozFb`P OH~y#);̀LRh )+ԣqmA>Igʚ4TM6UTw]- ۲uM"S'_wTe)pJ,=@cYçSb'WGӇ): `>{ULKcؔlzɹ[nf[8.2VK(ED/v/w;Fw=Gu8G"˅`uV>A۳+MCU !ch]Hmhz]ӄ<^U7\R٧).N(H)w0 Nvm3No&JGkOVF;{ $0Q||Czsfrvd.~w͌9oޑAl9aH|2U < vUoWOɼ=S$Xv#ߝ~xSli%د7 1V U7'[g:kFj++*+JV?_1Th)ufU<=*%9qQڞ %bjNu"2(/t:6!$)6tOm }kqtsXe!m|j4"L; XZpZx{`W9s?Q#AE14ЌA.Y]iwj;~r?&~F_o5Xvlod0h1^o0odyDI^OzfkRB˴!JM^Yq>DӒaFqZŜj-=ғȋ-T]؜Qѥ+etdV2<"Ql y +%Jbb7jVYDTO &vwv0<Ɓּ⮂RmKtcݍz͆[:ۦ:cʱʑQcXnT;R?UV2VPp5=pb?vxk3v'cG25o]q!bCz}{ - (vjZr겺4)]Y5G| )m-ҋ݋NAb<I3S D~wKWj-*2Vߨini2nnyv{Ӥ~z^?VW2Xߧd\˾2x%'%#9;MӞRu-?:n' i!HZ\IXD r2]vٍD򓧍w^bgt[f_I3Һķ]ڝRxK%EJ@$.cq8`W  AVI!VsU;>M,ή\S\WZWb7+G*3M4Ls3+G EҬ̸ZSړ2/'礛M)ںvVXAVH_=xc:""AeLJݑEJZ^nP0e)ěL>;^{CoNj +DZU(+ic9b'5:B]kr Vv _`!C,, ? xFȎ<ہā`^#q.LI^H2=%tY\֮it+j$/J BBWǽVHɋ%I(>|kuaI.ّ/HJH! EYYkWH,~tz9N'x9@Wظ| )/d*Z'%fpS:;fz+yB`%yEYeo>enw5_;Wf.F.W ፲:F]sBbxyH[׍j+'rR34(3z2")1az( $vr2; <|('Qۓ#L45cɖH%e던`nx0>,gf ZH=y9}y;YMɖse|U Lޱ#FxXp!{tɵ:u?;P?1t ;=KKϠ4Ic VBTnƞnhVժ ]tuYnOVt{ldWҕֈ΄ A&'*-P%dMɉJ⤦HrZ5R*(Ȥc>z=.t5V)9YyE! _ N(_tٜ&Z~LJ[Gg6Qb/;x1wI, ^;w yᝪ6pkAϹˆ\<[=/ˆGb~1(*uEF]o K(T;\HlRVtyi%GLJΌe&tei{30b+@Q3j70zݦ/6LVlqn 1;= LgfQQρab7zNdr`J;|,?!|hvs9lΣgw+8gA[\UN?ԍo4'C⥁%`AęjiV p`{BxS$UAd~vߝ/=k~Z^F8^f*7=O,,nj#6˳.=q؏=F6[4FzI;9A/Րr$yNJdG|$''‘8EvX]`Ӥa~XO?t߯=,>\;OÝ5Cʿ>ǗU3kw7tS+eļywϚ4L+.]㦑%r5fgͣ΢_56uʊ2/Cd Ԡ2?^60;1=PL a^N>#6+N{t0 ȸCMHw6y}zmBP;^'&@6dydt. k ]qa~eh;-N<2]P "1vC ԁB`OVa:p$෹n'ѓ}w[Vth[  KÛh0v`vN{-khZ;|Y992569612>U* };wmN'DQ>2Χ~}EE[*3?,'yQAB0Y]PFfdώ49MFayY4P)YNҍpnL?p-|=nDv >O{?=rqRƏo2BJ2v~{s5oߺpr[vh3)ߣށ̎fӄ]u͵zqwsU]+  n*W c 537~ܜcd10O؏ZuvTo;B6`D^dfb٪3t̉eɱӓe@țʢbPLJHRp apaWޚLVhSWS%8flf_vDGTF_Fj!^Z5PiAlFrj3ڇhJjp9ARН쌌% n * =݁O_-0~ګ= /wwDFtAW֟< 61 όRʋ_nŧGPS=γF`Dh|uNPH`|$]uT!^mcܼ$>!dF$FN x+BțT\ŕqOWo].r jʁؤϾƁ܍eU`ɔ´ |cpCjltmW#qW5\u ;Ɲ +W μ 隧a]~>yY*Qtr%)oQfɰ5`xfl Ok9EɴzEets*;%WKaEUi*v?ڟ9{vApZ_p~ofP5tMAQٕp=<_$) /$1a6 1Wps+{)з`AYNF R>@)+ox%A-Wq퍴TcH(^O׫m*"_u 9s߰b}ŝW]XZ$sg^m_f.܇J=tLЛM vKJֶ:D Ԭve`=Y{ثx*=ӎ= vE|" {d[h=:IZuNm奄[=xh?ZNPX. +w@\܊AqX<|BܙCq97MԂ,EypUh EW L 댊&a/ǰxކ=x"{%E=@ݹV6 T"A)%+wn'& aw q He`??d}G+KP ?pi)_R`jf}_5mrpI/2xe &W D=KN֣_e}U] Yk.WW鹽|pTNUфg&L&Z:sL=Zo袒zuEvwz ;6EO%U8z!7pDPg2/r(FUcQ:V܃NJH\o믷z69={w'2>Z?M6T>K HJ(zatjTS+)q@wsYoE~Amc͕A_9g~sUP "u;XP'>inV~4cxm[{+YE)I(ŬI䀦 %K '~dr}rzszɱg:wp^Ȟ2ƚJY /KVAm%㯘;f!p%xqMAx زS deR"/1;95:':@-_9`  q8th,vꚆz?%=2B/4/WuwuWs{SS{5GI9lB I!r"I$c0&Qn{_ˌ c\3j^uZyݚ;4N1;w^~ iӋHc(/`mOLMFE ͩW6FƴtVNJO%p@%b;ܯ]Aw/2><[hi*](TKvRkiݽomB~$ 3w1V+JB`ojh{LjS#GWG:}xi索sqJ)N<Дv"A՜ژԇ]9U\nuµ*bI-3] S<)%5.z.Gՙ,u⸕͛{8~lu<`ip^GW<26`?>0jght1ݸ~fnvٓm#f5Cymk];u6lnDSSOg_<]XPD:׮}AG|aB2!'hB TĎaH?vZY!\fbxc>"\~W E9CҪ ~_Ux]D}Ff=Kݒlt}`\(EIx\ZVE)|9w*8лĜ 웖2Ɍv30nv>G̕ҮغH O o ) ?v&ul =yzqH]"?\swfGVڎMVv:];KPO:ꟕ})}Hq|p fl(%7p @:lО z4f/]LFgApx N@{r>vN5t6n-xvj7(7vUs_TZ,ш_7L*MO;kàu+'2KI8^S+lJ؃ġMIYeynAMZW\2(C3n#!nl$E@Wf"kKMfil~mr,ܫ^/t2HbR >Yz<>>_ӭ1"zbDxo,x` r+z #^cF`"c'KGLgJ[-̀_̍j`ۂ,ekͽbdw4Z(:~ܯe4J0=;4<&k^%%' { )?g}_N6OU8Ssv_ȓ@+ >>Մ#ٙZE*ת{ų:,m鷧 ڀ, rxՈA.kz>so Q}sͳ2]uPΜ`EskӋ[Vbu3R0L?N.Ώ::+e\yTZۚ*zy8NjcR~mjBv(udyjo c!ٶ wjyRTu*`fƗpc l N)i_)էZ%HÃF[ L l):!G/lZP5`h Bxh@=+ hylk^x9g_O*M{>aUGlF8 5Wƭ64k#e3{T[xӖT) F7gve݅!I;1-4nnak;1 Z{x`6'Z72ъ땞7E~{^6\o\4n;MˑI>ruE(/ۗTߔWb$6v iJ i aV?$Ȏ|ͪzEޑ:{:;P>Bv ݣY}=֮6VA`gsbv%|#ZX Ky/.w5%DW6^{ef~Pc`_>>66Z:D^fhOIH,<%)7`/,e6 s9(촛 vhfc&ԃ_۟HW.[",%27έl}PIخa9"[*f%OŝOncj xvf?[6~j̞syѯ v8ht Dop4{ =/T)yxI:My{{*Q:j`ǰ z{ ߧ~2i ZFY)95?O(Fkꚧ!TS kXFVukルC+ki(52EayˑG' #D4Y^ab0'}@VmvC A5뎕VtExFՄsľ1ٍ^Y% ,QiyÌ@YW٘gY#(F0~|Ȑ>vO "`IُG9xafBfvd`B/dMoL0kQ9=JH*'gz/t z_Ӯ Att=liOFTy-!?auD2#Eq-'E%29V 7V| ~?e$V6l}Ǵ8NM_ͻ.8DpH6zDGMWbFP]SSP!j H#)BKoۚoZQx1Kݲ*ۜ 㘥E =S GO_:?e/wob0Ï{k`t:2eIX# }ca[ت*2Toh};707/,Q].:g;3JٔL_ٛӜ/ atjsNfs{|ME !8 #vf8IaX@tc1gI?DvDq!BB1'QߘנφPfrς혍+1>'-Ϛ|=+c"=_܇ AcaR hŒ%연݀k@C)[[VQHAP>YST>+nF˿ž|uyq룵McmY CikO #a$;312ȧ:,TQݚ?XZ˓ܳJNbyP6R4N# 7Aۜq3_dvnnfz*vl{8X]pߜ|3}I&|@"?؉_fˬgXnޱK/ayƁVp?{{GG;]ב}8 wK|Q4`ҵK#C p!4>Rkx{1- ApI8֖ՒSS$(O,(10rf옍&h;iI̺8G$</p+sVrO‰o-hͼˍ a; m#3`YW^t3RVԞW?l?Io>/w _ig(uk?CNH@cKz&JqGdt)摥':v{ڏ(aq2=6h5jT963ۭc(}xQ>UuLC hKTX_I(S[sZsVDruV| bv!Lqqhkx1;nLcK/a`Y  xtz,Ӱ311Is7/˨Zl\Ʈ2\5q+cc`aX3=-[c2c_Ȳ<ONgw6& 2`2ƀIFHʀAl2! RUnݽ{:wTx*Jz}sqf7ƇK'4D12 :_-z-2Emuv ,; Čޔn0'[9OʍƄRң'47- ="0!7԰a14Kx& 6sj:6` &AY1Un]c]!:-LvT;C O[' W\yXvI)Qn#F;H>#f7Bku嗥ylnl譤Jk69.R7G.ar lW(L!x;U8̦zу5-/UW =zFV(D`Wz8 E^eO޵!܌䧔ۧ5}O_$>nGڗк=ɊwDY;uf%4~nhWO74H=DZJa5_ AiؑΦº^c9ĝv̷E˲Kؿf: ],:焭ӭ{@Enw^BGr;i}7=4ܑTJh"kCE h&/jJe<0Z%oPHzT4'fX[}3>Ï!KڰS n]W S¹0F ѣ4fh:5PO(zaXA&BDMa߈A &0aqfu]8qDt)O49>8Q5lL$ZIPUzW(^a?z~yF6 e\S1v#hm% =U 5@:sɓ.a >1 w-udsH7YҜAB.(ԙ-}-+I^Ĥ2b6 I':y]L(=qNg7`um51˿IZ<{U3bo:d$I-% a;3Ѡs" W4)h>£/F G86hf4kv`ۑ``O[!FE­]xҐr;9v53 ةIa<)c5h }յլi&kC]"(+E]Smqv`uQO1Vwc{ϣڀ 5Y` L^tX&?*Sqq 5QԺ5/&CwShRޔ[jφ(勳#}Sc!Jh BBh`Z"Jl 1\ڰ$D |;>Ȭ# QHu8 9܆al F`z|';_+2)AcCD^iL.Ƭט4:zS-{_gH]ڡAk<یJ⪒}Gv&x;`_.&x#]IBxGt;i~(=G譴&**z>ejhӸ44^oN${ M읫3X=Y]OmaSo24"$3y`X@K;<5 -\X%1DN`'2=X'p6z!NݙP7jPz%48PB噅iV3ssw/LWu9 z8?~V`cQ<{y#PbavaK00*ɉOYүaepZ[EKBZ'.a[^znc3Ʃ+- XhO>p{Ljs%{eK=(UaMZMSYOzўL c9/;ɿLltL] oB$R.e &eϿL@Tqtj88[os+'Z>!_?T Oϭ ɹQׅC=c3C-o,-W6`A 4fft,!{{sK(Huz&`~HF+w.CZ\<3nm&vOB+Kؙ}5|3G/.[B ?~4>9~ lW8';أl u,avtk/#G+qӗANgfw彑V E?voz2GB Rp|Rf:9B}/s8A߅`'QjM[Fgž*r}VjVR@oݕn_&DŇ= ;I6fG=)=v O կ`RwXTJCrzb9`cg  y? YJH#&"T(IBXOQ[4ᬍx74w>)T&aƜ&U4vMs!3L2,<2BjYqL;kU;P[]\ ;xuzwS#Ϳ=$ʰڌ0IsZ&'yd2S[T\ڒH.|Qt!'5IK9;mYe ?vRʤS-sh֦zRB*?%yoB'~YZUj>M>ъ&zPmq}@Q')_M۠DԇD@=Er9.賸kusc|z*2&zim |w ;A<5Ѻ["m+ΐe^zath'KVje52g8L.!.]x7KULLNɿw,:"1ʬ.)~.ʈjjU޸{5"Kd{p>d"jv߄4Lߎ. pi4*'?Ա>o(Vm/-8\G͸s"bJx^^Oia"Ÿi-;xv#`1ؕťF́$캈0Iog b,xS np {/,Nd Jr6{(6)!@}yd,e}{ >G*%VvћB Mh'(?> :b>^Uaҏ>9PtpG֢]h׎|^іj짵Lq,}/Y^A)c'&wgvg`93 ^~(%`VeOchg%TJghFդY<% T+ Ԙi-*Uϯ,\ dŽ'ZUX$~:͂;7:LS +~; )[ûnI% RW' G `ʼnrsgx$pd 3).8~Ww :;sа1T]|&Q@"[u*/+CH|?=-BAoO oe'!_tJRx4/_D:2RK#iYU&`70MCv=fh<ڝytRӞ "x _BuE޹\5^Tx.NPɧƢM'6vqBZE#Df^zV?)1Rapnqut؄%w*hUeu/̷uv@ #)K^@ۛb׽>9ՠы#ä@O!&L.@,#p=m|v$"/%1uP >_O,Þ=|ݜƛfКF9~B>533;;;!=]$ع3\,_L,v~.E&ozڮ&vp[-j֫~DSJD(uNt2+FП6YOxq`[6ʯvW{-1٭gNQQ^xҒMhrOxT1Ȝ9G>spJF=bY"]_Տ+9N0,pwQ2z ྑ)+`,!TCu:!~ն/Mchs# Ϫ/2TDqhM<ѿ֏noMݹy( Z/&s9{GL胷\cXOpV3XB58!Њ& X$M Dm 2HI_wE.]XG(wBnT]Ó~q?%56?Whs;-S%d^894h Da](ϴ^ž#NH d{d?dݳ9ߝ]QbAA*BQ!@Ho!@(IHO e|sqtfws'⦅ǭ`|\-C`= Zo_[@Fپ; x+]`PZb#|X~gÄAx텕eINrK{"?uÈi[fA_Dz π;w )Q.ξ˹P+ x@9-B/}+މy@(rP;QI_I`*^ڋc;Q6c'*1b<^Wlz4\#n#?#_T?j;v EeP:6,nB~[>DeZu-t ^I[LKgX{h9ә%)>ߧ]AZњ`tE`\c~8}l5;՚ Uw|z:SHe2#CD&{z #ee̸H ~zӚmQi1?74a2\OnXvPzHx+h PO jx,!h#5!F؈HJ@n9Ԭ @R~0:/O??8_iXN3}ckwq~JfW캩jT]x]rWBʰxMOOoJ7fOaTxEMsbhm} y#/_Z|q3=%>uׄ`(ݶg6 öOP7YA@?_874r?ԕb #Yv*qqϠ]i LC#@Uz6UJ<_\`vTʝ}X|X-Q3C"gdRVۑc@ >-q`[FCuG:FsԽ!vbDarDŽݱ!ҷM=G݈:ˆ5-ӍK;5|l\>91 #&aOlJؽY~#KZȗ|-+v؀5fky}Ux 39v: , aƱCzJ((sP~iL6ޤ2XZY xvA)Fkxܸ|t@ӜBJS`B:t6VPɟGxzHH& I>_loD%h|a; A!TBx> Q vņIK?] ~eD؎չkY7wӹ%Ci]XH6>#{=*OmH7pC9+;qr_|`JƫEŒ`Pv'ql{Lߘz˺|aF N(ƢDJ\]<84uο*la#ŏ菾o2?LͬSkW,VΠVL=(E2ahu[Ha͹ȻWWíw !J*ex *FP\%S{?z,iG?>9o(QhgY[`'xjZ\w[ܲLk =2g w/vfFW@o=*3ٗA}"1fުʆ7ʶXp*A>؄PvHRegN<T̢d{yēAl?륕:x miC=9vc(vtwML=kbqqpԁnv9Ƣƿ+]GU8! 亣iA}r\=nsVcD 浕pD%-R8 0^7^;"z38>oN[٭y}`7~1'jěL{Vcz_. bؤR\j+ߪV%;t&e?af">Ymv UںvUedBUd\mTTEdrCR #40I :HnOM.r݉(hW\vV6bVNLFNK,,&~MuwJv!_2o󜞟c9ECA#.)eDG̫tA5,2.bniv;)_va,ʺ23Bw84kz\3 57%c+ͩI4>q#`ޘF,x)Ÿw4'܀Ț֕Wܔ1\1ehrvіak%V[7b+"kcqUщ M%Edknd;1 >E]uv<5vnBTvm`sEV'-3{v9/ -dp!Imft~gٜ݊Jo*D%.3|lpY xbfZ%*.Yz3 f'nvQz[vp㩝9_=0mˀ-.|p![0d&EaٕgQ٭/Қ*ydrӫ!Z0r`(QD3fNqMD mg~'_CO/n`o@HFE:!De6𼰳mvqn}蟀=/;؎<.!^\mk-W.lph-"եYznV5?-W.OO!ػ{~ {AG!WMs12}Y;) IŒĻ4 ] f uS(o'4ƞRRo{\m\dEԫTr ҕ3@mIHv*LȊnkmh2rS>'HtsBl()'ͳe1`ݥF'>2ێ*c5Fͅҙ+ȱ\Wl4;dziG~P7AɁYԈZ=PVO5-vɻu.ẃg50j`#`]\ۥm.=5=.Əw?`<_f Rcn] C`{8Mh !1Äp ;t&lU,kzLȬ{ՔܒܜBQ{ 3 bΦ\t̳32j驅UccZ3E˷6-x#E^7*x3 <^N G%.hI줣}=Vvs` Jv"K@W^Ӫ˫GE˝¥vbۈbxlK"^AWkd@a_ Zζ֍'ٻiy~B 2po2"jc^5k^qC_hQhth.7&{{ȫVT!( -/2/A=Ig'O&/=9fciWc͆ԘLV miioCRsmdzWWGD#B Np~|6a7Y?C_|c 0ҌJ+ %>0}.z@YiJ ZlYn੹,.+d1;^QOi qg /Oe\>łkWKG4ƒj 2CR*ԘhF[ Z>6cV~at83vOXl*p/j#uV^[ڙDbK>}2L0iZEݯM˦hzlׅ`q}KVTWc NJm>{s4@qر::ub9^&+;Wb֌W̓ɔ샲{ǂ`ǧ}Y֔Aܳ`/{әnRϜZz.QXcTRc{ZF6bj̈́ TWwv'~nï2Uά,Fo(56PH.sgYqW]QLMr s41;d%*tSDoGfWC~GBI]$k)씶Tajl#):ěأL֥Ν\F Ѕԇj{_2> vC1atdR;s8⎜<6i/q([>U%CmfBuù;_!@}Y7 Ԕ?/_vSJ(+ WF6ĤrfV5Ym/ ؑ*lHR4X9^deg5քk`?ɾ߯"EӋWš){{g =v'7Dep.kQS17`ekM5RY`0'ܣuv( `Y'4$xSe_-MotM1_jfΗ|wZۥ}W@TqAQFQ@0laI5@ ;5@ lIH.;bޢI$<9yk9f^jT ;H77547WFA;Sb*XȄ.r1 ^P?R˚lGC.žHf/EXF6Ѻ~=I=?5{XfL;ڟ; ,Þ֒e"U=g_\pv3Ko=k@dȈNWXf)v;ʸr-MlVT Ή;Bd]XR]'pҴjF lF&}jn`^ =;%?㰾$#:;Z*qMiKnyoINGeneɚD VE"ظt,xG֬Ø4Ϩ͇?ϙvrS"B͞Hb+]nv">9jvH%HqƮ3Ǯ55-)Ҷ)! n{;.#豎Ljed98ZmMgh^ҢqX,qXjV.׿?Y VuS L Ìw͈pU$^XsaBv!?@:oz<bZ=@&' vϫMiw ⁢$Kc"pAvoe o卌NkC%Smk[VV쫪)wcJ^)l;^ W Z!o[{jc_샳ȡx{;[ؙԚ^y@MXTW5GqMqɷQ]-~[4,gQ *ܛ燩yEz~~Q9!7I5?hML)Pnj!bm[z͊r승7t|_\6Pb&{ i>F Z@fxóYPbmPSC.ezCXzl:=?ĭA:0vNz]ex,6<%nTq)|Ȟū;v=vVFtKŔB*;ɹQN8osC SVl/VV5k)kJ-ʖu?쇵îQsiw;=ҡJ{T)إS3gbGV7mxQMQ.O&=@]oH~Z<{XoJ^Q4!y`gqn\O`f}9:JYDGGՋ>ڨ7mWז?nc/Y[nӚ{sY/xŔZNm켹xY덹O`gjv /,'u; x&=Ͼmq.1{_{Uj {Zv98i:!NoeUO%:}w _˻X'a|oMj`K+7db:vn~k'`žvH㋫R">Gx﯍˥s#=?O$>2Uot#$`!KQI4](Bkau5 RW#;E#>{E3ݎ%9~dq9Պ;A:̳O0z rxKo!M;~Cf&qɾu[s,Kz<3b% #ۋ  n*l/krY`^vKR(Lʏbbgp~^TC} iV۞/k7xY,"`/`W3G, 3;4748:dSS ͨ5rVQsz[hµg5D_/>_}mݷf@iêǘh 5bߝvQcҭE뀽wEUƶx{B]yW#ܮw[RvQAիH)!2RZkKaM?_ ;4 %!sI iC5 &LYj}.1/F vTk vS %rS Hz Yg8|h"1_I;Ta<]Dli#(9v Yck (t@ߕϓ>-JVl`'cԢ5:F@ [I-͠~mo?Sr(͑=3'';[0T&ieO\lYb^^rYf֑k9lo$ fa兽HҚL_v{MdXIN. ŷߋ aܮ;̯Nh]c=5{oӳ c{ ^'O1r1ѩ]Q̫ jtjVUݨRM`^{/`|--e;k "ɣU3%Ή>k3c@r%`}Ȍr6 rxpU@Y~Oaf1ޡ=s&9p4`?uR~`5YU$`'/+5_]b2erZYsᢛ䛎8 ݯ$t+J vN(U-fd~0}FeX静yܼ>r!njl / ID+cjc(v$_E&Z% BN=iHF-<_Lד)6Gߡff_}D{ƻ_׽4k*#Wy/KcM7r]wr/zɱ>ݶthO&zۨ}enR SǼ;0iژ}܌wHܒޢ:~5]ȚԒ%1w4s2S9| 3P($nq;זa$> =-Xw$?srYQOMR#U.4b,-ڄ,5ktzN/W= Şz<  X#OOνՄ\z!YW.)u O7[F]i~X߫iTJte(jDz=6$Y]Fg wsjt"2kF¥O%0{C;iqAW tYgطaj.v4z m7Uj5}PrhvA>pi]=Nw Kb&cS;S:ʑZaU8gzH8*^ۃ]?alg6h|y$&ĵ$7Ku>=M# O]=}ȷC+b-aӽ*zbF]cBP3D|h(}Tmyv*?oÏ'>ƓDmjR2c7hHOXrk[i4]PmC!.Wd *ݬ<:s9xn^`fzx =Όzbb25b!?µZqYmRʧ߮hQ!{7"_){gºڑ*@i~o^&mEE.^w&xĞ>{䛘obOfxx?{յ_~O_I4* B Ҥ>t`)"8H/C JGHإM3w*(} b _\+k5ܹsa9 V!UIF3 FȗW ZL.yטy;|k:k:׺~4XrV!P'ހ]@#!=řx GTDWh9JSp\^aJӞEp$ʎC^^-_}Im1UF:q9:uܯztӻ=}- ^o=!owY7+ F}/:{eMi^\Ik& d tNHG؉z[¤+y}M.E{cL<QlvRGq+]J.#`W`GCjhyYZ 崕ѱ1>A4!ZuJn`HO\xe4|NEP2C2ocgV^/xFFօ驭YiEuC5c=7|8֣ޛ{&ntwkinͺ4XLHndv:f=ݛ@ ohad %žrP -jE,7v?6TPPu9ZA@]p{xϵ}]]{{Win3U)-APMA6oeT |?Ii*7:JziHZ>r^+4D:Ws"Z҈TjZ%(ԫTRdJ\1'Whp\b*FSsL h6?09++v(tۜ3.9Nrg+G=ˑr0BQ%i4'V 5 Y;TZ7}Ǐj?e!6=UQ+ K^;fK!wG{o,ƔTL\n@5b(Е#TE=˫YwI/!}u.陼] a!~>.ATvhLctZK #RPc#ۯux=TWsܕ̄$jmKE&Lo}ئ7oڶ3v߁cfV,F}yvωtJ"z3f]k $+ՊפڛH%(q BT1^910z~q&"jmQxr@*yMU@nC Xr!j174g<;x+_H FP!gAO{ŗJ NZ0X05ȋHuz?_|1l*`Xioyb_e* h"~Ѿ}j%/tgSU^.N zjlc|Zk&Z~QoePCvP}݆ƻhXUElDjm{Lszԝ7 zcȖ-aY65!!ڨ$#bs6ùbT,'q9! dD zPmÎf؅؂+bJGC)wۮ>h+Cݱ7ZHQ z>=R̓9tp玫'Y缸]kZYܘ)lrή7xpqB !5Cn[|:^;5xǍƚlKxeU9wp>C_+GZٹt]+s|/ F/9l]]GPԼ֛=VۃKl(5~U>椳97**K+**ˊ { ]͊kJgQ=K|OeYm]OFY)Do{NR͙V.enԦ$dvбY7$)(Iq"`:LNx^p2\Ps2‚hNWzVZSp^GD+7۹nG>=rϹMj عb\!I PPQ(uXnei yeM5s8 !#@7p}pPAa.>|ཥwˮ^.nޮrVyp !ȧS{}uyV9,wm02rWFNH% ^Ɩѧ3mY~Υn>hΜ̞BfO~^A^_~Nu"ȹ仙g[H8k囵~_Ӡ7Qwgx䧬SΞz*>:)L%WH'u p躒 4_j8R>/Rk/woJjuJ/p.&~F?$r*'`AQ&*#IAj mޗ]kZms<&wCvG?(|AlQwQ =1R3ßUP 8rbtb =t7RGOGhqQr1 K˻t]+s|/]%O=v]F!2Ԁ">_S.smx3=]\ ϔ9\ n`ZS:2R:R:&'Ǵћb 42{Sø[ÿ|/Y{w8nrꢭ%oꐰHFmlt^ pE #cR`W]UB7q=Z0I5e7]dY`Ggy O&ERb_+ɘBM[uYB[R|1eȀG2 ;x| PZDvAj8(G-=܌#*U|@0 /ĸB'A_nm}uy<1,wrbI'DMM|@,H.8Oǧ)'.]tpɲke_uxp -Φ#kB=)^na6}zQ>? ۨo;hEPYNJ3=q0Y&ʅ<xb%>I&HRdq)ㄡgM#`|F*1GUUωFF}rsVqpMC 8G>B1;@ WWp.mPGo*N\9hɡbQVP  ~Qp$ʤ-./wRaѤ61Ty#h0jeUQ+_0v>K髆m зka@MT G܎:0]͙f'N)t*(x{W{T[0mrϙ;9dg^_\ǿ^kHؿط%7ؘyL7+(JNu.dq8@BNWI0Yx%!<1 = mqpFʹy< 6[O|.'ǻ{?`kVØlΘΫ^Dj>W|U_A.Y j$X%9uNJ& Ǫ '=iGi- "nȌwjѿC)7h'k4FWbuL]a_tm]A~`_zoPİrA5:3TsNfYvFY&yv\zL l{\fPCi6n*hu{~OǾ|~}o۷g[-D:~Z(` -jzC& 5nrhĴwr\$|b`jvN睆8T aۿz~#=xJ4I CVs$ #M,K I/W rU;%M*VN# ;ͲZvC}S#݆Yߗ|_sۼCL nxL'(64hˉ໙VLk\\kl+Iv1 ܳ!u}q:\5ׅ~1z=GϙM;VPXQGgdzh٤dj=g$:_RFǡ`Wϫ_.ףPŘ ry kռcQ9,0o|5;(=;̜yLμL$yfhQQDfYDvdQ ;Ⱦ(+ /&BZU]=Ԙd̓hikGF X,D\! F_aDob|pn9Q;Xn?GYzv<(LH!N.Nձ# M=hBݝje8R?LfM֏%k߰盕^_}>۠7Ehli[ژR|}ʼb:t~+I [k7U)dVΟ簹l`tHPKUGvZ`C}GIfts"w:fR)1A\D6흗KYbќ{t, k+DRó` l7@8D{EuUGW' _(B~ZRz1uK{>KZ|IY?cYWdX \) 8 d^nHc ^ }KZ A[W[stkW&u~M;~2ʹٻxgňh臷}[{?KwVLU{ ֔ 4{V G<` ҟ ز;$=pn啑9m9bNղS;wD(9hN@"!FD 9҅00ؚvOe>-bS*1ވ9WUv[Z`<=Eˆ}Q ԓ㧘rxxKaK99gr4,:MuHߟakD1IchcJ5´7jm T ߶1D}}B6oM7I%[fPg[W{XZ{ʚ77ͫtpL{ǎWi uH:5Ϊ jV*!ǎrOs `$bk `W =}/_뭬7u)ZO㨚QȎ- 焈0ΔH8Cر>O.47wpwm)V ZG3`^ !>΁|To/CJ^.?_L;\&kHfH! +uW|7r~ B3Ӎ6-TgkέZ["w#uS͑[Ei6ȳ)q=^I;[l^kc&jJS,{yYhYk*p2!CfOZgQ8XX(_2/`fjz}OgO[PvEvXl$|126 sAt CR)U,`_X;Kr#wcRpAMG}6`00 ٰ/u>/vb s{AK.ݛ8UI6QS7O06M2N bvvViMwGf-];untɖ+?\6zZ뒳~Jc!4˴C^h_@ e !)O$cDa'bRzƁe'#n ](sʳȃ`-XØkK7=nJ/8.$"ɰ<!0c;%x,R` aY?N}xQzǤ#xDjYUiKP6< .q('?93آ9&2eeqJvI5Kҧ+hf1dA~ nddlbBޗje[\Y[TsB[5-W ZmIVa"&x D T%>;?(ѡ>$>rFJHK9X8ݖfNѺ:0;w=q"ӝP0G2q:B^f;4tOL+,-}.#^I}vD$?K wC~#XI\U`h,v0$@`%Ěs6({4GjD{D  TsnpMvyԃTEy)aڮn|WeYit2BG{ҏ  U VgO?2=5ԮrQ h\%ŸGf,='qv3n]9q+?fMU8amXa5ƹ/G<)VN# 1g?a)3z{r-2.)Jp  `%vF!b^93˪>Ss]9Be b q)0#ɕ L]Gz1O ;WÎ-!`܄V\:`cG\]<2=ܲݲ\3ܒlq<dbJW~jctWW 74Ѿc=  DčGʓ&k2'WfJǮw\̊J=XPs%TRD)TΚX׶3Ej #wOp p .ėE VWvPH%GF VhkM7 \P!R%!?^.Fv;X_GsSãx϶u ^QvcivQ[Y`R|_a/w~kV{k6C#AђDFUD󙍧͕W/O\+Th(UTu4 ޓ+< 937~4|OYn{Gap=RЧӕf)9G҇ x3WƲ=qЃKux9W VbED(ӎ.B~_Ks~ k !&@:V&U xheス}/>\͊e߾l{˶Xf_kK&hI9;Ri&OCGFS2CƋc''r&5W<7tqyeqrZP}I3=j"Oq,tUBw{O}GI}OEYWAe)7H#3DK,| Kk![vc҉& f>7vU8'`ԃ2 + G* </A[h0kc gB".*ࡼ*X.r]-w|=JZ5=f5ku\M6l5hq6kr5k` !ڡ`JɈ'WLĺns8}79}Wƛk 0X_ZSZSDqrL 4k*i(1Kb2955&``dkcP X,ww#( v~%6̰Y͝-sՁMs8r0(*etR +aE`U_K!D*c%`s=tcj[._ߜ?~ӷx">O\HQCѾd{A.˞6wlFb 憌ǍV_<~nv=g]<14gau|Fo}pHCŝ y9!VJG/52.tlJKN 'X腚xz;Q1DxqXicQCm@N3Ď{3.]҈u1U2v{1={D}BnEڪ͵eWim|q}zƭf>{oYw9Gz%{% ' 0yC%J`M7/n7 {DA0kzϙ1xsޛ:n{NMsCSt~wNGΑ.APتc,bm T8`>O3z00q 78lFPDPnM=FЀtBc߾|d|EcYkM(4 A NO.|A_3o@_߫sr`(nI8K;DuE{M?~7V݁wL&:CsnA^х0^BH^aj] uƋ Ņ*2N@E$Ya`z (PkzY٤0R4Nj2lTXtSVĮ }b:ervG:pfߒY~h7_{>i7alxo߯z7)'w%_nvi,nb 3PLfA86 39m$O7AmӾothשn|e rdrvpeא$up8sc֗F{m`ڍ8,Vi J6.8=HV],PCCm `IlY2FP]rSȳ[;零n:;-y-.|6+:Hw֬SdiS^划؃[qy]lq UnXt%m& a0t̷$ >ͦf t1%H̄oN:U} mגjhÉ@` n1 isYuZw^[6׾ :|FP^=+{wjN:$;=t)qLZ(z2Qn"x lڿ$x]݉)%% ګWm%PzC;ޣ d&$n1Ȭ3OUxb.;'}|4˯OW'm.T++p4Y}&(QVm,V:+&RJ} _v߸ŬTvT.†f;J}caɕT><;z;˪װ q3g uE(<^|1>#1On /~oW-pp#gwK|stC֚y׃V |9k(KJygXIa DvSҢPU:M7r{ x}YPCթBkfhK'W zM1D MYS)BœDm

.rb:[ F]>+:-ʊ]VQ/;7--Np]$I╅WZBln<14Bere5 U/Nr_#lܢUb D.6OLqD䔈-ib*!YVqE8L¼xk5+K՝l9j誒7d)W_je*/M't%^K4Y7Ēfnp8͌/n~u.rlL 9l31,mw\ abH/m0Z64 3# KET'iiN? )D`zigG͛Ӵ񣛛mE?!+[Ol圔{,Xs *OL;5tt Aˍ,Y~\g̡΄#iix~(#̋$J \ٟeִM0j!^nrtQt `(BDl "YvMu>Oݘj)Dkt}UHaU7ܬn'| >K`$z sZu6#D#ДQ9 0x TddZA-8gyQ+́{V9, V-0a\ d89 ȗbJ-*!' 4[]UA59QPьd80N@Â?8Y(K[)ve ҍQ RFe)0b p[a:,HUSX5r_|#%u+җ_K2iQq#p^ńݿjNE'T|E7;R}va|·vf+AEur+dj1aIKY ă w?+qV‹,,K # a1W̰9Sh"ws(;t9 ',((pz<0@@8ʺ08Cu79 N܊8I%\ Fmw0j×ui¶ Z-T \RPMn<,P3aIk@37~ydų<O<<蟟{<b,he <j 쇻v5[U$ze}6;:𡬯Tƾ>TKU׮ɆmI͋>j7sq]%+#*D3ey8H{X%Y]XmL#qԷ 7 /2 ``sUpC8Nn  &7gNS`8'<roc^psC@a]p@q㜥w8-FT=C ǶoYpcPuN8 *L֕'F\ټl Ol//`۞c>v֚_=_Կ#?~xS&nD^_!q,7&?x&CTiʟR6穚-% n+VMj;+}Ɓ&x 3$jUl&{ *}t TJ:LDD[ 1Ql@%B:W^ X]9s̙=,xsu܏t (EFQ`Ҕ=5Q ZG7gAJFS꘭;=URqБNM۪6^ST:)5 UsA7;=U+G罽u(v f2e,V +OYLU+$JeD/;eSp|*cz ޗF~f+b` iTG[{4퓭׽S7:50[5(є@ph'!\5K֢%-Z; 5%/WY+@but$\ |%0WWd"I/.xvoʓeI6~9Y)hu446M MSBӑhp ̈́gfxǤТ=MÙ{0]w/# ^Buea=)93_zRaTsxziG~JyG9?f(Vc9mOIV/F <.byBasp|>ǣ!eimY^p@¤wI04@5Kt < $ 6" ]8F\쒥dL$+OU,ffOdYzis?nfe00 /ka@NG <lwݥNK6W۶DcM6jRW_4[DfY-fo>]y+#Q_ G`ąXiRE H~lnTVTv8 IȦbB SXDAb1dɠ 8L&"T<LVE%1}esu,l_QefeA@fJ ]t#@#m'=-U}IstKvBֿ9×& a x_n+w k! wܙH&[\3E*n, ݥO3-R5'z5_$Y1zmHYlh,Dfsd 2D>8Z8ʛf|DUm2{>w˟bM f6)СC1ijЛE2ߏVzysv&aX(@_ << $5I&٨~2x6}Q*஁]W%j_kR_ek!%`_`5@5vdRxw\bǛ亸l4IϨgL*wޮ[ֿ>io6_)V]VmgۤԥkєV錜M@A/7vg&8+wEgE 8Tn4<#0 q^Q^3ay2\_#n0@C4JRHcQ Nd|K1eu*ヵu6PPDm֖#2U֝P]]GRZ/dUXQ`wP<&& +9)v~Z {-|2C@&ӄd2'"4._k5ڇd]W״ZYB$.UV+gQȧwĶozn< YD_ǞʏLe(pGh`+,u8n^.")kV>OGQk+<'CAgrxݎ3\,fb>)WD5,zW&\ar 301&KL(jĄ:A z. &u{$9ӕ}~.am~`m[ͺ~Nj~~8c_g6ni1 ḩ d X$\[d/D,אҁJ"H`gDȡ@ pSOZߝt|>mg,pv,+4)?Kۡ!%YKjpqf[,uo o+mϫo:Ζ&NϦg ˉAeD,e!.Aj]cP. ֔Y\ @km B" !C`_2X̾ W[융Jf$%;cLbh*b E\dy[[C.@ݗe>(Fj~:_HaZ8.~g'Ynaب"b:e!3wCvÛMBvgr|Ęf~\켂:;_ezy:Ņ% %|#ŵ t)̂xӧCVփઝejuurQ#yG6KZ6=+ӗy#ڬow7l7"B5#͉1 ,fLbxm1bY k~X@t'Zﺜt6UO_`$$W[xF*js.~<{#rUx7XF`Yq{>nةwO}{UݣcW-j+SUKiTx&wMYui?+B] Zis|<3,џ\͉'/\J| 424$_H^$`ur`n a\NqH+fq3QgQO,L)n0!?*i.eM氦)5s(\vWN4;YY|򤈍r :DP1Xg \B.c(Hɨ] "IXr(^hT.XYZLeI>#X,sB۳nsj(M7NJOU, 9n"2q7Qsi$i@T33eϨBt%["(<<%)sYyGbkY*O&Eb3~'X#nԝ @IA(^ig˜lot҃;Y㸘2!EHR{eR ʘ;q'HGܖ<-T)"yĉ5ȁEτ'̮ԦsuQ&/]oJG9({"¦"VC]wDc| .[Ŝa1k\(WxIO@zw+ ` x\KLZUXq ++X̒x-!&ٞh2"џ^WNyGuJݔVC[9 xJC!`Nu'5[ީȽUj &M g̟s96GF/ÓI qq? a.S~oƼ_x v'xC2C!Eqdo=v0B]ctJ pde2Pu;W1s֙+eL}QuY 5rV[hސpSI+ԥn Kż!`˚fse"s8D'2$H_XL>̫Bp<>\RB+.0j֎|aAb>'b=T05Q-UW~^c[d[`˜"3 )\X {64Qws8d8h! 5aN6Cc'XG9A>Gjb*Y"HNq/԰i*,ıf#Ys!9D㡊ڳL-7ho i^P&<)Dn"J_[Jo-})ztFn7>Ŀp1RJ{) Ke-0^/ %m+"W}[TG"IzzJz0(佁U)纃U2"^µ]bCr%+b*Ƣ`5{ ֊jU¤W81Y=_\NϧT/DF@Sˀ\-뭵k&Mi_iO ^6ioԓ )[>B_!rb]yԽ}Rvi+ݭqJΐP9oOF>=t}8;H;45(yXcbg%r;G\#xD WKM9q~5Ա|_- Y9Y̡Cr+n<[ןT\Lyq դ-nW}%o&|Gݹ wpP\=t?7-4y4( c1l&/ b.Q]̣٤FHGXx1&^WeNpAcB:K^ZϋUR{Wxs?&_oH+6Xx?ˬ+`2˴9B?w/v}2 lH&c&4 lHIx=glz.@5?/9w%g7џ:P bXDX钤"i5{ +aǗ9W'^udW a-o5Ef!3a_U=ӈާcW Փl )S6r\nr[)&(%U쥼SU꧎Bp}ml{)}eO*{Yvg.~o'}ʹQ;׺_\琐Ohf(8i&g SjOᓌ .jz*';$r` VT0mcuLa1ep^I_@XiHh^^[y^[( ~r|Tⵣ1Hi$]w,ۨ.rWκ+K3!1cDLŨfbնBӆQ1mt2B^@[2 xP\/Y3&5.* >;WkOt {^"ׇvDjy*LLH(efiS?)#ЦחSft:a[(&*jecZ3sDR,k)EРthɄ%3`,hϚMC`/+W۞3ژck|Z- Py+:1ELk!h{MVwWYj#Z xtԴBn_tu';?>8n:@ԞMhDUTFT5]c<9r&>Ї2pG?R/ s֖1,JV2^tM;J.8bMj}6T7X̷/O*^Z3!I^'WTN:/ΤJ{UL0TIٯlfr~IdW2R>cmy@=yj:a;U9;/ݫA6F#A=mV_z>NjG>gnm~gG{ED{,\ʏCTf.5ڪ0Mvx5ڄn[GotW,: 5m ~)NOO*ed"غjWRCmZ2j[\= 5w8Uv#=Lp]h*"_Q םH3l2(]r*h y\B4{ޗ#00-4d-^EJx<< @sqc.AgĠ;n46ҘL,Lsuo]>ƅ$!4Ț 6][hƍyt*qCUPqOᏔ)Wނ'gڟ6 1fS9BRSDJ4 ;c3a soc- gsǜsg]Oh+`؟77bLH2jS:7A̝ q@\kߛ?}mSܵ& bu|ȻF~>{ξsr6șH ,|qPqzFrN=a-vf~#ʅjŇL5kTiQn]qlG=vgԍ٣-ﭱ%|Wس^m4y6!Ҩ6/L}3֦ާndTqj7pJW]vy緔(N]AԖQu$?H\]&Hڶ1/ksP0^:.1iEh)ب/u?mck'Co $ǰ;J_a̭RNQTYopG.T'T)&/H|{К{3{2NFTs x;#~28?i f!.1Nw7?yR~^eMhy&rgM{GFf+@Q` ń:>\U! 셟l7u+yLDuPlL#QES注̙07{ g#nHg>o|* ˣϥcSɟQ?HWxp)gQg1isq g-1s !8!0LJXeˈb.,OXGqKذ"6x[-Ĕ)Xt _J"3Ť"1TLeφCD€3ux8.< B|؃8]琕{ E*}6:_yn(xO)ӡb>4_Co`l&NN7.{h&0`ûFN2S9ab~ŔJ)*i*F*U ThT֬5ת5׬1VeĎ;kjecQwfpYbOJo3OnX m:03Q(ܬ)l=q" ^% 1Bd2/@RӁdR ZB4 Mnsј~l3Ϟ2dh<ޟwh \ew%FU**R)u!4Hǒ"0SApUzL0$^] -˨t28HơgB>FDhVU+b62;߁pRo;2Pl`޹$>)EV1w6 h m!]|<(dyu5,l ]Ag"AP28Q(fJ,."sd<%3Bq h0%0e^Fe.bʨx,ڳ! WDbpuY(DYULEؗs,}m5 bE.Ÿaq5rJvU-7T-ݯZdZ_V!45Zi=oq@e+&ݻ5h;n=noU\=@!LgKI$_?RݙfkF}6Yb{P=ZoS훓 -v<87bIBN%Ӧ҃"ZK&cMyZ46]&uSW涍3-uk(8ʁ" T>Jb+fDLWZ6pNJ 1#6+vzr\uLӕm{Κ̜BYx,N FyNGSazq{,p-Yci: ;mg-QuĶ^7tb_ EG[f.`\p8k!@Ht84J'h#z SŶ8>iFE~R'Y7Vo7~+J+bL6\~tRsR6sp߱BnR+YLb, Mfe$X9$9b4E 8!/)\y̜ ^E'c ;9er*.'d"@I5IO%S,*ɢaYz!i($@sb SVӑ̥R9$֜BᮾX)HZRtYwb!Uu&p5 ^%3Y|:."GҎCYS,{=?"t:&?:9I1=r1U Lѓ9]\OzcZC:f;k;bw;8~Г7H9+^yʧgK: ΪB'6+puQmN66mhX{|{q39&6M?xF ߜl Oe$q\^|Q4'7x }22DIK( **e-a0Oڬv܇4JQ)>[T,L LkD`NHYqC›#[_kԆCwg|RGP]0`4u>8'_k_5dm14=zyiˏ3׺ +J*"f%Dt!P7լbbÜB5YeJR;Ք|zxR{z/egmf:Y$wө46 V׶ ewe/rg]EږnSz|OzZ-w|Bކ3Yj:`YϭcN>4ªWW_\i|z!سO|>9Tf(~0'rV2mڤa7_5j4j|Ԟ\3}TIt[) ;xk;*8X ,÷Ӄ'rçx su?n+VsS-Om|UKkM/meO T)W{,|:,FNtqtUw >™fP}wKFJoB[_Ѧi1d$coajt<{ԛ~xyp?Ȇ Q|ts1 M%̄ghs p΂1:nfa9\Ȇ$1Ca7YwAW| tr@5Z},u, -b+s%̄'~&($iak:--6D]DŽ҉$:M@)I侒oɯ:ތ/ut.n0W:S4^+N?k doznrU}y7 7?n}䨜fkk7aOl|7c àGxpVJOhG [)$ 5|j>+*Fb Tlu+|̃EfKa]^zZ/Gw*v/Z^exbB6^y`}0c$Ĺ*,xSOCլ&EtTiVi4m?Q6˃mW}Q{DǞ_ }Q{n.gؘ=VպR|0'4N !'{mO =9;Bٺ+5O+cXn[s|O[#G]Lu tc> 2pRtaҺ랩m86)mR^ 4# u伷jeYr~ɽߍU瓿˾W~=e\i4b7EW=)s27ǝMOFFCq.W>W|8TI\B ;Mm-71hlX'pl\#Oilbb/!*zk][UqYQQoj1 e.`n:o{.:6oNډlO!qTH[!̕`e6NQ8p]O'ϴmԛ75\o'2&H#ITB wG'7109)!!EЗKAw~O{Wtb\ǭ JżjZeVcw*u>** [l*SI>B̋_n8^Җ;@ϯox8e#x v>/0 iҐ;l ;{+fV)^bԖN,g]{V 򊘿,3e U#4ovO~.2hEhkU)4YvX/gb=55oo?muɤʼvwO۝ ;QQ Sˎ*rLmv?>rߢ症^괵춽\p\2ekXkzrOө'GX>0dۜgҟ_ IF4}@r W۶8hH'뢻&== YGcudW)9/#F}Qw&L#kwq?\_(ddPǣIIO+fȝ 24`c&6OO b-ݛ97\zmĀ'5R/4%s) |@CRՔ*nF&+gcYHB[|=T͑l#+|Ux٩csV'l|kG Φζ;?3Tc`{~8 }p t d}ttQУcG%r5/7~o~Ǡ%=%g`"4C/Dg@ϔOޘ⟩ FQN'@7-n0q4Xv0H;@SR[WrZ8Ƅ&]^b~'Z÷ (=@⇁(grđ@\'Dg> {]yC7HZurhb?\.W(t@S,G=eƨ1@SvߗbI|O4Ҍ) ]7k9nsv]|yi؛ﬧ>L9ݛr²u.}kriy:m)k偸e'LwDimS+D_ʤݭa7Ϗ';ۂ3+1ߞ_FGz91ruUgDv|υ[.Jb*\ue=1ʉFjif>*fѭh\heybƓSY*翗'UF\,2FT@!ِ>PƚΥQ&}߰CwCi l"êKTH~oBDH"n;$i9I.iGPؤn6ib%i`a b"9~>B_x\NLIN]fCxy_OH\ A3 7ܬA6۷+ o^a_nsq/֦Wpr ~_w}rom' qoĿX]Z LٸTdXY/wx\ja,Jm1]\F,PBIrYTx\x]|65y˕}+I>I!\D irƷ25k}rH3 ԩPDbAci !\hI8qbHnBV̔o;Ax< ,/NA|fqyLih̗amP#P3T/c*n9m~@y=>xib @t=j͍6#Nw$dl{?v}~Qwwxxhutw̽*N ۫Y[*L|ۧ/<_=nxv5dfUP/߯ToZmr^gCeG3B>pSBg+N:{ܾKgCN8#CՓL}S-V+1DYhqB𜣰S{ 7P=O%H>\ʝ)d3"~ԑoϸ~WҘc! -.1etH2y&aHÙ#ODR '(|vm\TQY,Upe4x> /vRCHB͓aU`6;iW6 xA޷g:k~QI(&i y ܤKȖ}ZYJl\|T i. [5MXG72T>Ώ)Vo鎔HL͔YL.T)+E )%)e|l :XviZ]F#vArS]hGYJ=r]ޠ(Xpﶴ]AxJܹn&Ilj*^YƔ0Œ5h̏=ctfstctsLN^.GdQVD4Tߏ|si$=2/*Rۤ#vekYcΊúW;.2 xS=]xquu۳ vw ^6ʱܟcu qU{]<{>opi=:x5L5ثfkm G :ͳ펅{*ʾt걚sUGYXN^GW;"ӣ&X! z%K@^;dvlZkK!|m9g> FJo/GنݒL<4ԘC mλ/J-q "Ts45 8G]#̅6,O,bȓK/Ɗ%JA'&~ODeBl4̧)C D kXˁVq!B|s>AOx0x k.<[dQ )??[tK'WKЋàf'ƠJ??k}}}Vu-[66{nhr깩_OgKwBtU{s]]M᛫*6JvixC5T!o{G`9 i dXu*zVDR(KS%ujX>h0@.zs2rS3۫.-lls6̊x젽u&=4" 7}H#L+mBy'v|.ROr4up!eWa=tB΄qs9iHڀω6ؗ}@v9Թ<2^vc0|6h"Us(Vn:CSu5Ǜ#jKtTM|X%SdggykiO}4pX&A:(]Y+.'H$O$ !wwwmݽiqwwFnhڐdIN}g߳STפaR]]7sJ:w\Iv<[o@ӭ"DX:žPܛ&]O=ZJ{CS@Jdp-l#1b|'z;wVX*[lv*FR7!:iNZوH`4P9Jt drړ@?29/ j*py pVh\4RBW dCd-qp v1zutzҁ#_ps|OTG_;?Bƾ"ev^wPfXf;PW?'g{}| 5siʋin)nv e ߿cKrBlQmSdWy"铖ӶZzz3Ƽ]GSq7Q~Xz̳(mt8\LBlb7J+ٔP+zǸ/_rhh<|GKGkmנ$7_O qz=_-߄ީ_* y9̙k & X*cޯ`]͠AU/X)5d8cеN\P^P#!zƋ.~t,SZxk)ОByƁ3_`[QM/ϚxmNV2UF!KnH諒%gj§5߆6ff"Wˌų}&TMY~ 8,h; zwѻ5M'v,~p9F.'^L+ہWݍѿm![kӯi6K׫Y sןEQ.u.z]~ˢW2}1io3xsQ'=I`z(ICKo'v=FCm \ &}z}6411p՟ )ԓg#)./XKCdfg~Xe$@&Q#?y3|i)i4^4Ͼ2聺oSVzդ;jZDx&ʫ)1{K[ $<̔E"Y<ϲ9ic'o}$jQzӬ-7a j5k2ѰyCLLO4;ܻN*[ܪrqRÌCW!:ګ>S>yvJ>5.:#0ql㧱Iz܀ =ʴZFj R75~]-_ ;Qz韘}@4ߌ/G屛Y:Ow!T@ydKʍY([LjL9L̺ͺJ{2\Rդq6/FNYk~ LPMRKp?v6JgI}˘Ϙ+Ds)+pD6ۓ d+s= O:k}Zq|s>֝F*"V)R* { N؟0{IS>FqaM<}Zb05$!O đ/_)[\R2ҽ Zx-S7_</1S&r1 r?y0C}nm Uf-2̛=E L(;/f,f8k`+%9|Cjrf9Uî#mv۴6ki\ v|bΖkل""R*f*74;n\*R)ڙޟ%?_#wiXp׾w?Hn ߲oVy4W{ݮq0d&l%v1AcTs(Uq  a9?ճUPa;9-ln7Eb|q=螺 ur@x!{MR*9I9/B#7/<]%\qogc½ĻUDZo95_s5cd!ڀ ӡ._6Kv胁~q/ن9vs/@םngS ~~aGh +ԫjO0l}4⸭R߳e)wpjijֹ~e㼻֔քθިޠ^^nV:Z j6?mD}ۀrC>hVY|wI>m}6 VX9)ܩq`>xrzfD5#uVPK#U= KU 18&MZe|jv5X+JJe! a*~S$ɝ.F]XHnLeS*_ KjI{`%Y_=o\'HSL֣nD~b1gQ3!Î]zۍ2UJy:A/GrvZOFN@g)ݜӕԣ6ʯSRÙÙdr] RW% TFtGn AO[h:BHB _ 'Lyᆾ:͜h 1N|\WU!Oţ%rI|'~XcE.(*+ѯ"0)6n(3]qRiFy㸓ϗ?Ùos!fsaVsa6aav3a HϹߥ)r5[NؔHs4;,$zLD;qQF  0>||~2ć_*YQJP<:xY[lBT0,z?b'h * o$.ŸV}.X̉\̋N bI 2&xX7 K f"omLG8Z%Tj62NN`>͢WO`Z!1s Z'p \dqMQvRgK%k5F3[5S]5Hvwe=ܚ0`/X|>*^E+ԟj0@ Db*zv6a!Y5y)JjxDI D~\MCpDuD>],xjd؉(v&ߑXF [ /BR*b)?rRu+94W@>#a^0zZޙCq= eNd*k=D > 0~[1iSGr祮4ENOAh)b2YgR@[,/Q/ptUjJt5B} 8~|PE%?CA8v*xvj@& %mVs_Da-Vai>q{e.wl?7m{ܲS7;_48џY ͇gZ)~PAAцḠEc K䶺.] ov@S|_PBOxkpcPCt / -^Ք"Hku2amW[ِ&Uѥ5|ڮULM ҧ;oZ}BA=IIٸ5~)|+[+F  .i>nœ..Vl1P`"~W۽!PwÎ$ w%(/.O9w'b˿x8m(g]?hȘOpaxץ%Ԧ*ѮݣnPtLnZyI}SdBZ:yc?a7i=j: w 3بٰޟOq[Jv1GSES>H!ʭFrԖj5!zXwG E >vMLVE8qX"}!Pd F2 jpety˒feG,%,,E%xüڽMg@Y~>抉J12l‹fM^"Id# oKߠ8fksn_ข ~E *sz9Znwm%cU#E$A" ov4!Ni.A`: @`8Tꮐ7.?^$;o:`Wr&ʳ-E ̎DO!NMH(^K}@9P6 HNoyѼY.]ͿUnUtt %%?#Zy7wc ܩ@Um͖,O '44V= mƀt|{J&*ySDx+ E[\ÈYDC]]RXjVZ~L~"V/Qm֙)2qpw`aIgˆ*Ѯ{U:T]_v[u4:SRHi're1zCdڋ%O[6";N03>f3l/(g~n:i> |pVyzw!`q_O/_y'`.pLjZoLk_ɌX΍گN,3Jgz~+B4UL\ZFf]֟χX8\\6Rg\\ƣm͉֝ vo|~R/vra6j!<]XnX1.' |>YvC] ρ+L|aR&[-Ms#@4nh_/7Y2Yv,h$d,;`(g4o:&k>y9qm!|y*AЌ1VF,A(q*:1Dq!Ttm,g-w-yg0o>վE:"S->/` лyF H4 HK9N1A:vo>Z YAlQ[V Uz;RغП7jmSOZ0+]KnNl4_4ˑ5½:b`:=`݂tprץes0iebv:o4Xũy~{EG9@\y (:j i۫@4wqVLVd0`6Q 5^\ aU*Q=Dj1<HKOӓs239T# _iA#Y.Յ.Q=8JM-ŢL-ɔ, \Pixb z5 yvttvoW*z=YH fڬcf+}x^OyĴTHu8Ox*8~q$5xJwƹWh.%TngGkJF2K0n51U&?n4galyt౟뺖ౚNZVVrbBu5};g-m"z*Ρ^5EV(`gB7r_[N6J0`ID?0" r7͖&Ӂ6NM1y64}IO ѩUDw|;`MbB;or"oFTT&+M'&gV.]/m%TpEZ߆ٯX~>U PJ#ep8F̊;=2#^;D0mbF:ѽz-hB-CS:{qVIRikTFBv]K-ҚU'5' |k閽8wx,we<Ŝ`&fv&E*LqSރ}i:VRlЁfHF9㤿cbj?j﹚赖佒乜豒깕[S=8d9D}.ѥ\Xf1c-۝,Au0l_9TUf7̀ P6"uU`,҂9Ј*œ8'RF<HϺ@=Iok$v "`2νc|Yt\ `qK5( $=εxO:߯])*w-X? T2jo{w+IGFߡ^@{ z3;7n<"&;y; X*dI|6^$XHv,V(6 )uOP2d!E7'H.4F$nz3bqZƷo>Jo(o~nlYo;ޚ(?֚5zMxt8"&?!{^Nw:RMWT27rl4@n6 K"[đb($Ez"R#o2KI6'w|>UӠ~gHD/Ui 'Z9 MW˓X+?U~{yxR*ŝKRzz-x1m6~o* 55h5 r<~8`m 3Иn#0nvv93~19 [4{/l.AË?>L{0.O?O{mWr'\`$ ~m|W.5Jtnr= B9~Mb)g E#i; ;)YKa 3aSCaV16 N#NѮ IK^sN)SF o]t7R| I2Eym^F=A# PW9/op|7)[k>r|\CHWAYH{E0T`6 iл0x'&?-@0%UzD ^6˗oz]HyEGJ>C6"b`lD3b!r9t8`'^& <^ݝۻw7sH2ɦ3mų\hTnDg}|?h f)z_L,XIC3'߮aZ.W>fA7Zh5MW{S}.L[]]̟K # yv޲?y|nHDIgAN,5j{͊S[&ΝzfcCS]Mۡp٣rգJnQ4تQɗZ.Z5\w`h:U(W:ɒ"َ:)>sDeRwx6wvY#̉Twe(̬F)UB3*?PU؛4I{.lh8j&J6RP:SKқ[F_7 X-OL?) l {2MHWh(bd8 LK5`N1gOdK0}2z2|lDjH7Lp>R@4T=nz !Zp#QwG&M-wGf?Ė=I}*$9̹;< YÂ?mXE8Q/_S둶(eU<R~x9Q->n^\lH:SXhwU]zDt,5ߠ\̟s}&Ycw0ު/5nt/vuVNԄTV$[xx0/8v@TqvsCmDI7V\g]bV&~ly:S-dvV~"NiTn"[ V"1ќs:,u/Xㆧ2uЗc?ѪU|Co  GM%a/W/f=Yk0kbϭz)apYX-Bo 7›*Lڽ3/eE<-Gcq+ Zn#l5x9p9}v>a)m1c>}1{%͗ϹDfϯf*%Ɗz҉o42uK39v{#"hù>u-) bνjd#ً#s-=-4}7zk`)e7j&L̽Py4mQ!#&z<43{9:; e`V΀vɚą=';+^oؽD;G9ʅ)B4N] c|ȻwRt QDr\Jq\N(FV3B/"%8Y44IvobXPTͥ*<Jwqcqc~,2r'o_?gXʏ3Ck-Y ʬƸ,P}+3!uY2i bGcAjǛB":T@K!LOG[tP]kD/]8vb'Uk9^,xۿhLR( +,˔_o0Z s# 9ա;]1fVdM1挚 Ecnv.j*5`qc8~P|h3N_ V)nt-8^J_L:^;WJsigK)W[)/z[ ,"g]'lVھ4+ֽځ0C_{$}M313YФk Oul<ߤv[L#&?ʧ܎po:0$Pr[r맵TԃOb=''XLf ZL>OM>xk2\d l4֑wNޒoغgGeʟW{uowϗoJwa$Ć Nt JvL4x,=ф?*~k>mUs#3#kMAŶ~ P9Xj1p&ݧg#X8ݷ4u2ՅqT8TSFLE YzUn!+IW͵;1{ 88T_xnQa~^vfF/T hDZ8h\HeNxa*~M=V,+ _j@tJ$gP>;7u7$,BB",HkPQO'PFzQEFߐ๴[/3LIv@#f>rf=xɽ{{y) KhJ%wv n;* P1ּLSЕy;HrHd^j7MM4k?SnpZ?c~$iehuzmi`9;%aα}xd/ht ::@FPmdV t|2Tӽ\޳\WZv׀=nA7*VK{2 I9i->yi{k$eFKм ^r*LVW-WH}\8rHTsP6節, zth^#oɎDxjz6==~>j#pfr9iw¯sK5b=鏟rd߇|8Jtz]m&SehC1KFw`PT$acQ賹4ď9t"G O}NydQ3?~  D73YsZ>^]_Qωv{?˳%~q0jg9*<V£fq?XEk"uj\je*j4y~Vrњ:n缑䵞omd"|gRR\|)s%o<ޥ^-HF7< f!"4B90#]_ƒK6͔X:˄eYٸژ0>3kO@$W'u'~u]5WPaGRXU,rP0gUO?0\6ON+V?FSaGo_:Sӥ6~ 2$֡3境u9Al Hx-m{cauzmxxtr`p|grgfgpvgvrжձٽ?ـ n5;`5򞌌dH@ZWHQ4H?3$5A,Dfi-dMMJ3 1! Hpo^rPjcGv$5QtԨH׊`d?c;Ozkâ޴DŘ {jr/Y}bNɈ^cg$>XX A̅՗ hƬVR 0rvq׳|b*<+j!9F,xo/6"{- }?.'XI{+b)A4.Am]Vb*v#XKS׻":exx;4=Eq8TSlI#-Mw*Ǘ- a\p?y;pE4K}\bWGb<'q{My4l v2ثI p%g(RRi0531a[}Og1@!`.Ll\x堟i׷n߆|L-FC-&lG6}r}{̔">m1DVD"|R}nH]\m r65H{=-G{側5 Y㣒RRB-=Q**,H}PE2{#ԑWIXL:jB+[GY1' [C,}0n=* [ɑ9RMi,/D+, 7;۾ؽٹѼLWk#1UCi¦ʶ XLrmxLq@D_׀2&ª5qjH 8PT%npR +Ɵo]icxcx#-=dJXuZ+rboP>lVmR؁}nI,aBtٳUJw撉i B{l5¢yJd6!{NǼN"O6qL|Ŭ2.SvG<kkqw̄;vk_/Ws$x߭1?w!k1ؕI^vGLm\,GF# 7L\(a.3u|;q~nSx0lgML8zayBWwwfdTOH?F] ]a^.N|^`qssr>#89Ŝ"Oq?OO;` Ĉe=A%;|9/z"q"b(ܠ'j 6}i&o.3h#7iWw=.v;~5~!ʖJfzp&;  o=~힆6ŶzmWw#-S%)p[$ Jq \*s:]/h Ns2]M<@ֳ#u5UO5Lh0Qbڃ2ZT6 ;PCFcbn l.zC5 jQIb1QNy ~qXʹQƶY+֙`x;FY=YXB{vx3tv4w|48\=\mM  ) #zzg8~N2MC[NZX^CV5⋖(͇tfn6TfsV*_g8eIoLTK|-Rw]g6}&ؘY.lKiG5dݠ=K8/Ov]psNVZ8躋nJZ>v-d&xyFڕ7]a :_MeWO?v0;'+\rxf>STwTi"#Ax r=q L]\ c%b>5fm%GdddԆ+zTmLpʆjzk}[B2 漞zGjʟ xͳ&֕r<(-_?vܟ؋_?/|ϱ3˿Q'~cyJy>fFٺŠig{F *܍&Kfȕa-U]+3rך5#r[wwy,$x-',%xLF;TTDP[H@B>\Xg^z#mW[z;rT͖;)'hx^ |Wq+ʕ+RY= F,́&c1˩عxLB8afhMS "jziµ"¸W[ـլ-~܊?{DmWIf2IdR➸^c00lz{^%$Pwֿ9O=ﺬw}K yz}5m-)+m:SӸ˔n}m-U|ߕg'.tm۹ۄm;y@AӾ4o5n%TnOss8bFW JB#^ x/"`s強+ekLO055o|/e!땜0~ST{}'M>M}M볾6ެ#͜%8r2@JC2ATh4<z&e"bTu~ 7Lq008S saEwu0,2a5^O,? q;7? 0yg;,7PM=|hZRiFRO>K꽊 %c~[Tl\yGn1V_5' KK>zԕSIDd&a (Mtxv"l j{8Weԟp|r̗4Ğ, %@2uL=N=b ޤttl~Go UԶsH0#鹦=w?|W4rO:~_2q?v=t hߔCȲcz>2n/rALZ1nQAQ^YajntUe>~/凭;f fY*<2Ļԅ2*0$l9W*kl vX!xrG))B@!2_a BX~qPcPCD;"3W]as7Ԯs}uG64ls}h!&N@'z!ɾ TVJ~ 4PrBQA09A0XNbr/`Ly//z<㝃Nm˼}2wLfH\,^dz;]9brŇpU0?N3 mיFض[쮛 j_Cjtn{7Վ^JC +5FKUF?z<j  h"V#-&0yt68@VF+[ ƹ4fz=#Ml ïC-r{ ~ z WW4[*?܇n95]u23gv TiN庭!d+2gCW:a,3F^IwdjH?@ްUn?f9L(iH S2" Ӿiko!~ .E1rNX&Ph ?1ęrcNQ'(4H Fsi3`͒ǂ#Mf |VfVqNAƯu_6!k,Wltv_tvtcwmX߷.8$$LɌayۉ{YuYXջ?PJwbwNN&v9aν_K' C#>Dh2)X( R@%k@e]*KrB 1P8TRZ.ެDhYbݽ)w YU $ӻ:2>7`z~LgZŽYW+6ܙND҃i@2APLA$  @ePx/,?mjyz4 $kq83Ң4 d": ;ʢ_չ#KCOA*n.kNnrGwq]M63J>yzvr{B ; 遽r8}U.6,ٞw>xqO<ٗ2H_m`z̙޹atKHnhyAKfMOQeKZIe@j+=7[tAF{q$Mçw=; ߝx6ގӘf}biJav R^j!N1Z˞!U{` : _~:|9}<e.&M7j"v}`}nPwA7?;aЅ5,"sR AG&\J!Lx2CGq=Ao;);+zvn@]]#}}Jz)Rq0j|˹`9%c?}<=H~޲خ خ 4*ʚ%2Līd]X_(WZT[Pד?iop[]&Wn|.@+hM)jO}[\鞜8ZNHm^齯3`~qIPpGB)w)] &ppx/,ӗPN,g }Eߕ@L~6<5maX?Z+ z Ըs0B''?"?ھ>;;;<|Rvh`XcnYn|7َV=)U`6IBDA:ָu!A3R B)ңHWQoHvR$Upe T&f{"3[tPmhGvM2:ԷmL>1bk0jw{սiw h-1H8/=3P_NAf!2}a Nfb&".'r|};z:+ݔ;lq nEZA7L$U:[4?{G+˓κgm?mOs848?؛`/%!A(iI$fȴi:yIG 9V!Py(cq\!+HXcGGu qIa9n>O>w惧t]ĝFdV`7%FWmEUoE@Tl'7 5·NWf7cGZ<< 4\[t$\_c: XwF̞eMOc^t<ɻRT൳#|C}.2C^tqڒz {dAH ?!GЖKq(L0c?m".`K y4!>Mgc3xl 6[-Cʐ9RD._NP-Gr6@\ogX[\(?ԇlI63ŦD ;MtC>2wc;& m;Fyˌ)IzކuI/˃:Ӊ Rʔ`4*f)<m՚L*Ib@k']ưer/+JP4 J磂fc]Fcf:)(fߧ[ޏaSȎ87z{;/aaD|a$[B.Z usB`򂠩$7g^JV<׭}~0B+9>S.l|bu82ZL,'!s9-)q/^>OsjȆ/5@-DD+ոYJ`Ed BF4]l09F̠KıY,jN0xX BD; "Gr% gOa[fʋҒ"kB"_'{WeWgTyzxC&+k O0ۮPjc3 n0.uifM꾵Tw8pw>'N`|#ϕz+{1'w2s,}V![ހhn}mxіrHݷAcp]m6}!Wy$.* `9/L7[3hR>b[r%Mzg|3^)O;ece•DА,\TD19,x2 +@'JpB|%! L1"C KŢ`!{*4iMq[>O|MS쑱1 \6Y~twh6YIbQ"57.]H[@ ϵ7$b& FLҨ[)Ed*U#Bs`!R#Dxu1^hVȘb M,eH'ߒ/Weկ.F w=0jc|] w8qyW6׻L.L]CC3X"npj нi*-((),HiKnNnMIJ{dfGĽ\]87@u@׏.; Tk?ٗ8?_Sr?u_s}w_>NXiI3uڌHm֐1GԭG'tަ >]q"ykC'k1pݒ`qѦ(/CA"zBt'dJQ|p׎2d/ɜ-KЉ pb5bMO/f e`R3mțeJ#EkDf4,FHRUxJHd2YidU-_[UY_ռYS)kUrU*%2nM H&H"D(KEbY ,bWIW]o-gkYXa%l% xthsƃTB[Ӌ͏?:xp\Ё('B71ӏJ7>O /%V @'GOj H)e8Ln *ˏUI|u t~& pn;Us K~0fbne BODZS$ql?2Ƨc㨡AhObGbkqkou~un$!6#)96:(7.,3!)23/#"UhmPU`}KMdpdxdudSnlьӀ2/ o>Z+/Lt@fz G[r-AG|>(ᜳ~sb w k ϒ:37eG1 uR:r)=/0O,WZ-*}vFY\ @β}%O#Kb>H.s4R C/Ƀȣ8`): t=-x ڏp@EЍBtbL{9Hr$EL\J(,FqW=gcߡ #;̑[@htvu~+m+@LhI5oLTbybWJ$L*׼i֤U:@Z Rml TUo(UTk4uHʗ+r9 J{6' 76o%xr]/71w]!Ʌ2g6` וR9:2B^9j]f|p)svF`'s& M1؂@x,c:eXY/ 3QY!`ln0"WofqCqw@Q fǗǑ=C1L{ݏZh.@kg+jf+&ss2ҚSR2RZsۓjB"J#+^& /MHJ(J,pL{ndi|g|va9@9_ ʐui5MQz9R~{0[Eg`Lrp"K bBx@,r%):2D# <4>`Rru3ZP-/+q$B`!] bwDfqlTP$% EL›Ht!7_`tvgfut("iZsj&f6t́#I~p6UQpW%UOH8*dR&SER5_F y9po-?W~?\=F>r9ΰ߂5(HP)\\+ԉU"B r9/֌+K-)w7L#i3Q 3^1w8s܅x$A(Be+fJDr&_@*jDb!2]LRZ.P젵loawo'iF;a.L6rŪ7z1ZfU_ `lJOXV5 _Ɨ8b5O&RhIJUlWyk*\k nLr  <O{Kb @biϟҵ+d~}Q"U@HB۫lV]w/ՏQG R$PvvPͯuE9E:wFg2>8bwm[-/<[/-G:#i>i^4/t.`!@wqUMVm0w@>]ٛe38;0B#^`,ſLPC:k' r6PUYQc&ѓ +lJ&ȊԚJ{nY][2<1Y\e K̗.8@nT%]5`4#* CsuܦO5NX/\a &S{M+F+䮇6kt ;#}n Q{V;[ז|>rU~SP hwy"=DʑRdY g1Jj~\at}܆1Zb1J!> S˱ƴ7sƇ5˜ b.3 HX΃i,.kT"j/U)-$ZoX(E@WNYzcƆo&jJ)jV*jb?vRϰ %2L*I."_\NO?:xsK#C(l7.+m֞N* =,^۱Bulszad2 0w\M|tkbytߌ}TQXPX\ <ʨ /h/.銮mk +w3M.lLk.O{j]z$Hs8V;vm/G7ᛮ W͗pUF;Gv F9˂a뺿p{8| r/N\W߆T, ok .6C[%N?PrעG1N9r T"_ev)MockJ0i .Hyt5)}%e΃(I"bBB[ !& b(!8BT&,"Ej)]NQ:+%Dx[۾>ob*Rz\P#83=Zy^۾̿N',r9-QBL>(pQ3bBQlZ蟑EqURJ+)THjM{!~ bvx !|C8]OwoR]ѬLvʧ?1j4oQy@_}ބ0K#DrKD3:po c%@g*bJw:q1n:<,RXd=H^s j(Ѷ"<@nMηl[s24=m)'aW޸;Ѽ;~P^b>kȘ6o˙ A҅r IFPA_DRzȢυ1]5!-Fg| u!)jF!57& 1X.PSCSK)|H*g) KsJ5S;*JK1a$@#3% !ȱ)rL ) ! !;};2l@ޟ0AOޏp8ےNi$Y8| PU kBk ƗBԫ@-2`^HמZמKёR)տ<&J~\) )LK7`HavQ" 2=/m9`.:ْ52b952lCDwbq]dR<ϪI |5rI%, ļ ]FI/~bU`r@usx㣺::t~8\do0/ ?:{t d9hJEREr nnZ]f}Ru[cN͍+^g{6_xX%/@F@O/]gE3/VdL֚ GAH19˅RLd%WOf/DgΘFưo:j-7msX4WxVG2^SHmlc-Q}HI(O$cCkZZlS/]RQy Xt)IsgAD\9|٦ B9GɃ Y%t`OxQGcN1{S#Ƙ)ss"w8Q~vrՖ-cq׺oV:+ۛr^P *ִFQ24>x|:Рo6GR*lMoarZOoRkO Jms;BNk 0,T=/^}+9 њVw;rgڛAHeN#S/{LsLN#NrMkۃC * ͸;B_|0h3j x7&/H.jAchzI[.Q-oW,%yE (0-H%nv69;z gm> , M!_ oV|[uPSux~ۮnĬ>˯;+l:C":Yo~?KғﰣOJ L[$#rBKr.1i)QLnDjJ][Μf (`I{fGysqH]& 38T`9Z t|H; nD[G+d噜2[x|{wC-?{YA螶c}{!{qFbf7D?l9e_b5_4]_Q\ л 7w]fs}nM`rX0u:{ÝL);4[cCQǚӋV@: j^T04H|ғy`D 2B*u bFZ&exAЪy'pư{SU&Gd/i2x *ʗ1+Bj'rdKB~uu}y~ |[{v'fh']џv'_n+M0We4B'#ylF~Q1XT F%V"["i5>PוZ7,wbԺJ_Hp^*%Y]s\I϶.}+]]Yߜ_;o7v7::l) ,w%F-uMO Y>JXO* "򃈹XRq,(f!PI,g:OF{,pȓ^?^_(F/D: tCaFYF;|x( $r>\Ij]~}oAէݠd᎚8&vc5zSl/l?~/X?Xo4/}6&._, |T] x1c114~V!4r ZM Q׳W#wk !gBơ\zR.dhc~Į3j{L0y;֢c{?M:1pTL)Wq^R.e pҔ/A bbY2KA(EA)oDUpFd^ c1eoE} CkR:(M<Y{oO,m}IhB9Bn9B??4yxcЄ5nA4]5GS3LekEȞ"}X)!dW0/Gc@k%61Cn!>,2Ҙxf}M0*&+ 4z |Tm5S;M#iorQ$(LR\% ٌҠ/H5tC3cGCϙ cLѦ苑ω|L[*GI0l{Ώ6ɇZh3AX:9+fj&1UDm*xb|)D6*{G'v^"th7cԧZ.3.k,m}նֲֺvXU~|*uEP{A? kGT]K> zǞ 1cꍚ W*BY_rB).QK:X9P%Z}uMV5Z3so1+m˔RSמ`߸`@o{'_]]#`DjB)HR!M#$;j! ΰD;EapCڵu֛ߓ{]/=2i2h!v)@z %đRUiTBE,_ P;$LAxӽ0TOdginVm"m|~(h!S3dI6v_cv g 蔸nN~#|\yhj| 5Ҝx_lY#Zl^vޔsez>K#oΝ !B)2ʀ: bB[%Bh-6SX@1$ZN$.f)8^%\7jq,E`i"L_- @..gS^gH%Æ5&BW @8,y @J,ʼn`D.Addș[鴁r^G^m/wD>%6crm?!# pd;ٱ'z&ndU0+ʍm!-o{ ɆDƸqkgRS/GQf]Y v\dxL֞ȴwahXTMRChDu+E!'Am4e 7<"r}PfY$"],hk2TlE24~8SF( EЊ"a,l: d&Pr r 4n6PGmP]Rn5ٝRD j;^to[Ϣm7]?)r(i__VF>c .Xz[^.(ᡫD؊UB!c9ʟx1> m2\ܠu( 怌/v@x29HJ-uę3Þ x-t8L; ƽ`sҀxd1uȖ4`[Tᣋ ֊1U"D`)OΔ,8Rtx%+Hl5JŃ'm _Gp/:+KíIw33C2̖dْl3333333XER13\\Utzef̋^gݺuuoIu}`轈=(#ңC]Msi'ⷵmɰ-L8L4 ^jT^3vJM/j%n9%@&Lvy*Po Yh?pqIaYK|hn^? UMf Mr=ufNjw_]1r՜ g ~䀙TM ʎN ͧ1Nq:&n=g r9&ŵrɐ^.wWb%%d`,!&Ec Y|625 {A;3hl" 'pO\5ǚai2BgFC)cd7I1FXhm*df4*?s`z4JԖgBt BNqFVANjvx|O•`G\`f3 rS3w1 Ns ş.v?BqJc]ꇜک|K&g{_Rk(/[rYHevy1MJmh\|h0tްi1+"}Q?GGlU0^'T5k e|Znu@:!\nDD?29p69p*o*=8'd2CrpoV*NPMjD&wnn+sWvp©$@$ʼnXF9'b|%f;7o.I@(Ull%\!0錙8Xo܃i"ɷEjXr5H\}"` :J#2(&Ab9ߌ<-3Y\LF$PGȃ^;t GcqY\d:ƙcN9LaL `Gǂyc^|-gHZ(,>=z]t^\|zH;_MuӎBEl)g&OF8:w+dþ MVr w[bh`㫖;ڒkQg$B!E ys"!^(:CP̬%h{aQ A(_\/?`ul}Ip_ѺOG||nnr>Xzfӄg.6ɏa>OT+pёI@DRTTȌ@tF|f .3v;:~.~.f:дm\̓3kwש4x`-P2KB(^Be #xݦM_w9WrX{٧ QX@Hb"3"l2eԟ7C6e *勼)LWjN֘ = C@2ܗ"MPhS ̉Dh4uЗk6 {M=NL`-a!3Lw'wQ~OPi42OIf"Rب4.*5IbLn^=kąaEl2 ]v9ZB͏QL&'fZ(..-߇?Ud>}pva!k3C=,LLL*A~߻+z+#0c6yeO!{?" BIVĥxldX\GD-TD"Yt ffOBcِ.?HVSؗes \E#:R_e`B =Q ֡+} blQ8'L|z>+L #ӃQA@4iP0 | 3y=uA܏aw{>5 4vz8X:o"7e +,KKlc {@d3ᾌ wڃ5;ns#{g*3\Ti0iC~``y2ʘeā:bj6<5Dq!tc;4QoFqo2AɅVʗHu5u$*TA_**LM7`&H]JJ5&a<삈*"'*1}y0<.zij`V(Z֋eh :`B (l6S(~^x|Ye_ GeGPCg7bˬ]{GMg" nTO\/Ɂ?7N>;9hUl2KAF1iIoQAw%z.oC%9[ޥ 24u~;;$B9N{Zf{us')M/6aiЍmE2tPڴmv ސ5ݘmB aj[oZL0ܑPFwgxO5dY]9v-KЭCrME ¹"\!ɂGFN>KvKڬӘo2u:PFfsidJ; TotZ`uݛJqMS1c5o}: w8V4H ΆR,mZ3w&*I?Nq {҆Ɣnjv%JM (&8|w]uz [;:i5WWnuaǂijռ,AnSȃX OG2tDPpf5אթh\W-x'ZP916[JͫX5fy$J3rU3`Ї<٣Έ*F87 2GlXڤg+sKk  77FSO t+pKqUU#ϾJȿJkQ(c5ȡ1Wscu#3~[|]!hG-:+D~IlңpB@c4_S"K!%WnUl&nL؟jOto~"wz؍-C`o}ZI%Y/Yl(Q%\'a>S(8 B@:pǁ5JϟӡTB&EB>l5>RXT"^{q?H4BtLAKK F`!O0/K$;J `3W2ǘl.~4bDV#R,g:F\ h9BOXME#=﨤Ys>do`k.;"b6cb"g'#D(U<jwg(Do4ʸ#D6fwHC֩'^j =}Ryo(n_J8`g [1zdE'QyoVnԜ`7b<6c(8K*(?,?(=*?Ω:(;$^7.Z<{xWv ~>s-!{;8Nۮ# ڰ̡ׄؒcҳ3IQϥmI<r/žlZvكȗd&g?J$|D\F\]"Y VxEఋtLEc }՗x\g:DDYD~ VlI, CIP"i:Bcs UeRJI ^ w`?`BS:7.1=U*7?襝~ j〭aLᄧfB]ʀ!okT 6Ňea}!eOtF#mѶh`B̦|UߴپPuOa=pj:b6J?9/Q.7]| HAVew_"j !5U WyR~Q7 篥lVU[:*,M-I)n`J1ķ#r?/ބ>Qq >ZX~O?.]3]\^M..I (,I*6&^A;{< l874 Pv?yxL67WxhM>b{Q/CD|3>՛@ e )^0י(Ũ0 #oތApՌ}uEmͱYڷ^O'Y9:lw&7Thm iQׅ.V~FnN>blr~TdM :2?LRYU{^:va0T mm"Y[Y7l: fzn&V]̢+JYf}zrU|⃤=)Zݷ-1^oq`㯢ovfm7!'vvtxo7=C̮#evKȓ u>sC'<-9K\e`Yb9a(j;w֦(-/W@ š?[-YNJf4BsKWv---@)\.]Y`&; 1 20w܀^/חj5Vs̘Snu zҲ|)9@Rn0 TDd=<ĺUmӴW#yx,2; mղ5X2Onwӌy}a8hx3ΞdBmաtjQG,H/ 6aȂ01EF~O֐#GTq^QUVbugӎ8u-xvWXѷ9h+tb|d=. \h9IvJ _ֺaM0d_Y9kA/ x#&7Tp|:`Oa6aNŒ7tK_DߔsP} Gؖxj}Mg6>K; ɺJ|C'Ũ>!IeA e.0@:0 ԵXQC:-)uῇ]gޡd쫼fpi8φH_YX]f ٙ=$ ~mϰ?E?a5<1ԏ\8B]Ě?c:+ V"s=Ld&2I g3=ǒiTϱ8p}!6 1Θd/TkQիחmUⳳM%]xpVPLpzyKoiww`͑1AYBlx.7@ NR{=N5r,8j;TӉߵ}> S<{&w"6Z;<^myI,Ouݺސ-Mu7>G%fu |_kkE߉2K@ vKR cROF<$b'8,,]W]ܒyq[ŝw\ܛaOޅygݐvvmڙ7_Zty{-6\R { kCTdM%:d.%@[il’/ V_mV=|^;e 28lKW =8{/׏|^`Ha.pK[ Ÿ #!`|xm^nWDL2;; 冣R)x6vTW|bю$|lwaw.!#$Ml}DӋKѤ7&<S8 vFؾ/`>̶'g>+'gorw A&y~M[X獞εy28|羐FÿD~CX-.L@LG/8I>?~r]vav{`aAJ-ۇ/yXc+d:R.{ցkn+ Y%\xzm%W?DJU޼X̦s|_eI1_4O &ˁK^ YII?] IY|'UeN(OKΞ/ٵj7nTqw,r˘ 62LuE L@w|.'t>?PC)I@gVx+@aÛ!GW1NXw̦xG)_wUv{iu 1BK>"=Hw!wXS;O[ -Ԗ۬ʝįF"-:JKkM}篮b_+嵵ʷwҦke(Քiy{q9 plk kQzTDkJߕ#xp}31QbvD =㾿jw-a; ;e܍yώT+]UTxFJܕzkM כ_hQ٢xW/5=?[xշW8P~ygMEⶊ˞ΔsX2J"ڞ/-,.~o?PrFSښ+F·&vr ~ȃ^E>"Wfnzl4o[} KP>~FMŸvkv8hv{胐@ėQف@:(QY찹plN!'N F'NZ4+6>i7zmt#쀷?Xt-h3¡pX`2Q4Owcِ ZUR).ukGnD8+YKYL}E=An/'wv={zlo~~g&}OMxq9xLk}/w wO./ٙ7WdhԸUvAn֓.}>~W^3P՗{A[/7==[Hͥ]g6W__wa{Ņ7T*\VIVz ,q>,9lOق#}b7g3,)%CA7i}sl:hՈ/!Bޝ@ J7/I%^7u/åm21F{b{\!$wlX}O@x&7xGe҃҃@'C' }tz,QtR}s+kl 2-U[Ek} Ext(oiIܦ|ԗ 5!שM88e;Y%yee['Vi,Rsw5ST[)>x؟}t%洈"y=LRf҆JʢL*d:;>;b'L~000000 0u0m00#bkw*ݩӺרUIB7#cnfmh`Yn 7=l$߯Wnն{'[hҮKd5<СR  Oģr 3MڻNJ9;𸚆f,&@ t 9wZ$ Df<)s]/5;ki; }p:PyD|plҔnj!hEIOi4ymNN<_]xpNB F;ƼaQd%ϖ٭y:_}w4LKb:eV2 d;x5 6kP_lX-yW`w[s';[s$B$ |U"/1 8 +a/%<|0.\ON֗?{]8w6E{i{ʭY8Y|L֝zg:U{m5Fug|M!6sNs1nsިt0L?(QqX/D2ujd`4 V*COo>0\]wu>4+`ƒ`/_ N) zW_/@huԱv;L% hN娧 6.otx uYx鰟Aڍ;%OEwǸ#YәS靖(P!3D@l>2evDN Wdj^q:vۃ_E}&ؚᇌuuwh4t8dT޸!Uʬ& v\ɃQqE{Y{PmVaWuMÍl=uwM2ϧX:K@< .`E  Hztp̓i&Û[}t6+hQ۩lJ 0 v sćRC@Ӈ+!%jy\SZJh-'uy|U8J|ݣx@-O4?9٭r͕K :MNm sQ|%67.p`7sPuL8{emMS[+N^zհ֛j [luv>0(#|.ϖ Mo z,y!@OnQzre6ƦSUlT"w<<9x:=ʌ@M'C dCl~f㾆޺c.o{,_iזmPڬqIfL WVs%${%WX ;krWW%;u_OFK\sZ*Y֤j{,}gjq v6JFzfᖉЯ `i:u}wٛ+TDdOέEL2$T!c/xƼּ8otw.G6snw-7_jӸc(7{gD2 G'_HWgsͅrbo-q0Jm'ڨ#Np+^1W;W)KDF2ٔRv.ФtERlb++ b%GZ\4+VJsl8 tBtǕRƂRe@N; 4QoGis%m1>FP*vmF '~_;)_q-RIo%6+/)HސŐNjj7:[?x9NI&UM6͵.h;Rw嫠ǧ&"zZ܌ SCȌp@ljTTLTTl9*;gAڕW/)xyR=1vF1 z{|>F~>]3,GӚyDo|_2ەg8PV7Rh=6ymçj0?ſs}CY"mKF&}^d$|2`\BÈ^߹Xño==5L#%*2{7a4hvǥr"ΊDle 6ېm"u*)ufX'uGif6;œe Q=lg5 H#R"&}M@?`,ߩ~Ͷ72-o/i\нm.lvB!uvi"@\+W<[\ݛnJ苂&[^#EkKI?z5._RzCik9BЎ@3y?(_.\!C \=6j3U~g:ȂJ E$zT۽zy)@|xD;v MESi0Pҧ'|bqPG`Bg픻L>nVZx̛ҮKq0ҮK{ ntjVPu(qM~^M6<6T#8-}؆szm|XׅCi{W`X^LCHDE f@g/;'w'{.ĚSknL#ኇk寷(ڼ wF%C J]>r[JخRlw|Ou:N00pnEB2 M%P, = w[HE|ff5 zۡzL>kAo#[RÒ&Hkv=`)@rl])ٳMyvi/aG꽀/5)ivC yH|1$,OqRSle0SZ>L)iq{p<[phe+6*)M3Q' .o6%@j3I~-"~?c4fNV 2?$^ْtqKuǾ;k?)Z.zS!plṉ-QP}.awgu`_"o+.O8%`JaZD=_4yl(kx.xU|'aN/mgOh~hawDy۔3oιƾez4 q5:30ҴzxX[|g|w =P%;@ЩadP4:9)N~>G{zq*ŝZ,Lywpu̫χ-rub\3޶6#fr@{o~sKA@#_Sj'L@:buMta]Kّ8y騺43t]c;'f7c{w/aG*cwvϰsEH*{1 +F]b5kPyg"̊S=fEB&l/6!۰VLq<Op7t<@L,?>28j;o1?o4jcpCf⥪'+gs_q;gZtp)Sn,H7gd&̦-}3Mn_-nZy x)_o\8SUV~SS0Ͱ7aÌO?՝q|Nzx1{nϿᚻ*nŹVkjz_YkLCp9qآtBu^twwz=ľfR3yZ;Kv1y w"*Pr֔a|ͫ {vyt}O<0.0KSsA>k2Tt2muC(oTxF{ Exs:zi0o%ߦ%FANJ;Ǡ ]>riׁQ2nU]Iؓ(+ba0*ͭJ?#m-W^n)iJ0;[_QɔX.[|Rr⇗oݿb NU=X`҅^ϻyZ9MF{S#婤 rs>_M%z AMkʁf`3u:Ie2',4kX6&*JR,L XLcS+a3bQ^&c֚Æ Fui>C*OY)Y#Miˢ:%<*b`E$ r(^K4I;DvKљޓa(d/.R-T)D*|iCć>~hafCï  }vDeb|NW6Ǘ5&j+V=l\rC6AjƧ[]٣tK&{Zs0 rOJɋC$jĶRwy4PMvW) ԞZw=YKFj$!# &rFqx̣Q42L@ p,dc&3VBk%*./::i=7dϙRFσ y댸u7?  T:GD>b~FSXG#]&"͚Sc? (dɨшf[ON\y}_]WpnG¡uve\ޟ*s$!ǽ/N0:a" Q//EE:M'X Zxi:ؿUygaieEng=/uwjӗUS}3oXjR]%*^Z12].pSjiֿ_Ցը\ .&20DP/waBPRdp ^-| reM. V% puZz8J*J2$'BDO̎PPY)<:6)Ρ˰yKgPk7~=mSIwl;~/إ!ş]YB[鋋\$SrG<4^ntӘNzwESnh}j] *zGQL"xuj92nGyLG=Hzث7mqdLR ](I-Oa[K0mer\Wj|{dPjs  \h!Zp _Gnu'xbSp,: Ni4*D0c.[SH{?>B#`*zm@t%O§A(-^K?]?'Л#d1yؒ"%wi(,T܀@F_$F ^UdpiyFږ3)"/='ۡpÝt6 no2hy+Bt&!5w4oI>@uC% >ުgw޲{:%bW>sY'ᯮ׹dMKa_H[L767`4~2ʱZݳ7j?*}.o8a8n2z2b< o16 ٨>1Us6 l`hl| h7h<19>W4WDeϷ@>^>QCRm,`ujsl\M6(sr؎Jbo=i8 (&8 ̢QT%q1S`3J w1;XѫxUjnZrGJ%ʲD}XX57(xp5Fwx:=|v8];ҭ{ʌmV,AE&6DP@J{w !!X6{q}Μ{g=ﳳ-k-?-@kW?ȥh `MJ|Ōޑ1|@kp7&Ԭ O?w6]sR,lg+^`prspv< +qvw?ЋvpMƣ2ch/*n xϼIG>4;:0HAE#B; 9z;0n[A^+R U]u{uڬ4M9=4jv|Vc۔<h_^W] ?z|sewDjV:[tE Gl9a?Ys0N>ǹE} omr\Ox"dqFt-7rx9a>``9hOIQA#ez=i41b>?!ECqnD_BZHN8TJJ'd(-E|X'UeGRF ƊɅcI0R~,9/Jb~HA<(Tn\?T>ZEi vMѬQp:511MP)349lh1Gp^f}/tot?^vφ^F+'9Lazf&0p`?׉1ggUgEyZ:鉹w3y6VztAf -pk=; M ~ RW$̬Mki!-~6VƚgD'D p8 ~88#2$\ 8;x_( @a&Hp _Ϳ%6edJw cY|7,{Pr׊͔B =!&^Pbmnzt'U&wk-Z̈a>3Vo1~hp4*ϕ^?YzQ;"|~'NpW#won>w8X˱"بp_51}<ѻ8c-r7*؉y;b=ldhh*b(|(h@j!7òhH31֕ C &GGcɕ) Rm1p\\ b=Z2Z5!;K ᒃI LhfHV$Dļ8ba ,k\W:\;B&(csT, 1E#!OAGfF3zWDc!8y$-)[CO0_vjl1$2M~oun6f}4vqv"m,NKx,EC /$ΐC {SEbCj S['ث; oG~o\3rkjnUJLK02y:5xFQy!)( âCa2'Sa#AheeJk\GIpʺ 8lpDCsۿ_V߲}vizql`a/142*Eb-a7GM%ؐS x~}lڽVZOW_},yFg H'goN{mo{BvܠL1rZPvS ےH>`?ӓ{-η{.D^r=kķYek)>T`2dcSLСȷ#)Co#"ml-@  C؀ ڂaBlv`0;\ 6-.I¥Ē8by:TII`̓!+O)IA'2F20\>=0 xRQ* "r{AM ,h:YV>ATR~z]O`堿EB"9l[˰Ǖbpcfq]'F}mn ۻ]).>jŘY>znoa/Sa`36)X h 0~}|>gOL~ar]ZvAV]s- |HU}%X[B Wnλ;DٿK?` >/|3Ks噙wlؑF̙ťe2N\Y$Kx(\g<~utptEhF; mk oei]*SpyA:,7=h1R64|f\tC*ќ|œ)@ _x`$(_ֹZ WbAgrn~=kl]c#7fj7Chp1|`4o8s(ޫ?P;:u(e0 :l(l8 ᄍtFD:\E {%z0BIHyHEHuh-rF+ӈe@:0HgEA#I I~#$@ x&#YRI<\[Bnl84idft}lj3'S(sd`:=cy`t{݀ R`1|٣A[AAWoC2mh(ΓP?-1Y˳̥ٹvv>Znv qk~]>nGĂhRF5y*qD%.9̰9B?oy&]v^5ՠpXvE=eN lO`ƶX bK=vW 7f-߰#/#]b1VIy?AT0U7RjЗ/x! 7>%m7fmF3W/4VR,~, Q=͠рsNGEZJ^kҿgexR 2jT*o.?Q~X fI9ǵeڠ{}~ա' n}p 4nOJƧbR|1I>/灎E 6CEGG GC$MMcӃ!0BAy+SiHD5H}{Y*$i(MȎg"T!]cb"]1QÑN`^@=x؆<82}rm!|6`Ӕ6 :NfNBI`'CLB`3d<N wһ TZX~z 2Pe !TXxxDqAN=a֩J V !!S hXvͣKAgϕкmޮRP+ŪoVDrJX2 S^{} 0AxpXƎwǩGv.hKHIq'$zV{愍d`BzPK @(N$јxSp'Xdry|6%p8-ˍ)BBwruXm&>! VG-M#AqP\r `Q8< ftF;`F܉^D`ZpxHqі RWX+M২IN'MN 4 $VŝTHL#FPC&o Zֺ&>VdHcT9e  ݿ|qʾtr/ٍvv*鿄}aabx40'c-6w@0޴f^x|ֺ5h_/y6 >`S 2VK,XU۬|F8.= I VaA0lF.+ a90HLaNk̛hȣQ+J҉EI@h>B:.5Hg3I+6bZ [ Za¬ #Q#n#qxo?pp.\I :{t8&0Su01(A܁wyx38ZNΆ# zFv}QoMޖ(۶'G7}h g`O?_y=,;?þnvnΜYX~SZZLR>Mӗ0vJaw j5jTE*DjNe]o`[|.e8-& Ɏc+#Z` E' 1 5Ea0"1&GXT88nuRFӇsqA+[!/+M9)+E]&ge0;)ݟ*?vd)懏?h߿fƺEIK={pPlX2[7W?-VfTLBͣ KT/>լs2T(Q:_$R.'T~YRZF8{ `/88}po׾޷ */ܥ/-)/4=AH-'BFXhQHa2j,? 6KGrFr$ri:"{*w>oRsk/LL6yYq8`v _B2Dݰň%ͨAQNk^{!W]ᰗ ? i$9QEت,|SW?nؑ<iYGa2wHޑ1 MkUjEɐ} x`~fH%gA(7s倏x0r&w$ضi?ag?P|#3XS?TDGG>|G2)+,Rŋ b _/Ѡv1ENDʐxxmsK G2|*M;+.w@΁8WpZtIRI~b {'luɵ5PpQ7{7q1ׂ\GwqIyQ ;}H))HIۯf,Bگf{8pri&,kR_Lk*:h]Ք jgZFo(ΥeR ӨI쨑PBR >g4¼}s13iڢܬwQFrz͓A'a׸K\6I |('{m hINA,vg*E` uLv׏7" h ub\!}5EAzXqamF]ɣ+ջ|ο _hko_:=QNN/3?0)8];sWr[:%Ki1K9u S8=UQ\MYWxbRmnϗ;YpAY湪'˯9Q*%P|p`e8ɝ/|(;|g=wpo߳ɐgû7#ExG4}OlbMhu:w&R?VWDmVM{j'hujO>ZJ/TeSS(dA.DHx\0hc^vcE*˔EKo ݕhrj6Qg#x^x8ly+6#(:I4d s~IhpVSI %"Ёh!/!k1ҭaGHt {w]0?5 /'hO}1-Lu3f6177YYfTz(wLDH ~Gca6D?&KH|Uk/jˤ_;rNJռkg$JO#Ӛ(-(+G¡B B< GȽ5(O(?ݯwl40~w/yۣ˻EcLJ9'r#" 5eIDSZKk)Cz W "aZ{DGn>4j}5c5plRQ:)/KG yVBh`ţb3DI%֠uYNa 8ᆊL %6S;kh4l?u΢)*}blFcӤa&BEΨĤcNkd?kHk+j[Ek3S)Uk;Brng5G˱1CEY)(L4ojr,3JeJʯx )ޅa +B==P犷iR+qB/('Y* q(Gj\;;yȾ AB\ygx  9sQx<6ةn͋]߿rvC;woT۵ّ]vֹ!r"#^U+Rum*?lmzjwxWD72T_#H$8 ц) cuwVQː,\FI$gŌ sVFa=PtU(Ie^<+{+؞higxeOC.SsPِaa?[t*-H)τd:8㇦ȸi'qF%ͲDM]uY2B1)ñ{t :h?l `Nr ~l QsX ;%Ǫ d[$~0la#ۓwۛĿܡc\ !^`g){޶ GM9vls{uZsjApZHSBids1zviyJm:61995cuO=<5ImA:'iuŴʂlj^1-~$1t$j3e2d0dO_QFM'y}  ̹k nJW?UwC;|lm\1ޘ l&H%=uLCA!4uj>I&CtL'aRD(IwTĸ"QV7 A?R@!ɻ᝸L N~rZZ>=,<3H+yٙE0X`w`or=l _{`_qń Nٮ,<:qFfOĘ`Lfs佟y?1F{?A?*WHl*geF]{Btć:Xx8`C\*ZJRThq2jD 6)/t4l߆<\QS{oMؓ~'ނ39m>c G=[97֔w!<\wwzmkwAc3¢uHiFZ{3666>IꢢhC`L{C T>:hm5 }8d-w>Twen~bn94XZDws3,*sK`.;WϯKoVNA~ZV&:J(>aC0ߕ݉$;^˖O:xĎ'7.c18/|x4$6];R@@\doY{Dxr22dIؓȷ-ok1 ߙ]kg?K]wpo˷;*mWȠ7VQ*eMVj@Fq@N0@+Y YCFL*J%%@NL'܆}Ю:/(ܖ.9.v4.[\879rnpۿśo7OmIj1Wgjr5GyأB]c4H3|mHkTeьq"JNvwFaz)jJkhY6!/q8=|(펎p`l &Ğ㎏("䙶ѶʕIũYX̹_ߧ쿭dꗡupG ong6vf$}[[ɘdQV>/ uZLSIvD=47Ά˼/5d3鄉q{$gx|KdW"uEe;+K@d_!L9ƛ*Ϸ+8~#^|[%FQ{*?]ǿ^q@zH:xzB-MuF:h!,G@FM bޱyH`Bmtұ|rUiBCʌ$`C9գ6{7*UdBnmF=k]>9DpO).׬zEZ,]^v?0ph a( O ɉA%Mw2FP$,2:>>N(6kZE( a3c!ñHs>Lp `偏r:w4peŚ"{05;= |bLͬ?ÎDF8dpv!yyB0qeg }2_$jdL-/ 䑟F֯V{T$Ҩzrs>'d?1Gk(Rd|OYҾ=9[Ȕ>r9bsm 1N'#a~tȺˁ^F7/ڮZ]?woZx_R?&ڷ!JW0QC)`4W:jM&wT `m-SmSiאRbS>.TN.K" P'c< [AڠujܭxTp@q8m:Տ/<o;ɝ"zSο792=M s*v|\Ε KeN*FKɹ/lbIHvux_zY&R*lp=9|b|^օ;qЛsK9"vqolݖw˝۵րgWֵ߽{m_Ը7zᢼ?͈/JI±:˩UZW-nYX{ "a ]K1W.P:R0Z36GsÅc߾}iX^jd =<}dg?X‡r$3dOX_)UmmteAqP#& bj1?iӐO(6q# }FMA? Rvj[RKK Cg$cwtS_ !ڳ/`GEEwFI(K @bNO"{8Y;w0X3O4Nlҁqz#]2k"o.q"Si t kr9ozA0xsSJuJq,ҖmC Zac-ɉ]Gͼ{_doā,#i"-L3 9̿vod]ypm~=UNi:=\\ @ҥVbF!3T8ZJ(ʀLBzJ-P_4 SK`"rm!vY`eHu\^.# &c2ZXZ-[EOڗr+E,Wd:'҅3*:V*wЋNlM'imxUctąbY:6wl>MLx:8E%3y; twR&ʩBV != ib?P>Ƴ/ 2l|*ivKIbau|sO+kwIh~- -r̂c7?g{st`;ǃݛ/[sk¶oU6N ;T.l}(h%#K Q#'J~ 2\N)D4JqXa" ;1LHyD;c,O{;t*8W*sDx>`<wʑ=i'xr/8‘KkT)ߕ̻/a}l4_f>=zަCv0(Rr()7`䍶Sz&'HW"1gQ M کݍHTBʁ/K %`[ c#\!M Dxz\=?=ڻqfEg?}>3?H*}/DKK/?ҁq [1f8f}fwI2'v;p>i׉8ێw39՞vs[#i= '3'Fz`Nc-=RAC:dddEB'd"Ic0RJ)9 j!c=#t[=|sMOEj:B'sN fܛ.'w tS%N\9[%sF|MےdTbE~j6એ0{<^zY aBqxb}hKXW=@KcƇ{hp/ ?o"W3ڊ'jH ĂhRAhN(&k ʑ䉊rpĽutw'具x(ᚋVӓP k PίjY5Eg_ۨr@5P?:F 95x)>/vܗ<{W}dLջ?͜cf'c+boZGʍu( ?Q""ՑB%!ʞHrb-qy=NsݱNBnzo}po,mq1k`[]>yWVt?A&맹o6?4DZ 9\#\bB! dʑXXob1ʓ6F AfG{Ya]tiu5>Sl|xeH)BBB O޳sy=${RJF\J7J7j_/{taEפ?>kRaz3f~6__Lz(:7S-!N v900'Ƀ L;~j_G,5U%#X;eYh;=o}js'#uu١RGLv)6iE9R=P!6^!fP)~ymͤ$@^>Npjφ7usp1B=MM͠X`}̰^XOɰᐣ!NelQVuWk\P,ZxT^`٥% D)< h>T*~ 0=rK|捶JMukjY緗=m,vLy>7>^7p32NZ*'[I)5>2QGk0ZgԞ Xg`ǾLn8R壯LNZ+uPq-b)wHbɯnwz}pYA^&/.]Kw3ٰ;U?e!@z~?6IwPHǙsdOÝ_YZXa Ca P}yLu'So)SMK`dƸ p g$6ؽWWxsεz\som79]dvFUtY JuٖJn5Q{MIIVQ|J3kڊ/ժ_׻k)y@T+s!RVIɰyqkP~V!C~YtBU>Zo^tcڙΊt_[W%42/|\|`> v x\hdDl'Yٿ;G.ii= =} OX3̕ElO~ ^m|Z#_z_Bdp]r{(J3= hItك c#+ۋuo#|@Vu*mݽ߿>).`2xC8L`-겝 w*o]SԤ)P^J\ε' 7۟+Gv []Oov>ަyLM7/4*W˟.=QtX@ Bice2+W\:VyI22b2H2 eV)5ɴk_||O_U~VanC[wdĬPV_1z* >oVaWJHlK'1X]_k G2BF!fZyc - ^M1o[ܡ Ly Ksѯ9tE8 ƹ[ij\2q3|a2G[OX_ΚYd1a[a|DLts{|aW˳j/>̿_slq ye- ӌ~rvZ&aƛJ*Y^,2R-{qV_鵆JUOo(Iʝ(W!IQoIDRr`o]92s}Uaa~ '<$[`G=L unD^9${xٵ3u n5ȟvXXM*sշm+pO$2=TK-PJ6߹zNT@مEb /,p@@H`'*eN\Put;"U%ڟ6PmW1yiE˽K+SKOPc-E/?~d*!sd"'T{t[`NdoF(0LEh&8\1\nb~!n/^{a_8r~3?9i5һطIfߤwڲFDcYDתo2uy¢,3i9_}O(=9=%K e'a/.--?1ffitʧ K9 ie6=kc)/HNL_g nB]pO*yG~7p'\{w}w:>v#%xٵyٵ9!%{XWG_x~_.U5]:^whzeGK%KJ dȟ~ƙizSr'k/ftexSjSiM.n 캸{ݥl8/`Ip|{qķUjߕo}pοZo{U)7X5|73)O__U.,yr;fO|oDZVfNA>PqeeS`vȏ~x_\Xs˟~B/:k~~)xW0Ꮊ]o 翹WlR{Rrޭ]'YD:m0.Ad|6l=!q ` cj6J$rK+Y`}"* q?H/2Vɀ B TJ.p\t_Y^ث@pXB{ @n~^BU&ˍ*R*w\Whx(L&-w5mt:&rO9ge{147>8M%,N4HqR0ؿ*Cfhs0X$dF2 ʹ{yyb["k%vmVlMd_ŷ}{qZ uRwXȻY5WQ]wyֻ*7yc㜂uXj\j,^bA :v>'_wW}?/>J??)Pql!>gijC"`?]ٶZEqBs,&2AiO `enыKgl%UQMI.FS+30eR>eL1#,Gj_~|ߌĻw{}ƣa5>ڹ8PG51/ .Ff9̱ܱM`b[ܾNf&ݛdw~'˱M7vmm *{6ܨΡ^ :nb\f"sq974a} Ưwk0+ *쓬i`*2]ZYQQS fK9|Ϳ_|dL)7bN-ͮ||q-u {ݹTa]gJV͋-&Ʒ+ z$P? _aWC/(xfogd=\ z1? BwrOݹ;s98 wۑjwٽ89;̞8\ #5RuN4\9x|D-䚵;uo*;5ʚ"!)q$mqjten(RSxKR-:f(ȶTLb8OCcozHg_I߭enۿ۾ Ǻ8%96InY'm՝?\5qlPxkwwv}{{~GÛ_o})&!s/4hsI4?32jwvOJK#$k6띅NX_~.QT+ŭ7jMZFź :rZW5sUD Eo/Q:_xƙ 3U g+NWʞrRF`đ E/ޗ; WVtBp?`|҂ 'jdUK dO4\vNINEQbOz+лcAZr[M/U4M[hv>n}mvC &+KSL nfj|a`NL2fgAg&+iLЮ ^#.56Lcm^5Ww|{s:ol_VcU29ty+[)lpsJ;E \tvΌo+ޘ. j6א3Q꜀?þ?a7:>N?g耐`(?5 ]A/LG%ؿ=;5:Ia88A^Xa5i7ު^ʳIipLRArcJ RwīoTʝ,~H uw%ԥ5d4h˵=/[:MTzUQVC֚h!YFvkml+-Kl_]~|XKMty 2C^g8Z\ťH"|f1fhӔ⤧N+_pJ|vKY@{j<>>&;"*QE4vMĆ +vPz/ ])bQQ J^n>s+gLvͮߣ9=w0s9SݗL063~wE=ۣ?]?Ykiyvo[~vc.;mEvN=MW2qhlv^}n-VMM3~ 7ٚʊ|q"p{z\ZQː;𛉠7R/ }g.r:m-uB;VLM"lLv="uH#ͳ[f8;kCv8b뜸gY'U.X o;؅F9(W.]t zYvxHA ( v]uV׬hTZj5*٬a) e,%S8zQPNHq(6IK:zX1~[}E{=^8t O|b%˞-{䷼(Թxki互-Jzy!}|}KSKRJ<*^$o,Ax1>I+⳸NsS*Ԭ\IRBRRNMQJRH 91bB$vVIeШq`׬ohP`Z֤;vY}7r 5eRY`ɢk%n:hϲ&.ڻtGYXooim?4eپ/i.M{rjKGy?-~Xz$%}ܠ!ԜBo*g®m.<A.`ԊŁU aS [f2>|ނ/8h ˂z49Wo8~$D/'p ~cs zG.Eѧ@īwTDKM8 ~-Vf0qXMԊj]UcG#VڻLrxv.sop85qʆ Emyٳx(1~/c*^$T&V&\\<-,5d' y\ZsCٞ)a-n/+ fQIX$p-#`Y7 cЃ4GRZ ƀwiSX &J ZQ 3Fڛq'ӌ`]ۯ67uaiaү~]zn)wǐ=>ϼE@~]> mm9ƺS|;w>8T%H vHeȂT# oA*q8υZT^f^PTVx.V 7#T5vNBFs`*a<#XP)qHWy˳$Q9Nb4TJ^E(1ѵoB\]fs^z.VRݤ D<KqBpYƊԈ].]K6>M +^{Sپcl}im qca ~8_UxIq '6f5B)\&[IG3 {yҡf[b};ufp׬FZaqaU^y ƞlsyc6i_/|*à%5tކm,lУ]ݛ녗 Rօ pfB ^4-Pӂ* 3-0ZMCC߃ LXb څX^BaweY ZR qX,F07Y!CHIBXԎ%5*K-+!3%-%t }Vk?2z7ˎm|-i߹k c}sV.6'n]=:=cDߊ9)MoF*)RccMR\/aa`gyct獤Q臠~ ;{"Ԅ1}B*?-٦RN]ڭާg6XvFt2a5ͺ͒:&YuH1ɺKJCf ߦ>Y`sY]P8wi~/^ Zp2½S/I-!mHW&au~& hc4/%T`ޅ(f5TP!PJ·`@AaB@A&_x UM5; 0#®U:2`Ƽ1ZQX0~>ǯQ̂3eJZM$&eRM6x (fNdP6Q3^GV7/]9 ;C<=Vĸ8*d΄_͛7{ 5:d.s,&Dʆ{v^=iQ%yI*Xy%CVTRJ,"bJ7a-TBh% vB8zpLEXUry_f??̪Âi }nӯ "_4vg[N{͐ wPPrڜIRv6}r G~6/a+ oP oP'{kH9AWYbIgΝshY)Z`9)7^?1䮊"X(tpEpBX]ů;hb@=+ ; &H~9r/l+F"ŋ\ %|c^,QiԈ)p1N4QTAZI+гr5ި*eZE$` D]uZ+-V:AQnţkOnVWH_pL0) D͐Bh K mKR 8 hcSIkL-OQb^o^ *ONw_e׹q԰lY 6A=Yd5K֠N`كf5{О96F <_[_E \ WMc#{qwT\Ȭ9~yOtGWϩ&Nw0: vv4768lĵݜPqքh\ASZQ" , HBmLJg;uGPr)^7ՁB=(yja X2Z5?*PeqZFmt&| K\Q@P:S~5ˠp_c$ XH MIDO@JPm,+[M27hh iRAk8z S) GJIAH1HY Ա$_5+R)!Ɂf ӭ-ҩ6y Ud`Ko`GmwQVrOY1\Wg\#F[m=mX߃cdwh%#zf~jxs;h˳czku}IïMq}Ψ+LjBa]2>ڶ%w3]:&dP2Zr4{r;Q,?m~87)ēgഺ _Iy18댜CwM[~͂%!pSfL1p?>uz]1ϞcE (H"3;sϟe󪕫%l< vF #Fxp],eѠfP$+5X-l9Ǿ>z5dmH~&9k7x c?GwkvLtoڐ_ܙ>y~rz[n?vYxb=}U]\`J՘|NKK HʹV/!? ΜiQCރ6NkW'QN9[b#A>(*dOٵn7:{r6Hfdg+78}Hx(9 >zӚ2-3+vVq6Bc; Op NBV*PPs=dF;(N aJ4}A> ڽ-v/MJPh?k"A9P)( I>`[ҷaxWe/>8#MU5{٩&^78k{UNZAw NjqdKs\7gޚi{g9#.X0ql 7>\퐷fA}<>߷2+"'+V?yIUP4C291:=V3R_6&@߲Dçus 煄r`bU3u4'=eW2g»gr"* ~żsZ6z߇}GLC@to ͝9 nzԾm~!}pxz8~,AC(hKPMF7Z$I) ARrR4)JX#^W9z˴/O'ѐRcrE鳇cž}s<`n F>ݠCf?4q:qNT˜C[_~{:6{UUE7 &ZQOh.ꠀLQs-o{ni<}{fm _xŢ?stLּ_o o%&?ʫiܩo޻yDC bP p!@aR(zVS+yP+kOu soo?1RmphmCZ+~B%5BGKiI5)px3VK]'-{hhK[9[jwsa^M iQ/'fc|G[ {bB 5Jڡoy*};꜖ݾ39}, pyX<¥ %F+*__^")5ųOO7s8={ ܽw d?\ p֕kB bSt J#jo1蚤ؕ?65xkmwO!R%@e" 4+ FԖfz9ۦSgsxd[IإHRdd9jC莆{_'ʾK+$uƝHv@ z̨4EE}~z.4P}sz]8$'e@(x.ԓA-z-3D]i,[G$ړQ$E[8T,JD PWsDCc~؅A&o?|&! I1$K)\jJgFXS_\~7HFٚ{M7`8ian-ʈVR~bOmI|)ezY%ZoM8)XL׼o~v>5(*B][;ZӬsWFIB0R4GkApPQׇc>0.T#(E^H.xM3go3RTQoTPC:Z3Xf*^ň|xakE{L/FzµqWLOd#;S7uعeOnmzoPȠ!UE$ C~xFK8#hbAkpu^} ?pS&Ԩek\0!!8z\mV[C}Bߦ䅭y[ MhhnjuJR!U2xeu,+(Vsj5غŋiA^nP0`(E dNRڠiQhj-S^CjhZ(]ko_vCG'##vFa((d~I5k Qx;KW7?@ @4kMeeeGKpH &* TB@=Ԛ }ȤuGaLHHxZɏ$]̈x{D{f-]==FpA-ad<ɋp0-cqD2q$$}YoʬQRRO~kG?OU/ן_#8 Mw`_v}o?~~xǿ|J_ Ph:%mk6i^E 65kMc;ulaLڢ5-FV i[[WgY(QQ&Cգn*h5uRL [5Wi9qɑUyUsNdbO`zIY[#U1fdC+iҜiӱt H,U*d~S*xrlT~`5&0asvKuS&f5 QD4{p5T>G97uʊ+/Z/fW-+ *=dԉ.Vl썓;tn-4m]RN50 "‹dyӁ>#Ϫ=RM^꣥ k”VI+=J#)p dKSiKԥnJlrgO]!4R )$D8fJtd[unz!%OP4H[wiv[H\#qvۣWLk4bO >|=*^?;Yp"B\(T wceՔ E:SŠK&#ĆrȗRsD2zKQY6ժQJie(|<6#$UmJvkzmwK@jB~$*]x0bb̈J,@\i3QS-tx'.-6U̬ɮ=: cg/,+Ycc'Nvⰵe~>ߜZɉRC `?MnRNU=$\fFόtdzdUCuls9r&ŵ7BJ9fnw%n6 }@X U!\@p5D4uרTͺ.ΣqU [jNKO0g.`)j7W(IYdQu/{qпoZpِ>8N4WnGx 4  PA,+ǀsŞsylEom`QfX]DR]-v#ɞK#1`DKA@WLcُ0RH#$xK.`O-F 1{mP}-ޘ^ y_]]/v@ )G ƶ`n|x `^͆nWb@A!GD$\{/<C-;FoWs>2J]Ez`zCp6T  #^O ͔ #6:"Z^<1UznMxHwPD![ezv7J~~ƙ}Jfubj5sϻ`ν-<=z@} -nY4a1 d^60#Ol]㧃as1{&eLU .pqWq2cX5:^&wm^ :njްO\>ۏ{vCæãi@dՍc̫4:H6*1Uډퟚe®3{I|  D,a9|_&mq.v3k_xMmd  a,FT8#YU 9?%墁qz4-\ƲQmDf 5[ H6#K"H "?8&Ńv F2O2 %ifD1hRIЉPk6<e2\g]CP ܋m-d >F$2|Vd} ;5Ѻv˄/)X6Z"i -)< UC*Ӵ_#[WD;FF06E!ʶLU,5CZxX2[͔_4kd_М{)GME2Kɨ+XCdDX4+F@󮟇HmFV,aOq,&h3͋i,#|a+Ii>}yXcΌ(l/gy34>;~Uq"I\wm86 yept滒/FFNYRv3'ywpXe@&[aaw*XShV0q'Z"ak$5~mzg/JY~.l@…,V=TWU7n dJZx2<D586Sf&xr*쫸.YY  D8wG72 40E_ 3 ?er 't{2p--LK"(S.DrTECO>݌BX,eA.h[*FKy,|jxz:O}7?~']vdvA: ÿf?ۊ« )No죿W_dx*$ m9*6H@GI2 @x 08ohsgb)Q^_&z&OLV` \5u{W fV3WaAF-.b(x3VGO= F^]v+;T3=ҝ Yi˦G?'ݟ}Àe.r T]qnqyy}noL*F?np@ډplщ* 6"5LX-kYC0w'u>QG//r_RQfȞnG߽˿}}i((!i7,$5! Z%s.+~pz_?6˿ѫ֙<_ 򤏻mPMPYu *wLry\#1My()4.{QܳƯu$Rp(JWA9E^kNi=tH,QI?MwQ.-NM.̟{o{os[qwR3ph{5@~SlyZj {Zܦ:-}2|x]~݇2eUab;zܽ x[չ$yޚe˖dͳ,Klyc'N0B!a,yn˥ZR̔B L!%2'%kwIJ9C=}l{~]{%ؒD8M*@C{`jJ ;"P>?Q_=ڜC%QlKORux$"Mp>&orx :rPΊBP8M$9z@szK￿w_)4V[ жE>m17A"I}hY8 LتiSAŌr (4=ʪ9VujUCv/)g{{Q.75O!wI{8mUw<'4=MW$Oph@CHN_s<⯦gk<,>hg>?< M"*^ B$4X LQx[#Nje5ފJT͍"}5OWbUE$(d]ZOi:l3vI$szq˕4 a N3 9.Ar"tyH. vZrvd6!Thl|YE>b^B[τ E%5@:fL5Ͳle/rui%k/#>x}ox†qͿ$!p?"؎q"mqшF.bZAa;8!MQ!=\Jɦd#*0]1bӜPE@AYUfDJTUK: hC$矪u;~-e#Rqpg,C(Pp 3g%#/B69G1`EhePU (}Պ_޻NRV` VxMxA<4@qqd/IC|pz1mt}f@o;FᅩEvf^Ou8h'^ ڐ{|ڦ%cX{w ZI36i+ht:;*+Ēb7Jr\UV ؼ$F(P4]ve\ Q-%I<ĸ#6q{ᥐDL2(BYIy[.@ 1ݠY1H"V$IAخ6:]OR-. 46 > 3NwJ򇯻:D)243@xڒ60 ~zk; ӎ='-wE6Vobt|?o6RY7WޠDQYf6+WTƗ8sPʪXyTD="]/>J("lJsD(h3s5rP$,i9J#Bw*r97ժ> z^4 s} bp:W^rV#tX̹PEܠnQ1F'W\TA!rp!$ӆUSaNU+ƥc(}+AUR[V)16 QP5@jk9ThQ- e)䴩&YUJCxEY%iD$2v|Ω$ sȵ`nrL%z#R"둅g$c K4,HnbW.nڭpKV_UQ+QCu{Pѱw8'dEW"Y%N$slV!Rz"!beAiobPV!9g78!".Zęq֛3Fd$䝒Ye*UJ!lVz^To! I.%j ګ ,vdCCoa/Z2~^hrIm"6 kYmVa7t.Ɂ%sL}<$7kH"i |fȴ(hh8&^x! lYFY.ZEk9Qrdbkzr_nswRK4I bS! y&s'/)pmDiKYyÂgGp8&4Qb!z LauI7Q}<5gvWí 2X}lwVvX}.*tgfי;-~v|SRlQFNm֡l"Py/nv@!@:h9kׄN8:*瓏'Mo#sɑyTpkxv]:b:>^ᜳ !-Is4;tL%C2jcfx\ W]vbE KP X0n{ۃo{L=HPp1އu]=9 y@Ie_pҢǂ~=ĦLUi%V}*{16zh>j.˫uЍn#D ZC d5W O>\41L<~f.Xu~DЅPpOߠ~Ӱ}[^}KV}ſBCo66~XOM*>XY o5V !?|iS+Z+:!( g$8Ts2hz _qDP#b:(JtI=%%yq90{r#EXى_ N=󳋶mo-aD9g58Xi1no׆]g1_c87ZcZ#g1͓.*\>z|<^*֔qnoT"}D5Ֆg^ o۸igt(bt3[7_UGcx~6=ӫy؏Sa:Rzr뒻ptOXCvHw4^ɺkkPN$i!FG#l:|߼%|0ewoٟy䎊?=K6 /p:1s;Cx|e.5c\qcuVPܕ{cpU]Xt'ˏ{n'/Y4jOJx_e6$*ql=9{W&vþr8w4}AN>yʲ ~NJpb3et7ݳL>.0匝:-X|HcN9=>Djq.Ƚesƅ!\?4ǩ'^01Dndl/UŦ;}ݸ}PФ?zgQ!UD~9eܾu'MeBe$zD*6!8+QtDo5s (.UCh9KW4w/Vj|h͚Ի8nEpɉ./[yӊE*hdkx[:O\k!ԩ^-}E%P?~ ;ϻ@=Ə%GmCp)^w?.cbbD޶y_%[O+^]ӜJ؀ش1۴} Sx-Q7C%SQF,ѤˑI& J ajKHCU׽.sSOzcהp͝v'2DGzP,crl061ZV]bʉ#'_{jRƛ /|Q(?_%N?t\*U#O$$?6s噵A~ͻbGWJ7|^6BG&SX8hC1pZ-߾®'.o#_'<˄Oxmulo$$q|@rŒN3*q2yHO_d 1Bp7m9]JӡS Eԋ\;AV:1gǟnXEe /}[^xQXu߃#J;a!T<\}gά%]4كPt}Bn滩BXyH:GݜQ5dx&HR#V#[qϠn#tu"/~pѱyZu>`z֓ \u"P]VqȮ]4 >H}~~ы@ip]vaw$wv p+q{ȰdGwzdR"} ņ, :7c+[?K==3kVmݓ}exLOf|>cP]ގLnDʳ7bvQ?X.g"m#uG$62쟌tU'8SI]OVI|stյp0MPqD'Hѧ 0=&:3Y̌F'YD1F 8ch&@~nf@8lxe՟nV5[Pm~Ichk큪Q(72mv,6T ,r8>IȈ|_LHs`bj5̦cھerF٩x{C.`O;o"PjR.0@Ͽ{mzC D"uDߖ&}cb(O3\K'fDz/0Ύ#;?}YwDO>,3ۘ}e{PE [vzưFK&hjס$&̺M wĶZ@G :N)#Jcڿsk.еsSj |h02/L%mj85[u\VQN ]~C&Oo(R $JsUxnr&)x|՞ H[BǝЎx Rq){>.^?ĉVZ·GsOY3Ie,BM3I/vqϼ6YsU op6m $7JŮs|܀1}ǭ!!J1s9̖OUz}\|Lx \V %tԏn8toXUI;%"%$Xc7k:d!.BO?50/=g).dLKfvmKz*P䣱x[+ E/<3\,Bt U*]tIU-jmN/M \}IhR_V)gā bH4~*1X~Up/AGD9'HY^bfRtm9s? Zjz[j|,ԝ(5償lCpoGmw}R'O8J9!xEgR3֥<>}͹?E\ED+z#ww U4}9L`O*_5a7$sHx*5Ӻɡf+!mԽu|Jp#Hޯ:%;uO?$; 9`heZ[skyb>;1o;ceݘ6_U$Q^" !@x'[obl۵őB:l cyb"tƘ elw)PI &83&ϛg"|lI5{!ot̹?DxA&d8i1{;NNvrl`AÝ^)JLHeZN03đQ$&URqtQj-4B(D+'H/aw1lz|h;HsGo_?:a 1?lXΖovM5 kCpA<1v ʿ6yK(m[1 P^R^h:^B_F:͗g8LHR}>K!GlǓ;Yqސ z[(~Vb ІM4!rG/bз_|8"W8nrCv90spi}ڏ5=bot;3ͷ۷qY&Wm}%[a55+ynҡ+ b|JVr29:=v񢾈_C<0Y&ec>i]/<ȶ~QȺH!,;[]k^~5 p;&|àɊnK@?L̋u Jn;m/ `]v8H\eM[< |#VÓh:W =5:YGNMˎL=+*]9ZEu !cRXUu风FCJ WxvU8g_ﭟGUQzws\f{.K fRpջq[l)"_Ɠr:jZx65ֽ#Snoa.\ZN\Rpf`-7Xľ;o,I2&l}}}#$zPm B)Ii<(ߌe8`pkɧ Q1 vWS# @si2Ke͠TQMY}i+InʦZ(+swh&)=xaxL-aWڂZ8iVT[4STG(j}~ *e.~BvHI+c綞6 fDڭG~/ gCDSqxݡgzVnM!閅/o{ۗJ>^LV/}>G.>S9P:cx}!L)/Tv({ikXaX1q ꔤقOݕ_pqæXkPb*?_+3D\S6?oNen}\es]S|aEDx/?́oV |(smf?;g}| 8S$N\J @_F= u4o\>4[zJtrhVk3(F}Qc֪~ %z$RANhŚˏaT&n+0QӍ3gG;>PSiEܞv`l9,,;TIBuW98$tg޷qL /歨ҡvQBD@(SEO)(|b7Z%ΛB+wB|*["T< $4Ou?BOJ7bzUWL1v66oߡo5gtdUz&6͖!THjj\8d&Pz 14W8m57$ԛV <[+rӄ4% &)ꧬɅÝyؒy %)&iovR3iI$1 P, VS⾇gI\Sz::-y3CF{fZǟ<癖f7б]7jp#̊ oy*J2h.ڭ}dlΜY.3F1~@vˣBw˯f yjvDuJ~qSbf0˽fIc`ze!~µsܐIdw*a,- 5<ٻkнZ0Pv5Dõw1=Y2_uGi3/)D QP ./I_7zҲ^g%]Xezq C>khtZ3oGݿ^&;o:uKKm.7%qDR*ye[:Uԓ}[{u26F˪Bz' $TO"_޵KK{<ç- SxmPiY)y+}D# %lQ"Ͻ VcvGxuu'7}"驧2zՌמgPՄ'kްl7T)JlJk!dD>AZ]eӎ!5e+Im&vc ZT!96vԀ!3σKZCӇP;?Gy}mjZcEj|^w3]"S̈́dr=r>'sϒ BXhХ.qݶ /EU_~i|?=mDBϙ(kw+BZdhsUUw=>ulBLvcjg`Pw{Y֯MG<5)j4L&Î-N3ߖl_ڡ;%@x%?]Lo ۧ[&ptrU$=7OjiQi'JjqX W,?^^ UZSbu[vB6mv{4V#/~GX_;vNaw@N|/"֏ʛT]e'}9fI]-朗N=}O$V\?fqk){~ӤE t篬 N~JE(%H`V:buJ3AϞ\޺j+H/ӣ9OwD1&A/-`5tX k'כRɃJo\Uu &Yǟpq1ɶ [BEU-u5p1;KǙ;(U.S>m*&+h/y/8T*[2nML_nb;*lQavM5MMp.Fc#Nn\mo~p ">1198+ٹ-N~zB`H޲`}3 l+ QZee*Ϳ Nauh<և[[/Qhm|BCP9O-G&{ o,|M/y>nYyku9]lv_)5W@9rU~۶ qM&rqw dDoc~ZxiH9ӡyvhr?<#Atz"~{4Lz}.vY .U?0P;4N2[.ryNZطn@leV7 77G8)؟=ǴsT4[k(N#4 u1'?̱i|xZULz9=[A$l/XIU葭]`@;YMĭ?ύnŸn?bn^2mJn4zkA\^Q1yKm tcɟOrǟFq|Rd fP|{Y5W tW>VuIb A2ZJ};GmcEѱ$P6! j0X&.uiْ991(¡+W gr,_^ B)/#P mr~9Wz;ꌦM=|r1Rlzgݢ8yj0nDd,gKk_hB!a@ο|%\貫ob޷r;ϼpdMMKO|dT{Ó8"p^ҍ&v}V٭sO=]X~`ZN=pOSoS2$;o(u% !| S+Aǻ|3|I*H霨J̨dphΊebYƍKORX<fH,d,]~QjD.']ˏSN3U/3SA^ޗxQmTF1GouԂj JSH{cnGuR#Bx\,cgPѓg(2}]"Ód%.;>X6 dPr5O0l@FW?8÷{/Hq/y+PAߨWTkjbrUTsTGonc֏[zhKI<j3m.BpF&KUئf)|AW6ujq,Ocew߬@} O 6*bVg̮ (g?|WԨ:RDzBC:Ñ ?R%妊&b;HY^;81܇m]U)iZ͚irvȚz<4Q|qmYMWZ Τۻi=Z<<"ڠ&,q j]ؒwצp'/}RH9yb$X#Y>}29-9P:Q/R9ilIoy=}%6=ъuqc-TMaьTenGX`, j+DZy2#I2b?ne+]X}J)h2;Nr;4WQ& &s+D9Ցl uJϩg>7tIe32&P-֓VtsqgTWG$)bTvԦ ]&O$"WeNq.[ {v"Qdw4uN3[gUU.eWLF[Um:Ī KNL&~*k󭧞;Y 3R 7 }bpi{0i F.]pwzd9G@3 LYilZu޼3.;* jj;+cfvutGN ve]9KOuYxlpȕOY!M<4l{-z__ {m[󏯊e+LV?Mh]Oo疯l΅y<mBuj0xsk+r+ϋtNUQ]K!oPnAhcXy7r3fYUj;f;:iޑhLQ"تry\ ;]+_EZWe谣"6`v;)]<2,[4c$4de#Q(|"Qk+8ړ_4Ԙm~ߡ=fsō+Κq3;@?9:c5kW= sDש7(gwJ+`ıg]0sRjl^9[`jwLs+vUج,ђ{qYü}&蚪妃1-p$wqfJL^W'{LM霚m~p%iJ&Jo΀h_WwL;KBB1J3E}1  ~ \*lZHLrZh}՛V4C*Aڮn~Ohc ,fR F~@uEh"BYC'zCqAr'];y*m%K<: dnQ KY7TQj!f.ŠZΠOJpAA0e EJF. nR1oyҪ4Y R;Lg,dL$$,fQ~De8jw׵3O\v\O5zIYJMb&#zG` P&=J \ܩ(\>*kHndCe(CQCy~Nz68~!r&w|:)LS~!Cl5j8"Z-e2f6aj j?K1I8CyA ^F蜑mf)BQ噬I&Uz\5ŀP1$tw~d3%0 t 5ujԢ3 B - 0bwAwAW l6vP&S,^LF,596KIj/vAhfqBf9{$nY>b#X_+k3@{Q!M"1i{j,d9ָʓ5%jÚd+F\Bb@K]P++[6oq4G ObQأZ12VIkK=vH"@~5Z,\2/|1nnPji)SzØ &9vBgbc`_E ,"[rԒ18;H?:|- M=(PPTx[( K{OPS N{ߘ:rg5BcYV/8:!a0%S ֐d㕀] ?HWx+J-K ?amH%{ U \BKxGCIwTU"@цmW(f)Cq!*ÕV:×Ǚx҇8HQ*֠dU@F =to8w}1 5&*dN4.V 38 :$ 9# DY4$2M\I.YKoY`#uU:;U1b"I5D^F\4`PÔH8YJD\um{&j#cHӬT\VijvK84?h2$QHԝ:(3YF9 Y!S{pY_r\.3 V ?Tf}6Qen ֕11VEiiR(UpQM}QP#J0u<4)12XO=DyF ӤQl2S +w߲g1{0Yh RJ ~UEe^;ө,9]2f"mx" սcaʛB +!T"Q= c0햠/"Bie {SՌkC`& L#=t`3zS&끍׭bp, S"zxGT2*u?d#̑Zөt4_W$)Y"}(XmiLL6n[TX}Ėv 2>.f 2X% 7A[(+p=^mW)UA% 0j CPk"3H odž7:1gu¬nԡ@]KvPLvIkzPpKTyBs{t3'WY݊t(2uE5]LiTQwA1&4q0G g e!%Vܿ~N߮FۭRl!HYNjPld5elnj CVsWjqB =. '^ȟykAC\uH۪g]à qx#؅^'1i,8˥n0@2e+\vBB 0-.7$QL0! ٱEB KM);H1t@ fFN]fuۍ*8h9,#>`[ m|З??HtO.%dXz~5P?g[ÝcIP+ ., *`JMU^%"W{t==Pρ R6=_L9dgi6l/lDlgf.Hpl( eY"r6(o5Pz,e QTf1udCk#Ha1XB1&](R^#=-ϒhzş$*P{:liwbM&6PċX?G:8!37w!<@_; KsߙF’ a=Ś6Qr/7.FozʰeNR"*UkA`jDLwx]kB |s鼏$|c{gf2%;N(ۊ##k~/!<=@L]U_mZ^PPg$Eh:v~Rѡ' %mE=(+h޶Nw!yqX OLe翣yL#fȞP?!7F\oov>8]橈Ȫ67Ky}&|kl"7%/K5^t=2yu&ͧN6ęP5kd7W5M/i62a?փMdz+֏7]P^K"; H^k\dM;gճ8 vpkup^em2Ie8|Ə6}N:ϋ ;1Eg'uG6 jmv́zatO}9wO==O={'Og~kK8P_J|5H֙E=ۤ2}ǎw̦[$84}zW'HO2U&Ia2?cwoo` e}}胭kɯ|o3xܽg^=|SO^9~W;}[w}>?hvB5j&tFuXFsMz8$c_zu*|bWd/Żmx'OFz>ƭhaG:k~s 1o!C"ub=\O߁}0-ھ\t#5߶GMidp/[o _ >'ޯயїy}O'={/܋۷|߽~cVt|ujk>-1=L݊^m_A+. @ Oǒ1S5;I2z#eև86W_(0|,~[?wy=܋=Ss9<4|?7^?{s<ʟ}?q{;q3n[ %u{]I S;Srl.1@8q[%YeW ,%;;B !NHb;@  !IaIMf`BLJ,[c8QWrw|׭UXZ qΘH2]K tL1R7I,UD6ŒO~ ?^+>2u;}We"cER@S$aVs=/+OWv4v]Mbkd[\7k|lZNls5XepSZU=2I#1KR [ Ϥ3L*TjLf6>0d ?[=jY4 P.bsRO:%d%AHz"H*K8CuZ=UB]m3Hᑦ'ַtMm5;v ;m _~X; V{7jmzyG֓GoUݟ<k% ^i TR"eeBd  ?)h&@&Pn&p Bi9ˤO&1fSY0ԃfbKE[?ĽUϬ llqd%g?8yO۫~}}a_82`=nU{ͧj<]z7}]Euڅ7Q1,RaSeCLu,J%,R`tkovaJy\MFB %$ Ugibod Rf(Q -үo"BN*&PmBE G1*ݿ7;~lu >kw{Ojo#ͻFp3[;κPwxion:mkz{_7WY?&Ij 'i<hqTbdN5/X d㆟+I'(U1vyBp3^B.ǃ./pj5G ~2J㼅s9,)1QT2 >AfK A(KAL3΍͕;@HV8lXz ,RN/Z+=@y$N߯-6lA,3y`G$ !9< |,~i{ɻ*0LAϚ:׆ nÏ~w'!IÇ]!w< }7>W}K;[Oosvm :+XƝ?KpO$&w ڮU[M/Uq ;ueko85ㆿN /[N R٢w|g7"[vbaU% 6H`Sh_<+r+/CU9f`݊CwƼ.Eawר7^0X'87+ntl[xMHD]/ IsH/;(S)2ާ50ŌUm9sff._zQ30)~v 2ǜ$vrRcEC XC ]ד)k+ 3!eOˆg' ʆ̹}>`g(aL)%}j6-~UC; zzDH>qG<A}=QÇ=n0[1|_Î/'n jן?\OZ5Ρ֖SLAX&s035/P \V վqnl.;A7l~Σj{S1)-{c[&'䓕V v” \!JRzBـ(]e  >ר+2zRsϠ[2-h|ĮcbaVMoȸ ~DcnH ux­c/ !LJvxοIlt[:oUܒ\+".G%䫌!edl + R(UzIvAoPP+\|)L8p<-)bQ)#}6Z)ʌ4YLMg&9jiZ@gs#:'fV#wq*Yq' VEq6Z0@8`Lo&T*yRJDg&)? H^zZ/H'0% +(o@*:m1I@ NXbq1f02a*HSB1-DBc|(I8LtYK2ybJp9U X!JyXkTeX`pBo2D8rurMw Onuʯ C;JA-nϰM{?(v]w|G\y0<)mAީ;)VqG@Pom,gH\ /caXhLL\Tph"r^(cDR(8)musy8"|)6<pP |璥s2vE{yjA#s8́O Z[ hqy"4ޤ>r9sE s& T4D}}f1ybV<@씐b9U s[L>Og0R[&fP6@.*$hڢ7PtZU |bWGۭs4~qwoJ^l;1p3[]otmn~`|00bO [GC=]mP_xP{wK睦ujծkߥqj Cs!٘+qA8{LO]0pm Ms8 4PN4׉ Hgct/ӠT)P?vh8j*4ƧOmїsàu8wcY:@b !3)g8Eq_<yBGǾU1|7|\KJ+ΏBGBLrte*@؎%ff֗c] 'j97Ӛ-%)*:9II$D9S_uцeK ͏*Q* NTc#J>nlBVr52kO0|s':.?2'O8GL.J?@ʟ/u:r~~9m(Rq9>5Οӟw{,1=XPqŏ;X9OeS. |hp\>2][ %QB P),' =/?'t?{gԵq~]SHn|ojj№X!ڪl-UD @ֱ J$f,jgS;7|jZ-x"sg}'˓NockC9O>9hw3_Ѣ>qdM5j.[X/u7_jb.225wſVt_j68r2@ŶVU[v?9ƲG5'Y 0&@C0`-G0+<ŀ8zB`QDKx%D% ⍡3Mϖ/_aS'|8z5OAχAaH9*D\go^gcUۓ' ';ْ;3~1J Cd scG@\sC$q)) vBDء>,^/Wt_̂O3e&LK5G5}lRoe NH4q",E,$@\(W* 2 A3M|eM NLٝ Ǎ^"K]_ݙW+:-Qm\]i5_)?N^1W1}Pye% "8OC9kԇ~7s{ǐ'&PZf="ݢM5nrFmׂL.?})xC5[es5_Jx^` 2"׏5lmvz9x{Ia"* "&i|IzEa0ZB hXn-^}0[͏'腎NaOBa 8NDkRoOwk;kM h _E/- '~,2:Y]}ܴ,%tsnc<32â_e7g)('Y:DCKZC *J`!Pv \I8q*"bP,lP̘XO ?6\ZkGQ]W~eG̋sM]zKOKniż*ϦO 2$!۵"<Oc&˓Wl;7ܹ 9'C{Y#X7`8G ;sDQO'<RoOc8S?#;wp 2h7aN"=gvE"yGTz"<CQKApzcRDCD9}@iQy$BL=E-yM1I!iX)$FSno%l s*+6>ЕwնkY_uPsr`nWKcЙ[ 743_`j I%FD /#"l"(6hb").! g'oud^oN)~xUml(gcM]7UPSX7wwdTwg5_Y3ߕ͊yp/gPP>R *1J'DWǠ)T b>bźC_E=SlG? #^yySA@Kgx3Mg?@)^"Qb` +%._~y" <>·M5B`T 4B'wqh2 \,'rYG$FӡLRJOJ1h # b@OʑÕk ﻡ.o)l-ܒfe_m*kJ;SyѪoOX}V][ ߓSޚm.PSި \n(_)Hy-%K%.AL_UTwSxب%J$r. i<PRJN2W*pƛ1 kc&ɪ`2:&&12V&32Yf&39ngq b!T^YA?xgCAġ%pf&ׇ͈Qac;s˘j`vvQVCCy;ViH=y+DҮuݜ껺kOoSm[67굑/AzK% Ph dMt1[J$@)+ vlp6tF#)9y/33jsG[[sH}aϺtѣHbB%F\dwT@''pciKċxn( d '5bi8%Sb-f࿤$J,Q#D?KK,I?uGSܪ/ћ;sK[3*2+[ NŇb&\xKSz>h}|3J !DdaGGdM*P $cAm;&%;r/14dg¦NyFSգNkqt$Ek>pL5lyђ_;^,}PPhnӔ.<(PZ|۴iJ'X%."0lǂJbl]/F?i"(Y:HE,}LA# |F6?&ԧ"owu3=̎TȠA,yStAS`4'4AH%+_~y2H1t)-,Z rZs|i ]KPnќY_v0>C$vMJ)SI0D Yb,p䯕yKy<˵m{O4ZjV~ 7kMikJ{O0y+z@9_K6&1O_@`64$,4e_7 %F0RL"8y* ;}fYQ(1j&&j셢"m+ $=E:VQҖe("me>+&=#9g,;}~̀f'Fd=I _B\8ļ֍2ᢤӢ[R.e,ɱ#ivif_ 7q!A\V 8 ¥\PoQLhVDVɇ(sCcx( VpШ+&fUl{)Wl(ݞ^weXUoۢk.yxM[{mGj^j?i,6ҹ^v6dcVėt:lDB`WIHLB p,H D ֽ?@_z){e_Y =`xGp&8:Ntq<㛷=55>2mşn.9ؿ5kֺ'[ju[$Úʐ J~*AOPꚮ[oWj- ~aE;\mkhia'wvII` uX'Th11%2?ޒ$^M):RLYU*P:vuKNUCKquKSo2u*[uRu2!L]yetrL8lrvg|?{9Q9M贴[~yBp*#I!e'$Wm/`^<1L< IB,ӗ-Y(l۹pΣGRN9x:'fNNI|\]:CCI<C$E8E))D1\d{B8.Mb$,%!Fj|-&V͘GNV);tEuΪwN\XBWW[kMuUʧz\YoTV=ͽP=U|h :ϦGss e1CI1JBb AD?/SZYsJa5ϟeg!51<8`AwqMÛqvGQYi\oi!iSV߹M7?ϝ/7qiDY{` J4;:r?]VhةCMAc?#%̃fzeeky}b`OV8{pֱ(g#уQ;35^W3yP==[u5yU:"i i֢UwkTmEr{YV<]3~i>Pe9:ʺƅ2w#}.Q< ك@+ܝƒ w}bM~/ m,ٰ7?o?zJ 8arN?0BE\2<(pE7/  W~4>,Х]؟-?}X74fڬ0 PA JF񳾬Fs<9qjr˴[棳Gf|5SE.0>{tjf1{gBO(xFPS_czx, H #"T,ǀ<" KY1^+jPa>R+_/|}+}!ؗ,x>Ys½Yyxo(EÃ,fgƎ[N?m+ڎ vтCiw[t6jTMUZZ_-4i:UMn]QUڥ.7kTeevOFy_ݚU[>{J`;"%M0ᔄKa\1vq ;ܦ p(-d1hg(`CBAQ#mFr3c{%ێ)=ӍwtF BUUZ<PR}{UWnjdj ~=Uc95e*ҵMƮtY8~{㒘#CIJ@\<L%Ī8 !桑Fr(h ^K<<{aqLSf"XC]kFbIBF[Ph"L 3ɁJaP 55>>iobk:J.NunVWXr)eyA}hgzɎZpJke'YypAbXDD"_3"tRX+ϐ襼P mۜ>̤Bߣ@0;fx[Wy٫kij~[8wv=H~vqw 80ٿ3}2л{q1i gsW61Ys߾T^d]?{xYjMZȆtVf7lT?0.:~R~I[W5<_pN>3/mc-~o2ӱq_ߍ#ٸE31-E1 focε]*TMk<[jn쬬F4 A^kml+q2 9œn,,6>0Bis.dZ wIxQYWjׄ^32,b??88Uwnޥ_>iS_;I|_Zlp<-;LxtW< 1bGH<C))L2|GPT |t m4"XIb)a ];dMuq}mas/oܲ9ooyRy)Wą<|@_[0_q X|Ɖ8i澔“j3uJ\{x}*_B~^+gkttE83[a9W ׬I88kX|9IĊqW/8y KPYgFndoVfxZ SI5tgSwGymG5鐼9|> 꽌0yc ) #Kmv3IV;/ r@,l$Yب(GA@ h# ot z*z.^<0_ulx_  GX?l%?l>0_ g&tkO 8v ߇gD)@BBʰ y ~B5X!S +K=#2X.=ދ}ʐa2 iLJUA  ulSsREJ6g5c4 8>_RJ_Gk!bOS>{ Meib-(<[!h* 'C­)x %"pnK>u_jc]f?uYmP;yWon-ㆷ}ѹӡ]z-Wy>( 0$@x xBE][zqf] 26R)S*&9$# L潤 3Df $7p vAJUD2g *& 40>5<_nmn=~m}w,w-NU{;&vgʋow[[ܗ>8i;'HMb Ia ] 0Pk'C`?NoOTZB4)LI?H# 9[~ Yzs!"Q8|iH?N)T+VhOTc$aDOaa 9c# <@!^?3,ᨥjxő`+~B<,ӇͅŠYrq,&k/Q\#K#U~Ahd-_fbϟwbۇkr\ɯK&G-#wBwRr v}wsD^2Xa]h)"E2`_pY 'AdH"d,jD$P|[i`2Vך“4IgtL&<4a \h!t!! ɓ4C82HPh/8 .#/g ;t~҃7kr{;w5@0*hl5|vxw-@ckr]ydqV#rh|pzE0kQ:I,IJAu$W O >$.?ӃKC{ʤtskB5^W*#! K*,u7%Ob8G@eOAz_;,駖>cPT<4͒?!G Y |r 灍Wȣh,R A.DU  㣂CzGʙ&'lL1H6T# zZ^;|ȀWēXnHбc1]0ٳF"Vg$Oy}>-@ ~0Y%g:lG+DQ@p/^<@.?e^A,BѫG&(hT^="MD->D{H(oP0- DعԐ"~Ww"PF+"tzt Xx㢑~ G>qo߸ŏlF3^&hLx ΓDǺ~1bFB)B1ZRd/U WP 8lRO:.#T18 <*xWVs8< /,Bpɰq޸`z ΥcLBfl!Ax av=(-F4. 1MPDz悗ܡAY (\}#Y|u/cȭMz}fҪΏ=|?l>t:w}wnn d@-h-&Kuqcq7|ͻwmj*vT8Tqʾi7Ң{ J®qi#L.F)DLy٥rZ/$ݏ)Zº3_/.N/K$`Z D"`S),:8$ƈxzԒvvkb1maC@azd,tJ5 FDE;iW>&[cѐ =U.WOra<`gٱD!hS4ΰ A'} 4YбFtx*e/@>ohlj85-ҸP pq ZIzba޲ vaiG _zұhVNf 63os6oޫv-eh4;<t{kvz[jv}>D1na 71L8I&[D$]G24-4U {2' W63Qp8ST K'P* N4=H 4AYCqK'|.!79c SleL&͂vҀD!m&a; s( Q 6Rh o& ڶ[kG#'yYֹTeg59li[wm&l|,N3_=zvKw>m/w4ﲶV:/?I斗_LmC ADuB@KoU.?|x@x"*$Ygn03g[_qׄ %E"+$?;׶ST_:v ?vl(l^]~輬X-m~vR[U~n5S4Б_Jz +.'n#7I*_3gn9)rGN:de~q,U S]Hq }.eO`Ec4e`y @` D29SB"p%ӌ؛8KuM|ۧ"C%n\vCYU[չ ke_|lUo?Ǝz{ggnvt6;}fWr=;Yy5}< ;II肺Uײk[Qwm]T:ALH 5tQA@(,C;ω3>?|̙%|;3_fiE]tI 7 d;t&}Yp6[oQ'$'£gZ ci eA?kuƮ䔂ns׉w(26{5D ;ULxwK?L~$T=-&Ÿl~yiΗ/yN?lO/veVCuer:[s 8t4G0*wXa PBGiq{u)f,>ѲguNO ^MķH&㟍#T -z0U*A[)hMҲ{5u~mk$򾤦BaM v'"=<0>3M2T?ٟ!Xi&)?.nHx7'42g,Xe@8|*mޟCS,S8qK銍330YJ^Qį6Ҷ`/D\%!@e塇ryڈg 6" ʪj^!c'ϼhLL, n9U_˗OLv1ojW\&7X8ݯADQv Mi1;*A|BRks=HR;)uw i̦{I^收-i{R]$/G\w&0^9'Jd|sKAnQ8$'Fdxm=&d+2sT;fd1t_q e 'y? ;bxn֋_[t$6f4$cj"#ucn?9G"[^C}Lu2"ug"L_ w"f"a_iqہo~ ͇@t]Ғ;|''L:m6_uP>Ud5wsgn`l5.([jVbM,T,ȱ Kr-8z) ILķFtTsRp$dd ^S[$Q~${[q Eo` K_/@7hY>(+PWll2Y3 Gԭ(MNBpX1˘=tѵ]s=$GUfwLwlj%i/~5H)cZh'D 3/A-y|E\y:G%<h IJh X=V04`Sv)AS^EN+ʞ\jh>,̏&`Z۳9:/v"F0!dbs_l842 v܄"n00uLHrDRb"ZQ?%)لntpC H `# .Fpis \*ˠ{Moп#>_wߛك"!!0yy9x 9"w˻V1̾;tyG`dIq/,GA / ȓS\B"Tt2d5KdM㛰[ނ̦UHBONKXZ6/:`&+鐻o6m#fA۝?LW /rs˃Uh(rcf',c#z4T+zxe--Y[`ږيXSr^L{Tٖ4Mﳩ$Kxñq5cE1 =э}m) m4?$f0S/y^|*xF7- M=DIIS͝VSncGâރ]ɪt &݈yS8`CvhjW Q<:/- ${➽{PV[ʍD5GfՅfc s[FO< FʋD]dİtQ.!"S * $7t {[̽TNQkF&^qޙGEqyy1WRKwuAqwbp{\]P ެQ3 ,k|8^6'LޜS}]߷nU.>7I44O|>p-) ?VX()l⋚枢探Z.xcݕwV]g?<]n*K^dѣp<@Ӈ):"I:CDzAhf: 2eqLr2r@~R)@g^پ_D舄 )_ 'qO`ٛ|́° Q?pv7qڝut&DF<ŨP(JF1ox"(0|d MJ'-aTi2VEg\qCO&AYv[TAY:b6C.`( zZHbu!GA#Z!0 d&|["#Ve+;u|YtrOuNG6>o/w,b}!^azn?S.l(F(w 8rIa [m?OJtȰ8쳘C .T7sBȚ+)XY} Dgŭ9׿*ޞyRjY{墊wӺԒʦO?ܝwnyXqģNƘ\;sHV[,Qk8rtRjƣUU '[ 0$°'LXWqow}{Y۩ok\rD7Sty[=7{J.w\.bǑˍfjft1*"| ƘTR\FKOT3 #f@~ ,Hfpvfx[9:n")z ƛfgp̒韄d5rp6$a0<@e17Tg_Fr0Wɮb$B@yӜ'e`2 s,]Df+s$: ^TivR-GTHb [6Lv j6MSܶ04 +W멺𢺦7(n)hm{ZȍΪ+jrΗ _<}~3Ș4prpULP4m XPAx5rLxR_MaG̞Q߬M439$7%ưAIOyYCG͝m-?֞I)coiZ\jǮT?̿𬢾#JOa*q">{֝Z&# ,GXC,D9>lx\L\aIQDIK@~)3)QC[v-pc?_.L]&_.C %E酮sݕk.({wRpSQ ˤ<?'<2q}x~`>F}?9zLA^N-yI%VzD!IݤCC *" Usv*v ︉FoK%ӕ<J'ʥs lWfr_|L:_P`\1VzcBj]\K%Hr9-"r[W* Y0t K(Wj:$PoZVڄfDZ<@ipLF i%ݩaQ.9ٜ}V*jn|\֮#=-Ok+?˗4M,syB^+Z{|t~gI\?ݽ᝟n7| &vgsۿ/8y5 |/lyRTsi"Vp>(ս-24$q.rq4Ó9cMӴ X^'hiG%jAcDm:{j _~Tc͟n>so\b}޹cqA+9hb20l&T%|F߮Ap Ny_7ƇmWK}'?北dIص.qO*|;p.aeG:< Ty04u htd.9htXW߁>?$(HEUJ`er42s\&ZWKKDH #1tլ@uQd)}Ex0'dh1\r*|ۣ"k}*27f҈#'(*>/圯9[stiU[ J{Sj4i-v=Um'hsE:0SMGưxGRd&YL%V"9 ?t{OK0y\9RG3YN#/%ҫ-mkgZOv~s{ެT$?{qo/5PyesωuCIN^v_͝[w=ufS=evϦd8g; -IQL ͂X}pF0{Fs^ic#Vv'TJ)G/OI;^uVAr߸B Gr!Jn5sk2v='/R&l p$ /O+u`@xե/Fp$N^NC\1r(H8`t *7I0"6Zp..! 4Uޑ}$I#R,lmZU/Kdj_94K")@yOh]PCb]je+Ao&_˵5=Е8N5A[afywL ]6E( "6Te7sԆa'3wmٶeف-gԭǮ5xٸI&d2Y6&;&9sO0 ]@];?x.3'ІN8Es0dQ 00(؞~/ft,Zp_,6𥷞]I.˯ztf{WSkO_n246ֽ{uj<㊆# L>)fx! k :#>)ڲD -X/TjE[yO1!b{ dݹT#kgC:ݐe[ Wa߇kEY矰7"FXC .u&Q1Fn)z}1KƋDq10P7&RiGR}ܽu ) huP(? F+In"Hbt/'cAeeIΣ\\&H$*ᆩDWs尷Q# ErJ%Z^ J1l5jZC`xJO56ku,@COM(;1"!4KCPraC"FTx7 <-=ZwAb6(M2j̆c̐h]2Iq},cH6{9Pn !1dt`7gSt`&kF *X)^jIލz3wnU%/t][[wOM{p7=-m-=- /Z^ܸP| OnwNf+~㏛i+<`}gOujrz7@Řm qU52-y:}"c3y$`p4w2{'M&_Oji9B21.1 q:Ȱ{a=`~h5.%ઇ +M瑌lZcޘ&`ٗ20a[@!Gh ՘__ {&|߭׏Ӽ`ps:;zH܆]F:9Iƻ8]&;qT1e\1 XwA%)"$7*TbX<RxC 94J MG/(X,%Sx9<VAcx*"_K@!RЛ|Vzվj7[u c+4b3X0K`̃_b|蘫^#.^,fYvx7$:x׬0bXqH iFsI 0&w@i$0NXIlo{!ad*)b\TϨu}ׯ7^lY9˹p^ty>W>/xYEg*7pљ ;L TH{+ke5bXn0QHokD6UU`Bu-t,o[}ﶍUv8:ԙT]oZ=C`<:J%dd41IEόF{SFtS c?8 Dl-|󖜬WQ,+R0/2?DjE{A~F^H+y2C;wh Ce4Ru!uCϺLa&6lcE |hYh82Edf9̬G漌QaC^0AC w6 L M&q #p]p5eIYb nIeV7/u[nZ4vٷ.3sV7~%;~ʽ9+getY;Rg}?'ܜ?sR33d<ɝ8@nCC5D~=IT~? <w )(\7 : :J@|B}ڑjV:ny@͚\@3(ɦ-ا֓}S!0dr&/kgL&*1&F'F.dˈUDI2B؝flezΒW(Su's$wf;1 X}49EGⱑDw=<OtgmӍoGo?1to_9DeaS߈aQQ`U ^LXpB/T+1| R`‡* *" X?<bPD<`oJ5P۠2ݚix7=S2!QW&C@rĬ #Yf LNEp:>Y2iJ7ءAR `zzCt9DŽiB1!'+^xՠ>'؜Gy}l 4nA_Jg5N}`{h%'m W2ӆe'6`3<4WÊ^h,DR2#k7V-E`+Qߕj=}G˹žHh,mX=w_92>@Kb2S ǒg 0]UzZ7f*ioR$&Pb6os,ǁX|u3K%'H~0y9_psp}ׅhûr];rAVބT鼋S|5ydw &Gz;FO!) ;SHޣ |x=-|FK-g{nY Bh*D5Y1|-N*E=4"xVl{?C v迤YX1"ƻ-DehKDs>Ӭ?}ewI6 in<bU8~y s`Th9P NTH-~A@ >W~ _৅y??/X7 T^*[ )WLz;=iTKZ y _-6J)!7\(U~$C{}6s^ёP"U^sܻLJdt=McH*KEbXW$ՓjOCȿ>rbߡ? jH8{g˖YJp#:F 3R "RGnjFUD/ >@ > BsSsI*>$wM̶Yn'̇El`1,6,Lڤ(is _6@BB€ ˈ[ Nq i 7.γɦIyx3XAyμHYGKZ. DP.@rCS3rC BR"gDBU)k7ִl+oh/uGWQ?;"y tc8I}p{ 4@ \5Ύ>'<(ׄ_',<hB&+Lݓ(?Qԭ\TXe_Z[uAci;؞Wmحwnε6߷566Uvʚ/ΗK[V6m7;Aq}\Z07Ś/<'OPT.,n o T!U8%h(=!\ d|} i14j:X5xpO1{%hrkt +UEfA7i7rb3fſt5z*Fe K.9d%R~u +PSS 5@ R(ZhB`\Ԯ /w4XYvVljf'٩}fkj9}ՙo<[۞LEI~-FP J^8InK۵!/#!_l~fML||M f w@d=IGcY5ӆigsA2,I3ܑ9/\hhv==vplC[9ؕe̿rϓde,yDWW|;Yʧ^CZOnNin k;E"J{кu hLLO0=f[<=ׇ_|c4;Ҫ٢/]%SղT)^dKKS%L_Q}`\S')"1+$t$A%*@0L4B2*J5HPDȭJіLؑڻ7.NwMc,;;Acv vfG ?Գ)!h^xVE"7a7{ORUΊ|;__w[Wb <(X#D0̄SEO[յV{շ dLEVX+;LeuRk|+UӔufW,ls]]~^wJ̡gӘ@)`%~g9ɬe;g𮙦X^P>I2BMFpREzB` BmOIii|ZUQ^SwSR͖.&)j6SŦ 5ðeJzg"xOzj 0Ǖ ~Yx|D-/LL 0:%3afmwx[ @A HeyG;ǯ4:>OAa.uǐ,e<10Wsȃz; <ƚk+}'|.I +0 |II~|w_q-(ۗduMJWZޚiiL֥h'2evIŨfAWU4.f ۖ wrS^z9AbH$oq:tC㪚*SK/x9Ar3Дu,,A%Ł*X얧Oy,)R?PbZ2<&W+0V7dKWqYZ$1ӫJʳYa^Qt *?p*n3q"F!sp5B|v()oQjDGR:EsaHܦгÎP9`h;1]w  -Gro|98s=~};4ʺ ݏItt0 M ͆"!]hBԏo'9X+렙!Y~9}#P}+8|%|k¯  /Т kY6.=B?p¯߻&?ǤQ>¸QHx"q~z#oxᰦ*O3n/ot\K̍e--`=.Mòe5٪S,)gXds~HGQkA0BFRZ7 H=AaL1+Si&ꦑ?̀C$!/4?'%AjT Nj";μAYJ=ZJ%ֹd&V?RS+ӤybkV֥̪4EL;.WL1.vɠW.Ls*o}D L\p-^x]=9j8Q2L~&]90 xA޻+Ş[C7]h^%m+-5]':>7yw~7&SԳ(\IQBE?ի''|̊>CCO?~&ߛ+\y 8AIﳝ@`O_|q2HXXw/HO|_,cj-ozYC n*:r-la;>S-eyGI/N|K MOHJGwpX-kbX@R?}tr9hٳ<y2RQFQς QO=_e0%jV-^VИ9QR]PUji辚t? 9|"<8w$4t]vNG'SiݹI㞣uen-Dp8nR`f5"4Š s P2R^Ԡ% LG@p/Ww? 'q5P`w'te64 _쟮(71>7pʚ0%@DnVS#[CCxi&WAGV A%~}x7mxۗ7#߅uM50aT1BYamK>Jn;r'F󙲊+U)%ͥDpN.9R~gxίm !dJ" B-\Gr# Ԉ1@x(Ry8!DW_gKjlm'3Hr }Ƴ##{l2xTHYJx$6BUŪ Mm!ϰ;Ө-_KtTC 1&&tޔy<5&O͋CD*qbsd02&BU4o-?%XTA;>*[R_={]3uXFCfN@iQaXM6i,b8 Z0vr*zxTVP=z0-=i=}rfrp|S{Fm |%t ?#ډW7 n 5:\}cnv, ./@:A%3t $!27pƒ^cŲ1hХ@!v^pqhE؇SE8k(.3@4[RdHr.7jtD8ՙb=T8b!U+_=$<]@G0@xl]lWFW"Vh0w?8)(m_bi44ib$@8 +!MӪbڣgZ6qށ36r@GxW4h)GVOeOC)$}tU-}.a)und%.X;BaiЖ=*duƣɧt^$}Uҗ'kպ ?_tksUSx|R^.:ECG#v1>8gJhˀXlE3bl>O%pXMY1z=Ð>r %"d<~4mN$BQHM$“"u6܏VwR]1FW5[0Jv|`GxyvHHQ䲄ȕ_%%AC ڵD(+P C3R|hX؂@А8Ic4NqQі:m!6G𢩸 <df4dΈI;:z!=y,[Dfs@G-t> (]$ hC9Υ5Tx* 8MgBJLl _#!ie Oa1+޹6+i4 YojJK>x궧i?]ܔs +>0m\ɛ_C[o5-]>S۴63nҽΜWg'jn d> ZϻYKu1CukX~HU/<5_ܸKrugK --CRwggk[ v_RPS\iܹ;_8#":KRq(K贩a<&ys>Fr>=$)fRb6q٬ӊN_C FmeC5 i=T-bō%ģN(, C"9@xX,SH9«EzŨB4 /;S r2 AЖ%‡,{4CO }/4lvXx\xrwL:i^hHw ?N_3ÛP mxV) MV74g-(phHŗ1rsUҼ,2b`xhHJMW?mcݩJb3p6n8pAZFc3mƛvmug䚄>)RLB_g_y?LK/wLO|Rwtٔ|ay$cIi4hRn/ 5:BKT1hce`8nSӍ4GYH\o gay3H> ރB/-p'DC }e؁)(o">l\Hm4&5-δfJ{Ѣo(&|;NNI?v)hciGchDКQ1&$EiTrkR£Lr |xR38$,2jIG>lE iBLk褿J%ķ@'/KxtNJ`8Xf=c>)IL#=ba,#ɖֺX ז>V2Dcpx&I^_i8uD3zCOʧ魔&xڢ}z9KSOLo9C5B8[TmP.EbOօ>Jkn\.λM5]5ׅΆ`퉶ig3K}L* >^g})RyIMX,aUVI,Ҁ(ET4?uZL,`J8NPEoq:~F-B}% x){@/ }.@}H;w/1hoޭ 4oVL5xށ,v`83qbWpY=, b8fFQ5ʋD- 5f'2wc$9`,ЭӼ Պ3b`J6nߵt\'Se|/#A KQ0nChĝ(|iBje2M3TRfZvLfK-y1fՊ5U(C&*r׬|x$ hP<) 4t_hjW5_ښQ>5rvpп!ˮ9:}7u&i}GPncjp ^4sV )Ά[VT?`9U07s[7.wz}0?BM'җoVXr"+{gEP7Y&|޵v؉WpE;5$M=€ :7GhmM_K.8Fs_l íBWh `{7rZ{u45 v ?i8wzZ]/|a˃VG;)wmO F1u42SX/X4+?*lLOűUh4Fm" 6N;)q5S*'ϔT)|JI1acӎE<ᰐ(5 AZmХ&gF QWn'UBk-&ߥ #VGLYK(6FT)z* Bw>!7Oxr1ߐ d+OQ&j9]&[2!Sޘ!M,j^X\c`EȤa! &O y?lܐ Nz-8 'Zځ?^>0 ?ݟ^'8`:lq࿛h,łtx3ݮsmo,ӿYXʫ{˝y0eOUzs/|= [}L_Fe ,BK[mR|%(e%Lu.>?ⓕ>$U*VV&xV',?XZ|x-g7]{q0Ub⌮ 7 õ[ywQM{V+*U:!$$4]Z*kW`\WJS+ B'PEH $!ϝwz?8{99|{~I :S]*??7xh HfxdTvVN4tsfŻfl̷H>pQF"De):l?0dǠSuSjO5A$}-¤x!DS9fρ W஻wkhfThg+il]6dAyU_]'AyOYkwW^}w:gKLM;&P_}nR4JKK)FTRt&蹫:jkyQ^m !@诡9[n>|TkY=mM5Nʮ>zꊷT^"i{o~gvjWW}mC!:+T?O-Qa 8쫽zժQZ꘢[\\os7-[|u, lZa_H/~§^͂!_q~[n? 0C'D]45u 'Y፥e2+vBS۾uZzj zg8}zNNnþ ޙ >j᜺O˗FJMFEg'֝PVXK_"_Mx|s" D|bFͣ_$ǭ 0@E4(L2oY$Ke sueIZ@k .n, s7100W!hh-16'2ڧgEwV;B8 (%ty<` 10!J蒳H0S|π ZIUCeLrdh9}6.œ*Җ݂q_@o`n`H68 FqAx/ǫGexr~@2+7Vh&٦=]7aDhnn,!No8 ꛁ6MmϋW8"ySN5S|T >8vl_`}olY {^Ռ7{[Zyp˵ZU*AۋLUQv6#;TTvyڅUg=DqQXg];*nt@YVIH-+>\r mToO 7DϊJZ؊H 1 v"'G>u*+G;m&;NjURTBt g1\(ZNxuݑuk̖DÓqQ>b1DI'Q1/@~6|"3~\GblO[H`'|gaF@t)8jJKB)9;CFV!e>lY@4>B!5H!{ :f:X91lo=n~ >d⛝YG^bvkA!P0~89$DD4E:=2~Jg0<}T~P)^\"%*9/`Rĥ2}z!BCz%Ʊa C]m3o:$o:1ȷ;es1>(->4 0 EX(nj ;Z˲w Db<^8ݟ7S! 7m믕#5ܷ2k䒂>c.aƕ!M˘|+(~ωqa^?8'8{:$+uFUqé؜orHz߼3NZ_ WE/$/gNS.|1dCU)hED|αS qu'mo [n1#CH0+M W\Qwll=+iRZQZ F&G;z@t%jyڭwD J&8|׿x&/8]EjT"-~, I$[G!\>LKe~RTZ6 R(5#)޿O |# :5D)6lvH@8!;!4?,{FG&e#`f̎qtS<.kv[gz@sLĭ=s)K@hy#(cN H$Q;?SϢJƛpLHVl ~Kr.7v}#=5{f<~gquajQeLЯ社G0^]%VTtQ#f{{("&i *gq򟢠)4fy|RCȋeC=Z@ L3g9gEc1ɽo%1ؓh A{ HPf*H`a "(8Co!My+owۿ9SNr~[B!m]ǭ{NH<۟q0:13<>;2n"AYÐqVPu7hmo=S_NH^CBrO,, ,zDF=Ճ;ua7hקƶѤfK1!uk|ӻwiFW.X;Jʈ2̀ƙMcOV[78r+>jpbZ/q;oWgn=|TQx\Neuwm/7ǧӓuMGGSw:o`O+*F[یOܯC}-?xύ\;ˑ\8rsX%.jf7XMp ? |VcJ,bҏ?)v:Fo2Ӥ쟔`+fc(h"t獾'T})9@6zE|@gϕ'o`InUZ[t;`'%+<8^i^4H~q0z31ĐQ2$'J ` Ou}PX|%i4`:Bj%2ξa>}dea}vKy 08 ZO=x=({>0ml.mnzV>[ A{7!wp`&S%ƱËb//sraSv$GJMaǾL8F9; MM/_ibgjDӃU|y}EO۠tU޲22\eGWr\)A,3BُWFTVďߛVZ ]µ iglH-ضrV_yC{?6nոk/#B>s: Ll|e݃oW_"!uy!(Ƿ$ooꙛn\/A m{=[V]];zLҥo/Eal'-,~ BK%Yio)B޸uDf* 2a6AganJY[I@sxPQҐ5[[te^%cyӹ15Ƈ'f%\o1'& (S98YkDe+61RD'Pm76SG+;k 0B1G3vM 'fG~nhMs=l 65{H9lBzwT])-a72\$ ŰgrLC8 GVVg9L%΋]'qh70a+90l,:Ȯ+ p1/hsNY+ g;A"ˢOl7ѫt7tR#k°ex9,X]iVv.ij`w[gG =K?[elEX}fm0_6_ѝffZXO粥0?|ϩVT o<!9saI%9?kc/̗I;,.7͘״sZoAPXEtzWaHMa^VGv^waxڿBuvͦ~] ȄBܹn%J CeYX&_#M / j!![w%gяtzgڻ@_t~<0vTw6 64['Z?LL5]A];g >O8礸'Kԅ@*M)PaIP)/\Y h_*FahC%"%bGrH:!+H'0-q9lV驮.KE+{/ _m񿳳rY Kx&FHHxK'#߳3sHN2[.ˣl3Yp$W#xDZxsU=fḠUJ*ՅrՍ{˼91R$Df6*ϐ7i55J4K2&%w dHxS _7SΕ^|xԔՃ8*XwRܯWgշ>7Po|mm`ufv斾Dcuϛ`9K%.W?6V*5 Y@&UnI"nLW(l5lm>wV_[IncK;]拿\ʎKXmOO-d"O GI $G!/,B*lHh^[mtSf| 7S#3Ar(I|^Jy8A4>y:.ŀ3(g4Ԡ݇ϼy>R$%oxIރa<51RK3i' Md5xI&I  zr[.# `>/X9*h#|vzٖy3mvӬZ[f8;apΰ ŴfK<"r'Ob;5jJ/@? Tb&I"//)%X h%V_U~rOݘvud\\l:fJ2h#ɐchʬ*s:hV}$?ML+?uo7%f̟(<7$}{Fq8B]! .6>gslcmcd[e=Fsit[6\H-Cm! yGBNlm/N3y錟!%KҽӲ?#ڨNy_!vN0)T_0HY\[fee@x BT0K:q${O~o}/|_w/_]._}haJ&-iJ."? =eQdx@pP=NW` 3¯l23=‰Z `U~a:]joWMJֺ&s"'&Z.W'oUͪr\$#?] ug,+H$'+ʮxTWv;HHd$)HbK$=˂c 'GuP0RT7{< _^WP FVBʻɜZ_ՊY晻09q{oyX6YK3=x' 'xFާT4zʻKkkRO]__Ց5|}Rgg/շ_:t2s miڱ-wANi(kL{y{ia2n\/! 9*ǺV0nUc_$;vyo?~\*i_zw>Ç}O>Oјܴ;' ]oge*z L;;BdRv <૎,dW*3cb['=d'X_Y  sU x!]9,q{nT@vJ/r ?;i !g8љQ(gF#$ #I?BEF(mIe-ag6etDNZzŋt֮å+pgQ]kkksN5!E癖hfÜ < bHWB  M|ֹ+$H+q 7@r|&tYn"G1>aqTrV_뒨huU݀|Ryxr70<SŔޣRǷOj[( ObOAhS <  c TWWVؽ!خ X3_ xdSGo^tr񪶍K|~lށǶW?mv=1jN i7E.e Qeߴm,!3C9K\y;n%޻' V!C' I`~ _.7KY? |Uf$2g_i 4AgM.%Æ1dn Œ.@ 8MG}1hq1d4Iђs>Ps=fW(S)YZ7`ёŢ* rh 3o~b!ڣ0I{ s3d_p O_*^'L1n%LTN(avN'# *)Z6*\$ugnn憿jֵY5!\+8&  39 Bv@0-XpeDFV?;(?%|ƷDxTǧ nqtF!|zpN#Q |.Uu{I>GY(${xxr{< pmosGpz`e'l8x(lwhP>C$? k^*_J^]~oKPx=}Ux.̽3w,g u!%X*㔁g3 t|I&L. 1H&lDKxr9o1svf;xGgp F~F=(GU吪T}e$ޥe償I?=%ՁRئP1|&r+ofjŭ"ExאY%ṳlq}nmAr:@W̄wڥpBۏutR 7h蘋wQ" 'IRZ9'Jb7(5]ӮmF7bRǢG#G"чuR$Á!wu* V+#?w<%KgsG*f ?K9ii9.V6j&@_th%~%;8J/Z \ԓ6{˦yEi8$oP?`kT:n'Z5=V!3GVeW&15 ) 3mvp@*ۼ\Fk'lzm$o2lca#RcxqIZ0%/6)bDT ֨aCtlyᬰ=#*Cη5rQ ed#^^)(45?ͤzg|I}V{KȻHNtܮN:n)׬/'!Ix^W%q=!!!CWxU!L_j_IP4!ĻCɩOևDk>&]Ն]H.I~e.qKYOxZ";"<bT {}_A-+hQًB0iۆc^߰h&;/E&>(p 5H۵w|W׊ /hF#i>Ln"u"e^UV@5et^U$f#{vϫ|Ϝ;s |o~)*<wɔH@L yhhcUh©Jc]$JxÖYxwG"6F[o)Wz1#<#9i䇅,8FoGg%(gxfG(wQ)4K qPWn-PTLpv׃W44?ah*Kd|*^cA4(LduqHbۦc.9WI9|.́HgZZ&)gH ç6\e ?Ax[`8T>s &Tn<軿[uߐuˁPz5Kw;.p+^ᇳlKdžv}Dۥh-]FH;Nl]&ج^C!?q+!?ܓ`Zld-jlȕVzQ(*d9y)ESgϋG vNF?SZNB~H ȸg_3|E!Tsvl+nm|\VO1U_9v*)kƇGDvxRpۆsޢ:qg؜cԃݻDܨiS.7.%LK D'Hu }ݓQ v:>gggg£ԔUˬ!I1@&u rZ4 /qrv醈/!yVdeKisz~z6vLl͹i3jf-zZl>ں;mC]0+\;zA7>vO.7V֖NPVI~ცͫ$%޿wO}WRrL ;y*9A70W\_(7'_o^_U3ҡo4yi* jU^M| Ai! [,P "ëΞU}lG}N ,.C#PO'!li{aqBC3UW믛k*S Ra1Ϸ@_wlDq 8'6KtcФK};dXHM`ꫯ/ W~VtCu>YkאJ6mHE$Z%x9R(HbAL2<#<#<#<#Ue4Ԥ{)%2jZ+t<Y)ޱ;yI1[㘿_w9r*,_-t ֮jR!(B][ʫdX/NjRR+ؖWV7*2v7E5`ߞc'6<}뵿8u!nɪ/? sgω_ࣜ3+}> }\M󙟾|Q>2 ES \Cbq5T 4}a1FP3Rd.弨pj C<* 69MV-6G~gk͍`ފ}JK+|JSu]z4՝M@[Ҝ}CkLSog||o l(eyZf}GEOHL(S`!v[Ak+^Sb3 )ňCQQo3!\n:z/=Ssp"N>FRZx*E ŀJ`J.&PIMfI,$ \#pM.-_<V"A醴XO뎦8+eu 䲣}|+5!3vq62{!݊e[Ac;n9n[V&cQ˫dDoD9$&/Fz; ՊfLK9G6x/yxJ+#<#<#; oG9|}]*)FkM;]KLLN1axKP<#<#<#<#eX!hQT(OJ$фc%2RrDA̗eS~{+,&yxe 뢑ݥU y& \*$^cvw%8aոj%v1R"+f?Y޴1y99 /p'uRBRLKPAI1Dx eggggMx9Y($jg"€8n"_rN."᳐`*Ks7IA8j!&ɌBn*¿T2C") J8uV738|Ѓڦg+NT*X;wQ,@X5 i+ v>1וM]#αKutܥ 2:s0h, Kxc5݅!*{vj44y=OݵGW]xJ~w)ef/PZz)`* OmJ|DZJH+PL>%I,Ib ַgS Es4RqحԴ>4{\s>*EPvƤu>OVp/5>꽼>8}e7w_XwPޗex$QJBގce\bz%%Y1<o(<@gDcƠc`#3=*MޟS̄?pf5CoK4g܇sa4oG>0VcM c5g݅Am/0ǯ1b'v6}?u r v&:cGͿWNw-_;}CghC)5a8s:u N٧axS<>뼀3|wp_cvDx -9)C;O]4ˆ1E#%sE.;:Եm{cn>Ѽhj7AS XERfƲ[qo[HE]EΎ;=Tv.oL\XhM}?1=Uz Tfp/.d/wU8U Fϳc7àd Meww'< t-[..OcޔAXOD~dе! !ƁA4BI 3gT(<> G>rEIyC(BK!$߄"/)# ,P}xt%n ƑKc%SPFoxs^_-Ç_\h)y/mPL4WbU|i3ĴSӧ^{&%cgԁ!IMSlЅPxoCS w" w ~?N.] }1K^ G~#(<J-D{js]xZq'5V2i>TU1:f\fN]4l4&] N4۷qJXYe%yOgحS}lxbnUT_rIjE%XQ)6i$LGrC#Ow@%<=ل/W\PlCs=ݥV톪]Ử}dNSe£&d8x|!ݦPm'GWlvգӟ2ڌ&|RU4L' Co8Nju^ZѽPff*7JEWZ!b:x8' O^i O]amN #B](wãQqT=yyD9 :h3:-Tv$=M5:h>5Pc!Y\\4Z] >ev uz2![NNs8RN؝ԬkUr6e2,,IJJ0kO$' &լNvWfcKy [vi܇h> `^iE oC /d{-< ߱OE1 D޻] /WZcsX2N l_#X+iIY8{xkXhА!B[K G£C F QBɇEdx@XL-@chm3EY@,-A ^xl%%N3Ӿe[p-!쪞{eKo/+ ג3oj6|żAwB4h-׻-hip\K nWjdqZޖڮ58%! 񧬖o('m#jz)hi7iM,ӬsN̕H7[͔jr-d_ir+<|Tʘ£+w2YRl#KĮF$+en_i.G Es"KBl>&?] !M/SaGFMHhEAύDDߥE`ᦳ9i-<0+. "XWSn+<' O~qs"q"` xQ|8Q|$PXX*D"/3{#Rh#߂m9"P(v*.<٘%'oهnGG c4jQ3ҟ*t#&פ7&X[W<UQ@M Z|NJE-un>ikT9+9Nsa_ 6R9lTk4Ai] epiσ.㼯 g,G~"Y$Xޔ"rG z8{_}k Y`A+<]/aDӂx!QcBcC T&¬U/"{?%x`"Mgpųxѳy9\K@c0J(||rt@ e+ n|@ n&cKcb2,ۤRN erN.;}nB"+n|TW7OB"O;h*8}pXG+cv-":;Vh)z1Q?DbbWZ]U7jӍ8au\VXR}P}ysAFq ǽ5Uu"eWR_MZZزqo&g/)WL]F签M[u 7̂hcVQi2QT KG/K+M-iye7- 7"̢- P9a3ȚX>f6l{քm`ĝ k{16q"{0r@oyv`;sgȝ ؙ3}wyw{ f]00.(>`5yއ~؇} &O &xҼO&cS~MYpxᡩ*ŋ*&/88i}k~r_ŪEޯ+v?qNŤ'=4y^ŔTL]x:ǐ<3OhGp^2U8Cf>pηz'on8Qsu͝ގm˝=wּN:xs֔29$kJiV&l9e-Rƫh;o>tN/،feV ߧp'(ܖ^utx^ w䕦-疦0:gczMY ,r@h輕rxaܲl֛)㗥 Aj)9ʽ=vQjւy0^Jxa^}} jUrؖ_xZ_<~msx.6:ζ?z}cΟ9Slz׹yx[:Ϲ m@cE߄.k[jX\]y{kuvZjǕˠuԺ/=Z/z~Z/`}.Է] W|~ߗ `n^~QYܬr_e\ür\Λת_8oZ-2 cn7@is:~_}{8;nV 5_?xܿwv4ȧEW:t_Go>!qrݪvGvm9wnUUF~%_wIgp:y7Ǎ*/^*]WY j _GڮY~߄i@_Muۮ } wV繎'e@uy?iAHuEPT뼈'=(>#\ \?cZ~p] N\^K>9 bYCCO}xGm{7Iܶm/6wcz LЋzzB3` b !HH}ofVYw`;jf~r%>WWb(!G cE3S"3bSpL)-ka,R-+i/KD^xx Ƭ(6hlSqMgE5kkז֯/kؐTRJk?+ۂn+ Q^ngEDy힪~_E]Oڭ%e5HyeP6vvE7JuU05-jEn;-uM h7<ILQScwȸ@}`ݸI0PDvO;@Mm?$_o4I/jKZgȔ؋wmKgdO36UZ&"-58Ho&z&|۞4=8Ե>7#ihy"EL_FV #;E320*ܲTr?ȭ CIG,I=Ȕ4dI3-YqYlՄLyR4g+[sm$f2UMI5erjB7k+JjZh*j9PVu+5Uj5 M:&@6zkY󧔩d =ρ0Z,,#Vq}Xl>M3ghl*pK]9'q Uuu5:oNם\nϷ?Y -;=Vw!{+=} 8?AAx> A+S6t@@1hwu[0L_ZE= >l-cfQ}Ut KX{Y쇱/Ko tmBc،;ڰAN[+Z:J>*|lJ?ȵ2zif43\̈́u$@jDHD"jU6(嵀 VNiBn-QQɉd䄐@F`ed ˗% ABBfC$ ?2FSR]@(yNDApG` [XF4TZW4Ru\Eru@5`} P&~&S):Tl2]44s4L ء3.ZbʴhMʼ@gY,zyh`m47%Y˛ȁC翙VrM0xM \%]u-ߠ^?.` rݥeO:=_c'?c=.~+Ͱvagvc;6z;[l=6zoGf[ɺhHmzuY:z4z8[r0ZY(U Ha" '4^kljC1JcR_ЗuJ$dF_ 2O·$h(cd~fv`ԇ\˅h $8'  ef<,_*BUty2U>Jm\)Rc @ԌUjjB]ЌSj[ֵRQYN)Fl2 1e|޺H`[X&Tzb Vf3t!qJ&<ܛLx7~}x7{uy /zc*9!2EKxa@Ɇ.g%hq]L ?&I7i$ωpeZs/n$^/ÑW/دybPeoJ#F?iU9 .Ō1g.C_ ,yk+zt38˞g^@Xำ,{$3S'ar$'{v!t(!aE$|7_}ɾ[ OeBHxlk˝|x0SMT!B8pCi Ymr QhkEce*R*KLYSk* АcreY4WQ ᥹aJSH0I B~"-E(^* u v<^ӈ5+M mj;1#F&w($B᫭pVY&lS Nm0eɺmk6̼ٺVm;mz7mE`~uЃzK7wH=aV8xB+oNg3@F/C`7K+o$n | H ;D(z-± 4H|ᕼ؃`>{V4IZſ ʋ?ǞaOpk`4Q4>#@(-F#7?o/tP(r;}-:AAV8$:Gtc nG< ! lg\>@;{h^ĵadz^w y,e FeU'pK,4 gstֹASQeB`e ie3: Ԋ[fISjT R- m3ֈ/A+4ru\])WV(T u9^c`تqPYBUe45BIN>!,I([ΑErdli$37$ay,H+/CdX%V `RWhUZjM%F;hc)tz)AtT3~Bf4L@uSQ74&%I% qŴbZ+TVL̖hœ}վoZmm%}FuiHڶ½h sFe'Y0i&T1ñB;:=l^;f8<_2CNqsκ W/>) j>^^O[n_ Hb.\#.qqʐd U$uź|0>$尒E.􄬯Ga"iiP韸1S;#&xS,u ~4|X4lݓ,J??J.D%/ŠO TɎGھ[~-p_rWsp<\^;ss\8I}s^`Y9Ӌ! gp h3nFuk*YiW4dœŲ-wNxBuiL aY Vc0Ϭk} pi*lx9B@ i5G@2Q*WjJbIYV^A6ijYX.˗IRI4({w^(CX%" eٰOW"p`3*ԬNk'RRL4SnIa6,BB&yJx3|+Pl>NV&ˎuBd.'Ef>uX; Nkۼec|dO17{<` uih< ƇD^E|€K,-/>ߵaU)I /&ß,k}w =Ipi$cһK֜)wFyw{y\Cg}# }d; e]'y;L_`Þ.rvv0bp2Nx\N68p/SA ~t _F+qˋՊ HWO'gK 56kVο)~0\Ƽ.X=x*6Nig=5ˠcֶvvQatKLfÊgjZ~Pטͫze5َJZ;i&i6nvٷ-[mO=mnVrnav{轜mu|nKr'|I&2b{ Y !0 V- ]' MRߞTq¿\@[ÿ'$<9 wTIu ~$q+w罌:)(\ }II^8 H%IT1;4 VPkvd1v21m(&J&;"n,*  qMLҦ>s$Lg$'ml\$V!*t$=u{BPu{Md5*дC߈yUyv5X,E@P(LlUdbE& e!Y'<3F 3Jx8BK0d= cIp( #4I@)vǺhg|f}2rYwe^?נH,52 Oh(p~e»lw\#5&SfgF 3Mehi`1*@VKZnl[jV8sinKz|v*ev䪻^C2ncNsS5~w_]6@nTRzf|}god5ڬ[Y5V{VgZ-JNCZ7eCA߀|y6d,鲜Fʤ*SNxwt`{$<^~Oxy옟k(oC%F5V֭Y~*UF#?0C~[2Bxd"a8`iDf!l !Py%  G˄"D8AE Ϣ uI4%E6MVT+bʥJEWs**O ٸr +Wa7[pjDܐ*;x7^k`~עBP{Ǫ(#q k.}Snu;ԧ*klHxk+ҥ _ /V* W}FwUfz.0 ! NY & LgGx"]4+3Ḧ́_i]0ppSպ jxpۧL(WVA ^L17jjk"Y=}BG'`6ňOEЙf'lE(@>RIpAXW) `Yq4+ < = H9`NkMD2d w2XL!bX6ZW\<'3x+sP6D7QkE!mb N]~Cn如썍7K\7i^}G,%VJm~\dk18W`ޥ&P}Yi3I}Kn'Onѽ^iku_JkdZN_+2Z.ux9۽Z{UTzE<KX >ri@, ! I?h6Epw|GU>6mJ3fa`roKse<+~V3]G=큔xV eJ|Ϡx84:bd4>k4J꺍)b9MF0|L8(yϯ 1@[ݍ4r$qW$o) NZcrl Lx!vKi,r}>n~V[ ,Ex|!|IcM1Nx@ÂK1a^~MP&T5|&KIOVkGj`u\),SE:i x@}Xf8K)6|޸fch6"XɄ2$#Յ 4'en0t^y9Yxv@%C+&0M^FTACLo=h&{)jI/?'aV ,b06YC qz"(:a'bSqAkN$j Ѩf7f>Y>YV ut1#8$kGH/oJMiZ p3Jţ`12Y&L+D"DžD/-NRsׯ"Zw\\UtuQikTsP>*5t\o:tu V4]o+A't^`vT|v{!LeEϙTv \<%q.H*RDZ\pGZ3)[_o8(5Ϸw7_nlbKo;[~:=R]㵲Wk^;ʋ /Z1p|b-@=v;\c' !3e'BgPx3+Q27A7၍xw.U~UڀmKפ ]g_IqE>6oc!z݌C 4(`1$_yyg 6 !r pN1C v`; ::+/Q/b$IĘdI2IINtL;dzɨfTQ~ѫջ.< kr~zD:\Akٛ ^!=l^ޚ'ML\N N|q}p<͎ؒҘbOQx5MZ2tLJ#O5!f"#QO_¹rհ_:|{O˗ۚ?np[>O[ۺeϟ_:;ϝc׷7vC:[jZGiy2i/NTz!JYYfnӹ GQSD4"IcdŒD  c{vG*ub*pC,7A9gKU ҔKYfweni}Cۦ:y/OI] G3w֪3osOW}PBm;O]^tQ:}:#BGdIDKif,`â7oRtûޱO%%G ;?z7^8WRŽOޕ;}Ds婪϶퓶H?Uutw<ޑA>Ok9q=6B>lؙ\g#23i3ppqMTѐ$E]`X! yJdO5C{Gxy'K;ۀ 1ZxwwoyDQEg7ws/x?3Wz|a3tʶw5-\?wTw}m}fg"JPEz[JQ ҕ]9XIFH[eok$x}ExP56ٞjoA2|L Rr6{'|}уFh"{>,hb/.^PY[oZ{ľȗJO?G#ʏF{{&ts Kx[G|嗮c/v}w8EsB7;qY; VEGnԵ<On*_-N;6R5T>R#3T,αJxWz%ZP5!zQl5JuÓSi{J"/TހpC0Y52^"%{V!7E4B%7ORe_󼀆楋/Z"06?[cHMYbY(M5I( BɒJ,=|iRvSH Owux<*]E%q9|e\X0fkRʺG^<ᒄ{|Cl(m[k ?=/ Gg6~o޴$[m;.z}O,KZ23IL!/@,-*,'K]='T1Ĺ 7_]bkq &N=nQ)}_$ X jM_<E<}I\Z&#pxͳkUY32P3 OŘIsH"JT VWͽ;ykOp݅gb0Pxk*vaSCWGCs;N7 =۞]ퟵ/Ye&\UCN-ө,~*U?_w߅M{պ!-3 >ՎEjMlr@hRdvQ6z\Er=|r#W,sq%:yҡk=:h"-^-G+\oe &PdK"RkZFڤVI3հ46Rmobo\]:%E$@ $c`2ٱw9 0,D@3&S-d.'㸐O l'Wb8nl3ۓ29 /.×nfg87â#WGF ʄD!v &9B렏""6,#o4?:r~5n㫔-+ ,6-CaH4=92>2<0ʨ0B,2`ùYMU่$[-]%2ƅ%k>LtR3w?ן~}ڇOmZu.x-9ER/wUhcg}xn䃮S-~}=hӜɣLj%I&'*UJ%[Ҡݣ7«t*\.t}ZknAՍB (Y;;:oZ:,ueĺ-ܸ Z0$^S7adJ[ bQ@QETrY ͞<@.Fows 3 & ߦEIe3qB2 p(@< & <)XF;%b*t td3HYd\e;G,rrXS\+E5aƲcQcp F-`L?v [<xlgʹ.b6R] Qẍ́{@HRxLOt$Im4凈 Y!j3)/'y%BQʇѕԬT䠒, \B N iU{9Bt}/U:|#ԼhE\a^`_p&>hcRgTfV#ܬEz-]hN\tMV0hi%Jqp]׼8 3ᕀ-hbS|3}. 3W$:i@ 3@`g?wST%Vd,97ʈ%T 8P' &y 5I"U'Ϧ{“=< ;,ӒH@"sI6Mg@PIJ`Yay9dJ5N^_."첌ỷE9Wrfja Surê+'D,O)pNbpsR] <YpZ K8JHD@@ԦX"- WZuw4ux* ޓKw糜LGDn3^tvDxtCy`Qc Av@`eLryh8#@9&2~ry<&xK8@)FA2 H|H%p1Pd  `Q1"^"IQzJ~=/^9]wن/#nʙ[۹ǜ|y#=2ɣ?Ewoۖ3_F^K;>nSC/h*UiKTx^bҷ[v햕yVLxݒZu7?ٻ(MaBO Ar$rN2DA@P4Hk@1yUtWS#qU}o+ת[5S3>}sT^2m&Dln;H3yyV;U6qfhW:qj"U )qEIZLD%uSIVt?9#+,,7;4;#'4c~}d.iNgkJ]UQW6Y0GkLlEvn@ڬlwGrRޭ,/|[_[f\lU1W!h^](\9ǯ,ɻ1Z->^Eoo1YWmXP5tkZK#n(fKsUkzFBl癳ώ|XZsW,_!Q0,uB@>Aߟ\42 2['珠7@/gikH^ְB^K!e f)&_LuO}x_ufĥw{7uU칱˽l^tիo-|_:P[?2xzsEoơαNGVUdn6@Ï #E*O) |#)iJ`o2K=d  1uc2u3Okh[kE Vwnh(\~7LŭBs㷭B=ӊJnDR&gqB*!@JfG]?q8t|5>>1M‡9 ׿ͯ>绳䮎F{>Ǟw}"w"M?F8NIŖ4%fz8 !oEGI9 2a?7MXG bk:,f_r?ĴBR҈ˏ_|Yo`F {s]]deh{,` `u­G@r/vvvN} wKI?J&|ӧ_1 d={Eu,`f~%[*+@q9T\>1!tLkfz'7?\?v{@t|[wcc+S}&&<Rfd[x]6.fhtJhtslV/ Eou ѿ4:w@ 8a:0EVV5n=VMӮb=bsC]rBCLDV"3ZwiqCN9ox7$ v'%x=YXAjBXH^0[w8%hnI=kiDn'!jO!cS>^?mwxٹ/ܣ;"`G ?70(\e{ԶmqXvW* K^HyCKKOJgVSEm>{) zxzxF ʗC..1 hkZ(HlCOƽcy5Y^ҕGy;830 &瞜gz:̌2B esY(PBʀ %d xm:ӻ^5`=#ٷ{w뭺?˺[]#}7O?r6+dۇD@psǿ/(7<-K﯉]{ހI`˷?Z/ohjefSrE".F­@|Q쒗zpuœNgnvhe/ۣn~ħ޳_>?c7 vhˡ{?#.ܽ8y{@ѡbKōyBS:vF%Ҫ1qV5 k&~߅Q~I^ҺxGq AXuTW#zYx4X5\?kf6>MW8̪X6n:o"%51%#$5oCV]aU ӧcm Lr\d\TwzmP|TAe~.Xqt.=b|8ǥN&EuDGGu%et&MG\ 14`6b@Zьmi#:"ܻ}|:SBSH;*IP+@x < 2~EG~ՃK;wB>)࿿~x?2&Hq E[T\C"$KW$Asq7 bϽ;v5=Ko?*\of?{Ţmffc[oSaňVWO^yil)d~wãŜj~8O;zʏ]'BӾ{x*i >81wmGVѡbZ#+CBmGNg&3K-}ʁO;W+/_ٿ\wcvOz0:G,gޝyePhbJQk=|C@T)uY\7aRS?uګ[0mZyuzbRJ}=VVmIy]ѭײcOɡmi5%!#K[nhFXJ) q!o YLjIJIHj+ι%gums)7љОĶCY>V #{3f $gG4eפpߙmGn>Ze}(#JHFmn&s͆켲o#7'oې]M#wk6Ys5 ^ _C0- v1O>|43Sj̕d:7 Ot.~#V$hXJ ^[=LJDKcbh%1o皁e%ۻa(Z_/aTT2qDXV );=<15ȩ{ӳV~:sᓱٷN uhS}GoaSzl$nWpݹu@ k z^Ckf _"U~ g=+ J|F FSˌV3ڳ-::=.9)"=۷@OSXЁ-XD+*4Z ǃb3GV6UGGzt;867g E9#mgmHx bhdsa5ۊ RFSoF}2>~լy\ ,骫_N3' 1$a,ZoQ݄N7&ztGg DZ%]Ɛ3c jou7q&DPS`?/?__מF9~F.a #d\v0޻0 qQ~XrB-9.Qw9uDt"'sVVmhٹ0*(:ām35dd&-fp6^LJ8* `N KU¥qh' E5. B4 YzL.=ngGa 4#QUQ ut'| İ ǐӦg 8rw[U|_ Y፺EgcgpvsRÌ~^vďEtոmrm޶ݾ۶ӮppD({wtgņ0lq7z:bK:c.y)!ݧ[}ͷDDǖ\]`QY_d%ϸ޷"JN+M+OQYUW֞؞cjeF؞˜ޢ؞ܬy)1!a'oJ{78 7|/$،;b 7[;۝fE1A,XQs#$6;6. nj}__7Q6PH$k[*j@8Xۃ%F&P,Lo2كLjeAAnX4ƍr¨/J&#dRȠb eB~,N>+Ndc863Y)bxBi.WFc'@ Ӻ [(B9Q)YHWKA5WW* 8{r*˶=Kz^9ǰe [1gAتj`Y&kb`Ӊ^*>cOkYqJfR {:K)h9;n4?I6 mO:e5%UW*/+8[ڞT[_޴kgDV#yi>zL|;64l}"%,,Z|#A_ t7j28PX0K:bKcY {JuhvL ޔ[WZZ]]xǞ=m1q Qc9x\N@D i>ʁE^D\2PLZ `;[VF&U_%g`I)aef~G_:=7NwTOM4lurQ#HԪB4*)NvQ.#W;_Ͻ}n2k#X6%L3SM"q !*nMYy5~pF+ۺ[а i>2cO3#C+>eb"dԴS׷I'h<[clrjғ[΃N V JjcɈ1Î8 0WAGO5WMt8j8S8urTf=1y]Q)%aMVCTyҺ9 ZYvFK ųX\v,č7 ϊQx+k[YdoaXQMvV6$gK+' <7r&+sc&56K&i5#czǐT׏Cq? ΃B/ vQ]At :jA'A ejw `Q~7]C,Ÿ LR̦֭[`cYaף-U <> 0m> LfP|fOt̞]-a٬ٴnwIlK.)jJ+,|IYs)⟗~E~$A~&U-+s+6 i SrڶuEc-_P?:{0- |ObN]l~Mxq[LP6b 7'I ٕdV.Gk Vք'>@_^ < Vz=ОJqQ7sP5 o :FŠ2 @upT_ě!\؜|{Jr_ |Q\5 a[2i9c*0n{Ö%tΠ+|Aw szn3?"7q))=Ǯ`~Ǔojj^^"/9Q駅vS8qw@lΊ{0#[bZB]NLEbd ?WkoHm+(kٝ^6c$i~l>wPC9Yw''5&וWfK8-#~9W["O6̷$ũ[1Mf~A@[@nSl@{#@l^Eؤn[uP_ݴUH*ߕ~0#)u{jK*w( +,FS(xɄpӨ3c!GK!%2I@{s:صRao~~8عݹې5Lfl R_bUҳ wx#=،S]&m/Wア ][fuy ÀAQ9:@Y݀aJ =0 o*"! H6PH/SOQ~?}eјn5-hg<8Wi5z '@SQ T<86Z==*iJz%!o Z^)zM,}M&*"0M '%ݯ2Xh_F8mIPH¿$“1Wff0DEB^!tA8dp%jRvHA0{`,뵨cF+⻃_x"Mu66 v4w1U='rv ]a9}agcS+wWvJdE1ۍ`-&nx U)ag#iGƨ V`mv_C~M:sX<;GWb' 4Tӂ`)@s]s;cXB/x%柅ͨy6@ݻ=ܚPHfA}̄xlQ/=W{00>+Le&l]hߓrã e#OOĝoSichFU`*Zﭑ<ؙ}kdѡCh<3CCKK:BTLx{Rƃû3k{\]姚nl~Bv`ݥ۫r^xǟG%(icL*x 8L#mDŽmO+~1Ѱ38FVcq8=/% u@u OsTxKK.+#~~H 1'ĶWfVv4gwvTTdu5URه ̑#1-^wnLwXN-n/ ‰hwYHK$ $[^/= č1{ƁJ=B7W>>= Q%p')⊙>yPSUS1hMOaK>y]s:0s:xm M ^u0(Z!E+tsx|o,rE+L+,3J^ahO'3G\]`\Tpr+ZkF98o9[EɐH.a7Vح7b);uƢ}}P>4~yep~xȺ Bʬjޝ^?ݬ\:}ղ:[X87o}xy]y66k'$}k dE<"@ZEW~fSߓD*wCm||03xARaH&<`a Augv'N1f23χK3 Kuy嬪bF$sr0?~<[')g$R)p^P4q1I^א+E\`yp^Al퀊Rۿ*߶O:Ի@{@ 7>B>\Ϡ'[N =d! }Ni(}@֠Ʀccy5em̶֎ -y  0ar9e3K ^5^0hu^[=:}KoiEz&=W-32˒ɊyOGK'XٹxᰓUb9:@ I2B񄲕Y_p>/0%z۔x,>;DA&!*,a8!Epj!CkݪeHbX!gkWxjEͻ#kuz2]O) |1Z?9*6gM؄7YְU }13$IR@Pf@W=ԔQ<*YRjhon--VZ-ѓĦH_Q%&v%I2 :dؽU,5S;9VXӐ?48ZWG /uuKqvM;閱Yi!|Mxh5̫&4>5uӫFIH,z"U[ ӏ'wD<ɻ"ԗ: f%eXkz1?3,>QyD_P dQ\ Pg) X>9d%J,$^sH:\[/qgV, D/mXPrj}V1Mm sC7l.ٛ*ȸ|ZJxQ]X?gI%Ům j4Qh%bc=u(#Gs%}ŧ+j**{5Uܘ+ B9c.-m 䭼E޵{Vi]5`p;´.p+ CuFk9;'4{(WLb<̖L,1:[qcpsed\ qLIn8wѲ<\I5ܣɷŽ!X>, 4"y( 626b[-4ZhPX-& d@#u_E? ',hֈyiO Egz8`]cVOv#l~ V HfL ?bIHB JG%'I6j~S_Q¨r?5-7?#əIQZlDB5`kgJOf$6dw57Uj9[Y@eC''WVŹte.c3T:lU@f{oC ".k(JɥHT:bᡒ#ۙ!\,;8Bk&Ӳ[ZS‡SȌāt &puݦ^́wzWR(%ؕd@=0g8`1363/~jj)k^pkpyN w,7/)~/»C YU v@8WJzI'2{{E˪\lŲF)D<7ZK_(y?7G ?`16.Y WƖ yUgh( 0D͋2+o[%X @)р&<^MB%:"d QL M/8y6V^o>VDq79Q|25KH^8L>Y^\YhW,ݙgOH1%|½n`_x_ۼ&]I9IO#I%8 *m2$19.`,|5v G GEBs-<ײ8Qw̏%8jE~AMf2i4j}1%McؚB6@Xj [ Q/;'|BxmX6W`ۡНPx&$"@(]WRjgC+#Ei%yy%Ogn7onMk:xq+`ׅGrӻՏ@"}``a"]FP|D0jlBxeGb c^+')*}= ##M |ii`/z *;m;yv`1o8Hx ܇i!nb=żN~>;jJ|7!ޭb NsX)iL:7[#Ax3„1f$HJxPۨW +G`:[TZzCn9jUfjg"e󬬳H]qiݗpȊ9~+=#+KHȎ 5i6EXo6GW @1gguz}r<(.mÅgV9S^5~ HfȤyuJ4$Dˣrwe'yۢv$夦&yg$aXQ.H5%dw p $#Sĩnت ޤ B4CaW P/;&|Bx7`@S]Z]:\=X,Q1-[]Kȟ՞fEՃ'g~x]=Z aQp`:X Vů%C3Д&xd=,^eGqU1X2} IF+Oڴ";Ԃs}O^5utc]wˎצ(HrK.WQu `'Ə^먾2Qq[ n/3bae}"a-u9#&Q Oe+hᩘ! Z9HǓ& pq,aG@c1dD7)u 5IeVMV+ru)%"1̶ncxCs.m ۵%i$ 30MNJZӭĸԳ EMzg,Z̠nK򗻺<5u+ּ:`7ۣơ7=*?nWzzy\FQ.=du[R1v6 @h`# =gZ)qrxz2sa´ aAj` 0K!Bx1uI7  ¡AR7S@oOaʋz-F? ״k{:{fGUOwiw߯Hp^vT9>NF5A5#43 z[iFQ>UW3j7;9;[h9Y!I9{}tZINm) iXAMEY{9sqMOMΰfI06> X$V_HOQIK|{X_X~pnv49=z25gIA$DְE*{ݏji}N{H bD58~Ojκ0=H5p*@ RYӒU%A Rt <-tVn#~HÁcqr0tEXqt Ts>S1aN ꨯDZ8(&<ɟ'?ؗӏ۳G:wbr~cYKqo_.]b\ߤXW<Ӭ^jǣq6,qR; 69,+ USN/~9ymlp](ȗ$ō{, `ǀ:jA}e1U{ jT|!yH j||&X1 wK>A;OyGK1F~"y1d/3C#Ac.#Sd]9UNjTQV|9m5VoVcDY6f ^Y;|񬄎&6SD- SML@`^5V׈w(p ooĨتPuh<-Fx KP$+xGHP2 R٦Io=/= ޺]^^~Goiur.ѼաŔܹpw͗g[EK/FV/4VIehxaսC]"F/Z҂D\nl27:)"59ˮ 9=ggfjt^Ȥee:p r92fvg?4>6[i{EUF6}&L&<ƽzcӭ΋PC֠- mRf0Fv-F: X^S#W$A\kej%b‚SwKȆڻ^ +b-n\:9ؘUC䉾 ]+c7/z57H묰uOϢdrԫΞ9Ybvy% ^𶷿ݨY_;݀7bqX|߁£ ^Q$ol`U"=QuŹ^.=R_W=aMɴmw[>{_=~L8MyQՁ͎F (8cJ O %I?s~o6LT`(l+qߝTX\śTR"\]d`BIieG$vpy:elBwxwts Ze^Xs;H )` 7!-g[\&'?%*;5$-.Hk3'i"XiY^7KKdz嚵޶pF~Xi*:,8;uGvfάݦ0~BD|Ϗ^)Y:; ju }]~3twVT+Ya(H,Ё@X"+(KvK+2ѳeʯ|tWGo^媡3mEkTM:vo♚7=~G j\]wVXDZs|.b n"RD+" 0,G!Ɣ2fl^fًlhe|_dn.86i/5bQ@Tj);y+ 64;ao> oo`@4o`Bht ܐ`   >yoǢ1T$& I o!4chl[BpQ;+FU'Uʹ TʯvWeFopu8=6B>x ^ggo彿+]}UZ6X<#isP*gK֯=HGxH,R ^D#ZLP85Lbk%(m*Q.̍Ԟ.\=٩L޾0='kX.zAwX|csPKezU3Bq׶.{Q{9g/EENO*?''R)_3۽҇ZOA QZYZG22Ry38f߶\ eEX*mh D.wGւd27ط:˥d~ T {0.≕#6 W<7[ \)Zѫ,.Rp$Q.ۑOP1wĴD/Ǔo'%lR=(% ?d~i\Te!?PQ<+xl~2;5)"}g0uC*4zn_ #`0 < NoIFbR51\M )$D$* E#9ܚC"h/[Ʉ62LY./DBᇬ _ι^@12thIe c_f3_:USʍ)/0nCGg|7ܷ^\]WM6Q#xx˳?L9cCZxwkw~cN_\p͠/ҥ~X$9e8t@ %PRdkkf,)H: Y~a Û9#ó>%hmy Om]>;ws}{qHlfXH!d#7Бelt]cVvd^lN6'sS-*pnS7zfsζw/iz~˷(:>1?ͧ.*v6Vۭ|jW{+wl#Z,myqѹii[]2V`nH.ȆyCC!HmH#aXlJ&kמZaB&<* Faxl&(BpFt2[wPw{5>}poOfO9k"NOD3STNxVh˯M?}uW|^>Iq"mO]1=4 &$ZId_'4_j..s3 Kh'[VĤ$ZCsG{4v+eĔIiH`|w%eWrRAC^߼={ڻ;o'i8 QJF.cQ~Aw7aI+) '~7!n~~$,[Qi2W +J_AC QG] Jh(߱2)Ưl`UIއb,g9ze)uQAR~8sHbDci't[]aFΌ}iU#6sw:u3:5)9>k+}ݧ(sl,A^FfmЇJ1B붸x.`A+a~[p;3ɠlآo*Cvg9$ h>$ea>*AGAP1HH(z :@@P7 A`hQDH.Eh*f'̈g&y& \z{Tc򻞮WRլvNqUp ګ{ĕ/"@s?dh{h*3*_;v ;ov^lkҤIk4Ct.3Z=4f ]9AlAn"Oh8L2sOR,͉}vGFEX|IΑ>gP̎Ԟyx|аi5O/:_ttZo`ǽ=38'|? zW&[=E(ڎ7)M O1hDs!"TbWҒvR#:])kR[eؾ] ]:鬒K9']޶0 z ѹg`%K i䄉|]rf%ھ{zv$5gK'zm!t5+DƬ '[::Q{'=:&5"ë rpvJ=ð`4iw**vi_)v[64l8느@@F-NudhVH ҕP p-S3ID($S [ ]w> ʂcX*FkxC `1D#d k 6!v!090l AM0y&H>4͋[:$I5tF7kV_9{M pZgԊ=5aŒJEiI Դ^I5004]~'L+Ft'sڝ$!Ц^>$ ȽDjQng@R oqD sS"ʛۿ߀aV\}%\;w2dm?ޜ_nM]bvon)? ~'۝ a[i(1!1tm#hZscs?OĂ6Njr0*4Zx\캩2(ߦڬ"VtnWCr)tHg[SY}!j𘮄ب&̒EBZ{ZMbQrzJz4Hsΰh *"2`WtQ7 <0>7OȆ͢톝(PeuH-%6*HJǠS$SOsR-XnӸ9&3C@'Bz$q(@AŢ1djT*cH44,ȯ,hACx,*j |sh1<ޥ`8Lgfht|K>(?t_^M]Ɋ2{}_ ʋyU^w,(.2FA/CYDj^ NX4Cy;3<*Ot0X )|C=Ɩ u uz֞,~CFM}'N8/Ψ*;> iE%A`57`%* h\tfrd✎h'#Q,2/L#'}MwYcIb q=`wlB|cf1kϴN]*C>gpYZlf~Lyz ?^!>u833H{8x{Kbj8zCƎUT-ˤ5[jB}Z\\[]KSÓ Nz׹x5t hm +Vr f%YY@:WYNUoFmhwjuz5< 8U\&xl5TF.2@#FD@!PV:,BΈF2ֺ(>wy'n6UEbl9]CKґU((.;r9ڻnu|p닕^Oxͣd~h;.reEp w<+zHehÓht˚8^ٚF!< Mx\x @k:UU#m}ɭY$͌a$'2>7YKT BU7;՟Pl 9E/e9|'eYos {(͌f ư1q\N:@H"R@Lgք'/w9i]%?4:-]ml` x3g>bx`3 5. <0/=0.-#$1*ؑ:#T7:ȇμq>%{jv:4{f(\[ Ų֙Ùve^N;YY*-x&n.BBF> o(#[ l> zfCyeAaURHUcYSAkMRPn֡Bʃ~Q)q}F($(4S]3O"Q(}h4J3r]? |nEjA c9?@Qkw]~m`ϾxgzSnWץǘO^>y_|b8(E0L/Xb15Dⵖʢg[cpb1<|K?~u[HYVBOO1[VD^FjGI34:CMie\)" :PGT2L&120\=ז^" Ј<߭3ȬEK"{&Zr,5q(B?kNɫIK(JiHMjD&,|oZE;^B 6TF{cM'cenXgmYE6k|оEyN^Qjo`+v5`nclg9Vqůc|fwS/.wpH/LvOv1Cl>=IO%ФkCkõօ @&+π!˅W jia,$3n܎.k;y,='"&|Hp*nNGѥUoNn6ZcIx\x{\DׄWvS8h ,8r8ȑhfA'8{Wt.+Oؿޛ*7(qc/?~CWZu~R2{hU0 m74mzatƦT1n?MQ*@F)~ uW'Ȥi*o[Rx<%墝8wTV{4>KUeoRwߚ4}X[WᓉǪҊ3ׅ6Dvty=聛nTYx2C2eQ;vMB/U R &LEH;zUߟ@.A !=6>̴2.?&99 & %)75~ba+խoa+QiRV![p8lUF,&:"x]?I=k뤾XхgcTEDLSyGҾ~+hU<O;ns_hdͷ xldaM >n`?۳6 v]wR˽uG1(\K 8*Lj&Ǩ9*2 ^/R/SȃT2xS~ZIzȟo36GoVe7xٻݱ6[#g-P6]j3\K"R֦IqGRҎ[ Gϸ|bwqb%~bjB X5 %>LԼ{P6ۺ[%Տ7k=޵޵5n'iؚ[;?@s:ǃi9h9{DέQ#w F/19'OTUpaHHŪkxьu"kkj Պ\O"<2^( yL.8AaQG Sf. S}˜AGg@ 84o_D>pvXz78){6T͖FVS,HF^ ɠn`Z D W.b NHl QH^F"غ%pFZ|aʽ 1 NJHSWhDuY[?7N@~Bp!Xlp`ODK}(Y{)}:-zCﺢoov ot ,J{{$D" $ꤰyw~pۄa +;C1ΧޯU"l33w&}/j(6-?k?6a}%SOj$ȹ%G*^1uGѾG *AܻS/ {=#0`3K!HĄv+:VXP;/Mw9w0G>2pd`OPD鬾$]gRb]<}sr#+RCt28qsɢ:Fx;§ዹ|AT) A Ԉy^4Odhh~o3t|51Zp٬.˒kbF{K29ђaF\O!W(dDHFx|%Ib4KV|lReam5M]zDe|ɕg3L}qڑ]ӎ֮wzFk| ޢ+- g\QG=|?>uOBk>5x~B^e '9w%9]é>(L[|5섰T1/X 2#(5ymmIQ1%?%荈Nd=K? y:&>Cvd1<۷E/𺃶C&6V ݗeđOL>?XwP\Y{.CWjt&OIh,kOsks.Kl-]PI.n,B7ԣ8wh[LhWLؕ\6 *pjmdajG&{S #<kcgn in!qRDE4^ 2n%$h/y,k˲k[ݝ[F?3is\6ך;>pe-ú*`H.K$$tAnXց۰?*7"蠻3<:5WjA 0+MCîĠ >r` -L/(Yx0j}`kd3˸o7 +U-09+4&l ֔e%6B?z;7vk-~%7Ѡśfg<aȬPL< .: :qtW{e űEc|g0ag%gAbfCH;BNal ҆b/:" -"CN@ (Slq;nV7js)J椡y52/we%i|"jY(D3ۄJȼuGjpL=_)- schK+5dG/yyB`pڐƐ]jǦ2ɿ$VW~$NzzDӴ;ŐdәNE>[za3pmOoa\5lݠ./.qfQcbpxmіe;/@ y{mpIll'3|V<0. cX[Y[=^3yɲC F]RE&kezv-< f-(bAI~Fn:ўnw63إҡ_-}0}w~wl}3/tҐZOݬGTČvYFT/)­f&f.#{wݺjhG_Ao3KJbM\`HF|a{ĉ)u2QǬ$a maCiЇk؉r„mEp0iR&p,N; j2܆3c$މֿ"gc5M$9L+ )x*$hAvSPn֒7D Ie9Y%:]/{i{YYu0&/QՐyCuܔV  @ۚ5 oFD۷|[Nhzq\̎V=-s>? n2gKr2 S:BԐF9w?8o@L`]MtY\N'd:g$KpSu){1}sZ >-<7^;#幛KY8/;+%y^(* bQ&,rILxN֋8gP0T`Pj᜸D]. Q[5;\\QP=,+%$It@/Hxhk6Wf #>@_q^pr=٭誤S4fjo} 7Kձ:@eqch.;:oNI9\/bYB~] ą\i8˓q%y\/.rKe":\qyD)$#qHJ8Ye8]u22`#ab<t@_w#< +@Rn 1oo`BTRf&QVizwly%20mgс=#*T3Rc(: #Rͤs04Kˈjk1Ҧ@+3b[mz}W~ɼT*T1o"ʄy$jb̀caexPyy x pxaQȚX' Fn1ac5o*.nnJdYC+81 5 q7"}w߽ L jNJ̀ۂO\a`"' kUJ2xxOP iէ33Y-mWr 2V!.ɞy^]jn SN~rp4{|TJU}Z]fjDtRN)>*u10Tz#>OXe{cr+ ņthbH=Ox^?#zbٜ6;9& X|wwP_)*b 8<8\q>gK JAA (gF+Hn8eD UРTM 1q'(F$/uH%Lɥ퐼/ "n7&adw"&1* 0v Pv54-_-;ڕT`ώN_jJM!e _$y+j;DM{P[bF dH!&Mw@۞}|kt_C[X\j[Q@̋UFxh>N WП8A+wAm\y'3gtVwՒ  c.smn,ls)@qclC&Lf7$n2Ğd=vc;٪5VTz~}_k*"3dYCKej4 T#i[F^yD`f njtC55j‹?7>!l,l Pl91a^GQ'I` !Y)镙9- =ũ !ub4J|#bnY󿱤oϮW:g^>4fPz3+2j\jGԂڜ xUDld`Z"(\I&)w* RO_?opؿG;GU%8:v~e9 <GĐɑ]“p ?=!59[]3TZ6gM/0YY1VW,vE@_/N |d n h`P/tDF0@Z .IDt8h?ٴ:z IjHߟ3EeeqyE!ɥމuҠ2W} Tڰb{Mڒ3* a8R=j1Ȁ VETpF߁-]}vt ӹK"Y5"P&m$"eH<csxaِBɴ~@*plBl"%Ok".+7pJU7=95vQ]%gZG1.u_Yx 2@pO >,"D ќ1BN kĐ/tsJ.kФMyy9Gjt*"-)&3*#>)^\EoGh$Ч=5 'BܷݦQf|B[13y3C/T8ݑ#x'Ҧ&UeyE9g +5e$w$GML[ bsk|ldWzV@Կc_1-\}q#?{(%`48$3c* @#'ЬbVDp$˘]ᄏ|Dki4Ө O$sq6ޚQOfS F/ʩv,2eYqOsdi~>ycck+˃זz,wq~gakdf05(;CRsfrpaWNxX0#5[g EȈ|@.p8]w>TU1o^_ﹸ}8|miΒ\wx(0^eڳ4Nq|ݷ~Ea}cEIgZ҄s3f4 WJHQ W& Υ] Δ3)Eyg k ++{ݎ]پ,b;:bП;\t>.-1܌c@'LrPbS<"5iIe@xoO#dOWK>agd㾝DSq,3(cЪj TF SF ʼ枝ޙOz2ڃ1O*iZf滙ٯ4S*/tG$b-tv'Nx ppLABh`D ‹N6"a:yW* =s~95ä5_߼7wL|^lZq \iFdY5"F8#zQܖ˦fSso~Ac[0y+]4{wp͇,z,G 1 |`v(4a~Agb:,IN?"3i?ަx!.7=#>5"¯)ϫ#mG9}Ybsȴ?Y]Ut>;7+| {"ܫ?lWC]h:{޽΁"0Jx05ZFJeZ2-jIKR.%Z[sw,̷Ys<:N+2YJoO;qgڪ?7~oQ5 LCZȜI5i2Mswu[mUf]lܱ)S:qkes8=|&hNGk9 5%õeҜtEvcb*&NX9YT6q \`RK`X3GvXO}X36^4ۄ?@&!*_̵1yPk.7ގ `L< #yש¬4Ilr޽{t}<|QZ# uQJ=/<;ef6/Sv瀞U[c_ X^> F?Ҥ_I},o:sRR3BXKw#]Tf_2^*Y o*= T T qi?ӒZ8KٟnA= ~LbHHetycagmgmmEdnO.var)\ M%{"(RQBt\Np ot?kLcFwU>Y7-Ι'~|7j1o. :W9:$sq5pAQĠ9 Z \خ'\Y9֚濶WLk&·#hJTƅg&\޾yi?4+!(XT d]"pCV $ï_|,!hEUj*)78A8o PsdMF9';V}`OfGA-w;6UݲԎ.m-κȢba0ͣ}7oe\lij#o*&f{ hxϾbr"Gl`Ju Fxx;`Y[|3 *6%&B5U,Q cDOT[T`uem_-* p|y=yLShH Lz&6=7`I;ӰTNQ~I^!ɳ6Qd2'߶0CP`YNvѹdnoaWk\o%w796zh*Rc[|D}Q-Y iH亐ܨ.By9[>M%X0- R"u8z(%09:1#B!`N# i&@D>GWQ # 'ťO>Ү[Ӛ&j}[w.j^ڰxwM{OlZPߛ?0twlՃaibz¬OGyd]C(bPs0 Vg'^9~OO9w4p[:Uh͝kXU_sbpj?-xLW (lPt\,¬f.۸}ۤI[L#2C̖Y,YX,Y2C6Pӆۤ {{wVZ5k{d3g rـ>᝱TlחAJ՜s#)2nbAX[`yst {N|f]vްǞ-g! _?ͫqP }2DE qQCYdhBqBzȄS w{ !T O˶ĠO`IhNzSTmaN|.cD~86 }Bj(Dhm9_QêHLMOs!֦Y|QIXNct`H8VN' +:DN(L+lLUA겡e#tuщB&W@,aS|fVccr"GV>;zlsdyk_׾>7gZ}13 N+@eWʉbgh@Brhh G7«ëVCꦤIf9JO6lА>ys 8"|'{G͠bօ䜌n swHV{0nRha̯T|Io3 hhɈLT%I86r~q"aLyS$rä>4f(xȀ$c`19]yïmQƌ Iؗ|r.mHy3bvPlsi]zM~Ԫ 
7|q]<[hbއOR);T`:KNd QTx!q T|+F!NL0&$9&SԌaԌ.{7TzV6&{4:4ǕFԭgQ0|?Ƹ<X8S~-+<+2ŊkXSUMMOJdVDFĔz4, KMmj5!ʭ'Ft'huf{1о* GO; YJ#2P:Iuup5HO 6, SZ=L=d FfQHd  ХHg坝i^ξM pB(_583ҺS0~v̙Ӄ#?,ޞ3-ʋ3B'f@"q܀0Mi#xZTru+=߿*Ǟg}ll?grp}44hO4h-=co,]l]\ i15byMP*}IR;;*T@Ӧ挍'\ O0 s:YuGVI5,},,^J魗ʎWdG Jx%MzE9k/xm,^:|Z5r%h~E*~ܡtPzk{=$f2 uLT-+<]+ 2&J8>m6NX3z J- t6mXjCh~oel <+[&O;n," #0//"GTYJV_VrqQAJMqt{O`p}~dkf]pV8OHe #^՝ $[ #Q}X~#Dm P;gzK&jTZѐNi*/ʫaÙžE1xu1XT6 KEⴵB55k |a-&B=B%z_¿3ш,4ql* ODe:bVѡy}GOgǗG[M7IvKTMgo{saͣӻ;xF̍/G$)&eX IpUsir EOR ` :b]Ů<8u]ldC}:dD {Ǐ2P-g:_4+\Y;O.9.jӑ.Զlp(f)CYwb TDLT-Yy^qbG+đg>]",O9nbzWOpl(%74EgeA{Qqveq|za:0&68ݡԾ1.06('n(>n*ovwV"/5 *nF&ֈ>3k(`EkA'B,φ]Қ5(-mLϬdY$F1R0h/uuRzpD \@3u^ [^;gk4^^:WH K[ش4!_/L=$vxJz;ßƦlhOo zqpbsmro% [Gwd$֦:WcB<7faeSMPa"+E} 5ׂ.鬻GsrsumGff(g[Ti 00 36LcP?I&bq@n4GMᩓ55sIŷո蕿Tq>:x~_vo}uս;Ɗ3<.^!>V5x_ٚϯÞ5Byk릲ʫ)叓 кu<}bv)@d4? 2Bi}⌅k@kH^U͚?},ۇ3䌰fא׬`c^쾸x̤q焃7И:k zcX9Yѵ)%ʬԊ,PۺІԲnxTD`7-1(é"ݿ63*%(c^l:q . rkpQ&>PIվt\+C|}Eǟ)?$Q*JCy0QBD\PwJ\QNRjMBx+ӵk}%OO;AxmuuZA#k`Pf8B#/;QL,< ❠&² Grqӻ_-.IFA&pح!1xpo穝~i~djPNU~|r2'NDƞ*odP6*vޤ86eeHpTJ!>~3 O'7$So\?t| m_;tu-tO6 VW H+/"W?Ci\o4ON,WU̼O|'buԛ8 :[^~ u#' 11uAW=O"LLǰ4^iivȀ0gHblOjտYrpKz.$uWj&ϟw_PԷfellLP?5.k5v~ڡ=&)/J-YF&/*FGTEV5>?.?kܴ!Ae+O kê]%jN}8ocVy++3M圱bKF_;5ye%c-Gjwj}qP%s S+s ӊK~v%̂tf_xgtJQqNOnvtQ~iineQR=+)TCjO||@k;no+ӽ!'ݼŀT5kՏi\Tæ3zQP=XZxDj몇5u4<}ց ,=D FMtP5Y!@ҫxm%2ptݓǧ.>a9̲Ωʤڜ@|_~+>%a i\/΀&l+ur3+q!2An(IEt0hANu(pdECg))VI7և_(^Ə^ݽśVҶ ݜ;}9 ~ E>[KlsN*4+z}59zX(Q>7ni*ۨ)<6FͬPg" $eTDPΠ+$/hjW. { qﷹ[.nMt:4et?Hmmˉ3f+EM ]֎\b8܆䢃/ABK|S]afFA[ ~%*Oe7_5\j(!` 4ʘ17JiͫTS~A7Je:\0oD~L>5wLؿc 6$oYh,52j*T2y<q@U_qXn@^qt059|JxT{H~=gL-ya!ܰДDn(lM&2AGb K[j!Z8@g56ߟ^śͿv7m=;pzYQ-j)Nn;fi[\jWOkEkD3ttO(w"9|zg#~0frԒdZ_nCu;XAK$Go$"|(}TCx2? oH22/_^lR]~{g]}~⭋sJsmV8낂' h v&j==[ygQ(]?\#mtIBMLa Qw O$POT F Q& 1rJbb[Ps$K+WD 삾]WP'g{b|v8l(q&}<%>7+=S_t©]V :rV'KkCJC]B>ݿ&7|GD`$$<? Uд^MIaN \=\5IH&Bg%.Fi<]X BW vn~0? g̸~Ɩ6b W:/vJ ͍Hj}xG$=+_,MM_7qsb LJlnqO''xYoly;:3<3tk|'g^8<8tkonNY:|̦贪ًSk['(kXVG'&gjxx'/_^T!YGlB E>]ܐ5{*4;4j-Ɇ'p3*4pgc^bkqGy͏ڄKs,jhL޻+) NPݓ O)MF"*I߮VWHT.!P 3b VR;^,֫#(]&9es #*L q?fl2ՕْUXT*I̍̚N1XFYjYsKqm}Ohn{]7JfWiXhhZC8ڃggh pkX$(#:m8d6+7BP G b%=ܤ7)V;9) )-l5Gw֨,!>CGK_F. nLnbg Yބ.Lv;rZw (}V:f-V/4=Tҧz?i2E(gc?,W#R 1Nlэ6:1k9|&T;O ՉKgv%99kmwꈓ$н=*;1ZMd&r33Sgou1-~≮E8a_QҶ1#ʦ+(tD^!B'&&tP\:}[B,W hkFzkE4En۸j'&3R/O>TL28s GuuA5?9&&$FJBv8lw6ja,Գ!?ϵǘ֎4wnd8e"3҉׆G"ԣ) ْx2(X]WBπF|yQ۬[hM/N&Rs>|2[0Q{ՏH>ΌrVNuLmipesWS ;(4!<z}+6uU:2@g ck!qu NX8 !މ:,vR;[C$rz4I~jvfś72/sM\[rGSg*Yn3nG726feyCw]xдϗo?qɫgDSE|I0(:/Mn6 B>2JCA O%IT K(!\WM#iRZ'9.;m^)_Hw)Lϟٶ\uABn3Ifm.V1my[/8rw୯=%:%ZV @ O.pbT8| !COPSU7jG($d%/0"-1J Ԑy{hIiW~o*8IW^R$q8fk ~Qg36r2X v/I~C=AbN{EVfr#$G9*@) ٦ O6BS$),K(r|d w׻BMxG$}a D ` xP i8hSX[՚WYŎ)*J,L/H WY9SI amMvpm6#Ⴏm}qG@~bܕ^nٷ>-?,,5Um-1lՐΧ2)Ք_\EkW {췵8G@1c)8^[_퉊ˋrh˩JʬOdTE8hc"4dz$L O^R7` 2X-/Z- @#X@3 Gf!q5^XN&O|Cf4eg2{X3NmvؚٗVWT_? ䷝ ,M eJP1z$@5b LI4GBw%beĈ [\B&Sf g^Onl:*=:%ʟgJ~H~ e/<ɹMW礧G9{:;fLJˣ t$VB!ol nvKlMi INd cқ++)!EsNsxڂ~sL92li/$3fVz5.zHMHdkfxK«3̯ȢށT\_n,0lUW W}1Bѯ6/ԶՔ;K:se1,NXnNNJI rv/J lK4npI(a_&zN+L# ibh&BE.<\$RȫKul=<&٫uL㯤cr6`綟Yc28"?zbJʫb'x֔%;^0(k?w5k/ ,ʕį Q2Ex'J' <@&sHeDtmޘQ\ݵ4iqn$тB^wtBi+ǧxW| 0ƴ>ʶ-Û޵ۣ}8p׉]/ p|t>3ڄBË IT$"RIhK^!:1R"Y'4."a C С"|OQ//OO$$W?09ҚX*hH <~hx{X,NT%mvH;l|)~Hͬ q_)!y"~:V@' d  Ib8 ]??:BwT>WK!cĨ{ { ̭N6quE|46# ,a({:3}b$N.ri`ygksnu#ZjAQB_`KP "s ekVZY hqnpovq.3ecX =ىfsTkn]Oĵ@0b,t~!dGQmQVG"^<.$*K7vnQmN/i}/x/;%kMrOnJbW4sBn]^ލ~U-Yo 7e/*09kl70ФЏ>'RQĕEZy?xr߻9??:@« X?}HA[0623Š b}0@ʐ jzӶTǃ.cm1La]{JS2ܛlӪb|kkB#˓؅٥.uAm>sѿipu݂j#J֧;Td&d5D$wv '|o<5$9qB5G <ꢒʄ2"# <@4`Z̯Ek#t´>Zڪ$u"#aZpe'"B̀镨!qL A~c^~x1)(pygN>8pӏdls;on^z~Ѓ=ӃG 1pd]xfby\7(F  O ! AN!vSLBB}_%C7 f~pnߏo.arnt}v[G!N=#3?_Ww|=?T4/y!6W)Dw]z^!AǓ4xԶ@hgH"T8"T(B5Bng68UgJ_c <.:"r=r'>K;c7K[ҙHfS}hHDY_AS(>7Wu )gӭ(>Adh@UӉ: r!1*Q@ )ۇ><]g_kUO >;\'bӚ+*ZrKڲRk"R60Uc2@8"PG+HK+FG+Ԉ|+J wJm T&)"*f6 Hi^t=/ML G =$ǑqU!ˊ=vn}0|pk~ڄd[&M'i;M,dC..\9("4ݼyTHd/gDVm_Lsn~/Ży(pdՐT̀Sϕcim~5n63HqHRm<'A" й@ՃpV٩s?,l=&Lo`d2nS%<ū&;U"Kz*R#k 7_r,Py <[ޞߧpk0((R$v\pߏvѝ$tmgݟU?ĺ'>%/_.ŝ -g1^2}I[2ixau# _VOmTٴRGuu8. ׃Ю7(Poh2biץzIK=M& ] `$j6ץp6}\c@+%xIG| ѣH6 J{i>*Cz6zCRo>_f[jWg)G鉑%z5ո֬8Y\iﱾȤݣEa=۸o:.rQeG^؛$7V AT A$Ywq8q, Ny2g<w/v9gջGt$ksN.7;< 0 R;[s䒖RIyV{YAfG86 YHuPa˞v *.d&qXn}GGNgK)5{J35MЮ`wS`Z&Po];SZ)OZqF `L."+fDz#I]*,m~K@xT*Y 1HF g**T7?]`süW'.o~sv+| ƺyme>=azfWYq sqQEMo $ţG $" hZy~~쮩o]|qO\nkuM6s+Wf7h^;ɩg#Cyj_LS.FHrO1ڈ8ރC8Z7O_2ER:/{VZEG/?.r9QcU|sDut2wB2*Nr>7=w\Ppa|_:Ȱ踀p9.Lap!KՈk`&!@yOBA> 3<MOq9ꎌcM{}w%Y;:@;v${~!ϝ(\ kYՀj;jbXx܊k;{˵ ז cWf_6Xn^]zy~+g>};/+j@ Y&cO;x!WyL`%Ӹ`y*w8Gx01OMڹ{4?vImOۅr;pnAptcMQ 'XJtlzN2`:CzOnoLH$nޯ^T=\Pդ8ST:IO {u??~a6<SBa&@,~DL`kU`|$Al&6F.#|J %}DQ| Ha7`UA.@#(we:w9:w8 qaxy2U%ʪ؞}CmZڥ :û\؎lu꜕ FxǷKKgJrsN~)Dt0`213v1ݜJQf0q%1c'/~e6[66GGe1ieHh,+X(,O?t_ӂ??$MNkŦ<kE-q炣޵;h/>s󱀄zИt%6)6G=`xxQBUOdieO?~}j굙owsǯͯ.\^뛵.o`}cᡔ6#u\gH3>CQ8Gx>˃BiDpBfVWߚbUD_3k//}'^u\v}h<;]6wܼr⃻ƞ^S.O;Ho)Ԇ(>Bc$=F$.״Y40^'Npbď/ ksCBuX[2PX n:U%Z+%R9<9\1Oxƙ9 8@`G>|Ez {LmX.UsQ楁g [d?N^{^cetμؒ$9A?S7jZ D_6YzP@?S0OWG 5~}!}zۣEPe"X|K7Ao?p@S^z4d(Izb|+*kۮy`Loa^RoP°w`VE{뾰;X6H##qgc:&iʲOxF6fJ(LE#Z.F86Pl0(6I"QwZ5B{SXrėk_~zO<:9>z Q$碭4M#} r&g#x3gBV3K`8t쭡־Z8ݟye39.L9砘mDi;FN [qײLt9aD! Q9>n!=4@1[ K\%^R؊ҽB"'7)q؉ (S@jA+vcJk{^~W6Ppm( }-%5EşSœgM)!!eqE8g&g,Cv2<lx&`F"+ؒYtBfcB7mIRa1[c䱆\);SVV~t4iٺ{w*lJ?ږ aqv nޯsWEfU0Qڙ}n/Fp{[/lͳV6C2 U)iQ>ygΈ:5 r9 p#DkLM@%|0ww,Rr HʡbCq>"H7]޵5~yL]XZgTBrhݎyvG 6+ e_Ax%1 H"H8[Ic+¨`!ɩr[~0 $A:֡[Я'4+ X.M,Njp@rrFFyh/EZT2][{pqI ġ vtV&7h&(f#žRJвnYo_:[Z.qP%HJzn+9r9N, {pIdK[kqv-W]km!p4}NH᣽|Qt$iɁ\9)z)N)͹ UI o_B+b>W޽o^pKѬRLNs1. # |t׏1hp|cT#b߃[n%b9a#>`iGrWg&8턶+sd2;pG] Ii ʿcVGѩ`ޱW$h*oy RC{Cz}B# {>$qS^V]UѤreZijKvm} /VIO;>"r-)Pn3E6fk5r㯦w޲[ͰfnyۏqRLQp{ؼD}p>^/>;Ԯa'OdyF[L+=̏yTvro)oi/v-':s|CLҲtH0Qy9"4$~]y*ҟ5郍:QCw6q>(jb oEq=O+BV;j"3D$v*l(7L [c" 4aX/@rNIkiN ׹[l{PG`$>n \K '%5֜f&Mip M@i1Jcz U~Itn ^h禺ⅅfh;NiHN;Mup)|PCg@Qjoprz!` B0B" (r}Z@09֏JKT0Zux*] mr43LuМ^3S`6̅zJ1-rP,h w^4<k%F$9"D;6C ҵdE$&~ ew!Hi=x6X .H+TN.H kbaiEV]v#e°4Eu&7)'PU[q)/ԕB)΄hp4ފ9gQHBYRpJpLg #[ˁD9M(V7"AYnLu 03 ѝg<o.&i<~$==\6*ʜ4ŔVtVLd^s@NCTSP,k*o/iN-35}OHg9.<2\jKUUe-eҶ"C_d$(kĚ9{1b?4E'g2BLeQ{Gfo 1Vdi범e IL}}\$%G# jgF룊!~4)X'i h-uD;TcFK C0cHn@RVlM1DÀ(B'tGR;2Kսm:P\j(Fk&l\[IB.eNxg?@~)#8NDӖ ަZ1v3GY8ӑ v(_r;p;rH;CN3aJt(pF,%w V+^6L(A Ǎ 4%228=LN712.J>u" 1SƠ,K0qI-#K- >[{TÃO|殞=6܇7JG8asyZ,&q6+q)<|`…4mWumVX }̧.s A)RZ)*Y=º̢ p}d'xe=__JDy¤4OV{PpĜDOG֎4Nw)8Y"V_H(H//-vfjAjէi+#K}BQ|(D1KuM% #i^Ap{fY5ی3Xl T{;a~?;WaVa߼7l)T,5lFW( -樕E}#ǎ[s/:7q=#b<w׿:'ʮЈwnF-0l@!&a݂h'_uNi+,oYE9U^b 8sߟy'qxS#w+f1D f `w[`NᤞуdDhh`h )TDA\+sBJ>)j\0A @@v"܃q{!j`z&A*ٴ -WH ǀu\t C,嵁88mԈVx{-D 1u[K F>H-4[gy Y= #9thG{Q7ۡ [qw=xM-~:ZpUQ.9@ ]с-oi3B,qώ!Gxv:;I}⷏;ZhuWVV؈iHkHK>u4#]tp.#(YW77ErWPqR]_y>t8-A',2U甌f>q>90UU]7L%Fnm' 98Q=UiGu)o)c)>C.}~w#=GD88AڪmQ MՕ}BCN)Ј==+iT !*q'φ;w&Bֹ}iL`Ghf<ڱRkm%ݤucq;f~+V{~(αp`vQMq%#AlX:GE:)oobB2;/m@Nn<Ž}v7mO[r&6>?G=}.<ΈT>LHC|׸Tݞv~"R.*%RDQX_\3Rq6(A}6np")@&[(?ZNso;~mK7p\W|nkіLeVmc֩tSFR$19ZWm,)XM #Ao,!nڪ&yY%#z w `ř<~$*m֨e'"69M>f^'\(-;"%NxɪdPElі6+3@҈60BYqյ&N~r7'Ϛ׾뛿t积ΚW]~Շ7ݳog^_;չ]ʪh/e%0 'M c 5iӝ8KA4sfBrq=$=["Nf{q~yEIkc_m=w=?٤J,F<;7O=O>һ1/GPt(Gj15h'BJTRIRZXD;FH+Ó85eUeBS]|uj\)H,OM ;r(x!O[K!9_, OfSi>{=U>NmN|%UP2F%p $?JRo 4,q>]LvG6gKt.}];G92R6疛q2ciLA=kaN-^ι3E=1A;LSgO ~_`_wA vH6]咄QÍ@0ق<O+ljdB,rrjOhYM[Զw ;]-"Ṩ!a=q86[3tょoWb΢޲:F^&k2֊Cw qh7<5X)(̫IjfAVݱf2m+V>*%gR }PFTFzȞ܍ܜ?=A9}`g%ۛ^&kriN6ޣ'2z[ eV@Hl8YTʴΰ#._%hoJJx FU&WϨќXtҥ卫+'9s7k_Zr}S/;q?{N3O/gwl';V{׸eIv'  5? yTFr 4cp6 HI㯌2wʼ҉Oϼ4Wb*,;kT>37鳃"Qj(T'k$#zts(/fmlId;BQ_os GO3;8L#79ȏ*ɯHoXnL?fR { G=_-5UەMڊκSuA3SS6P^iJm,͗d%C52F\Ls:sX#44bM)d;h13rN6C zO Gծ])Ͽr掎)Lt ];>J,,I,ʯ.JʪRq]z(v3Fo5ri~چԹWV^} $"?:MkgPZI[,&7V>Z8qط3=c.IvfIj90z&,dyYA_.MTo?f<^٢Nx;3c]X'BD B)G·-ޛT'6 ҡF(g+ ϔv\b(1՚#5;?P_y>_yZX˩TuwuLJUSHbޗ {=T'MQzA<@d!_NE4[E[ٰn`%,CQVCu8@e>KNc: @.Ml{D"yЉ]ťqlkh1o )ܽsિ!J{8s$2{8&Z8y|?o,/\bQ&7$*M& TC )H%,æGx3j~ W~=Cr3{++UujmIL VcLw  79f4ᾨtSnt\o<3\^qdFX4X8U,o*Uh ]j!67.*Ru!@P ȞU.ڵ' #xTs-}O/U;!FeI@r`PA$-bPyA zƠ̂\9wۅw^]>ї'[/h=7?½z|⹓©/7~c黾p̥k6޹,seg:1Cx3oSn'6Ґp38išqLJ1-nV%CĊű/sLN-g<`"c0-偰g~mgK#{޻>jP xv@E78pCa ",/0 G,xgn&!%}/}*We.P9JBKL2Q Y./8lh:oq3'J/~*Pi揅צ5 K\ A# #e4mk X;F" U@e8,Au<Ũ@Z>Gɣl9 \5uaރozټlo,5PdD+oW?{ovι,CqUH\QZM D%jS*mqk!hW@{/wt̶Otq/ E6cR,iuagX0n_fo ᷦ)@2((+h=?ՙMͽ8`oշ7gnog+o? 7&M 2?tg.=]xw9$$Y5}*Qbpᛝ *o& %[G@*YmƒϥRu9ƛԄ4DuE؍:fŘ3d Li W77Ś[E)ŒnC|t&dDs?@K(+^1 a~j 'èYk\fl= xT!du|XÇ\hI3ƒ}TKo`͖ S1>nc{,Jz$%cB9A5fQ@'XuWyFX͉$͹ƙs|E'C9 ͙'5 }׏]N3Y-[lʨx5Lv2c)Gi:0Xk$Zp^A28yH|>H'ͩ*4!%1эN}CAcKnw69F fV:$lDD%̖4Eӻk*Wrʞ>½nk/ӧ {C*ڈ=rNIAQf\#eCuuNZڍre),2 gR[s\r˺oyx 2â;".(L֍6JNXh[hpׁ3s<eIZ|<#:-1##:kpIՄ=y0wUrׇ,|GCE)!=ߔ~ 61i[ٕ"l  p!qmHsHݓhEx۴_%sZ?؎M ǘ&k/qڼ>uefĊyu'Lw~jixƱ_|҂0#O78Yӫ<5#Ƒ7npּq+%-M7[ 5^' `, E*0);^e9DuPHu̸ AZ0O4zdc˨T/,mɈ{jo|7{n3 GC 1Z>^\v4e=worGfMwQ;dI$l\@lL *V(U Sr U^(6?$z,Kg>>gx?{"#+On,:s6.Wp O9BK*5ǚn^ֵ᪗hsZj0P%!Ri <ckw _u>zc[+n=aemLd zvߺ=s$i8!Ęp11go3L1G؞vzM??lIRX[WǕ}]eNsX2n1Z|GcHqR[S([%X ^0yFOKcJRu>ۗYmX V4J'ݛolbJW mu~2{,#m.;xQԢֺ@C͂:jajjmiH+UBEWgvAOۍ8Ym 7߹cao2+i,oAg]xoO.թUjmL&˓T5U\ 9q|6էJ&bP>7:ھFh_FmL(ŽŽBRmmvd2Lx;_!8|4>]Zt"2mlf{[d0 8U0>oj\Rz3Oi4|,=U{$Wpl,3kH ,v+ncm PoV5xCqH[0b1YWVo:am9IwTtl|/?.S[O Âb:r2(ehQR'k;seY-Q""i/f[nj#, g7`P{&c솟O ͹,6~GȆ`FۧKQDMIl*V4UƩ ӗcZJE}%5KG {`_SGO4ˏt5||-3Vw'V7MZrV7)˚co +ig.}.q[ۑۑ;c`8Ѩǂۿ~XbBIm~.Y8[]7X^2sglcoAğ ֗(| |e#X`POin&a8?ZT񍨲Qh*p-*rt(Pf< `x Ƅ-G~ | ?njȩ1^4byyej#??~M%$iIX~xS6B}g'%Z o?7/?;v%ڵyI%}IyΕ V1ʁo6Ob/;^O7wTTWMzlHr *ކ10;H (vcLL&v5&Į=I=>k=yVX8^>gjeȇ;n}7Oޛ:2pq{~qۯ/81aS in;:ˁvl+(z؀<^J15gZ`j'16}M$Ccߊ۬󢆓uo50 m<ږ EDl~e{+_MMq!誣x^SaVv\1w9\Q[U:L(ʲtT@Kpɀ P Gxx $$RR:\Al, ~ްԎx7hnz_?u:6_ukMݧA9AUHK_xekvqzXLz2bN|SSќѫcF&c˖O55~-[L;-vN67'y$iod\/qHɛayBMPΚ Oؑ7&oG4W< PNIbLMB|IX3#e|E!4AOPRZOX6^i2 ~{37ytuϥ᱋-n;z)|vQy [`s U8ʘISC 眳HlԂ5K^uE3_}LĎ١&jOv\=ݹ|G7xδy7oӎ9t}_#_?^]=yľ0j} ,eXSexˆh Z p%U[CL*܃$ҊY&ɣX>h?I-;tmotL7UTZƣ]߲>ena9[&Aq8O^7Gꇌ.͟ɤ9QMfX љtXOErA@  J4g0PNN@a/F&Z]#gvZh%vFm mVpB +_f/_ w;"56Al㰇8ӉovDXm,XU쵹'>5Xg%65XC3y`֢該(y&T" ]Qt02zMmtK*7R 9jm"8U֜i>V\\u=іu&-0NT}EccČbK[8iW6}<:}[}ƘڭeZe^P-/OSkY*qP_.Q)lVW|ΤwCorhesɵS/J9|l|GhiNuV'F,+{DM1d*5(i[UZqH,ݾUojG1OdK"@x IږP^/(l>1hd_f;/z?>{o0>q=d 7C~EGj.;o_{O~gTv2>i9ܩW>8{_ooW wE]w푠#d-wʏ 2ڏm]׎˶۸/g:-$ZQ@xkΗ/;{e5>x.0tޘ3X^|7PuYХEtA4(yְ!p,&-t MXB%>_hA+6M _D`+8펡=1ZAܱ0[ܔo0ҧ6/D'jJyT\͖g"w>%㺽=QɼhzW`y#ɽ7J#ڰVjm3Klvk4HnA34i=C1(gG[R◐zMhZiSQk FuU>B\X̦pX[k>#rmԏS!ȱiu >ŭ>KTxLlk_W*O.޺|&WE[{)K eĥeQHAm۬li5E1~'~p݉JZu\uF[.s~HE>bb[mօZX734a@OPHGA%F1(ʃ 6RfK:!QB cFETDc h&WYQW;E§zNO>ػDž];ZYWgٳh;I&8`zdm\JxEjAM^U=Ŷ >{|hNUuO%-Ђ'r+z9-@Ct!B+&3MgꨈȅVU3-@nF^(źb9ogTi,|RqwzɉE@'!h]klCiaMcV:bxB-ʧI/J(5SE&q0YggUZ@<"7CY}Zd_Jal`YBx7YQ!R#tucJ~@#'/to Qm>k,z=N}׿:޴ٯ?%ѡپ˵?W,5dqOn= L*2IJo-eֺ֢b0fa-]ss N6(ԥjMXϻW}@woǐW_jL3($f7FGKT+ UJGS=HTaLMP5*I|R c4.JK](ȷg5#`*<ŇKi Дt[RtkUM;۱y<5orp…3Gg*Zk$*Ajߖ~[tct:훓)Vʚk+wް$~hnuMW =ƒe <^/f=!cǍmC7vrJ&-tVII|/PQ_U$bMMR ˁŐ9P<2%i0KHvWo01 |+ [b,ILW~6@\ig+jvI|N|zm]їйots9}T-#bbFZJN\ֹcߏzxx}v+]] EgZҋh! UbL`HZbPc!,Ah&J;Eu@S&v8>40Ҳ[qtU`o}:]VŻ'o?ſ><7znlhfn޶n5aiLTAX'#44 M kNz%՟T.|r>X.o-h,P=io[tfCwZL^sUU´)\Ǖ)&;tõb7泄![ƿ=g~q0AG{on8:Z" F&w-膛a@kd LAU ,1P:RP!0Y]wn|{[wz@Z zeEhc{LUi u~w;^w~߯56:=77[0پWa* CTḸALMi S-riFT|$SVe][2c{y NY~y= }vNW.u6k_|`7^ (*Dzǽ?/[;JSa.b {h"1 r=UG '7y\P _fXZ~X0K6!f6JS{c}j|/_+pLMw!+uwekx\іk-L%Iޥ~6?t;í?ow?w}s]LT++ c[0 f562ˡaOkXi|jAtrQh:u4IY$T+SW Slŕ$ nkVz#oԔQaD,jUF%]]/?- hȊi T֋t22[5>A⒧<@ ̎$K߭^ROpr"/h3>PWϊ*NͩIWUUk0H B!a Ad!!8~$՞9㗳_ Jhx"aTHx5@ hRhi-??vޱqÕ'K>_W|^i v60ꄳiwuEnSmg~wpю>cm谂Iע҂aT PPJ1PAǰFөA92n8Vsftc yUQ1e"K#UUN'h̚Ia8:B"lV%u^ec62:he0YVe]~ot^0Aٖ@oZq-d<&BTV+*Ɗ1 !?VKFr]O^YZ^!+H=6I;;miCs*EH1-hYt$3`Tи'iHJֲƷ[ThJ 7R^'O)I4qDaAT&InEErs[pw?lP|ۄk3ʕ\~[C)oKWZM;*\^wۡO/>xFvݙ{xhMoF0 H&ZeCh UvT :44Q20'^: ^`P],اMtfurյqK<׮?ڃW|rOo{o`٩Gf/EvtԂP & Seȉ`h` "#)th,3eojʽ!z)pW=9*2/G}iaqW*7o9"T 3;_~}~+-)o[};d?y:GS)Tj!zh&0"w364xZBD|a9(,v:goGUı9%Q=鑰557yqD|\$*ٷ#mڤͥ@}AJpyy7ɧ7.mxؐ YJ%VǚD`i0ٜTQHfO!D221N0YG!'QHi 9!MnEY즞5F|h" >]ojR}:=>㗆 >?xUIA`'?=u_Zc+?dPb2 jc޳]sn|۠PQgfM*RI*תҪ3}Hҙsmu ȊqvH5ۼ7nmXƲڵGYN,K-rg|{B62E:\MQdaB"Щts.لoNU.IX0L%f:!KH<3d5TVg kB/APBUcj qjE2!k,{~ǹGv㓻M0E~LJvy:}dُO^rn3#.!?|~rȈjjWߟpz'g,㯍?{";ذӈhS͠%CB %@N(gBԣ%,>QⒹyÎ43݇;7;u G뒝-Ky)Ag7M1O}|珿<þ cէfM=GtHmfT*E@SeX$t ĸTZF2Qȳ cu)aױU8C*Գٍร/06>Z7aftw=w&ʦdior$om.ά>~VkoZG!k ۡ fGac`q,ôl^Z,fZCSa4ySB\* r".81 $_%tܞ6sq>̋HN/J n^l5R)XJ#:@9aBQjx! F7<GdO -crQ*[ŗk,l+z!DR Jm;_}e髭̷^2}xb5g,]?h?s 4]qa}K(^-qUѵ[]u\-﬍XǸq\bXx!} (bX2坈ܤEb%2>J[V- 9U`WlհV5z=VPɬ_ڜP%,q湦~%V&9JJ󕺂 5"+PHGl @DvL% !]ÀJ嘘FYr6( f O'< Q*&UgMfk4Nmy|z/cǻnKMuw9{_娸޸.l:・OݹmQ+dA CeW2 /0 (" PANJ?yoh3%52=g&Ϩd75zeׅdpG}ݧ˕k8ym`/w"3ZW$WmMg1LQP `g1t,Ax:o³L@)[ms 'v#Xx7Qw!' >Œ,<M}X;[~ (9fb92b75S1͕ @ QP"EE?!,“ ØIxe"BSP!y0Z+ $!o'|䀛.oז&;d Ϟn߾Mɼ,.՘[qR꜁L+rkXOA4 kH @ݠ%gTAL" >e&T= Hլ`v~Yenؽ.1@+x6`qp+"U4&m=ccȔ26?_otmޣ Qn2gBbUc#SM>.:\IŹUu;xIoJGuL&R-lmhd1%medahɾuVae\/%1-CEcJ!!K&%Q!fbb)>%*t|R))_S]5L+UFt5$@4FODi\1[XR͌Jjʛ>a SX1oItkOڰM"זlKnv2M^x|XE,'m3&5߽KOL*ݘ )Y4c 1qMZa9|2 r">@!Q,dj|)M&x6s%FxwRCQ|]z>kS_R*U] m'JJZt2)|(ĥB2Cj4=zF8 d2Te07ݹt 颺44ٙAWl=GW}O_SoCӡma+֠ڸby{\= 1X/#Y וiX!3kmv}j˫Nsw{Wm0fcb]>%}-h$>>νc4d &/Q,VeN#_14wwZ*-E50#'rXה JN`ԄB)BI_k )u=B5`dQ>/'"Mx?! 4F,Bz@nAQ%7;y&+.MߛہΎ]{?<OOޞ33x<6o>p{]Yn\ L"FE"6|uS]ǒ dsG""xI*A ðHA4 DS!$@"̵U`瑒T^zTXKrI3y\wIm n{=U,vBTS(J-6bmzpVOٺo FTJ<*+J4h -RP*_(# 9DgaPS2 p dJ͓9yٶKj.SKG·$;}RHb6Vx [3%[ )9A:dlخn@\})#?DPI*XB1LxmJ5FZ]%=3}5*/W/89M|ַ;/gͭx~dت9 w[:-t\Wb=K[Wi3 YC׬ŗ6E]3)sky%Q]I.J*p(Vwկ^!0Qv9FF FF{LMc.mkDm^1AeYTY†00 Q * > L<+|yXyVK(!x$ Rb s_a);M!UA#Q3%,f*jd7><~opۃ}꣎}{>q7v#|7oL_~Dsǝ?L??h`O4rva{?K Zw<{u9Y=RFBId 6y0{1{*b$,$DQkșT-h*"1b8ºcsy>mkxj:)ׅr״Q%٪:x"7sN'DpRUYqAT㠂qٟS;΁j3Pd@ zyNHY0Ugaаp,;,D+84m \*eTM]!Ez]bHߪk6 *EREd3+_+; T0HD I3,@#,+UR(! aդf#eL.aܖwoA×`FqnFoaY{Lj S#O;]ZܻE׭Caɵ|M-lI%"!WTJ O/fZA\˷1޵߭ѳDb=I%axBTa]4Æ ق$Ut N.@͵V8YyO١F>}z`} - J0LBeon6u9}w[s̾5T0˚Ԏ_:n|~k{~G`DS  PP s R# ̌ F1c!r%NΠe93>=6|JS ʪzNWQQؾ}Z֪o5YSo*J f\.a >Y}?Sq8*%4 0)\}B:/9DKJ*B@ X-[C3rcZ-n{թt4djgd<̋/QF[ۻ6Ba$i ETQV4 X 3a*Y'I)h0q^pE|ÅOlYHؤhMWUCwBPo" 2;8'I0*(+JFXAM\qK'(9\}" EV y V(muP`/' k6zфqR kSKEe9l\)V*T UNBg sy%\VpwˆڀlNmikM{;ytKmZ5 ^-Jk/ cN-p \NK2xEeD^OEX1'+2RRj&Pܿ &d@"*ȧWH٠tB4fёI* Ykn* AI4 naʼҝ}W:{gys?x4;}g~}{zSnE< M7 .9Ql³ )yHD$چ7y "Je(qڑުytu'bEs?e]~ewߙwЎ/v7ol%7L1P0H" 1t@ wl*YL-40HTS2j3!H)YE'E_ovCٯ )=V{zk׬jk>kZb;ֱf֦F0ƙr:bY1Ul:WfJ% "~/T=U.e Oz9ٺyɸeLdjieE-D9HDP z21$%$'#fƉN5Oxx6m%K"4C`)2"$QTJ&\JKIT.=Qj,,?4yyjw^½;&wݿj;d%Λyy"4HVlSK B$ğ&TP:Ax Eg"J, f&ْcK"L"jCw:GPSttǡ;z jVw9k{x9>r';k%*T cJPYR3&иda; $ L$F>J0UF2eL!){Y>h"Yf 0ֱ=*GC4g+gg7>𬾓s%н^>XM(~f_qݹvBl)i`j49L6`90(d >S-GEa 7HSD <1¶|MIKO. _ټ5&1L5]˦L 0_]%\,b"^T1YH9h 5Ԕ F d1,R"y=3Ϻdž'w Ȑ`4 (%ژp)$tV_-NΛɊuvANxCGTˏկ{yq+eYaNZ*uID}aG#j<^w||nx 4f1ӚfvWxqwF rm%D)-H2Sj|l۱址uj}Ҵ&+h7&79ex޵^aXdzrc)-UԨT" 6WY+Dr I1E,@)15%"bL%!Dt"#"GEXG%%=AxB? o89 H_T!Eϖn̢(@ 4”L9Х0,b7FDzغ}\~ױC_N~bщF{X{@GQv㛞;}H!! fKel6B {w&*(*`W,Q 6l n_{L&ws~}sYcLuIa*5dAw̰8{uhH RD{6([\GmŹھ#8tힽ׷޹꽏>v Gw5%$;PAGoByHHZrC *g5l Nvyte#,?ɓxE1:F9uDІs32,¨YU޲2ncÚ7X׬^U4}i#-S\3,2ڥDaâ^-@V4{VQ-jyB ^d'#JWA9[#Іed$ (@x?^wk! 6ZyHOFJ+j (QJg[@<+[C Yy*"'68Zki4~ys-ߵrNK&wZ}S-H+EYqQ5-HiL|WK^NBVGKQh ;BA,Sb2;U,ɭ޿サw}[׼aS^>oy$]ѯ{It(&@fO7Maln&b=d!d@X3 E1VajCzZi+4.n5av`TY#S]m K{=1qsPໆ4Nm7פ&ֆ*MRUE62V$a+oG'cP6!VI#ZBvI,q2+-P,{hՐ[KڲQe3;5:lKkKZJ8˦45&V+ILT%],Y dhLqy&S%o6Cx0pS!fB(V6viCO.Kjbl֑M['߭-|yO#bUp]S]M)MYKBWD,UP~܆&vSgSYgG|AsgV+7?RJpa S\z:E[{ s?vRe=4dvka~~~҆ڦ0sRm'iܚ:R5D`dlcJ Xz|\ǐV,޵V_' wNj7# VEG=!d.E`YiU ch#+3NH36u@ʠΤĴؔ!JR Խ dlKTAP25v-AeQg \APq+9(l%7R &9nt5jΛ6fɴՍ^:P2HPzXF@ZV_gp0JPS{M ;<_}8jh3)KE`MpHTdT9)6DL nLэ>m!SqZȬ$uAbD p`!( MUzmۃ=C_f r$R͞kfZFjgdfF픲 3'pǸa~SRGd+l-vMmQ:F`T)[)UD;N]jAI7ad~66btyv䴺ic-{MsF%<`͟R!]G/Q*^3US W{w Wy_yK kmxҮajm1 k0LzzFRFU)2+H v\`c045Q<@P%Vӎ^n' iR^aVjWуղ.).WF-2ԖekdIɨ`FF")EQeznV2$GAUd[J%*dD&SpMLW-@_eT%-Ӓ*wJ`IBjRE"졪 9cv)BK* אSBJe{g9RjFjgN@{iDKYdRiM; 6|0&5eQvM.lfō45J^2 A$|z^(U&"RuJS.˶ؖ.)iVvŢ֩ê'Ltk0=V\pe sk'NWMki̛.*\fͯ6ϯl1dҙ#7%Y[;_9l{q9_}?-w[ݦMgJu"CI%?*)b^,7Ԗ%R2vL f/IRa#D_jʩj`dG8uEHR'ʕ>4?o\t:AZ n;e$AYƽx:C}~ 5UUYE8VI8S)!a"4+L2ֆ5fP$*hE/f TՍOyg*z'2 L"D$a.Bފ)Ld7R BH6P8/ 8pd+)>R_)y=Ko;{сd5d!a5(H[%kQ;B-LjJ˹|.x.! jĤQD$*Jm(huޕ Mhÿo;L% :TBY3bR;B6v@xyH#p{B"*)kVRRU‡!6D AvF @vB|ʦ;b;dB(]J́_DU!f<@ WU-uLӘgL\vYT]\n_P3`fF51}"2g*f fȟYR0wV~rJ]3FuV̝jv,oUR*7Gg.f.r 7 l./&HwhjmW1;dP[54;l;umfZJkYi?!`elk}7iO0i \Q70x`sll HX;dy@dm Q}+D IH`l6TW/ׯL+ldzŻrkxRGepI$QqrGZDIi iz=nRHHKY~^9 !W݁ϋ Ƙ%T9F(y%"0AyJpd:IbvERY +u0lAjd[*8Bw#^[u4r pBTM5TNZ^E8$0t$bTT0*oHZErY(pD6ĴI=BzW[8P 'SD?u BU?nQ1m*QXJϒr _E+*P0~OѼA,kX۸ Mo)"-$,j@{7P]J!,ԡml,껢sO`.~&aYEW7NUq`hz !ئԷpuM q 6K._{O}5Y20rYWtjm{:;6eSSfVɼKan!+!#_Rx~,SfiNS˸1MW?UZVˆղ5Jwāj.bd2~]^;mP e,cXΘqk[~^BO[<jVK)ߨzƺ7qIU28nr1% 9VbŔ8]GZ/SQjbjqV0˒ftHIn(zS@YVt4 *PZFeR ZEؔlԳ $2YN8R%#ephG DT#.ʔr ЌD_5ԸEU1x n$HڌY9.-gh@#em yBQ%Rtj?픢+ˆ*\JeJj+g h[r[o#CZ k!M Db؁QU@a("(ѫk8d*6D֨Pc+{h1<UNoD@A)Z ~ Y`P"H],ϔهխ]곝9{/x{0|~1 B|w>ws+4wƮ][P>tvṲĩ9dj>6![i' ND5e*3Vvpkp!h]RrJO)ݤCӆl˦Vv4l9s\IMPѴP(T53H RBE(dlexX:gԨ{Y5/ʓH zgO<mA̓&@{BUU N)NI %"PC E P;2N(*IRCQ:/8O{By>9[1!For`RԲ\:%c mMh$gk35xdF$@"mEaFd E^@f!7ޜjo)[ pZ4mAY%bh$p8'Z, Hp¸+d`Bb 5eBaZx)!FehB /c&OІ%@+; [A98PUӅNAcMbSJʨ FNxu!̥7@Wk9B?-gR) I"`20!EHvrVH\*5̌&J$r oϸ 5(P8*4:` ]ߴrmK"^ 2[Hjg|VD-wg@O9jE{A+ Z?~Pue  2URY^EzuM(#сAP#' gI+[yf//6Gwo('3((0_@۷ 2!T+r'\ 988"ԐJ'*=D]%)X[ ZZ !Ex%6$ek.׌y#GoԔ /Ӎq.`-8PPR3a[tt5CNWOc#F.-)efc/n) C-2|acui#ӈN&KRZH\~\id΀а>; e"F&7giBa#Z]%XTF,1%U-o 3P4cbz5{.Ы*$N%YIYe@Q7Fn\coW wA[8u{wqb61.lgv׷WqWO]Դu -'RO/Jn-#O3z趪M%N#++0n355nj͐;k=&֢H4r e:r8Q7Ff >>,9XBx/{b F[ʟ bq]~w/p?KDDh| {Iv؁ 1"K J޽s}+R࿔xwQ 5(wB[ԏ^ >MT>/_}ko~޹!LBRbP84RlQU\R~p>M1Q1Hi/8 El?/DiS䊅Y,]L`b~NFZ۩[ͅDiksO#QrT ǎ}qSwWܟ~=#?y\É O lu'%6pᦂ|h e{gxQOL7T" TwEBm~;ݕ_~s+wv- KA"^_VEl[bDwXx^n\7 K&%*/+Dera,2*Oo'0ACHa v" -A_)!2; |p`TcUtt4\|ey}|qIV¢]fZ\[=$sLhuV.X (|wa}k 3޹=qbmhM!*/dG37}G0t誮akzӣ~l(ֶ;{ɲCUJtG"e0oVx=ս}K]vhl}_1v/j^z놆4UV66n|w+X6c͚w|}B::}x)a 7#3kRXkהn)WfϬ]]OQpY8TZ|l^}كwN@~>[cfU2hf4NOms檋""y&+$2K!к 81瘤,2{5D,cF tMDx/7!rxoRH Zxx雧?GKaE=֑'H.55^>w2o՚};~DS{?vOyHn&Aɷ^ wtE[ޱy;Po8][:]M2Jyݻ9rfҝ~4i͘ѫ=c=']Z0o_côK_m{|Ŋ.+kt8F\޺; ۆ |޲M|=j>IApxs͑6Bd$'?ӯ[r8}O_ ʯZr߇L|/mU}:͛7oǟ\{6nOVcXJZNEo/~ܽ>=vj!?i|;Cuy w}{{8^8aŪ{5m|vW>ç?p&MvnaNܹs}zѽqóÆlY{#z P؛a!9›HZK1ԆZ ឴:).0Q!M˃JB2HmdVߙW? V%-˄!W, Kp(6-W6vDw\~ny]>|iW˺Alo S3loÖ|~3ݣ$$p|^vӉ?WS{W~EK]s'~3909ɲd=V&ce}uI<ZB]]5ڝ ;Wqj&e2'1ott\6møq?ڍ[( Yɧ|Z/ePkU;{GމN;#C/tg?yS.Ϙ&='2tJs~Xvϥ/E鋾jMPSյ,Wp6Bqջ8gp}}S?eEn+Hpb!*v4˜2@u'"ށK?jii !ԢG"FBRҩD 9fQ:.YƊMJYDXV5e]%x|899[&Lnj?7?I|⏔j4/uOeͱyGn"g tL{ C[vW++U!6UkhLraYn-!rĨDUdRz[֍=E4HvaF**E%^so fZ_ggWw>xNcqs=g^+3 OA[ܵ7>8ӊ}r$n_Lr Lڛ=S.u ^id\Ro:mשuS\5yŢH=aa9[>{_TX@nݾmP7h^\j {#O|3gN/_5{X)E¿4--JFE7Zg$G=zZHm{W Ʉg9s+ xzr0#ŏϼ}ٗ{G[||¥VFN{;P{ыc}Hbi2Sy}(\rǏٱ㏯/]4Վ/T^rB~ɭ) b"=wAy._k4z̘)?6i-/E)2^<#EΣ$z\4`V,Lb^ 6(dza^>n&HzЌKm&f+nPVe5: 8cc]/&ܧKP4fxQ] X_|+6d{2j\{{ZY!7; ]dDED'ȕZt9KvhqDhe&ϴwBֳ]vo`:IB o?ο7NuX(])M ӀBLF`dܗǞ}=#3/TXΜXvP\=?6%bG!` o;oyma7E(,H\~q|ɳpcO6a|a>4{֭>8sW݋>}nmO? n0KæWFϛ1}%3c$mHͫwvF [UL-7_Au3OEG|wL|{{#Eۮ_s-l{5- hV' (1aZ>(0/9u,BzCWvjsۑ nϞt6~ܵkWW;핝?_sϛ%= Z|ts O Y?jlt?v߳KW ɘPUXBA- ?HpBEOP%cD "VUr o KyL>%Y Y%*bZ1kQ@^L[u-.Ul PߓsAQգ F]ʝש5fqc:oHý㹹K^IW`qzˈZ5 yO/6wt/RV)QpB 싁ʭA[ܻ`&wV AۇΗi_6/J=$ZjS{a˖Q4KMI$%aOW.Pb]DX OTH5܀wcqw~9O.;x^ܹ((ߐ/-860d1yEB\J@=~o pA 43flzΟ800dٯVػ7-yc>p8}oJTׅqc6\{yvnȰ*UơC7~ ]SdAe@=o#7/~Olj\/*1=ϚAKDh]/T<ٜ9<ѡ&tŚ~>xOkg~zإ9&(?~{k_/\p'5r(?cƖSёaZT~ՊGN >N5"~7B&@P!=T@ }$Xwi B0Bo,URl[Z-n=VϋnXR>v{JMdgˬ!#nV6pEƐMMFY 6Z=ȶ[ g.- eWTI!P !^U]/z1%U,BLϭz aZpp烞"yxH<3kޕN$CO4R1!·Dt7 d\#gSBAd@T@x I"J$DGEx^DͶ0jː! 9bq! L\EL`$6~@1?0'6ڡVI.)A@ Ğ!D@ȥ9,Ryg|5"LK`PTAD럣djXHT P! 2& KQzpЇσ35AUio<.L9w, +imL(k SDQpRQ*\brPq›PmA_`)`,^E:! M 5!J}DLX҅(<7>Jl^PrTi@&D_N"ck!xIԣF)"f "APIѣjB0&17FD8*Ӵ*U,ƓUE|Qb/N'2h\,I,Q+}*T~}laj=70 6FSdIjrSJ P*EQ@<(0-') szs %,aKld^ÄfYiͩ K`;E6*tqx†͓O5vxÖkw2[3$neSSu 'MX࿟㻙C-%J52lj _G*G+UP:OK?S_̈7K.=j̆M+'{ _ނ\4,"~8-0KV"xOW0 I^P2ynP,&N {70 28H'D"|{=n{31x@'/ʤ8A!q  ) @'#*C~4LP$e@2 8S"̂iq /'8X)Y&eB!`@OKL R5ⴌ+TbR@sD1yb,??MkA%yA~9 ;pU.,{ dИvDPo/'\MbB(}zۥ>_{J[y#vAj II+H25T l)QcL\@ϑR_Hx%L y)%(J΃\=A77+2JrAvtL.y] @  G@@j@@:x8M࿀<^cX b,MB As ??/]-3G/' |aP!@0@/VI͌Ċ }B}s}2 8A.`JV9TS#<,nϴ;&yA$7Ǒ(CLF |@YݶԙxQi skڦmgִ +)#kUgW/+\^ض[  TUbI@xJ, q8!!TJf OiR0f32" (J1W ̗1`nP&)'yLЄat,^|6LP ACt) \5\e &ZLPGXB GVԨ2NSLt" T(GHzG=gMY#w@b'@PFJAZ%[p!К WHrJ[>}8$PoDlO^Rȳr$u>@KBH(A s3Gt(hz [X=X#,)V\s=R.QhU?x\nS J 2TO:dR05-PKX s-l)QY<ǟX~@\?jPp*`d@!8  D^?/OpEP I*YM!Wf(ř]0 gMoSnMrä%zl4rswvVnY~9'6@Jkv&6SP;pb`'(8|؏3ż</NJ:i$!Lgs8q$=>e~:|'PTJNP47R JVD` Z,sR*F ǯǷO'Ba!/" DBWO_mi9(8>~8?N /8!?V.ODyIaSO| &s8Lϗ)* \ћ~o/i3z$WrŒ,~@`2/RL 3WBnVo aۺm r74ݩJ۔CC8,=^Ts@xn0DD:/(,;e2w|QC( U0,$fc',MҐi8kek?H'i|A?B9<< (.3IeS_ra2d~Z 7.Yx(Fjv 341AY r'wˆcR81>$!1 R||3TJ< %w _ꩂzFXbQ\tBqٞHh18!qjL!NX;]$@Bow-M%n煖(+Q(7 83Zw.nX2+OڌcIR&eQ~X޺HSv=rĚP;MU\5{ɢ6˸{~%#8}-C:W(E[c5vaE~8*>Qi Ȕ us*ƌ^=fUTN2tH liSkIN1wvβZ;87_kӪfLk99U"Q |սt鞆I۶=] Y9|CJGtM6|ɠ"MFC^44 'uP9m\{cúWfԄ[o4cc*ƌ㦘G77kig' r <;443%/]pr̙/Q1C˔)k\~Dv~]mjs5$DoNcKPpk!y`^B9?VLpBF۸dAo`Fv^xҲ18qj$GQno Ҳotؤi6tȍ!cVVLdZn媝2h~׮7l8(&HO%>,**ï|{Y޵Sn5uƶi?:_q׈E׀ˆx _멿;Dd(AbzIPTX h">/YTD d>LM-r,NZ(ppws9uڈEٕ)9 TpyDO(A /%4jjz i)33f El7O{#-PP}{YZ)ƈ^9!<qI*Pt(w"5"2<;W=xO^NB3* ;brV5n`hB,哗O{xlݶ_L_? ^A:vܢs?{;v}kwm;4w3o_ɵU>^k(|xCG{[2<FDς@7z[xC ;}{/[==W\aWk&r877>3wO?_koػ`擯r +߻:lNDK|s|ڛT n4鋯'^zW>{А05^oF+ 7{?ҷnei];ذ}=uֺ?>{lÈ1 8ucϽ|~ԄwǞd֜} )y~ÇxV;sSӤzk':R-W_wXkG/sb: ʼ7n΅Gf54O^?\hk>sÏxßV{D+A/葿= ~L%4V* DL&%LLI4$jT^ L)eҼ4cMcwGd}hbadٱK ̓%ָB6<$3XI!+,ey"$(YiqB\'QcfASyfyhNJGi^fpHWnw}h ` l\0 I/ TPF[EѼ 1(E7Ƈ;;xUxa=w*ŒὔfȅdZ^((X«~xj\R?稸[vħ|=O_m0UzceQeږ{= :n⬶Q|z%#K[8Ⱦ~}\Y[YR]3GE@P([V}I'K0[bg{7rԥs|c/6{ Mx{>a6t]p(;g߿듧]S;}^-8x{Ց'Oq1w>!z3.3.멷%D_@k>yw>꟬1MJ>Hs_;~&2*o<|9Pͷ.DtZ,?{1`'+&75N?~# Zm]N 2j'n1ﭯjnnE\W϶UR*˃3٪+'j_䪝>siem hiKA $;5jU#DZ ՘LҤ? |?;JbazlN3;3d؅eaia9( (KV$ 0\~{ѫw{Ϟ>UU]55^xg :M<&\OyC:S9}c˒,vW70 Y®ђRHlO\?|⊒u_q0yμ~ qm;S2yUMo93|Cg_,_­W_>+z;:{2&)517ozYsPr>53!#~Z. 3 &R 7GlxEw8sݛr3k6wy߹4s2J?; Jڽu=}B׾y㋟^ QW?/>uEn^?}!"y=0vRZg9f ]T8yH&sX$-v t6,#ӝ{ }FO,| ݪ~hhpfRr߿aL\26`pȅ_ym ~t+ّcnڼS5<|YY%0n.E1\~dbmt߾m;OyՑZ&O|̅b4*t]{e9;8wg79|k1)[8s5\qϿ};{ؾ`P s}դ*_ymJk8tFWB N.b|qY )S5ԒVزP30*ve./5t>EIVHpV[;M׿x:`ٽMQ[yy99ٺH<>uSB[Rwg:D\̙AicӦ 0oV#QTihc'U5|s 1 <-3 /d3"˒K}`!//]R^qO(9;5k׿ڹ`6b,dձ.8yՕUh3nv|}jzqHu߭g[w;׾3:xm(i_Imޘ&:zP/N4B-{6vLA9x3XSȪ8zf^i3o^/>un/.񕝯n׮cw;52h>*ڽ/)_dͭR;wa漅L5sΊ5DG7;Σ'eX(ypa_od44̙Ὧp L.ނnV[W7eg/l]?}ޭ;2 ygNx7ͮonOr6->kϬ~ƝμF#\{ޜH) \+f<=Yd6[џ>h((^{Kh h#g}G{c){#ߙ_ҶGO]ykT$񏆙apq󃯶~L0o}o#2 @97?:3{ 6*{OElx-]7yr~#zi˿khR9iv'_4xO7M'v?Ĭ' ɒOoK!`N@NT%gK1`thsicm҉F^42ΩӦ1t*!NSFMY7fbhїԨ3H_`t]OmedN^N"EqL-)Z!}cRRNJc(Y^"KVؾvڹ4OQ&{lUjת['L\ָL+75crX^|i kFAKL\- riͥRǻ{9[Fkڿw2[AM5}?op::X&ϭ}M.\x~ҧ>)W|su_~PX#>Νgo^zvoskS[.g;47DB[Cz)@c1atCK'yd;xmӫoSJ7v_:{+_bL_s>,j5a-Ϯz>3w?~Uy;_5+TX[}_/YRJz^oEO݆VJUjb}eX6_|xg&߼ MS?{!9Gnm?a3ie>ࡋl8ֵG.xSgnw/~;~&_tkw=z= U;|{9{k͚Gդ{:N)L^>pO:&w~!E9HS ECb+y>!7&qDS0Sj8Нf&S;u֐ƛ0OIm`:բI9+7iϞ3ZEQѭ_޹GoWkeMlRb̮&-jժ&/J}AuFׇUMtI*'(,zo@jfdZ-#T\q;w_BQ!t1=%KC:FM97][Ԧ.MN~})j4i&WY jhzl~n?tfÇ^ڣ[}S2]y.K3fEJNjSU9%-m~~7"1$,g>gi2*<-r]MdAAF,MHig@n-Vq#4o FLjbՓB Hr"y2 3hNNHyXwl)28F\hly6d5!'㖭u\::LӝbrltIe\<%_겭Ls^-JŌ9דz҅KIDCu2L&L*,ERѺd~H4ڵv <|ǟ54o5RͩP#GCRS;A/['&ɔ`k:]_Ǐ:|b:$8(dcү_oy~)f]dS=dmx}`MQٳ笪~$FihnQ.?a@r.2XcuXATٔJE4LU)*b4"̹کeTvX^huDZ/jqZe(dTRr/0 dTĚZm !.Kˢ[ɐVkq~tɀC9sϥ(]Oj( aȨ:eRp)2"4Ԫ8<FdHZa-BԪ)*[)KϦ1$BHRy&xyg#Ơ?X0Vc>:\b8Ѧcfȴ3(OBsbtV7k& @?7IB [$.I,dd"RXyfCcůeU,-|Y_i"u*Oga&^ ik iu.jt,Fnf%Isb6eBFPF]Lp̙h<\P|sZcEժ񲕘\=2G%,EәF+>}x1 Ջ4PZMB 3tr\Ѐ7AM' զ`8Qr/BKK5Jक.Ok9)U!_e@|Lْk2/k2yєI`e pa]I O5)Ib!ɉg.JkW+ %D uV a*b|NQ@s\Meb9sg(@gB֘e,"Y,hO6;!6:po ),<P'[,cE @ !5 `?`ER2Ͻs̿y@ wZ44jҧ7n_&%18U۷l &T^Wb̘%<*ܹw~mXYuƈo͸K?kߡ,rs  K‹sDŽ7q>%mu?ٜzxa]Q@Mxɚ?,(^,-FR,,bWi4$: GE<(7wk>ȏm6 Q=RF6/\JgY&4>JC-\bYBqJxyB6?b3a@:) albt+ƮBo1-u2=ȕCu̳ŘSbF8 !jOf! vhfF$,$>8å(DB (ͽXs ^zib՜8` k"pN<,mFdz5'"ȁ:Y+`3G*"nqZ <-iN6 W a:UvBB8 'huU;ҷǓ* 9W -¤!Ip.q=j2Sm$ÓB[3J:+C/iR `ztTZ *%xt4' u}.h#hy6K )dht-j[^Vg49is ju&^+zIzS@ѐIdXl bI>8*=t3 x}co[!ΒX] *Ӣnj; 9 d;g#OƄnU{LpΉ๨3g3mA*u04I‹֭=ЫgQ h»`?EY`Tvݎ]DFe93Z.Xٕ$ >x2Զ#Dӑ o፿$+# Ws@u\ DIC6tZ;y4#qC2JڛO5!4 NI&˿GI &4◑F#5L47p&O y:1Ix暙,.gZK3lAadyu&NDtlFf7?[J1Ӏhۮ8bR*Z0Kj]Mw)&}" o֧t0Bd'10ybU0IIҺ Sxh|]52m$K¨=>9A||RAxܫG_UiayAukN~цOVer?9? k73t[[=)$$+&ZjR饥}Qzy)6дЬ;Otą0 0T 1R! MdMWC:Yݚ wRA)HwkN/"Ԋ0o|8BH @z-bcoq$QBQ+s[;r]LH(!vБ_殷Fv:{{L̜:m3n;`7 YJfmպ w|c\sǛ&/ vlv}ZMՏE>$XdPD1<ӑΝy gztxa&p^4}Lm+ oV\7iѢV-ZTԝ,V`0 BeeUC樬{S er) t&<\1ވ'ɚtgZ/}r/\?g mZ/\׊K;H;2bgon~7\s^hM豳6msʧknᧆZ0h\ݔw~4gM(Yo7͞|ђ>⛲w Q g_{qg߽QgO†W\]g1gFK›'MzÆIM%ˆ|٥{1fo|y37ֽ{%:9v mö]{?bY_ѹߏ +VoԱ׶n=aˀJW+bLMi\.H8xJE={L:s QCn^ᙦR0tJ>|Äl؞=fͪ} rsԯ\==<\!2{v Ǐ "즦v9$+9E*M16Ģ9V\^u#o&?j!^:NhmDRR>~ʿUFg|K}C6](ymލw}p˅W#+'n `CEEK\|SbmA|toނg+:Whs޷v>F3nHiNP&h=nJu:r}v#\Zޗ?({*2p JP7?A8+>pՍ. 7>dcnaԘi<ꥃ}|].-oݥ{n--|tCQM{onϖE]&䟔 l𴴶 vaam``WkB 81d۵t `/ @Xr/hvv9-Jwdh|)ʚߥkz}F߭~q KQܬnQ,; ٸsɚGf2&HpI]cHܹOUxx}7m-n?>5C[v $ &]QU{5xظQco}(>7n 0;M_0bO?vSg{B0txݬ9 #A W۳d.}PY5n1c޻xs~dOO>iĨYsꛆYsV㻆R24s,FkGm޲bd1e|8Sso9fN|sU ;|#2\Gr#՟;8Fq w6N|c'(oJK1p u).D xzo _`FcrCݼA 2"pp{̘E)_c LΙծYz-((}\ajޖ >" iNvdMdiKzdl5pa~~9<ډ~1%%]˽&Lxf+ymׯ]O$A[qÇCyGG/޴toPkw v#Gn\p5^q2$eMI]豫Ucx}PNVן^I/_±׎jMQnv-vw"7FUA!! /x56}/^>0~SM75jիu$Fԩ?tڴikUg,vYP3g{?ʅi51܈ UJhRm?{#WfKܬ=}J~)PxwMm!FS=#WnZk48b`Jpc N[1{sݺ}cb ?/H5Yרd4+[zxrɚO69 m0$tɔDQjuDžCp*Z-ɲawwGO`YG@.A<[ b @NA|},EYt#hn@@!yRy[,2;`9 xd\o$u8lfz s]dV1hhq/&`daGL&P/e9'zY,q(5T/c0yr` )%E̡(CTtEϏ(-W|BQZZɓ4~ v}55u ԬYoLj GZӛG_U5mĥ=TWbϞcۡӦ/3kclְ'ߖĜգl9WdMd X:XDh0X6R 5|VD/5686ݖjb5r)9 p[AQjU0X!p&'`D#?fx@Qf#2^LikXld$!Vsr{;ug>3w-aA+A`J!~0"9`/rKBI)1HHdlJ@I KJ+E`$BT (;ЙқUtY(J(cRJI |Y#QB" c D"@µaDEz!R %bh-g!kV0 xxl {AZd-xY(G<#Q~ 0&ckTǰLZ8sBfZlIGatA2O'8iP|'"sVZ60p >q|.բWaçM^"Audt[T12 A`X?ܭ]0N)SMqqŀtȆի_gguCIRp\N5*ڬVYO{FPȬ ޿{ģLhuSo&hPt!<|N>\|A02O=8]p.-[QssfmH)O-_%}9dMdcHZcµt%%M5 da "%B@HR! YHCH@x0. Of{YH $QM Ĺʴ6 A+F0(i!&FBႍ4}I $  r %gIG#ZvI ?2/O6mHo@;O4lٻhZա3=Vd]v::]F?f)1YO6// $3; ))7 ><5uS"? E1/{hc ˛z5Ec#w6TKn HY6 ̄# qx6juR0D"l6C4L~Dlq)1l^.@ nJ%9..I+CHSr_R" 9D H/FR dRpGē I ;'7N 9y>cJ+ _TiË{;n\aS(k䃵* %M!a8>PK8z#b~4Y5YO M! u^0sۉ΋f` 1~0(yq҃gfDc{UЁMI"AD$nr1PQQ`N ""E P$#VΝy]ws|]]TU+u*VǮ߱"=("RޠC"S\(a>T(A0r{)Ah8 H!@RvzxAJX~d: >;\B}C`݋K#xzow71G$a"x'I䔁^fVUCCp+B3g͡rv)` -80  ?cibny~|fbjn 痖'"f BE65R><LX.//A,./A>?}h=? ;ˌO?@24sc4 4+d_00==?5S[] X?[x"$7ŋeFKUu(Ub+p_Fwā 8Eqa+(,vᗯ+k[ڻ״uT7=ikd456U3ꛚk-u ]͵OZ 5@VF5-:ۛZ;kMu-'] ']Y,` }nH[dVM53d5&mf{XމIשmӚ3 ?084Cx"'l_!C8W3g>O)2uA1Lvd 3TlYy?S>^PP7ݘ1TgJW}K^SCV5#dm !e QKu+3kOpDg89U:7o:6cs%%)T@ !aVQv;ivtX&qt~&7{s_}"nO18$wpx<9~=NN3:!3e={R&kóB΋~1E%\ɼe+W_e\;{=M_nU>y'ᢊ{'7pP^z,^9_GYQͪTVwܪ=XGc0z5e4ZZ5?Yh{qtWrwSg*_x[C_+3ߤ3]aM?mErsdoݣ/LM邙? ]^^X\YڷlR(I?} B\n<{2 T ,$$萶JYH[گߦNCQ~ҤJm tuj8! ڔMt: twlu5 3Zb`Մͤe[Y% :oVll 89;;^v wj&9,`stXtՎ4O:L #6s_r܏]_+vHIH~kнj{O:`t`cJ!iGrm?vm1t |FkfISSfٜ~M8q{.aQY0ZdJ]+'vSb8D Pcd[gRυw|I>Op} wBoz`[\QuxZ֋m5o{z_迲swt|kNXЧ/_Fb'HMs aK:q ԁ!~s4A0@#4D!)b)4B"3O(1G=Ct ;ig+&3Fa1?pNB<>C%?rzpvprUqrTnms{+8'AY" /MSUBI-k.KyI JwY˵[:u++ )tڐNa^[vIYFwݖzÄ{LfMIfV,Xl=eA1 zmwgO(ݿI$K@G8B)WQ ə{m\:li鱙'N?[x+9_|*۵7\}MF%Jj~RUO:&6Ί^g/!?Y~~M}866q:im~⡕GH@ W+8 ,F~E)BP7P>od`b* +M¾e`/apɸy|~Bwg7W47/w/ @!7u‹"Ebt wI5$q)Ni̤d5TU}vm8~oS)-1mM:g77324"[nk35wȷ6Iw88Rvʃ3k' ]"%5P,(*cxjZ)M1#; vċ'LݣwzㇼR,H˃f~Jƹs#s^/rԍ/jM.!r{VTΫ;`onjVlomCvt^jԃ|&+\KWj)ƽ}}H׆c?}g/_Fu&cg‘ēɤ S'fL^<+[\(_,q.,{05_Zq8(8O."< XGe! r,jlK^L"%,Ɛ,;Rt|\P\ʦ2= 3t2+fxdg6͂8ɐ Kdȃ6xi.1l+LCBL OlݔV6#*,EňŔ X۱X2(~)]``bb HRے J^D z G^9b /N@Femའ} gfySڼ AE$"ɗI?v[9aςm>PosE&KA n u?حzײyI&懤>oYWTx` QTܶ5!"me^@Q@R$n~P(!zMݾFQ=?!RMUfՈsL$Yzf1T|9.&Uް4xnbW\cLx7%Ed ,bHA!C%3= ɀʕL6e|&%St,JG*ni)ue账z<,Şݿ-}m,CsӡWx nrf $ ^lZ..@o|:Y~W=w+5(|:dWYI`@X% 4ʀeW<Htӡ p~?%PҮT'ܣfd&g/ʇn^eݾm8js(Q!j?(*˹!~\99|jN+4R)H#L&DEK`ϴ˕t86[b yue٣RAi¼St憇Z JJ2Ю%Xz!_jXεlvhj --tdݛa羇ՔeeXnߨm^DD"KKKJT*c~rr,OBOZ+5 TRW )f2jL L'j*PI$hY z84"aj[zwZ;e%mքՒ2&CҠ>kDjȽ/ϞcW=/t!٪7l wx#ɇ,,m4~22pd܉ ϯXo\2޽)sKV:rUo}ۜ# 2uP8rCh',W{~@3_LENL5$RD!k 1[Yţx, f98kM"KE=gmڑ{7'.\g?y?O_{|7v:qr1ՙSF f'X#W9o\6ܾ&rA8m9f Mi92|jzkOjU?ohϛ_~cdS[>u(9x:p@/n8GnKͪ[Yޢm(GB#bá[mʳW cheѲ#Vİ=KU񲥲E9dEs0CMTOQHCzY%+PDhCrBHX! l*#s]AŒÞ2V+@ڎH٬SE`e-ʲmjRJy<5#d%ó󁙹lpfnul`=^]:tSG?jOٹxpӚKaES,YhX!ta=]_q㶄˾]7wS<ޅVoLǣ1~ԯ*@@5}/龼ǫ2n{mϹY-ﰁ@fE8lpgΘכZCLgL`j/X-y%'5Jti)\w*KƝeA޸ؒD$ 2LGK3tVhj`nBDhW+o۠tj)RPkb VPŗ@Q,a3gҀhBV4Z)8YJ~0I(̈́  ޼ 3r]Ӛq@@Y @ 0C]o[q)K њ8vwy !:W==Y=O8 ;:LW._1^9{n3O;rTs?>p`jޱwyc׽냯/Og|}#W|+Hu\] g,Bd $( m=m]-cbpâ8Z am$ݶߩֱG;vZ zrb0㉞t]Umc)JˊX ?!ҵg62zg=FE!YrnOփȸ6GdCYAoAM%L g``SD:SA4BZ}LgJ,P Rp~1ovCsKȐ}-Ϯ_ ^^8?^8qr؇#tb{o3ޜk7_y#zq׻c'Oދ/n2D+4<:zdPOP0c8OP~H-EAb4Khu @ZRHK(I7;KY8l2[QJeEQ=%k <I2S]EFU d(^7rZ&]M&QR8>>́CbQGx];FvQQtݵk荝w֎_űt?q?rW.8s0~a|ȅcF/ a46ыHƠ86qit 𙞁S=';5766-VWWV̗dMf$%'ď DEE   jkmmAzu ~x,m."f(n hLkC# Lsg! 3؏"X0E8{._=7vZڥ򙒒\s2#e<-i4%a8!vp@L@TdOXhohHOH0?:;}з ;"p,^3Ha֓5J+O$Rj)f`pFaw/˽irc2)P!vvO!;<:< MG;ǯXl8›L'a3;>چ)$HVӣG_=Ew>͇OPP1|?73>gPRhMFo?C>(ށ*><_|_ΡƄʎ'獹vCFtEg^뛼44 48zq`D2ytOvt<ى]Nt_7xxsZ]ӑcM es%sEP1'ssƲ2G2GS&Ӓ'GcFA8 >1DOHЋ6u<>j:HƻU9]Udpmv&X$FքԻk]H厮.Ŏ.EΘ *J*2eSlnUC2<TN:8S[h"̷'س74N^_h4çXhݮzMؠӇIqy)Z.5)Z7X=t>F)+|9s3?8s%psj&'/OL@վ86ѱ#g]<7plOΞ]:A'ZZOlkoAyHCR}&8BcZ_wk| Om@԰V[nfzrb27o"'{<3s4=}45u89q()a(!sȈ00O+eWУ/j8\H\.W1PӋe.D 챑̨#PW@m+m+llml@69Vֹ6yvvENN%.6;'{@#z 0^h*i:*%3+UD89g[$zjv/-M|B/}N߽{G^x.riwal0:\LQS>{/Di}uOK75!*o084Q}@vB>.fsXlEtzD.#+n२;]K\B\klK, ++|KkLyVmUUmK=+\NL  l{xDj#)%%))>!&6Ժ֥b;|[lkTxP cWUqQ @,1T^z۳g0O/7fwE7ߏV˧O|Ek?aGtT:z kGQ0 > [#_>FS޿kwGwN=vڱk7ͻ9'8' db@c>>Lp˓@QdZmjuJUJyr RebeBEhRUťꪣ5 EE˥sɌl s<5 4pBr?5}Q`g_pPoP`w'"QWg@7xuN UdV :i^BvUѠ,vtͳ,up̬L,ͬ,msm@@c ޵DRjn؅ѨZ;"&uu e,eVIi8RҏRvpa;KN!/Md`IoclovTԽ.hI7hH ʋqk?~&ȉF&}>'x"=f®]>}(~{bwE;M'%ֿ@DwVBo<7vuե4^4='Vω.dcjE_is>h.p6`&#g* HJpjhfƸϑᬌ#UKسm}1̑Ѹđ؄Ch@?h;;}[}E"o/Hmm~A/x]ŭVN!HJdhGkXZ&J/œ \ TU$j=& KJZLM;K"sUokm?eVWxDYISI)pT9,HsL4YyL @*GR"o%I}&'7=~mK$)?/W4=&~iii###[yy灟 ׯ_VVVΜ99~[]_6?@0::lYT&6޾Qsq# Bas1MAUb埾227 w*]GU#Kd$\wH䤈xR;@Di LT,~]Sc*+0T䉸D6^[H䷆VebLQT﷔VzzU|3l60 SZZ977ښ>_`+6 ?؝~'N`@)zR|if1 w>v\tQ`f.L͝97>uUv.0mmZsZC#yD JMruRUbeby%b2gf ɉԬѤԡC }1aam]''YSyC))ᝑQ@igHx_`GP(=0/ǯE,nMwASeհNj(*2H6 9*X+(> Iub>Gg£"u{s{^J$+MWR`,'"-,29i NTSEP+Ih n;Ua.KU&U U|vʅWP SmTWKٽgNc hŘX|ŋkjj ~xhx<T__خXh\'O3o%FӛWܻn ^ |g/^=A ѧytW]|,(Avґ닫W/.^;?1}vtȄ>݅~hS#H8gJM Ή /0Ϲs:`*'pRp"r068<y,#()0:ɨȁ쌥(t= `8:UVof/QG':˅ j:e7u j-RCs(Z7J5\I K]@+Dt]cQQKInej5wFSMr7*MBm$IZ 8tS*w* 4E G7yY'IT* pBWcepe()SQ٫_OS-@K=@{WF^;_-PCGUV,Ő;qszʝ3']TĒ0[pBDjzzzۣi|922ݻ&xX,be}◹yjSWP}8+B9Z$ y=t_͛}.r鋷7.Mϭvݜ_.:4~cv!Z:N6o^ZS\UTYP^ /++)& g J & sFs22SRzz>& ֻWAuA<6=,h!/7*˽[Q@( M Sh:*B#jIs5Djt*|sK+j3(*" ՐjfwaOwtٻ}W+F(GPuQ9 mB,Ir eMIzTqw* 5wpUpާWjj.hD/Rg^]T8I.IIs`/_[kk[Z|r7/}g_= Y|W?QZZmzS=z;wW~–~Exe:6P05s?ݻ/qiRh4߸_rؙ9vљK4x}~cG'o-97|sf~dOSN7_Z,[./Y*/\,+X(͟/.+*-,++JKn펊1 @w!qLj&=Cz#{ƒ&c:9z]iٌ6Tƨ3$Dr%:j<3J&O*/tv>˜a", vCl>HKK lTsL&N HRЈB2PA@,EA$ݩ+zVA4PqpOCQVٷ+^[3tVcRf7|y=0g񆇐߿}G?棠?o %|-Fw?|v=ZP bϳ?~}t} Mn0ׯ/?|ީ _}rڃS^[iq@]ji;38|mrfvmxC5G!//.|(YyY#iC)iɘDGA 2.h幷plNS@"BCE!=~VN!֒a BWVSžSMc+LٰS<\\B}}F8l;2 ''2sB}+qW9$YV(>JrlUSs>@f{B ڣG9pRrRrRNȝJa^2['O$_si֟_@P?z_rO~nyݓGS7VE3۰ë7M,̗—(]甊88N_>{~/޿|E_= FlX!v +ij9u槵SPMXmǪ&:wnd ~ő]=kUg푊قLTndvxfXF JLLHK="OxdWHxgpRyz{MLn]OcUSi$r+:>Xmy 7yiWRK%ѥűɾű ZJ6+\z%}YoPkIdF:/uuͶ?4beᡢDغ id"$(R |r=4|iAw0Bw?7RsO>=jUtK9/C@6:¹ mM祮\{y?/xn*&84*? <@ql^_Y<__Ekퟡ!D;>~NRX<[`G<db' oyR0L844|w@_j=JLO-G $H?< }/L NԶ˓A%51 ˪WK* 'Zw956 HHKKMIINNB;|vEv4o`rXא!t ]vExB CoײhgC3d]M=:qC9ؖ۔[![ؚۘJ,A@iߵ™P/JN?,g'[~ HSv[vlsE@)+Y7YKeyʢՌӊ׉O#LC%rZݩt+M-Mk,kG82!pϗ/?2TBpb4g*3%f$Y>zVl ]}"kw`+O޼8Y2,ջ/߾׻~8xj3oBw}߾_{}m BrOh'.>{3g]XXzpbSN!qB@";?ޞMgny/SY@XZhj"āؤ3=0'˯Up3hVI J\\ll- l{Dp)hfCUeKXle*4ݐI)O G2G:[t2<~;:ϑȈ\`?X}5FSQUv4%Q^q?}MA'@NUV)/X8( o' s Fa] U]*gVAqB¨ ܨ|XcnTeiPekZb^lbu@>f*+`C"Apln,[gGY Ěƛmhaks^# mʽ~7XOHm K1>EVY(ӆ#kGWV? m˷ R@Փg[l:Fz:ܹ_Μԩ/^\Zz~zmfVql 3;XttfMgfMIcc㐅EwGtG`wVG ۽֍|*]`n%Evy6 FIf.6h)P.(ͳ,./)43-05)*27)43*43caن0J m̊,J-ʝ*\+\ J]ELFtx,EpB9 45%2U^,r"+iKp$LUF!'Qݕ*ʞwz Q^D{"U3Ыhtoqkrijsnwtt8;[XUXT:-+H%D\qAQDK%CL̼rPhrRZsع.bo>˷3>W޽x5O#>|e8{ZW^K XoQF6dvr9Ԕ>{틍YOb#}m贱1MR:RSh։'_\dK= u\O;:DugXYΕ3Yi)фà `ܡC⁦؞Ý!hO`B#la Z:խʅX/DmmruR,,s3lls6Kcaebon^jmSbichg`PbfRdbTdjXhb*035A-5/v,u.wW!"Ҙ~чBBn>{lb(ME$#aGɭxi,IQXEÞ2Pj*L9Y@QCIYꥦ{ Dff;C*l*+L*L 7;t)Aak!8aK žl]Cճ]țn?}lECB#CU}@v@Vbi{HDZXͦy%3=Ss]xo>8'D>}vq# bm^G(ݘ/z{N^WKԔ>~FGvȹk`=ɓhúKg/͞?5:|lXoѮGZZV떪J g S3Ɠ'SBPltlDLXߡH4E6xx mi: u!W]m -l mmkiGjDՅJ._zJ˷DsMr BC"#lm<}B#E{P'_\xOHFk#E1}Q=a-!M>^"hD,~=  8+m\k4!3*$VW _Ƙc܇1!bLy3fsI.4!M e}y-41܅_NuUⅹ3&GO=qX[RMRUBy\Qln6m49 D;*ġÇbc"B{#A}aaݡaA;M^MB&G@gcFZHw-r(vs,uȷN32L4K020ЇzJAޱ++98yy&Yzٺ9zz`j1 yP3[W;İƪɾަTncQH'-'HZ~o/wq @UPpC<LN /GPTpnJ2$)7MA ܥ kZ}aQQyゴv+Tdҍti@|uu]?`c'1!}<; ɔwڏ;]qg=<ͳ(t4G#OfX$9=HB3?ynw}ĭJD 5jewX!Þ16[`>{p+^<ȏ/俔RggN>wOP_~^~Xnzp:ҫ`OyՕ KΎ<3wxGZKZ}ꕊ‚ܬ䤩ɸCу}a!=!=~A vfozwïahJ"ҙPn\¾Ȣܦơ:(=}HK~LeInjebcbmhkikhgf LllKmm- K7vnvرYJEZ ps`MQq`_$QSdsU8Ϟ]| 4)z丒;8$Eެ.oNtposF)qi6)M{f|8 ApĴ(`Y_V9c,4e/ 8c-,h9qHCjMjeJIJQJ^bf|jLBdlÃQȾО``@= #r VqLv%QF-s%9Z9ۖ뙀[~)IFqZ( [8 zC)lc, 4-TZi:zQV9F斕f6w$$t^J67PqPНĬsRi*P128E VPb+(Tj .@o߮ ? 5sVHI!XC |Rdq҆)6eN`)m҃1-b3?K%v\X/xs^YO;{֝9eNI3Le'NS3VG+*\ bW{5D$rYiqa^A$̓IZZ@xQ^i+i7`p¡p],]E (۾^ "E ]W iR EⓃS88esWU.NAmXcнf.}QsUK$}#CV`G~?=˃όtteC߾?;6'A;OZ]6pqj=]N5m9R8-/eϤ$э474+__oO㍦۹ \ ά(b%&2<,ؼҶ%8j$#x#UVd&TW, |3LM:&Yz&z&zzFF1zޢYc11nR.۷!Il*#*# HReer80OMD |wE@[CcNu1<9ySZ}Z) jl͚md.S/uEQQPrg{sAs>Y_ޜޟLoړ 5-dO SHyT$?|ZycȰ q&v %@T/ wGjZ6ֱ=dU

SL]uwc+ꖿbO?pׯ}꫇_?|"?{$ zzS;vkyxKϑsC;Ovlm8Z_j}IR~RNĥر1h\x%߯w?Q7 ,jhg1Tz5PF*&!k&Rk;Hh1tyC](%cd\CedXgh8`emX9ȵ|ljʥ*Jr9n2v1BeЄ%7T؝Mh>9PyJ8 #`t`Qʥ).cǜq@K^EoM<<lp>]n?CvCz^S@4V!1hY=_Otg~K_7݄+<'ӏ߽@i)=ncw`sKGqGn93'txsݑJKE(/de`F表00R4ְ#D}}|D"8jl6u,v-QCUQ%`x|G+MJ:Y&jj$h k} ]UyրJ c4]|#\]+V.+CX?CF[ߧs J@Ӈ''E?y9z'XӗM^f;%#'>}2=u~lc[CGTZ71&F3H0`?|}:EvQx0"۳K2Y54zRAvC8e[Z!JM-0J cLԇt)n|-AN_sM- s-,cr'BJRKe|?8m @'˼e49Y]^./UƁxJ @u@ePe.];TD*"e_%o5%{\|Gm@bGSq!uiF tkm;z]m EN TEr'R7W]A j:1y Qz,@4g. \Έ-$۔ \=@NPKCZf82|0{<DelRx)+lG7oH)%{yP.]]~ZAMehJGFN 9|~rꙓ=I!"HE!(u#8;[Z@QjZ6A*tvurȱ1J!CO>@a6t4i R4 ^J?dd-2l MSKxrc9.bI鑌L&?m BGI&CNVVP)T*;1>JJjJ*@)hWAIm2tF+L5L75)2j7q 83Hc, 7 ;ygoRP>}-zPIѿf:ATick[78`lOg~8@2F7{y=KǪ?PzEQw'}`>uދ;wlL%v?wym KgNZmjXGFXZ4[;9r :=1F|f5 ýN(:όO*##,hUUkrdR4PM/|{OU+6p00JxtLc~;Ghvl8@ K YYrTUL7?~KUU򝫼4}2EE@nLg)s*pQ`G| =T*grԔ*JeE.̕ȕQ Y %?DTjNY^^~QEeB[ð>ň< "t4+~yo 3d2 y}:Oq飺qi (ItL,K">dHac17,iyePhEcl殬e !kѹ 5'8jh/)={ąSVSϟGz/cC_GObhJ^{ڟnte({Dgj=_(/.F'܄ĆI}Vw!PD˔6=PZVmf[[=P (20Jcjye$H[)2҄m۠)Zv~&-uO_oP>h\d`{ڀjjmUGAh-qrgegaU`nU`fFM,t//ؿ_Hܱ(S*- ˏ?ڊ;s*r'_d/!2䦌/*+ЕJl%E2*JPp*Q_eȲdd,{P* 55U/+N/'; -f-.6=!7u0SEHXTңN@ޗ7DȜfADj'; }Ln0]qwf'93^iO?y}5g.dHMTTTPWmP^n0=  p(X0tve$#V;2 v"pҷϟⱌx MuzWO\G: 9xbK}NWT۽ MO?t81!?,+$ ?|f@Z}By(D=?+Y 7)6{QYTh&ݛL3 Yv]Dqe32Ze%/IC8d C%`hD, !x.Q{%Q^<(>124Yy7FbtIߕ/D:Y3w8tjyEEM'|A9Ĥ X=Yp] 8bz}^BC|Ćw .F&lpݻy-tVuw($t08xxp\`HPhPSgBΆG[ClO#lJ\EPh)#DX[&[ P]z2wg:h ;I%J-P{obJAH'߾?qyb1/ν7n> BplΑ@r=T]Gm=ړ;<+,m r7x}<>D'*D==*=. )Bީαji$wÖ 5ۍgn[U (utȺJ0eR:Y'h_ׯ/oOPp$*:1T"U{;&b] *.Ji) D)Jb 4 AQy΀P7™O©#Ǿ Ag#.]8[wXuPl@AcˀRW;1<p;vvD>95& <z2&ԣ5Vn7r<:nOA+ãͽXXqIǣOF 9<|."|dȹ !׶'>)]`S2W+za}~!#t-,,TFUp:" ~ 8[ҹ)T<m<}( P B):^=޾MgJC' :tZWֶs  !ݙu83`rxT\ghj$Ϋ{zr=y he ; QsZBE * ِ(_|ݔvVC nIQ䥀R(M2]œ$7I,3ZWk-N=H( NDKph9t]Sy(HNѲ*,%TWkjOdGwh)fv㧷sи'.)8Ȣ;lP;6]n`(\7tIz)<~ﬢ@^o@3Rb/'^L_? ۯ+hxyJH>~21dB31gc#D^q>:RJȩX[q13=HUu,d|>Vo4F (MԵ$ٴD8 N )aTLу= g@2G YhˀcCw9|tluͱYzR'$쏉 nDo@3QgEGG=j !_+v$sc}nCtnMݮva9^/;ZGgR :r&1\zi7rιgӊEqh ?hv=q|:|bO% %$IK=t.9\R qc.Ɔ$_N-EMEK# q?01Z :ɺɺf780:0&d̽|/)E+HhI|J?>~|4XKW/<<~o`u}MgjTU8-'5e\<:޾8Я ^ήܹf/DK\KQϐ"[@ʮĎ\lk/4o h n2mnq2UFIf V͒mq*\Tpy3E-2+MeVYJ奩rLEE(&yX<GQW8):9}xŔ PꡭAQW_4k+T#K NM _cGn] N^6 1C,a6(| >{19ٞr}׶Fˊ+˟Ap>rF=|$6G䩠K0Uim%j[>~ OmPA >)EFKg==h/(E+0ݣG@ QKR4w!齶Ɔ55`9uhkƁ䮸8>,Lr{~&]8ʢ=jJ'= ;44-5ZQ<^WukzvEDuGĶ5@ mB&O!'R.l~aiꅔ b.$D_N qek;"4 yX[FT7 R]i|ꡈ!m\Svz}~syr҃ \=phtDy@ឣ9;zwl=-@ZRG|LkdƠoj>yp9fx g[=)qc֡aC5Rjf"w6izFٛ*iM̶Ga`lV.4,_AA '-Uk'-a/'e݄^0H`xOU GAGM5D@]q^D%*) !ʚ| ]FU׏]By t%:4ua|NǓs g9=\Q)ӰK}g~:mA=tpph7;߇;uPɨЙwx/JJ$,Q35z /R:(}7>q(CG?~Q1Փ{/{cWЄ?ul}񲒁z2gON茍nP**wn%BS!:2 F ' QHwqpcHy`E;7l4Esm,6m%ie%]0r@)(OP2@EE(>p2:(/c[&%q dF(|OpDO"xc!8o"G P&~xoi4CS4_!IжQS2|%z4mFgf"UsV3 nuc:[q2w'wX0h!7 ݩ= =4zCCMpSQ#w.Ⱦ[ICxsӶƧ[o{~r =-,#,jNA~o5+;ۿۯhh$Z.mO?<>lLŤ؈ 7w{>/_/%MIQ5 \)B$4*y/F/}=Amw]`:}g_ UkNk0}?pAH t"&H'4-E #q[5qm䑙WS)+#Cx+) !@r 8 R xxUM;Iy{ h;:W)5;?'15#;X@)tF(`DX!aW#t < 7 嘫c 9a8CQNy2qO >6}cGݼ=-o~yWDW};[ڛG SA]|BŠvzv¯Kq!#Vn΍IN  9|.)zvɑ bJU IkŔFEY5AGrڢ2M>Y)p~7@O(}ի.^|0|C5ܼodu@qA_nv_f@jĞPQ9*  Vh&^FuEMTZZB(pv#;v=QRvh]e/UyMUZ 63V$bqX*9^Vim}/Ŕvwh^Zv02/doD [(T;nv\HN`?P:~&%nqYő8-QW&H{iZkm-}qYSsw8x8ᵯ;(YR@tx yr(}zgoGspn}`t]ɪceGsv$)7.pdv/A |~V9Ӂ 2e`b0!m!Ean Qb~&J)V8,SQWc TuW bR2QJQ/(g$)Д[Vne]eJhAq$L :#EH>KW Kb1㢁>Sމ¼9QţfQ*$1Dq:dBD(bJڠ'sЛ3s!:Zr4 z;+'ŻUubJ_v4AƟuޞGuP>ikzu 5h|Bw@p!@((NwvlK=y&:DxdKi2S#$w&)$}4zyz jX~4ՒvjWyRт(܍ɩ7ѯo_{9;J_t[C'oC}v_˩ښJ :=PBX?Fw-r}9w4ׁ݉RjB;>AѢ ͊E~pcikiho`Rt9Y#O+]ܱ|T |ʐ)Qa8ɵI}*-e: 6(X^n',+( t%"$9Jj< DuF"IO}Ax+; Q">bZ܋;v%d&P rꥬ(M`&\{ h)dM䳻Jj~txR*~iM.Rz@MM5|D*Jl؟iWDDk0bS5ḗRgZ#ީαDQE*N揁="d6:֮̕^Bl"SAa 4UAPꡡթ4_E @EOEGYҵr+`WWaW˷`$ў4YJZb6RNXE[KpSQw%PJ.xJ7 }F&~~FgEyl~]i7/BG~hַo羼NM28ss:b H1.pO*.oIK㦚MO;㏶{uimnS%J-ZVؓE^JKJJz{%_75o_^  >zxm ?y AK^nu ɞm)qQMa! =I ~^˫BrؓK]v;8C]w[ b,^( Ԭ [vl4ɷ&st24D:de )I "UjJ\U%.MPSSUN(Xʬ l=AHIjZ]܄pQ5TmW$_$RQ~ve+L:cG6*A )´ZQS %bm5{(pefG(ΝfCLζ((vtA~=9fZܭIs0{82>hX]XcӦZRJDW ԥ64M47=kj?=)ꋈS =~^'#.g$_H  @?v612Hv弒4S;XK44A] 4:}=kFtʾ185p{J%J|=[pOߌ?yx;2B=!ćoee'IZ*faTJϧPswP!}SJM׋HD*Zd$G5QSql,#:! lrT%u --8w[R+7ɯ2"JˮT0"Jjtu"|'ib/?+Lf3ƆMm:vއ3 ys!̅L󷴬J8gm$Өl6shgWO5Jh}ͬW(Qb2[!oQ7^-}4r?8~ʛs.|̈́Vzہ'%.mD(o^+LH??0<>iA_>>x'".&G  Szq+M74<}SƦ0 UT^3bY^DxU)[Сw}u;7|J3>eZl(E1]{JR<}-leyi zyxhٖA%`vQkYٱQBɴ!{)+{君MlBυ0?FJ2~Gڲ' cj.c"DS֜a;|Z_y \J? ?D=e@)[Q >{1FPƭ-(zhx(nu$lqah'm "?tD OIx76r ;(y|C;3BtIG^OkhG_e]C &.͕`P`ae顪hjbea0"5Ft =N.Pn7JANTTq@ejmfBq;;x"TA,.7as*(OU`Q`aVr[%8EGe5 &k&Fo5z6_E]EMUuU7D>O D˜3o&{ʉO.Z%PO"(/"XkWaM#8A6sbRDH1wv)$tGJAN&Q,R (oQ Im<@p {:*׏y,o(2(-Z^ sx 4Xg#P>a}:Oi `f܊D ]mͱEJ^2?Pҋ'N޽ty-d_>y4;i]Y/ۛfCe'ꚻ ӷEfo\ήm;84Jm =t,~M@M}U=í[BTIY&6:؉cݞ|}CBz7 |0Tr(ze)R@ey U  w,IZnRvD E]I o)zrW*̬j -"  xoM-L=E{KbDXt7-hє(D"g3_EW J}ZfrmprsbwFBF"қѷ3҇{ұ|?R:\#蓶&1O5>ݷekǽҪc#⺂Z};mނvSG=p>>dDQ@`D oVdZ8c5xD]MƖ)ɉ@? FK﹛UF6B7 _t~7J#(ճã7nRϯ_}}md˻ٷ^{ãO/]~tzMZw?UQٖQuhGVw*:_e뼼2T ;Ӏ"s%QD+u5*s>smt r'j%ͭ%a:R8) G䯯ZU"Ӥɒr[dL jJvDX =4P #fGR2\:?hP㓃"!:7uezIބp̋@?w.]_D!ֿ7xIZuk{cstrE9u=__S:ZwIc'm?RNXG gfIJAK{C[|@Hݹ(f<t؇{׽/GL@͢ʭ4nP Zg|#ff'E;q REJ;yQ{?w2Xױ;&n߸7|_pýW>zCe=;vߞՖ :/}/U@V0Y.t&B̪Lk 9}ͺi`pllB4Ht) _襮  #,/ ZꩥQWH/pGK 'g#NBQZqV%6 8Im2CxhPFaj^WEZVY[sfZvϯ PN}A1e~F.* r1͊Y~D? '_t2NPq'<}zD7"oED{2|R (-y\ UCESeXS#I]Įv6i3ݝbGG@EJo*ʴrtǓQP@iu6a&ĝf;eUޑk֘]>r 7 ER4&ئPE >}{/o'>1;w^`'o sӟ?{6N{3q. w?r(;tn̓Gu]o8]Vћ}x@/{^Bԝ(c+ ' {Jkr}^sbK+|[<;]6v6Mڒ9wƵ,94 +•s'`D4=^y(Qk-UrHkW[ibr2* 65DUשHZx9魮l-/UI1WK7n^gᷪ@E#)C,Pn Vd{GpNxt%!TDi⭬T;['jQdI"(z1P)/xR[@XОono.7f7>:ōz:;&81%_ݹnI=bJX-6^Ou_L@mM)GN-Dc>ψ}EJ(ӌta^DGO7&^ _ko~:I?gG"nDžNxo[3x'qQޣ=UU5u5 u'Z10z=(}uĵbJoubCي*DAΤM?n Sε.{rm;d:Z98m/sp"S<[/`YVNFAQL@]Gh*"Mr&,`3t\/I˗D⫩80Sv2+J {=F]znFMɍf8uez*?#-S!x|q^=O <(VYyM͋/575[@e]݋5Au>(x\^t1+hxhox~/z-nV:Íærf B]':IB6R77k/4LKh)3$Ւj#K<\TD)G3ӳSTI7Qsk<{6'u扛.Ie =OtrWnY`2;JK޻qӧ3>L{n|'K>~(}8PzcDI))u!m>R+.lk3Z\Fw,9QvQ{k^¬sf6:صL^za$])r\qt zT}T55tCH!Z5-ndgm=_u .OrX./qM hFUfk6ܴ c-֯.J+r8uo#uLL$NKhFoS:wCJw-_PNNzXd9ϻ˻Ͽ$x#>vZmw2̼nnDžOFK++ǫQ]BW^r=bE]G   bJRS+ž x+/(<5~y[Ŕ{Q64u:.~MY8*Q Zi)P:6nh )拱1o(FEϝ=8xKmgkA?5=.uG`cx09n-l\\Ju.8Q!\T ʪ*`M}"!KWdx:$e*H GI-PM'DK/T(D0PG=OY@tZS߄ '_>+v8u>>|Q72nȸ3Zy;nɹ[wa)%Օb?P.I자okUWxX>. ;x{,fNujuiqnvjڶҳ1#)w"7R#N)&N($ŇIUll0j#>t^GOVDha P ޏJAKo!J/>QT8^\cmOM^}\FK^O43{љZ٩ęRkβ!iHJXKUǠ&xBj*l Ik++1pX44DV*+*/P %ijꨄjXESJ[J_/**74ssI[/+ݱI&.lٚ_ 75$'?9x^,,=D׋LNNe^Ë_f&bO0xoA85s ?rܿTfE='3=D z]HjHz_-UΤZ׆&؛'-ksYLGT(󍽻2cCE,2/fK.Q zuon?.qϾ3rj騰#>GB?=6r^I.Pzr}hPu_Wj|KRdu?FÐ4yą,[[{:V=~\ꇂrne$ǟ J={n]ڊ)1ФЀ[[PuH6KW1ƖkB4֝NɯCBv(wNJ}^@k#;O7 ѓƆZ|!X~ҙ4+PVzKrT_+RwM_HS"Lg캟~U2]j-ErRvh8)h:*5dI62VRꖒZf*i_tpm&HX)8(*A RXg h]# cEg\2/r vC|˗/ylwݹu_2ݻpx={ĉl6ʕ+ !!!_vsc 萉虩Og{B. 7hJ =H.T9bW͠:$YGGt&dpuTAQr.6@l7;|<j0V7K -U2fg\ߚr11dDHכ;JPRl{hvX.|8C|D=T\ktOxpw wpwww*pwB;Ƚ}wfZ{UN"Z{S7rr`0ܶBOHJBJ\Ll">xzPćd҃I.oN>\_^~@T'Ʒx;ڕZZ[Yef0O rCٹnZ?sS9?.08>CΉWCH[D؆UȚEЂϔǐGKKC ${\T,P2HL7jIq%~OJWR?H|#,1 [IoԂȚsNt7^`nWhB Oxs*pv Mͭ  "!!شTƆ?qoo?M٣,y8xDˈŅeZ-Dznv-%&go4TeX}*LO M [+-,*XDSHP 琧K= eafdfߢݨڠPwJhsGQ̴0WLQ#QJ`܆Ǝs~rINPUnO(jگUWtf#cBt*U:@ (LojnhicC?<{6~2FAbV*.zn5z^ zQYs.Ek05% yi}qMOaUw%w~9gn'.){IVQ F!c:C^*a VaKv+Bf,yx 88yhqs EH)='+3͟9(/F*3ZxxH .N(T}3iceae{dssۣ# '''@+]__\[[[߂K[hNvv]pp98HK{\\pX0\VПZ߮+lmA smM5_ /1STNcaKƒڪ©設/)_gೡ>3A>~nPi#zR4Pov67'ގٞR(/$ogA6 5bW&chOcĿm *>GJ/)͗#Zj*:[c՞n%v6&Z&5 u~fxFF#&9-)\>J!R;#I)V:\8@ZKDō_ޅG։KځS–M)-%.2SzKfAv;.q;n1b\b"Z,LE%hyIxp9^p> &!$""&$}#L;fAGHAHVB}xWhS9RW#= ?:ޟ\\kvq~biߎnοˋ燧] 7P?>R/&l0> ߽ M9g_娰ذ݊y^6U}yXX_UVV\࠱snn]98Kެ*d}NM-[MI^O\M }}݆,fFH#=Nzr*NҏytL4|sD^na-=# Ev!b*"[![I1_V 7rVmoՖmו֕noVnedf|-H*.L[OK^KJXMHXOy :@4Gi"UJ͚ru*U "UJS:Mv AwdwV~;FNK {[&(YpiTM=gfs2"CX==Ft-B CJ #rAM|I}bYcr1wmajy)^KS˵Յn^bYMM~j{؅[ Tt{pn؋]m5{KҢHxxBd\b|5p]77SUՕ# f&1jk;ےro? qOEv3id^Jm_rbxzljdר䘍̄⌵ʜꂯ҆ʽ­Ҽ⬍l`yki+)qKQ.<831`i0Tn֑iSQT+WPՔiWm53~M/2wbrXE]85aUlӴ > i .0! )BRh2)D){w)}ڞ ]Y\<<<98?\zSZؚ\\S#HLtJM MJa2ԬI1gYTeggtE7z8٥XDk*z+)***z:5 b"FɥH)OA,> 09\y<E\&weQJȬoFgJkBgJ"GGe`¬Oϐ)؇e,-qRc.|.)tvosstPZY؈@hyϙ}s}:95 Y/,315@ۏOrew7Sx  ] ^ߊIJJINO$P=%ke%dQ;8jE~^m^uNEFI׼/9 _V3ҖfcBcCC>~nN[MLa,ժ/ި R&\-hdf>쾚20Ag6:w^z; k6Z+f6{fqvE6hf.'@s{}"-B&'>9 a G'J>|::;:JfWG;9-5p 7';h9̴&R3Vryvei s%CA qZ:j>何e=ed$E, 9xXtY4Uh8٥I8$ 9% 9H89ٕٔX(ePyGV5[π(>#W0W5gQ`(j-ho/C!C'-eFAS t\w}~ryy]H)ȳt*)+ixǶFO 7W`ȨPG'[g{mOOWkk3<Ӌ5B:α[s#L ŐȰĄՔԯ9PESyvuVmAK`mOv؄,,]/^/_-^Y\̀Ef'-g~N t sv h {ixi``VR-F⍆&HK5$Lsl*q>Xd,_㨑o)-FgHKLmJeE+`NG_B󅻧aH(-vjn;$ htiu"0!tcIQaNhH\xXkqQ8>:bkgi%^?8pN  [ 5?m${UzۇA^t#N;[P@oUT}-,Y/([/((* JKʲ?gMLt DwUQA ``ͱ MxL a%j-Sq6 gU쪊 M4WJ1dpp`1"aQ{rcP}M%.f/ui{r _K`Pzsq6>3WRNKm usYj993sάYC6ϕfvyÒU|qsWPUPSPWtTvW02afe21b%{/MB+N@%K!B x'}M #~ X{2ȅ~ Q%0&t-(9E]<ݷ4/lcu ؅F3Їolu ?bA8^no422<߉-G'%9;UYꔚh&[( }xF_DLUx&j{IXY II9;(JYJ~ffddbfa!yC O//E_=Ps*ɗ %qU$U!&Qx=?+ ]ܚ9k~-/tb?DqI̓旅۰6Mna?`{pQz~ԇ~t\Au'@˃=26|trn3CÞG[#*,ӣ_+)_֋ ]'rmG-z3MҌD`Iz=iC9E_j|j׫V}\2a)惉}qZ(et|G *R=B.l llnj$;pNYC栈tRGz MsJ$2 iʝX7/q'M4-˰xskP1ZX &:zaw+L >:WJooW>=0(8;\?X[24팏oL* Z -4R-`@~RC &*5ZWF#aƭMǡAˣ,b-i)$m)*f" ͫ*"("$ȫNŮD,G@%L3|qO'|AFL̥B&J)F+F ʤ*F.R'3 g {(0,BD=ո|=;~؋^kk;J1;ܟCleMֱصsBtk3TToOnEN=v,֮!w R#POuk[ja\F\DLXqG*2R+U $ז"HEɡ2:31YJ]2$Di)d8"J)+7F+N;N;^3V ,N'F ?#%Rx𓊽qj1Cuv0:[VOPϹVi40ZOVD8GC0UM^9jHP01hЩPHk[9J^/cooUep=JżGJIۧŖ͕gΠ!ۛ+_,o.vuB *+0-!!UN%zJs*H=qEwqY9 8:ōUm$Mit?C+H"f,f,,<:?hTg`W1a2ԧ"cW!z/V93B$ 0Ke'R"WcWg521QT$Q%%F,+cZs^z#=<_ `cgrv=޻];`lcgO󣫵|/]# 5L\ αk󝛇 _CGNNg3h^K+BBAiquQ]>7 Ay= .NoϠu]\m^9"n6:q$d8B S@EH{ ۳UPJ2|qD(X=[!)%4np역ޭ zeu#/>U><_^Dp[FJ)IMAJ'GJ jL ˍtJ,#u$d߿`EWCφ[ɔ^֔R€_S QsJLL̚$,ZT:\:4 oU) JH#igy)BP 8+A/D)x9qި2ˑ%~iLLjN;؃s; $pl'{Pk6nՋCQsd9 LwAw؋v#EǦsCi^ߜBsNد#=^ 39~n``(ILl{2[SVTn/n/GtHe J!SyQ|d.d2# ̍JhE'rt%t&r5G"b?Dq5qa$1)2])ݩʽi}Z:12d$5t*\4bu=\uоSI.l<0j_BwW=i:ttšԂ4f5typ|Bp) C7'Xaflp}zwrsP9912SW3X-u+27+6463)W V Y8>FEJ*'HQ &&0-|FMB`L Z:8ZIT_(<{{- NMN]RUP 3)$(,Mgtx4xTx$84dxo߾ a6(=1A >~.OaNG~fɾ* l~'+#؛#/# #5po Kܞh{}8wZpHe{PbHFw,*Y@PTVQݪQ*Q@t+f7% by9؛"[c՞S -pq̶33-46.7,RS'!@"KO Ά/%F,!G"L)F-J/O&3fLY_qȽVP!R' 2b1aV4eU6fUfēdEZ?0#ycM3)5359 !19[R;{VieoN7C} m>.7OqcQ!a>ө)~iAّ8PTZTMtPkVɫ$Pg {z=9Sq!xbwՖVgZdڑe>o1gܓܟ|T3G~A]Y<0n1kl1m0GXtWw;5[dDA&Y[%[V2>-Y.Օ/LA&  ZgtvD#~2/6wfF{FdXbptpqx6Mg_ "T̍5ϑ<."cmˋS_\=uR U]IGTY|[EQ}eZ*[pcs{~yv}=3915ƌdac]SmŘLMrMt?%'%W%$T QUQSzLNIE/A#N#J%L.@N*[MFuw ĿH ;Y_kVVW@ohAKcNCm@BC@lIǤEH.]\uvaw`=Suk h~cdzϳf331>5:0ԛۗ?;)'q>?i,c<=|*'r,u,fy7i&+  +mu'xJ}DoL77F$ DhA^ONw^sR_IOvik.4nP@%יؖ ŏNo ̉IG%ԇW3G#RD;KպT2Б%JHAH$bDu>O{&6;!HPL*?S_2VqP h-sc˅1&ْPߗGE; aobN6 6/S zssu#֖w_)|s$b`iz dk_6'7FGCe阸:|f䙘XSe#"U~gHM_PPPW+e4_)QPzD */ /S\1)R*kw4铒RSSR>51{lIaBGoYo?[ c7ߞ@}3s gcؙښOĄa$ )wf3x #vKMG{bOviT'muo p}z}\_B#G?t~HԿCjfdhŅO_-MEqѝQ9fiZiƦp!q )U uHtHɠ1$z$$OE69)!!1Ym\ ·joU _)=#3$4 0'% ##r$EP? ݾ:22 {^a?N Ɔ4:Æ>n7D$|44䢡Sٱ KUyKuKMeOȊ̃O$Q|wxps 5[Rme ^[RݚT;Uӛnӟe9g:X`ܟ۝ؚ֑*7d3 ԘMGK#AhO~C-cm.G[z1y,tlytH@:"V9R>#^7M+E` dAdOOTo &E=Vȝ~8Sy"WΗ3B ,  osdwbGy8237r6ډXR T S9#B  ŻBܨ p\UG0xRDKmy갷'7'A~ۻ; MgWʼno>:=<؏BE||`vk_" ~(?#:TZ`ae`oX``dAEgDAIHCFjDGNS JB 'ɞ췓7#Rc H u 4ީ#~cDaJGlFGlD>[krR3b7oED~H\aN/Nn`>1!fPx~mwC9LELVB&"ҢK3+[0 7[Okձ!f2r>i頵ql*m4b4hү?_h=PlWbWb]l)G:!^ !S_F§;?b|mn56%&mYZM) - =Yj*m1by.uXt%td[0%ʏ/;I?Mz U;A ):'$ ww,+-l[`u֬ 4ʶ{ E}*/] ޗ;V`8M=Lҙ΅/4pRtIͰ[˴̈؈腥_ vK@)`hepanozr:U[ݗorv*647(21-JTVQ9߽"!֡ 'J)ȁPR<f+2rCB'3 "{gL.8'7$Z@gP'\h@BkJzr}ȫg2=TigdppxAC <`C^!>C#caYq9q˳ 35=%s} @ѯOa좺v;;{ȪưZ:ϑ:z&ױ6q4@HXddP kݭpi؞]U$^'ԑ"ޗؙ&ۑ(Rd`*&I'If(SΖmO>!Yce+py_\^ٍΎœ}9s9}#cM{TJJTǯNIHLfor_V%87p`PU<UBBRl\RPdT OǍ緗gFK>L/QsM]Ȱw2{bk#2 +kWv/ttjx@y-2hB7?EH`f ɤROQbCbb#"bc"KƜ،d$&4TV &L\o^]/B5g 8<:|wBz=h'w'QAO>On/.o`p(x_T@wLpVHQ@IpM^gyfyJWCc7g]}m똪/…T玄ބ=1s=z#b'~J3)wm:uy8v/d#sSFXUh' b*s|QbDLT[HO|/;&E:A%B) ~=iBW|Blklk2@i3c-}m1y%ޞ’̔ֆў^e†^M顋5qR?c84!⨃ӕz&T.<'ݟc왳 ؇}6**ܢoh4$"u1?C%=wҥ隢ͽϻS[#ڡDhHc1P |iIE)%.!5zdʸ8RKQ@#0=%-PO>R#2r]bR`$$f$ $%"#1!wae4"'RymDo¨H'ILhmp~u{pzvo'8|c}R?Q`>c^}=]7{S@@oWwg@JPv\WVT_q $9/ܣ!+f}sn0@n~dcka}zgv~gb}pglcLLǼͅõݥҝE3+)h 4iƸ!UlV)\ܑ#XNӑ*NfS$Ok`e[hGT?W2͒8Ւ ]0ǎ0ȑƃX&QtH'w)u{#W {%k/YʼnĜIᩈ XG"q❱ퟧYX.u" /ɑ6،>+@7\>`wGЄS rNwON./.=A+.(}\n.WlmOO ~lmkn .s/γ0ҩxTAAgرTDRNCAh'LFjCF $ j3e&EDCd~=;:|Jnkc}=RQaو;9( p6lllqrwq{ >za Ң&s2#R*RC>W/u֯t6mc:w0M{M5#UcSU{ջsʷJ6 ?o,n-o/ %DNw~4>b?b]Qǃ)O਎GFҤ:hhF5G4G:ѥ( R̉9vTlu, 7qDI"!.5*].),`h Pi ~0f>w1g,3XƝ؁</YY?dc]i0]=y[Znd {w|{e,(+oAdA?z RO';u%E[뻟>nN?8R^֓ ptfX'kk穁gLMe@Mp(}_}098Rh|+ O !~&ddTTDĦd$6f,b2ԔQPsCsk{ڡyRaau*N?pÞNnζO qqo݆=#3)39qCiamAEC)U-%;] k-5Oތ/KKiK+c éGRG>}IJ ktBWY5؎:5Z/:RgɗdoI⮏amalyǘ:&= bOdRZy4G 7 #dRa"m}>"OvOV'zO@$E۰ߴn:e3h7.UlGfKOyv3a?fZ}2eAkubL C3d'N fgv:z*z7onLu0X?\Rғ trfT%yfFG D9=`UADhHIa;GE(}B^x OF))99ԎBԉƌFOP$%d(^_=}@~Xsuwy{#"´icݱn~innf`5ddswv0y%FLŇΤF &2B;Ӄʃks% 3QcUcm3h C&PAC0aSСVfzӆ\< 4;se*Ùk#YXZc9:8q"X苼h-p Vr*797 tɢ"B|9Ѳ,hHp-d=WP E)tooT6 11 +ϔ0e՛8yzu}v S8>>>~*0رh MY^׉-YY-aa>.@=$U_x]D(%&>%rQp c|yh\8>0Q8鍩)-Wdd4ށoA5"`yRe{d{z ;[ꚣ>Fh{yZ_lkp8YOx:} pvq M:OK{Ag>G'~W؀x@3ӎ0ׁ`XWlEBMLqxnՆjZjJrXouO ĺ.AX:78 #[LtShۋ図Ey*%YUa^5AX$<'g:VJ>jxz;"$ёR2hw^Pw@OY.!h2h7vg DlհSITғ+e\ #B7iϋ(2,+\y"{_+{u[_7:!wJ+n JkKV!_::yQfDЂ:>h9 ګ| DZӇˇӫ"### n""\`vt7.;vj&-.s}..+~;'^Gs鐇se(Э?0;S?=Sҗ:PT>0Vd3XleSn Rr~\s8x0x4|4r HnNRGG3^ & k~N *ǽ9`%PJ90jl[@p{υ]^ߵZ?臔 ASQɱӷѲdV|Bw<λI\zHK^qs|(HHšz+pIdE~ %<,!ۙ!?'}u`RHJJ/A oo+w[1alB0DQc|7ȳי 5F@H݇0180(0? 18Ez2c=XT\Ҡɢ@^+W`;g͵K]f}'n|yuV7&l'o jN4WE|I͐,6|:-U%Ru '@^OX17G>3Z8i \LI@3^o3m6LG pBl!E Z:pRE}Z,ўx;FzQngCuOxq~3}O<_6Ol4 m`дpʃyHZ &~iY_J '1/*B u4\Dܸ)#!}]JS˗@H^M"EB %tY"Ң`/Xi+.|Ӻn/uԛI& +ۇ[iϝ@9f5O#;CX68 Æ>p~?Gà3?}u?My3H)/x< !FP|l{G(GvH?k ͉2Q=P#/i:FPTXZ E~dPDAg8j$iD]L HITLKhן1/6k aTK% =Q(_g_Ju&[6 ms:l!31Ztzw:5FJM/回*7=oyQt(68^(ƳJ!ҍQ2a!q;}3[O#җ>}p~pskwmp6:Gw{fCR ;J֖k@ぁF@)+5̈ !̽ VK @]r T+JHs~ 9'PQ_F=$/ىuPfon,/}mx{PGGFVY=<}+[=5ӄ1(1Mсc80(q`0,zf!o"H)נÀˠX_"=N|HOo@H;/Ņ`Npwe J|&aSJϙŎ.l2^PvH `K_a\I V.aTuUKRh\Ե`͙bhi^7hfK5:ZS]U^(Di: n[㽦aCy8XMZAerq J.3hV?ͽ{{ P[Y҇Lo1Z{hu RnF@r =LvvDTו|d=$!9}@)$%EN'=PH_]plsTz6b/^l 贼hg&Ԥa``kE-h49~!@+˞hN407w"}G|]~_p7uƂ9 3īo)V f2TQJx0:…0Yʓ#嚃7bmqbyg3sz99ӭ(z k ?bCP0<~o[#3g96Hrelmؑ}& 3ƈfӟɄ(,GJof00-Fon|åLox8t$Ӥ\T ?{3T/2(C|HU6@wD>@eX;Q?]3R/Y&:k L<+֙fW壡Suz5^I FJR50(7|)_mZa?z$s. 5_H(GEg9)S \;{PH7fHancwP=@tsc})ܟz 7}sR B;8^y7ry{|jٜNM) DYXq>JJ ~r>2>~W%aWRXYi,@ġ ~^8sƁ bYXs.c䀙8LCYul9ֽ!}azXsRXdITidTT/Nǫ=\xeCvb+V)#V'\&V v'L17=m)2()1ge@XhݞH=z~oq/ٴ7ԜN2"*鞵5؆3Ҥ!Իכܤ|:X0 fUyg 3famI'Ui̐£;+ne*ͥ \mC =xvbvfx VU`ln]G`$vxSobQ7Ԯ[%Flkd]tћflmi Eki\ /#+!)BqUDCh(H)1@)%8KbWрa i^\uQvF,u~Xw/C;[WUPQ_{**sQ.BvnWҋ#gSA~CX!8 6M(e;X 85j\rl)T;n6u:q*i<̅2DB!uXtP}ޔ7YLrNs.*,+-t()q.v*uS`2 Qh!JQ9 dMn'Uk8xl#~DОfG|vGD{Ȇ}F}&=8N/ɪ%@B& xJgI1 MŹnW!!f6I a߯H_;^άhjjW"L}:<#Bi}}}ssSJtwtP-:jPNwf8ܱ[Ѻ켉⒡\JdT2T*ښlbRW)**؂ zДK\FJ^!y )!C-%,+F\4|,I I>^ЌƝ ~ba #rd;700@6 AM/=֢ԠHagLk6Aqԥ:9R >f|+^̀D_*ܸ iڋ9qCvX^XtLADP+'ng4e ˖aΰO3%P"]D( ,d$,#~H)?b4fDITKF-JO$ A_AQ?Ѵhև5AutPM$AF^-NJq8Qc4l'RARyXa6Vw6Ī~jD#! &&LLLkkky^/qcc&|2n3{յ3 Cґ`becSBz2L^.# BHIcddqREeU0.b% ."Q * sk(j{x.'07-T hxK8Sm׭~?O64C1Msb3thSs0h4QvխoWiiBTX8>+Xm$h&i)g2m"c4ΝKvd`,H~-XaΜHxɴ,dpK ?ݕl͈6FPôZI71 pp݁Xd$ RLl,;~=xى}=`I2f9oo0adVOO*};U[(4[[R5nfݎ&sX..p>3AmYoR~B3IBz*j[ypp Y[Z'KJJDBQ=Sw9?Gh]!J?QrOU,6VS2~nHNAUPgcRWEk!o\G()#d22(YA^-q# E^2^F #$~/'1T[)KW,m&RQpvlmܸ`{oSX q Q %bA/ƞaca" Q;-Уf#pY"jrwZ鴙S{ fqQrL.̥ve^t3b' vnx~3p Gb\ìD NNuoD+6dd83Vu8d6~e,r,j,ÎjKfZEY0#`M&,)kX 8ps†{:G0j6ϩRSeqn"J4\wG~ 2h2&aUeJ`I炭W?P  @82ӻE OpSH;|%DHĵkijoMV fd g9d(h41j1וQJ(9,@4X^!DA #Fnи @I_ JP-B,f?[>ͫvO~h\խ5k[=.*qup9f뻇<~)&##$8'G&HI2f>p+0D|]ݬ:jew^DGrݸK=3ijݤ 6&8`u0l6Aqa11B{1L2B$934A'\хd8~. & EsFSivcIV#6vXI>)x3ΌVCQaNJiAmN7iЧXu[s]\!CxâR~V.h=kJ&&Ƨ&$$tvv|xfycc ~nݺ%#Utٳg333)KKK<~uR Ȣ(4:A/.oh.-+Hd&y{gJc-B Z8 UuZQ#/%*ʇ*Ʉ(\  ,{ CIadPRngϸ^8b.sgT EvG "E0D08!Dx UgR*lYrRhh#OGXd_"ݎ YO`y~n,OFzSvgJ+"_ļH骃 Ҵꐟcxu'Y'Z+L - 㐌f=+ |KÝ0{.ʅuvuvhґ`p1/̘SB d8[@,;p8ڊk3k ㍨H}ژƒDZ YlG`shw-OΠ5LcWh(珂>vKvskEB9vZJ~qٛI( h{kC4Y8>>؈FTjqqqUUU^^^LLLZZ`5666::6== ZZF|655d^P1DY}}*Gd?zҚ=V8Q]LIs*;B1eq&D NY $((vM6\Ix%LA$ DU +q-q ! *!pkK$=vz =6nlA3Ɖ~poUڃiCJ@f_/?)2П$P4 #LB[QawȋaI,l0elVk.w:+QU04Jg'ʳdIRmQg¾# hI^F_J7Z8( ?ȅ92|Yv0[iv?ܢ7Fp1zlVBN  ZG;p&` G#ewa^̨iB[E "mxp[h=hI5{Zujhh7֭7զ8YQԅc!?;ȩ`Ԭ<^f8#!jzx. aaaȆ5558n~~ϯH,+>>ill )--uvvoD")= xغ II7a.ٮN.qV&!z@H׉$UPkdU(U(U(2xWB%Rbrϸ_ZO^.u_K3ԞK>"8 `gpI5{{[ބ`%xZA#ذahp9h43F虈٨HRD|aăyjUc-_bu9ә|] FEn\P6+zk4)jd]bG-} P٩@!yD̎nb6rgLفFL>?@Mv[ L@9) kŌ4g{-D; lVKŀlьmgʴ0vtiq@XSϙnTؘ䔧^KliC%ܛn_\C߿244ɓ @f޽ba@2wwwuqq އ8,_:ҽw@ۛ[ЗHXY) zr{)-R,RK @iAF IZ"@4BT)BQR~p*t&~}s \כ{[ 4["%n{М<`+!i[X] s`#߱`"> ?BOIs$@)8p'ЩðN1@jncF+-ge\N^]X9KJIz8$6%ۋ:?8lt?Ԡ9MaVvxa>2cҽ5n]>AeBpyE95ϊer5w6flFQPS=nVJ{INc&cGٙoyշ l,/(]]UeE:|>~pnnwuu߂}#O"zc]av=nmm׻47NRWm>Gpӡ8u;;FjEԤjRL4(B>toBC@T`bb}'c;?}zrZzYyb#JO (<۷Eom&BO%WE)b߱~b G'l|x ]r 9Rw%ՠ.EN QQQZJrѪQj)F %sgJJ4=dd~۝v5ttDU YxieeMd޾~#:б(݇(c}y,=ȇy }gIlRtRt\ F#B#C#nD 'JG0AOaR9Jjʶ3Fs\^mkէjJvn)該kGKRo JY/9y x$~'ޗchA}9U0LF]zg-6KAsעjwY2u(`iwAP Q}V#s.[^W+@; 1IĊ&fl9,<:zp,-6+'dp 8!Qjh)Q)oNp+?9:--(}79*6ʱ;=ƑFz1zF1걺*1Zb4JJUr>$]q"Mc@Emlrn^TtwA}<_zuy/{++mޖ/=8v< 'c0Y|l!7174y7.^|ݸ襈`DxvTm n*7e(5)*O<NVZ3Iu E^C78vxz\G tLҗ௻P_~EHΏ2oͅ16N"l҃74b0ǃ|Ѿ db<~>-j>=a>%u1)^r万Iňq<wvŦG4RI Hh_ r>Ȱ[הuy ]:*XuZ>'UNڅI+7Os4v?^\wiiu9mm}< `z{3\Ut{[-fB8BR-i?>>'^W~oA 3EFqCI/th 5yv|޻[#ڻ2 Z4Qʫ hh~'L'")J2+RV?~'xGZzS|K\ow!ojnhaojkhjh`Nx!H^~MIOMOkj: 9; %8 x|t ;sW)sqvf ad`1;`gii2x1u{4ul{uV:tK ns Z4S4h6rfyڰ}E*:[H O~K<E9^_ғo5MK*ؕWk֝[,>48kkCc@^~ca=lskuiiqzfad?>p87ܻw͛7?yD \&'N)lWa,o5 P ZٻfZfĪ\KUri7I@W^Loo{uΝ@8,x.q)))d2ۋ?& voUr0E6*h ,&?,κ_q/vv|Zȸ^d@gcXYp][rOx^/^y_ Þf7=K.1ko7{4d V9J ) ո/¿B ^ҟYgXijس_ 2&.zVT'1AS'ɀ餏=Bkkoiwsv32g8YӜ,{XNlha|(ߍ!=H _!O$?)6=82 ^n0udbL t #4J``;[XXE Y***pt_JUU!Ɗr BTwqga`k=ke51Nsvp14I7H12 (I]q;vU,#GnZv8cwB?<OC]s\L|TT kkk޽&#ư3qa/rS~N!1o 3ӣPy aNhZƪhKX \Y)o}ihjK}DT:::R(k/t2##Hsܶ6p[VV*?a0իWpA2T,j%%禠27Ao Te=e$/CCNO_#LA~0_TDy-,--۷'II9I8{Jg+ [(c2q@ F p4,%; f ($0---qqqY T^ ѣG{ς|>`!xd@,=PCcG^ӱp%60@8)i\(~{s_\Tug j,Z:Dozo߮4$g1)8u5gtCl~ wH!fL%G,enL{PYv4α>u*DFavgv7Q{RjނyUjvCG8,+OܨўVcW}+]ŏGKRJSm  x_V!PT*/ij}1)H1*F?Tm8b"VҰ*B!g<ƣ&FBBoLJ fBǠIۡ؇obÞƇ$8&tO1Ri+p n:4alhig_[=8g"?1n]z[۟L˷x(vbb@Fo6;;{}z`E~)[) /###HF_ ~A={{Pu{ý'O/~yс6..X} zX[2o2|uS8gπ > D㌍ݺuD'A8/'p t/M.;Ei/hM˟6խ1hH_-ZCǹ#aS $yv-z3vvo #WeRSoQg3jgUR)6T* (Hj5k>jBc3zgORПRP3(efjb`$n!nyă*p')sOsf|N!;ez쏩F~7ruz76FLWkyOnE!lo:vm SWEqtEPd]!W{CN̜}4$z'x+ hVDpwD3kk?:Pj&ww)_?[=:X'22|=?=>Zџb>@_ ̰hɁYN,+Rb+\&J~~x;фIU͋#E>̈^g00O-ҠQOBUT:mF]V6c-pڈn?F8шapډÓ-g/ '2m7ѝM"!-zdVJ|DJ_z#d2Qlo쬯ln,mC^w](agso{mg{M/*{@KOJ;>dgf,@P gh)TEo0b'"$L bsbwƘSyfC״慼;ojf$qIUḻ4:lyz@LɮԄ^^x6߄]bM6 Su(1*՘K5؋d V-J '5Kϯn[w.3#.Hiċ՞l :׌>WySUùR6N0'xzKcKik,}6WrX%0 /\TPTVR׾F5w2ry:Ɛp;;6L`h:++#45zb=;JHEyt}Xw{~XcH_L\ ]({";7w|} uSTEhGW/^%"HR0b /4((މnmA{(~wJdrlVT\t)6Rn)I[f>)~!!vFxRe.wnӝR{E5wE;O@e+G8| ѮY%DΤؐ{?fNeD˟WE8XSQKكŹO MFw"JbKRkW}nw.ӨUQRW,SQQPTWvFRT/S!ߤ}jke̶4vaqP~(GdXBBM]OͽF_ _iaΕp^/K~@)!4D!R ٩mh{sY wb^M~{jX+PRMG㺲eOb)HBWhz fFwٵMJ:x 4֑STRLV *%^n(4]{`\d>+C*5}wsE5>jCֻ8Z'سH8#tZ*dMtZm,MTk5T 5ML[z-; hvfk6ff=V#NSsA;фוA\(|M ]iR \b fD#o'zi׿UWV*sH,@NWKf&,;ۑ%FIq"j* =ID`QS),b ?pqڀ2aM +Yxp{okpWAF S~?O:?<_.pySonŇʎόNx\W7> ߗI-qBݣYR͞J͖\rbͦ|2+zz9<%;_We2hm0dUkUyr+Z Z\}*;ņKffڈg1_ĝ$]}ilIo:%g.k:j|iĂxQ{\}ah(NFeߕd>JRb|Ll8q>͉}4JwsEJǤyW.K\ L{؂ҫˌʫ-A-s.зY_"l˟?_l}rm ޗbw<:?\ZQ7nחg' ćOe&Ԕ75H0ƚR\NTJ0.v$&eK{9s!䤸!$!dKo&0` h5Z(@ӝSj|V-GsjD'~xlieI͓0=Q!}1!1 ~JhFL^JQJEb[rW# TUII:p5+Ecad{t-&ԥ5K*|-RoXٿJE}Y˦sg'^)Dz{K ^/>*s+뿈W?{!ݺ"~W%9:=BG(Apt6=z!;u!/{7]-6(͒W`hRvVy~GJ"cѕ˕(BnVיjGsx: Q  k'$b?9dA,B3==Eʢx @p49qgg:ؚ$2,ہoݝ;i%$Y]$bHHgFpbC $:܍yL"Mia ݼ^QΏBݿTfp"Sp.|IuAw~91zogԜԅ% Zn˝ɯR$fܙKj'|Xrw":J|ި z):&pOm^CXTbI\E|Mn#bčg\gi%{d}2ێ'/USmXnL8+؇x<976|8ȁTbCVp.oK\Cw.--MNNP!x̍Xnmm!t:YXYY쬫p8H9L֦\BUup^xOXS!,gDŽQAñ͈[K/ɜCuEl1`ܗI{m;  ߥyۏXۆުy+hˤרE3~ͼX:u\yW;w'dՑF[;=şs?x)jeoQFg<_6}tmWu%ϛ?tAgUVV7l5lu4u6nUe Gxa-"[/ŊJK w;Z;- vײ[ܨ,H x~.OKBmU:8GKOH )-->g\\kjj 񞞞~~~SSS׮]cXSSS[[[Օ>'<^{j(y y国Fͦ/U_ŤՖ^KK9f^]^ȾؖylyWE׻PIy}-Rs%r, y%roW|7/U75%6{ '\E|EfCnsVcNs^{.c15K\?0;(.Dv =dy/ELÁՂ/W͕&2S0_'A8~V'?K)@=H46(వNihh 0>>h?<FtZC0Lee࠻;6;;;,, \Q\\ N@CCC@E|A:xգ0b|LDoD@HhP08`"Y<$>Ƕ]CUUIZ.5R]:n#t0[蚕䩔ajD'Ѱi*8E~x yω4(laRÅ@{jRuH@Ҁ)OI__aHtX|RzJvrqRmbS|klk\ Z"c pgv(B[So`˽kE+{3|w:% U}BÞߐʯ6F)(Dtwk3`ib_ͳI[(+huCձm$PjGG #<=-{MoS-p-OLvv ZQ}N2d6I{Ύ*]3E)Tly ??gju /Nc?fϔ+ UCxE/J wt;a Q  e 8ܴfS?^_,6TM;[ܙ1ނ~ x`fOi -@)w\ܷz1+~ t&&YU7 3>|(ïz؝t+|/e~ ̍Uw5]d%O"[*myf|":5pgѭ|G4q  mUIz [e{~#g==R*el,WUn N&[1$T\FO?JPzKUpu=aù##}q,7ω~WC߳0AOadrn`j$gl检ۂ^M -O*=o]C9ݨ %%.؄eG5b BeFunEnm1wy8|wHwcMF䴯ދ^D-Un5kHT5"3dD&;VښD ⬉`]8̩u2tyͣb,^d񁝑~ _={T,44ML4֏44QII)rEwꏂp-gR!W#jk(^>ӱq\OWi }(37Sh*0{JYomWrV& 3P- R>ɶVhZ%}D\f~1Zo`sVu&C:ZmzomN͇ ^zSfr6k.zՠY *CJ"p LLyllO;΄hn60h~jbOBLy"AUp8r_1>*؟O BبbP r.2ٹ{rd"Jr;DA*Bsp}TCnx7Ћn򰇱3I +c$5v)qfhj0QY5S/O'zޯpUi鳏n^*~^ۻE˥nAr{P70^K\ QK#A:Wl)$1ێh]-K̈ u:&-VA(?fB';u@JOS Ǖڵefa^;?PIvzze"q4}ElFLCJJ]zkC )9@h͋ dz?ϚhcJu!:ƅ_>MmTJw&7Z[e.%baE(VX4Y8Z6]j >)p7O(vعƼmBP!2*SʠId:^_RV\=-yifVPM?b;Cѡ^5%ahg{OarE~tT?36ᶾ]^TO7{z֘-6sܽ$/pnxם2&y ?4m`̄yvOx~)_ySiKdnhZDzLvLnD~(wlQаQ02z7p0bkBK$:w"y*UPЗ/Ve5.aʗ[*jW;T>rB>[D!xd:c߼VT[:W585;uw0ymhu(ҏ \R[KFWi@>:-MA{]vt[lrJ66& v"-vf 3ڹ֊:xQXzpLPנ+ÁhA4&=ژfc2q*k ܗ(l)6g ¤[k=c}rnb~Onn*ds ptg1M3QzU!~s @=Tf!R2)QA1aCQaX;k_B/dz=Ȟv4/^?w "O/ʞCW4V/7˘~fpǴCÐp\ ꆅr@?2 \oP7 jr`H38U pi]NmR0sͥSeqCA~?'c3)ܨ˜jcJwB6ZEޅd2HU,67DzD+bHޖ%3 *wYERdscLbV{͂/pKRdlN755UT|>:^)dp@*6@Wh!V99ͩew'_~Lh3GvxBv4m|ޘa qąN261SҍR,R ԨnBĸ~\x L0$RI}[lB'+[8B]v[fc,*c.7m<5F|g ?%?",qO(|o7~x0684Rv 1U쮍-BۊHK^*\} SRHlmɗKs3SR0 l`h5 S177ظsNNNPaaaVVVww7@ittKKKRRؙG%ZVVJ ^CU!:hKkj{/;#,|*>z2& XRLZM&Xݧ<=qBc3ᔍ80iQoEqRS9̕m_9ܯP 8\hA|Tgo)n0%N e,TWYK)+93<W~wk ym'ߛaBHy(! \ZT(//66UKErZZ'khO*[YܟL x\2F3P Пeee111`?88F&MLLDj"ؐ O3e8uP)a5mm @f6O mоP_v;Ӂlkc`ByfAwx D Gfϕ.U6oIDŊݢ^ 7M{$5 eHbv{Rw}[Doc ՅE ř#Qx<3#e[=fۘo}vs';,/>"jw6G4vpT LPRN'ZL#j{Mƪby^67- Pa3 F.mym9XS???p0##ۛD"%D(B,duPiHe:5EIp(T)cҧʊonl?6Ig><>ښ^N,WHaVTa\erc)p6ubIm;$N[honZvl;Zfj'k SJr's2xC1!=^0?#ȵ1㘙྾ŵyr|b#r H3ZC@Q#(8ps Hu/xaG+:J+2ޮZ\;*Ш>C)9Md2:PHqqĄmOO8 \7sŃtzž\Pd ܛ<*sr;֨\N-NwwS:B|бؑİng6 X W_g`.Gx >U4S=S.]h(]j\nYiA66obĝh|Ub]r}\UTjPQ8L.P @q0ٶ>G21X>>6a=x(?sFL!BR u4 bj :V^-eR- QRaY]{p1j^*zD\Q,@ߝ qAg(=\!,Ć5ݾPӕisC8Đ{֪}ky`gPzZ,R$D"?O+$0QnKC8xPmsu.x9;J8lؔnnΰZmCEU~}+4[t 8br$e,5Aa^'2Ԡ $׋¬؈eo )܌Q3yHZڂ`g'~6?iX[\/3{cieoeU05)11i3ÞQA#+3ɅuUv999`Rffsru}HU%uZдz݉\'s"2Ձ Sj$g(=-ӗϓH #T'iQjCcp>NOU!]o6W7AR!pRMG1"{x1q1 098,6'4ks9Ҥܸq# syc6'v\;)/A4շDP؎ ioq¤ f$;&ftb|vvV)L`{;]Yŀ=RsԷ/|"ZEƥ'P]8pDj0ۛ6P8:YF ϕK_6 0}qЩW?{U .*g(=-H?@ ώ𴶶VVV lAGEE[(>0 phXG m 'B {jHvGjPxZ8C!Z ɤaHJe%x1a!AؠѤб(^dhx~b /)nh /{HwtsM>w]+uj;@/*FUkG/BG=@JO(Gg(}NNzmNssE/Fߺu &&&55dfggbb[Za+4} o!U7@RɵA.[rF,cT hsu9ZWLbų#)ر8~BpJ 1r4=a k(#Ec&e+fpyw ijbpߎ =!sT+5z\4+~!}~⨓HJ_`pwqq(Bh\ܨ  a4QVfO"FV^GN>jQ2#MU#;Fa.4-'}eBSN͎#GfNWהNV5(D 6bȠPJcX=4DaVߓJہ8pkKC{y bO\.'p` ŋ <}R($tvv]|[ĭ8|aR 0T5xA*&tڣͣZX:>﫢=?Um] gC9. BA@uvQzv n>tDNNʥXt>"QL7W2-;;;Ēб̙ɿV;(8s ?ɹs`g_;wo=|ιn}?gg_q8n˿y:9l>c$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vl t(655 ac$$If!vh55 55 55 55 #v5 :Vly t(655 a^$$If!vh5*#v*:Vl" t 6P}*65*^$$If!vh5*#v*:Vl t 6P}*65*o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl" t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}^$$If!vh5*#v*:Vl t 6P}*65*^$$If!vh5*#v*:Vl t 6P}*65*o$$If!vh5}5~#v~#v}:Vl" t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}o$$If!vh5}5~#v~#v}:VlL t 6P}*65~5}^$$If!vh5*#v*:Vl t 6P}*65*^$$If!vh5*#v*:Vl" t 6P}*65*o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl t 6P}*65~5}o$$If!vh5}5~#v~#v}:Vl" t 6P}*65~5}Y$$If!vh5*#v*:Vl" t 6P}*65*Y$$If!vh5*#v*:Vl" t 6P}*65*$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdK $$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd}$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdI$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd!$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd%$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd{($$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd+$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdG/$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd2$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd6$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkdy9$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd<$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdE@$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdC$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdG$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdwJ$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdM$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdCQ$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdT$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55GasmkdX$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkdu[$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as$$Ifs!v h5)556565h59595{5 5 5 5 #v #v #v{#v9#vh#v6#v#v):Vl ta+65 !55C5!55Gasmkd^$$Ifl  0Aw N4"N%h(G!!!CC!!!! t0a+600004 l4as<@< NormalCJaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List4 @4 KWFooter  !.)@. KW Page Number0U@0 *I Hyperlink>*B*4@"4 rHeader  !n@3n V Table Grid7:V0_H%` 6!z !z!z!z!z!z!z!z!z! z! z! z! z! z!z!z!z!z!z!z!z!z!z!z!z!z!z!z!z!z!z!z! z!!z!"z!#z!$z!%z!&z!'z!(z!)z!*z!+z!,z!-z!.z!/z!0z!1z!2z!3z!4z!5zl, q Q(07?FNU]Be/lsq{ RmL\|yu  n0"%R, 4F4G477"8:AHbNSY%`:Z&F {  } Cd7S*l !"#$%x&$'()*+,+,-./012345023456789:;<Xefghijklmnopqz|=k, f opq0@""5"&&w),,2 37 :@BDFFGKNN QQU{WYYh_aaeeOj-l.l/lGlop r$yJyz{b}k̄#@ӊڒEZѤL@v޿TxK5fH*58CT{g(yc!FBv&)l       23kl&'    st#$M N   !!!!q"r"""G#H###F$G$O%P%%%%%%%%%%%%%%%%%%%%&&+&C&&L'M'T'`'x' (((((3))****Q+O,P,Q,R,Z,h,z,,.-/-7-J-Z--G.H.Q.^../]/^/f/s//000000G111111@2222222R3 4F4G4O4^4r44&5'5.5?5c5+66666 7H77777777777777777777777777777777777777777777777777777777777 8 888888888888888888 8!8"8#85868788898:8;8<8=8>8Q8R8d8e8i88888888888899999G9H9K9o9p9{99999999:::-:.:1:O:P:Q:R:::::::::::::::::;; ;!;7;8;I;;<<<<=z=&>B>>>>P?e??-@D@z@@@oAAAAABEBvBBBBCACC@D^DD7E[EEE@F{FFFGG>GGG8H~HHHHHHHHHHHHHHHHHHHHHHHHHHHIIIII I$I(I,I0I5I:I;I=IJIOISIXI\I`IdIiInIrIvIwIzIIIIIIIIIIIIIIIIIIIIIIIIIIIJJJJJ JJJJJJJJ#J'J(J)J/J5J:J>J?J@JDJEJMJYJ^JcJhJmJrJwJ|JJJJJJJJJJJJJJJJJJJKK KKKKKKK$K%K&K9KHKIKOKUK[K\K]K^KdKjKkKlKtK~KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKLL LLLLL%L*L/L3L6L;L@LALFLKLPLQLZLgLlLqLvL{LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLMMMMM M M M M MMMM+M,M-M4M5M6M7M8M9M:M;M8Q8R8d8e8i88888888888899999G9H9K9o9p9{99999999:::-:.:1:O:P:Q:R:::::::::::::::::;; ;!;7;8;I;;<<<<=z=&>B>>>>P?e??-@D@z@@@oAABEBvBBBBCACC@D^DD7E[EEE@F{FFFGG>GGG8H~HHHHHHHHHHHHHHHHHHHHHHHHHHHIIIII I$I(I,I0I5I:I;I=IJIOISIXI\I`IdIiInIrIvIwIzIIIIIIIIIIIIIIIIIIIIIIIIIIIJJJJJ JJJJJJJJ#J'J(J)J/J5J:J>J?J@JDJEJMJYJ^JcJhJmJrJwJ|JJJJJJJJJJJJJJJJJJJKK KKKKKKK$K%K&K9KHKIKOKUK[K\K]K^KdKjKkKlKtK~KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKLL LLLLL%L*L/L3L6L;L@LALFLKLPLQLZLgLlLqLvL{LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLMMMMM M M M M MMMM+M,M-M4M5M6M7M8M9M:M;M>>d>>>>>??G?o????@-@O@Q@@@D7KN,OOP|PQQRRR7SSITUf%f$f%` !!_B$  b6#I7*B$ }ڎ-k [|\B$@=Ԛ }Ja"B$l!C#yE95"B$sor^vEsbqS3-RW,G)(%(p"D\!D&)*)*Ux*f)+,44X=>o<* *+q,-n, +  C VA >@-TK-TQ-T:TST   C AÖ@24%w*& 9 ~RLi t "NsNZ  #%t+-279<=YAACF! GRH~K3Q3Q4NQ7N3K7 G/=B@AN=XO9H17H5G2L2M-Q)PMLM9QR vP F2 J20*%B S  ?078%`Zm]!I&<B " & D K 05'5$GL@GIU[k8Fa@m@:QQQbbkb@gOgSoYossssuvvvvv7w>wCwPwwwxxxx x)xxx~xyy{{v||+~1~^~h~ FJֆɗOZxXh5@ +$&06?juyDOEQ!#*,2>H & !(*028:DFRX_   nyjpu{!!""r"}"t$$$$4%C%&&&)&C&I&M'S'U'^'((((>)K)))****,,/-5-@-H---H.O.R.\.^/e/g/q///00001111112222224 4'4+4G4N4P4W4'5-5/5=5K5[56666e8g88899=='>4>@@.@6@@@@@@@AAB BwBBC CCCDDDDBEQEGG8HDHwIyIIIKKKKLLMMNNbNeNO%O QQQQ Q%Q&Q-Q1Q7QSSSSTTTTTTCUGUPUUUW"W&W1WWWWWWWZZk[s[w[{[[[[[R\X\g\l\p\y\\\"]$]]]:^@^D^I^g^~^^^^^^^U_]_____ `&` +-q)s)<<j$n$EEQQQRRRRScWWWW8Q8R8d8e8i88888888888899999G9H9K9o9p9{99999999:::-:.:1:O:P:Q:R:::HHHHHHHHHHHHHHIIIII I$I(I,I0I5I:I;I=IJIOISIXI\I`IdIiInIrIvIwIzIIIIIIIIIIIIIIIIIIIIIIIIIIIJJJJJ JJJJJJJJ#J'J(J)J/J5J:J>J?J@JDJEJMJYJ^JcJhJmJrJwJ|JJJJJJJJJJJJJJJJJJJKK KKKKKKK$K%K&K9KHKIKOKUK[K\K]K^KdKjKkKlKtK~KKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKKLL LLLLL%L*L/L3L6L;L@LALFLKLPLQLZLgLlLqLvL{LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLMMMMM M M M M MMMM+M,M-M4M5M6M7M8M9M:M;M4d{d9 @b> Andrea Young Andrea Young   Oh+'0l  0 < H T`hpx'Andrea YoungNormalAndrea Young540Microsoft Word 11.6.1@V@d@@,b62G"GPICTb HHb bHH0\bb                          B-kNs^NsF1F1VZNsNsF1Z=5Nscg9^JRRkZF1VRNscZco{o{kZF1F1B)JBg9cZsVF1g9kZF1VR BRg9{g9NsRo{g9^w@kZ9%))J1-k)JJRNs-k)J)J%)%)9)J-kJR%)%)9=)J5)J%)=JR55JR=9915)JR%)9w==%)%)B=51g9F19wJRJR^^     <{{ {{{{{{g6w{{{{{2{{{gw{{K{{{{9{{ {{gWBNFNBoFP1{{{8{ {{{S[VK>J{6lF{{{{M{{{{{{{{{wRcwO>N2l{[.lw{{{{{{Y{ZcNVJRc{{{{Bp[V_w>: {:,:n{2l{{{{ {{{{{{{{S{{{Zw{{{Scx[V29ww2w>{{{{{{{{{{{{T{{{{{{gZ{{BO[VcxS2[w{2LsB{{{{{w{{{{{{O{{{w{ScxcxJ._{{FN:LBw{{V9oo{JrNs>{{E{J[VkcxB*KgX{{{:.K{{w^{_{{{{D{{[4gkcxB*ks{{F"{{{{{{{{{<{{S4kk_W>&Js{{{[42l{{{{{?{{S5ok_V>&J{{{{cv:w{{{{{C{{{{{OkkW5.l*K{{WU6 {{{{{{{S{{{{{{{:_WcxFBw{{{BR{{{{{N5_kZ9{{[{{{{{{{-2.l &KV{w"ww{{{{ w{{{w{{{{{{{{M{{{{{{s.K&)*JF+]'jOwwV*)w{{{{{{{{{I{{{{w@U'enNnw{wXAJ: {{{{{{w{{S{{Q&]nQbPjqw8wZwzwzsYj{{{{{{{{{sw{X{#kb-4a8a,a AYrn{safp{{{{wQ^{{s {s^Aw+bffsV{b{({{{{j @HX]&IaXenn @4MGvfd{ fgs jZhs.{ujsQ{r{P{{{uwR{Mre{{({{{EQXah]ab H]XU4HY'n{tw/{sn{{vs j9UYMMb"zUvnnb{{{Md{{{&{b Xej YI&@YzMbjp@M%zvsff5A9^vvQr(^JsF%D9AVkrvje{.{vw1f{{{'{ZOHej jOMhrovkVfC^]^]f!A!vZ&R MB RR-RKvQERn{sj{t{twOn0wk{{{{{(wwIF]hn jOnojOEoMrfgIn9bkwkx9e% -#j1 nf^jfwuws/w vvvf%rfF=b{w^{{#f mnof-jOQEcwW4J>nBL$bfnAErnM{0{swOs0w0wsrvzR w{{w]{!{{E@rNnonof.j.UrrvIbfnwfnwuw0{s{w w rbfM{w{Y{{{b-aronqrn.f.fjd{t{sfwQw0{tw/wSwQwfz-AA^oW{{X{{{b-Ug]rnpj 8Qw.w/j@zUzvrznUb@Dw{{{w{{{V{{{EjOj.nrj QF]rvn=@{0LanOrnpeha{{{{{{c9{^{{#{{b MhnNnqj.]&Hb,IMC?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMOPQRSTUVWYZ[\]^_lRoot Entry F\TnData Ab1Table_WordDocument SummaryInformation(NDocumentSummaryInformation8XCompObjX FMicrosoft Word DocumentNB6WWord.Document.8